2/2007ח'/התשס"ז
רשומותISRAEL STATE RECORDS
June 3, 2007 התשס"ז בסיון י"ז
והמדגמים הפטנטים יומןPATENTS AND DESIGNS JOURNAL
PATENTSעמודפטנטיםPage
448Applications filedשהוגשו בקשות593Applications acceptedשקובלו בקשות803Patents grantedשניתנו פטנטים804Patents renewedשחודשו פטנטים805Patents not in forceפקעו שתוקפם פטנטים806Patents renewed for 20 yearsשנה לעשרים שחודשו פטנטים807Noticesהודעות810Corrigendaטעויות תיקוני811Country codesלמדינות קודים
iIndices of applications acceptedשקובלו לבקשות מפתחות
DESIGNSמדגמים813Designs registeredשנרשמו מדגמים825Designs renewedשחודשו מדגמים826Designs voidשבוטלו מדגמים
כלליות ידיעות
אל: לשלוח יש ומדגמים פטנטים מכתבים, מסמכים, וכו' בענייני, ירושלים4 והמדגמים, רח' הסדנא הפטנטים רשם
חול בימי לציבור פתוחה והיא , תלפיות, ירושלים4 ברח' הסדנא נמצאת הפטנטים לשכת.12:30 ו- 8:30 השעות בין מועד או שבת ערבי שאינם כל בעד שקלים2.50 של במחיר ושרטוטים פירוטים של תצלומים מספקת הפטנטים לשכתממנו. חלק או עמוד
מס' הדואר בבנק הלשכה לחשבון תשלום ידי על ורק אך מתקבלות הפטנטים ללשכת אגרות האגרה שעבורה לפעולה הבקשה עם יחד ללשכה הדואר בנק קבלת להציג . יש0-24145-2
שולמה.
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem
The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs.
The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50 per page or part thereof.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together with the application for the action for which the fee has been paid.
שמורה אלה בתקצירים היוצרים זכותמת להעתיק ישראל, אין למדינתקצירים
הפטנטים. לשכת ברשות אלא אלה
Copyright by the State of Israel. No Extracts may be published except with the permission of the Patent Office.
.Price per single issue (incl. VAT) : NIS 96.₪ 96מ.ע.מ.( )כולל בודדת חוברת מחיר: לכל
:Annual subscription (incl. VAT).₪ 1,152מ.ע.מ.( )כולל לשנה חתימה דמיNIS 1,152.
אצל: להשיג אפשר ב' הממשלה, רחוב פרסומי של ההפצה שרות, הקריה, תל-אביב.29מס'
Available at the Distribution Service of Government Publications, 29 B-Street, Hakirya, Tel-Aviv.
NOTICE UNDER SECTION 16 OF THE הפטנטים לחוק16 סעיף לפי הודעה
June 3, 2007 446 –התשס"ז בסיון י"ז
1967PATENTS LAW, 5727-1967- תשכ"ז
חדשות בקשות רשימת להלןשנקבעו הדרישות אחר הממלאות
הפטנטים, )א( לתקנות32 בתקנה:1968תשכ"ח–
In the following there are listed newApplications complying with theProvisions of rule 32(a) of the PatentRegulations, 5728-1968
לפי מובאים הבקשות פרטיזה: סדר
Particulars of the applications aregiven in the following order:
הגשתה ותאריך – הבקשה מספרשל הראשונים הסמנים וארבעה
הבינלאומי הסיווג
Number and date of application And the first four symbols of theInternational Classification
ע"י שהוצע )כפי האמצאה שםהמבקש(
Title of invention(as proposed by applicant)
Applicantהמבקש– האיגוד קדימה: מדינת דין
ומספר תאריך החוץ בקשת
Priority right: Convention country – Number and date of Foreign application
International Application Numberבינלאומית בקשה מספר
International Publication Numberבינלאומי מס' פרסום
B09B16930921/06/2005
MEFHOD FOR COLLECLION OFמוחזרים מוצרים איסוף שיטתRETURNED ARTICLES
June 3, 2007447 –התשס"ז בסיון י"ז
ROZENTAL SHUNIAשוניה רוזנטל
G01S17473703/04/2006
במכ"ם תמונה לתצוגת והתקן שיטהאולטרה פס–רחב
SYSTEM AND METHOD FOR IMAGE DISPLAY IN ULTRA-WIDEBAND RADAR
.CAMERO-TECH LTDבע"מ קמרו-טק
F41H17592925/05/2006
המותקן חום ממקור חום לסילוק מערכתבקסדה
SYSTEM FOR TRANSFERRING HEAT AWAY FROM A HELMET MOUNTED HEAT EMITTER
.ELBIT SYSTEMS LTDבע"מ מערכות אלביט
B60K17624512/06/2006
MANUAL DRIVEN CONTROLSידניים נהוג לבקרי הפעלה סוכן מנגנוןACTUATION AGENT MACHANISM
YEFIM KERETHקרת יפים
G06K17636918/06/2006
A SYSTEM & METHOD FORצילומים למניעת ושיטה מערכתPREVENTING PHOTOGRAPHY
PHOTO FREE LTDבע"מ פרי פוטו
F41H17645421/06/2006
EXPLOSIVE MATERIAL SENSITIVITYנפץ לחומר רגישות בקרתCONTROL
June 3, 2007 448 –התשס"ז בסיון י"ז
RAFAEL ARMAMENTבע"מ לחימה אמצעי לפיתוח רשות רפא"לDEVELOPMENT AUTHORITY LTD.
A23L17947324/05/2005
ודלקות בגידולים לטיפול רפואיים תכשיריםPHARMACEUTICAL PRODUCTS FOR TREATING NEOPLASTIC DISEASE AND INFLAMMATIONKGK SYNERGIZE INC.
26/05/2004
60/574487US
PCT/IB/2005/001420WO/2005/115376
G01B18005113/12/2006
קוהרנטי אופטי טווח מדCOHERENT OPTICAL RANGE FINDER USING TRANSMITTED PULSE AS LOCAL OSCILLATOR
RAFAEL ARMAMENTבע"מ לחימה אמצעי לפיתוח רשות רפא"לDEVELOPMENT AUTHORITY LTD.
F03G18005214/12/2006
DEVICE FOR GENERATING ENERGYים מגלי לאנרגיה מתקןFROM SEA WAVES
ELAZAR TAGANSKYטגנסקי אלעזר
B41J18011117/12/2006
DUAL MODE PRINTERמצבים שתי בעלת מדפסת.MATAN DIGITAL PRINTERS LTD ( בע"מ2001) דיגיטליות מדפסות מתן
C07D18011214/07/2005
June 3, 2007449 –התשס"ז בסיון י"ז
רוקחות ותכשירי דחוסות בנזאמיד תרכובותאותן המכילים
CONDENSED BENZAMIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAMEJAPAN TOBACCO INC.
15/07/2004
2004-208334JP
22/07/2004
60/590180US
28/12/2004
2004-379551JP
06/01/2005
60/641874US
28/04/2005
2005-133724JP
12/05/2005
60/680072US
PCT/JP/2005/013446WO/2006/006741
G06F18011316/06/2005
הטעון מאובטח תוכנית גוש לעידכון שיטהאבטחה מודול בתוך
METHOD FOR SECURELY UPDATING A PROGRAM BLOCK LOADED IN A SECURITY MODULENAGRACARD S.A.
17/06/2004
04102768.1EP
PCT/EP/2005/052797WO/2005/124502
A61B18011423/06/2005
SYSTEMS AND METHODS FOR SPINEשידרה עמוד לייצוב ושיטות מערכותSTABILIZATIONYALE UNIVERSITY
23/06/2004
60/581716US
31/12/2004
11/027270US
31/12/2004
11/027246US
June 3, 2007 450 –התשס"ז בסיון י"ז
31/12/2004
11/027073US
31/12/2004
11/027082US
31/12/2004
11/027245US
31/12/2004
11/027269US
31/12/2004
11/027247US
PCT/US/2005/022346WO/2006/002333
A61K18011530/06/2005
ופולימר,IX גורם של קבוצה של צמדיםלהכנתם ושיטות אותם המכילים תכשירים
A CONJUGATE OF A FACTOR IX MOIETY AND A POLYMER, COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOFNEKTAR THERAPEUTICS AL, CORPORATION
30/06/2004
60/584505US
PCT/US/2005/023745WO/2006/005058
H04B18011602/06/2005
בספקטרום חללים לאספקת שיטהאלקטרונית רשת גבי על אותות בשידור
METHOD OF OBTAINING SPECTRAL VOIDS IN THE TRANSMISSION OF SIGNALS OVER THE ELECTRIC NETWORKDISENO DE SISTEMAS EN SILICIO, S.A.
18/06/2004P200401502ES
PCT/ES/2005/000315WO/2006/000602
June 3, 2007451 –התשס"ז בסיון י"ז
H04Q18011721/06/2005
במערכת מידע והעברת אסינכרוני איתותאלחוטית תקשורת
ASYNCHRONOUS SIGNALING AND DATA DELIVERY IN A WIRELESS COMMUNICATION SYSTEMQUALCOMM INCORPORATED
21/06/2004
60/581970US
31/05/2005
60/686132US
17/06/2005
11/156176US
PCT/US/2005/022022WO/2006/002214
A61K18011805/04/2000
וממיסי דו–נתרניים, חד–מיימניים מלחיםפעילים נשאים להעברת אתנול
DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTSEMISPHERE TECHNOLOGIES, INC.
05/04/1999
60/127754US
01/03/2000
60/186143US
01/03/2000
60/186142US
21/03/2000
60/191286US
PCT/US/2000/009390WO/2000/059863
C01B18011915/06/2005
CHEMICALLY ASSISTED MILLINGכימי בסיוע סיליקות טחינתOF SILICASW.R. GRACE & CO. CONN
June 3, 2007 452 –התשס"ז בסיון י"ז
15/06/2004
60/579694US
PCT/US/2005/021156WO/2006/002085
H04L18012007/06/2005
לולאה של כוח ובקרת אמין מחיקות גילוימחיקה קצב מבוססת סגורה
ROBUST ERASURE DETECTION AND ERASURE-RATE-BASED CLOSED LOOP POWER CONTROLQUALCOMM INCORPORATED
18/06/2004
60/580819US
13/07/2004
10/890717US
PCT/US/2005/020087WO/2006/007317
H04L18012114/06/2005
ספקטרלי אומדן בעזרת זמן סנכרוןתקשורת במערכת
TIME SYNCHRONIZATION USING SPECTRAL ESTIMATION IN A COMMUNICATION SYSTEMQUALCOMM INCORPORATED
18/06/2004
60/580811US
22/12/2004
11/021694US
PCT/US/2005/021053WO/2006/009713
June 3, 2007453 –התשס"ז בסיון י"ז
H04L18012229/04/2005
מערכת עבור רדיו תקשורת פרוטוקולאלחוטית תקשורת
RADIO LINK PROTOCOLS FOR A WIRELESS COMMUNICATION SYSTEMQUALCOMM INCORPORATED
18/06/2004
60/580753US
22/12/2004
11/020410US
PCT/US/2005/014850WO/2006/007025
H04L18012314/06/2005
תקשורת מערכת עבור שדרים ריבובאותות מרובת סלולרית
MULTIPLEXING FOR A MULTI-CARRIER CELLULAR COMMUNICATION SYSTEMQUALCOMM INCORPORATED
18/06/2004
60/580810US
08/07/2004
10/887710US
PCT/US/2005/021056WO/2006/009715
H04B18012407/06/2005
על אלחוטית תקשורת במערכת כוח בקרתאורתוגונלי ריבוב ידי
POWER CONTROL FOR A WIRELESS COMMUNICATION SYSTEM UTILIZING ORTHOGONAL MULTIPLEXINGQUALCOMM INCORPORATED
18/06/2004
60/580819US
June 3, 2007 454 –התשס"ז בסיון י"ז
22/07/2004
10/897463US
PCT/US/2005/020092WO/2006/007318
C07C18012515/06/2005
METHODS FOR PRODUCINGביודיזל ליצור שיטותBIODIESELCARNEGIE MELLON UNIVERSITY
15/06/2004
10/867627US
PCT/US/2005/021173WO/2006/002087
A61B18012616/06/2005
METHOD AND APPARATUS FORבפלטה ברגים לשימור והתקן שיטהRETAINING SCREWS IN A PLATEWARSAW ORTHOPEDIC, INC.
17/06/2004
10/870026US
PCT/US/2005/021358WO/2006/009795
A61F18012715/06/2005
היגייני טמפון ליצור ושיטה היגייני טמפוןA HYGIENIC TAMPON AND A METHOD OF MANUFACTURING A HYGIENIC TAMPONJOHNSON & JOHNSON INDUSTRIAL LTDA
17/06/2004
PI0402403-6BR
PCT/BR/2005/000109WO/2005/122986
A61K18012817/06/2005
METHODS AND COMPOSITIONS FORפצעים להלחמת ותכשירים שיטותWOUND HEALING
June 3, 2007455 –התשס"ז בסיון י"ז
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
18/06/2004
10/871158US
PCT/US/2005/021477WO/2006/009853
C12Q18012907/06/2005
בתאים כרומוזומליות חריגות של זיהויזקיקי מנוזל שהתקבלו
IDENTIFYING CHROMOSOMAL ABNORMALITIES IN CELLS OBTAINED FROM FOLLICULAR FLUIDRELIANCE LIFE SCIENCES PVT. LTD.
11/06/2004
642/MUM/2004IN
PCT/IN/2005/000185WO/2005/121365
E04H18013017/06/2005
A PREFABRICATED SHELTERטרומי מחסהCRAWFORD BREWIN LTD
17/06/2004
04253627.6EP
PCT/GB/2005/002406WO/2005/124063
A01G18013117/06/2005
של לניהול הניתנות משותפות תרביות מחלות במניעת השפעה בעלי אורגניזמים
בריאות ושיפור
MANAGED CO-CULTURES OF ORGANISMS HAVING PROPHYLACTIC AND HEALTH-PROMOTING EFFECTSVEGA, GABRIEL, CHAVEZ
17/06/2004
60/580983US
PCT/US/2005/021807WO/2006/002093
June 3, 2007 456 –התשס"ז בסיון י"ז
H01L18013317/12/2006
ומערכת חשמליים מעגלים לבחינת שיטהחשמליים מעגלים לבחינת
METHOD FOR INSPECTING ELECTRICAL CIRCUITS AND A SYSTEM FOR INSPECTING ELECTRICAL CIRCUITS
.CAMTEK LTDבע"מ קמטק17/12/2005
60/749052US
C07D18013607/07/2005
שלוש – מותמרים6,4,2 פירימידינים (PI) פוספוטידילאינוסיטול כמעכבי פעמים
בסרטן בטיפול בהם והשימוש –קינאז3
2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCERASTRAZENECA AB
09/07/2004
0415365.6GB
PCT/GB/2005/002664WO/2006/005914
C07D18013707/07/2005
פעמים שלוש –מותמרים6,4,2 פירימידינים–3( PI) פוספוטידילאינוסיטול כמעכבי
בסרטן בטיפול בהם והשימוש קינאז
2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCERASTRAZENECA AB
09/07/2004
0415364.9GB
PCT/GB/2005/002665WO/2006/005915
C07D18013807/07/2005
June 3, 2007457 –התשס"ז בסיון י"ז
פעמים שלוש –מותמרים6,4,2 פירימידינים–3( PI) פוספוטידילאינוסיטול כמעכבי
בסרטן בטיפול בהם והשימוש קינאז
2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCERASTRAZENECA AB
09/07/2004
0415367.2GB
PCT/GB/2005/002678WO/2006/005918
B02C18013918/12/2006
פולימרים גריסת לצורך ושיטה מכונהמגופר גומי וחומרי
MACHINE AND METHOD FOR COMMINUTING OF POLYMER AND CURED ELASTOMER MATERIALS
INNOVERT INVESTMENTS A.L. LTDא.ל. בע"מ השקעות אינוברט
G06F18014028/06/2005
של ומיכון לאיחוד, אבטחת ושיטה מערכתנתונים ברשת לנודות לפס מחוץ גישה
SYSTEM AND METHOD FOR CONSOLIDATING, SECURING AND AUTOMATING OUT-OF-BAND ACCESS TO NODES IN A DATA NETWORKAVOCENT FREMONT CORP.
29/06/2004
10/881211US
PCT/US/2005/023719WO/2006/005047
B31B18014122/06/2005
SHEET MATERIAL AND METHODושיטה יריעה חומרELOPAK SYSTEMS AG
23/06/2004
0414029.9GB
PCT/IB/2005/001759WO/2006/000881
June 3, 2007 458 –התשס"ז בסיון י"ז
C07D18014206/07/2005
–אמינו–טריאזולופירימידנים7–פניל–6 בהם ליצורם, שימוש מותמרים, שיטה
וגורמים פתוגניות פטריות על לבקרהאלו תרכובות המכילים
SUBSTITUTED 6-PHENYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI, AND AGENTS CONTAINING THESE COMPOUNDSBASF AKTIENGESELLSCHAFT
08/07/2004
102004033239.8DE
PCT/EP/2005/007277WO/2006/005492
C07D18014312/07/2005
, שיטה2 בעמדה מותמרים פירימידינים על לבקרה בהם ושימוש להכנתםפתוגניות פטריות
2-SUBSTITUTED PYRIMIDINES, METHOD FOR THEIR PRODUCTION AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGIBASF AKTIENGESELLSCHAFT
14/07/2004
102004034197.4DE
PCT/EP/2005/007517WO/2006/005571
A61P18014424/06/2005
D וויטמין סטרונטיום המכילים תכשיריםושימושיהם
COMPOSITIONS COMPRISING STRONTIUM AND VITAMIN D AND USES THEREOFSTRONTIN APS
25/06/2004PA200400991DK
10/11/2004PA200401733DK
PCT/DK/2005/000425WO/2006/000224
June 3, 2007459 –התשס"ז בסיון י"ז
B65D18014511/04/2006
IDENTIFICATION PANEL FOR PALLETמיכל עבור זיהוי לוחCONTAINERMAUSER-WERKE GMBH
20/04/2005
202005006351.7DE
PCT/EP/2006/003325WO/2006/111303
H01M18014618/12/2006
וציוד מצבר להכנסת ושיטות מצבר, ציודאחסון למצב כאלו
A BATTERY, EQUIPMENT, AND METHODS OF PUTTING SUCH A BATTERY AND SUCH EQUIPMENT INTO A STORAGE CONDITIONSAGEM DEFENSE SECURITE
19/12/20050512880FR
C07D18014720/06/2005
– – פניל4 – – בנזילN( 1( – 1 – תולדות1H2,2 – יל( – 2 – – אימידאזול–
ותרכובות דימתילפרופיל( בנזאמידבסרטן לטיפולKSP כמעכבות קשורות
N - (1 - (1 - BENZYL - 4 - PHENYL - 1H-IMIDAZOL - 2 - YL) - 2,2 - DYMETHYLPROPYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPIDLE PROTEIN (KSP) INHIBITORS FOR THE TREATMENT OF CANCERCHIRON CORPORATION
18/06/2004
60/580927US
PCT/US/2005/022062WO/2006/002236
G09F18014918/12/2006
ביחידות שימוש ידי על לפרסום שיטהמחשב של מסכים רב מוניטור
ADVERTISING METHOD WITH USE OF MULTI-SCREENED COMPUTER MONITOR UNITS
D. SIT TRADE L.T.Dבע"מ סחר ד.סיט
June 3, 2007 460 –התשס"ז בסיון י"ז
B67D18015018/12/2006
של אישיים פריטים להפקדת קיבול כליאוכל בשולחן סועד
RECEPTACLE FOR DEPOSITING PERSONAL ITEMS OF A DINER AT DINING TABLE
ZIV BEN ZVIחלבוני לירון
C07D18015105/07/2005
–2,1 של תרכובת לייצור שיטה–און2דיהידרופירידין–
METHOD FOR PRODUCING 1,2-DIHYDROPYRIDINE-2-ONE COMPOUNDEISAI R&D MANAGEMENT CO. LTD.
06/07/2004
2004-198709JP
PCT/JP/2005/012364WO/2006/004100
C07K18015230/06/2005
ומותאמים כימריים מונוקלונאליים נוגדנים13אינטלאוקין– נגד אדם לבני
CHIMERIC AND HUMANISED MONOCLONAL ANTIBODIES AGAINST INTELEUKIN-13GLAXO GROUP LIMITED
01/07/2004
0414799.7GB
25/10/2004
0423675.8GB
PCT/GB/2005/002581WO/2006/003407
A61B18015306/07/2005
COLORECTAL CELL SAMPLINGקולורקטלי תא לדגימת מכשירDEVICECOLONIX LIMITED
07/07/2004
0415277.3GB
June 3, 2007461 –התשס"ז בסיון י"ז
PCT/GB/2005/002641WO/2006/003447
H04N18015422/04/2005
REAL-TIME STABILIZATIONאמת בזמן ייצובINTERGRAPH SOFTWARE TECHNOLOGIES COMPANY
21/06/2004
10/872767US
PCT/US/2005/013899WO/2006/007006
H04Q18015521/06/2005
תכני של שונים בסוגים להבחנה שיטה תקשורת במערכת דטה פקטות בתוך מידע
אלחוטית
METHOD FOR DISTINGUISHING DIFFERENT TYPES OF DATA CONTENT IN DATA PACKETS IN A WIRELESS COMMUNICATION SYSTEMQUALCOMM INCORPORATED
21/06/2004
60/581790US
31/05/2005
60/686131US
17/06/2005
11/156179US
PCT/US/2005/022025WO/2006/002217
H04Q18015721/06/2005
המשתמשת אלחוטית תקשורת מערכת תקשורת בקשות עבור מתמיד בערך
אחזור זמן קיצור לצורך קבוצתיות
WIRELESS COMMUNICATION SYSTEM UTILIZING A PERSISTENCE VALUE FOR GROUP COMMUNICATION REQUESTS TO REDUCE LATENCYQUALCOMM INCORPORATED
21/06/2004
60/581734US
31/05/2005
60/686141US
16/06/2005
11/155256US
June 3, 2007 462 –התשס"ז בסיון י"ז
PCT/US/2005/022026WO/2006/002218
H04Q18015820/06/2005
יצירת לצורך איתות בערוץ לשימוש שיטה PUSH TO בתקשורת לשיחה בקשהTALKאלחוטית תקשורת במערכת
METHOD FOR USING A SIGNALING CHANNEL TO SET UP A CALL REQUEST FOR A PUSH TO TALK
(PTT )COMMUNICATION ON A WIRELESS COMMUNICATION NETWORKQUALCOMM INCORPORATED
21/06/2004
60/581968US
31/05/2005
60/686147US
16/06/2005
Unknown yetUS
PCT/US/2005/022118WO/2006/002266
H04L18016011/07/2005
מפותל מוליכים זוג של אותות עבור מגברמסוכך בלתי
AMPLIFIER FOR UNSHIELDED TWISTED PAIR WIRE SIGNALSPHYLOGY, INC.
12/07/2004
10/889090US
PCT/US/2005/024576WO/2006/017236
F03G18016323/06/2005
מאגרים של וייצור לפיתוח שיטהעמוקים גיאותרמיים
METHOD OF DEVELOPING AND PRODUCING DEEP GEOTHERMAL RESERVOIRSCURLETT, HARRY, B.
June 3, 2007463 –התשס"ז בסיון י"ז
23/06/2004
60/582626US
07/02/2005
60/650667US
PCT/US/2005/022305WO/2006/002325
E06B18016418/12/2006
WINDOW OR DOOR SHUTTER ANDעבורו ושלב דלת או לחלון תריסSLAT THEREFOR
.PROFILE GLASS LTDבע"מ גלס פרופיל
H02J18016521/04/2005
BI-DIRECTIONAL ENERGYדו–כוונית אנרגיה המרת מערכתCONVERSION SYSTEM
.LV POWER (2003) LTD ( בע"מ2003) אל.וי.פאוור08/07/2004
60/585830US
PCT/IL/2005/000438WO/2006/006142
E04B18016629/03/2005
קיר קשרי עם מבודדת בטון תבנית מערכתמשתנים באורכים
INSULATED CONCRETE FORM SYSTEM WITH VARIABLE LENGTH WALL TIESPJER-MISE VELICKOVIC
21/06/2004P20040578AHR
PCT/HR/2005/000021WO/2005/124046
June 3, 2007 464 –התשס"ז בסיון י"ז
C12N18016719/07/2005
המשתתף פוליפפטיד המקודד דנא פלאדיאינוליד, של בביו–סינתזה ושיטות הימנו המקודדים פוליפפטידים
בהם המשתמשות פלאדיאינוליד להכנת
DNA CODING FOR POLYPEPTIDE PARTICIPATING IN BIOSYNTHESIS OF PLADIENOLIDE, POLYPEPTIDES ENCODED THEREBY AND A METHOD FOR PRODUCING PLADIENOLIDE UTILIZING THE SAMEEISAI R&D MANAGEMENT CO, LTD.
20/07/2004
2004-211279JP
PCT/JP/2005/013541WO/2006/009276
G09F18016819/12/2006
על פרסומות להצגת נייד פרסום חבילותאישיים סלולרים מכשירים
MOBILE ADVERTISING PACKAGES FOR DISPLAYING ADVERTISEMENT DISPLAY MESSAGES ON PERSONAL CELLULAR TELECOMMUNICATIONS DEVICES
.CELLTICK TECHNOLOGIES LTDבע"מ טכנולוגיות סלטיק
G01N18016920/07/2005
חלבון של מבני לאפיון פרוצדורה רב תאים שורת או שבטי רב רקומביננטי
שבטית
A PROCEDURE FOR STRUCTURAL CHARACTERIZATION OF A RECOMBINANT POLYCLONAL PROTEIN OR A POLYCLONAL CELL LINESYMPHOGEN A/S
20/07/2004PA200401133DK
22/12/2004PA200401991DK
PCT/DK/2005/000504WO/2006/007853
June 3, 2007465 –התשס"ז בסיון י"ז
A61F18017016/06/2005
FLOW REGULATING IMPLANTSזרם המווסתים שתלים.OPTONOL LTDבע"מ אופטונול
25/06/2004
10/875571US
PCT/US/2005/021123WO/2006/012009
C07J18017104/07/2005
D–(–10)5, 3, 1– הומו–אסטרה 2 בעמדה המותמרים חדשים טריאנים
–17 של כמעכבים דהידרוגנאז בתא–הידרוקסיסטינואיד
1 מסוג
NOVEL 2-SUBSTITUTED D-HOMO-ESTRA-1,3,5(10)-TRIENES AS INHIBITORS OF 17?- HYDROXYSTEROID DEHYDROGENASE TYPE 1SCHERING AKTIENGESELLSCHAFT
02/07/2004
102004032673.8DE
PCT/EP/2005/007314WO/2006/003012
A61K18017201/07/2005
TOPICAL ANTIVIRALוירליים אנטי מקומיים הרכביםFORMULATIONSGILEAD SCIENCES, INC.
09/07/2004
60/586839US
PCT/US/2005/023492WO/2006/017044
B01D18017321/06/2005
עם משולבים עומק סינוני בסדרת שימוש תרביות להבהרת מתמשכת צנטריפוגה
יונקים תאי
USE OF DEPTH FILTRATION IN SERIES WITH CONTINUOUS CENTRIFUGATION TO CLARIFY MAMMALIAN CELL CULTURESBiogen Idec MA Inc.
June 3, 2007 466 –התשס"ז בסיון י"ז
21/06/2004
10/871261US
PCT/US/2005/021781WO/2006/007459
G06K18017424/06/2005
עם הקשור מיקום לקביעת והתקן שיטהדמות
METHOD AND APPARATUS FOR DETERMINING A LOCATION ASSOCIATED WITH AN IMAGEDIGITALGLOBE, INC.
25/06/2004
60/521729US
PCT/US/2005/022961WO/2006/078310
B02C18017505/07/2005
בנוכחות מינרליים חומרים לטחינת שיטה מיימיות סוספנסיות לקבלת מקשריםבהן והשימוש
METHOD FOR GRINDING MINERAL MATERIALS IN THE PRESENCE OF BINDERS, RESULTING AQUEOUS SUSPENSIONS AND USE THEREOFCOATEX S.A.S.
13/07/20040407805FR
PCT/FR/2005/001715WO/2006/016036
B02C18017605/07/2005
מינרליים חומרים של לטחינה שיטה לקבלת מסמיכים גורמים בנוכחות
בהן והשימוש מיימיות סוספנסות
METHOD FOR GRINDING MINERAL MATERIALS IN THE PRESENCE OF THICKENING AGENTS, RESULTING AQUEOUS SUSPENSIONS AND USES THEREOFCOATEX S.A.S.
13/07/20040407803FR
PCT/FR/2005/001716WO/2006/016037
June 3, 2007467 –התשס"ז בסיון י"ז
C07D18017724/06/2005
בהן ושימוש טריאזולופירימידין תרכובותפתוגניות פטריות על לבקרה
TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGIBASF AKTIENGESELLSCHAFT
25/06/2004
102004030816.0DE
PCT/EP/2005/006855WO/2006/000436
A01N18017816/06/2005
פטריות על לבקרה מגן חומרפייטופתוגניות
PROTECTANT FOR CONTROLLING PHYTOPATHOGENIC FUNGIBAYER CROPSCIENCE AG
21/06/2004
102004029972.2DE
PCT/EP/2005/006483WO/2005/122770
G01N18017919/07/2005
תרכובת של נוכחות לקביעת שיטה הומוגנית בצורה המפוזרת כימית
קורלציה של באמצעים במדיום עם ספקטרום מדידת של מצולבתספקטרום רפרנס
METHOD FOR DETERMINING THE PRESENCE OF A CHEMICAL COMPOUND WHICH IS HOMOGENEOUSLY DISTRIBUTED IN A MEDIUM BY MEANS OF CROSS-CORRELATING A MEASURING SPECTRUM WITH REFERENCE SPECTRABASF AKTIENGESELLSCHAFT
23/07/2004
102004035948.2DE
PCT/EP/2005/007839WO/2006/010527
C07D18018013/07/2005
June 3, 2007 468 –התשס"ז בסיון י"ז
– פניל)תיאו( אורקילים3 לייצור שיטהודיתיאורקילים
METHOD FOR THE PRODUCTION OF 3 -PHENYL (THIO) URACILS AND DITHIOURACILSBASF AKTIENGESELLSCHAFT
22/07/2004
102004035656.4DE
PCT/EP/2005/007577WO/2006/010474
E05B18018119/12/2006
A LOCK PROTECTION SYSTEMמנעול על להגנה מערכתITZHAK COHEN-NEHEMIAנחמיה כהן יצחק
A43B18018219/12/2006
BOOTSמגפייםDORON MORADIמורדי דורון
F41G18018319/12/2006
מטרה לעבר קליע ניווט המאפשרת שיטהוהתקן
A PROCESS ENABLING A PROJECTILE TO BE NAVIGATED AND/OR GUIDED AND/OR STEERED TOWARDS A TARGET AND THE DEVICE THEREOFGIAT INDUSTRIES
19/12/200505.13205FR
F42B18018624/06/2005
מגן עם פגז, המצויד וקליע, כדוגמת מגןזה מסוג אחד
SHIELD AND A PROJECTILE, SUCH AS A SHELL, WHICH IS EQUIPPED WITH ONE SUCH SHIELDTDA ARMEMENTS S.A.S.
25/06/20040407009FR
June 3, 2007469 –התשס"ז בסיון י"ז
PCT/EP/2005/052968WO/2006/000575
C07K18018729/06/2005
בהפרעות הטיפול עבור ושיטות תרכובותדלקתיות
COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERSDOMANTIS LIMITED
30/06/2004
2004/002829GB
24/08/2004
10/925366US
04/04/2005
11/098758US
PCT/GB/2005/002553WO/2006/003388
G01R18018805/07/2005
מושהית ממברנה בעל בדיקה מכשיר ראשבדיקה מכשיר של
PROBE HEAD HAVING A MEMBRANE SUSPENDED PROBECASCADE MICROTECH, INC.
07/07/2004
60/586299US
PCT/US/2005/023806WO/2006/017078
C07C18018923/06/2005
–1–פאניל–1(–Z) ייצור עבור הליך–2דיאת'ילאמינוקרבוניל–
הידרוקסימת'ילציקלופרופאן
PROCESS FOR PRODUCING (Z)-1-PHENYL-1-DIETHYLAMINOCARBONYL-2-HYDROXYMETHYLCYCLOPROPANESUMITOMO CHEMICAL COMPANY, LIMITED.
25/06/2004
2004-188901JP
PCT/JP/2005/012020WO/2006/001498
June 3, 2007 470 –התשס"ז בסיון י"ז
B41J18019029/07/2005
עבור תשתית יצירת עבור ושיטה תשתיתנוזל פליטת מתקן
SUBSTRATE AND METHOD OF FORMING SUBSTRATE FOR FLUID EJECTION DEVICEHEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.
31/08/2004
60/606086US
07/12/2004
11/007103US
PCT/US/2005/027213WO/2006/026023
C07D18019228/06/2005
מזה, חדשות, מלח ארילאמידין תולדותאותן המכיל ואנטי–פטרייתי
NOVEL ARYLAMIDINE DERIVATIVE, SALT THEREOF, AND ANTIFUNGAL CONTAINING THESETOYAMA CHEMICAL CO., LTD.
30/06/2004
2004-193386JP
PCT/JP/2005/011809WO/2006/003881
C22C18019323/06/2005
DIE CAST MAGNESIUM ALLOYמגנזיום סגסוגת יציקתCAST CENTRE PTY., LTD.
24/06/2004
2004903446AU
June 3, 2007471 –התשס"ז בסיון י"ז
25/11/2004
2004906768AU
PCT/AU/2005/000903WO/2006/000022
A61K18019521/06/2005
לשימוש ושיטות אקוורין מכילי תכשיריםבהם
AEQUORIN-CONTAINING COMPOSITIONS AND METHODS OF USING SAMEQUINCY BIOSCIENCE, LLC
21/06/2004
10/872795US
PCT/US/2005/021770WO/2006/010004
C07D18019722/06/2005
כאנטגוניסטים רבעוני מבנה בעלי מלחיםCCR2 ל–
QUATERNARY SALT CCR2 ANTAGONISTSJANSSEN PHARMACEUTICA, N.V.
25/06/2004
60/582929US
PCT/US/2005/022034WO/2006/012135
C07D18019821/06/2005
אינדולילאלקילאמין של מטבוליטים6 – – הידרוקסיטריפטאמין5 של כליגנדים
INDOLYLALKYLAMINE METABOLITES AS 5 - HYDROXYTRYPTAMINE - 6 LIGANDSWYETH
23/06/2004
60/582290US
PCT/US/2005/021852WO/2006/002125
June 3, 2007 472 –התשס"ז בסיון י"ז
C07F18028818/07/2005
ANTIVIRAL COMPOUNDSאנטיויראליים חומריםGILEAD SCIENCES, INC.
16/07/2004
60/588633US
27/07/2004
60/591635US
PCT/US/2005/025503WO/2006/020276
H04Q18028906/07/2005
ומערכת אלחוטית לתקשורת שיטהWLANב– הודעה להעברת
WIRELESS COMMUNICATION METHOD AND SYSTEM FOR ESTABLISHING A MULTIMEDIA MESSAGE SERVICE OVER A WLANINTERDIGITAL TECHNOLOGY CORPORATION
30/07/2004
60/592856US
15/06/2005
11/153207US
PCT/US/2005/023793WO/2006/023108
C07D18029007/07/2005
ביניים וחומרי אזולן נגזרות להכנת תהליךלהכנתם
PROCESS FOR PRODUCTION OF AZULENE DERIVATIVES AND INTERMEDIATES FOR THE SYNTHESIS OF THE SAME
June 3, 2007473 –התשס"ז בסיון י"ז
KOTOBUKI PHARMAEUTICAL CO. LTD.
08/07/2004
2004-202437JP
PCT/JP/2005/012577WO/2006/006496
A61F18029130/06/2005
INTRAVAGINAL DEVICE WITHלניפוח הניתן ואגינלי מכשירCONTROLLED EXPANSIONMCNEIL-PPC, INC.
30/06/2004
60/584772US
PCT/US/2005/023812WO/2006/005069
A61M18029327/06/2005
A CREDIT CARD SIZED INJECTIONאשראי כרטיס בגודל הזרקה מכשירDEVICENOVO NORDISK A/S
05/07/2004
04015740.6EP
PCT/EP/2005/053001WO/2006/003130
A61K18029511/07/2005
בגורמים שימוש ע"י בסרטן לטיפול שיטותWNT16 סיגנל המעכבים
METHODS FOR TREATING CANCER USING AGENTS THAT INHIBIT WNT16 SIGNALINGTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
09/07/2004
60/586564US
20/01/2005
60/645709US
PCT/US/2005/024759WO/2006/017318
June 3, 2007 474 –התשס"ז בסיון י"ז
A61F18029628/07/2005
HIGHLY DEFORMABLE TAMPONצורה משנה טמפוןTHE PROCTER & GAMBLE COMPANY
28/07/2004
10/900950US
PCT/US/2005/026832WO/2006/015139
A61F18029706/07/2005
רב מספר ובעל בגז דחוס, מיוצב טמפוןקפלים של
A COMPRESSED, GAS-STABILIZED TAMPON HAVING MULTIPLE FOLDSTHE PROCTER & GAMBLE COMPANY
09/07/2004
10/887645US
PCT/US/2005/023975WO/2006/017098
A61F18029828/07/2005
פנימי מארז המכיל צורה משנה טמפוןחיצוני ומארז
DEFORMABLE TAMPON COMPRISING AN INNER WRAP AND OUTER WRAPTHE PROCTER & GAMBLE COMPANY
28/07/2004
10/900821US
PCT/US/2005/026833WO/2006/015140
F24J18029916/06/2005
SOLAR ENERGY COLLECTIONשמשית אנרגיה קליטת מערכותSYSTEMSHELIODYNAMICS LIMITED
24/06/2004
0414184.2GB
June 3, 2007475 –התשס"ז בסיון י"ז
24/06/2004
0414183.4GB
PCT/GB/2005/050090WO/2006/000834
B23B18030225/12/2006
CUTTING TOOL INSERTחיתוך כלי תותבתSANDVIK INTELLECTUAL PROPERTY AB
30/12/2005
0502958-2SE
C07D18030329/06/2005
רוקחות ותכשירי אזאאינדול תולדותאותן המכילים
AZAINDOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAMEVERTEX PHARMACEUTICALS INCORPORATED
30/06/200460/584383US
01/07/200460/584721US
04/04/200511/098751US
04/04/2005PCT/US05/11358US
PCT/US/2005/023429WO/2006/004984
G01N18030419/10/2001
רצפי קביעת עבור מסה פגמי התויתאוליגומרים
MASS DEFECT LABELING FOR THE DETERMINATION OF OLIGOMER SEQUENCESTARGET DISCOVERY, INC.
19/10/2000
60/242165US
19/10/2000
60/242398US
June 3, 2007 476 –התשס"ז בסיון י"ז
PCT/US/2001/049951WO/2002/066952
A61M18030525/12/2006
ADMINISTRATION SET WITH TWOמפתחות שני עם אינפוזיה סטKEYS
CAESAREA MEDICAL ELECTRONICSבע"מ רפואית אלקטרוניקה קיסריהLTD.
A61B18030625/12/2006
A DEVICE TO SHARE FEELINGSאנשים בין רגשות לשיתוף התקןAMONG PEOPLE
ISHAY PEREZפרץ ישי
A61H18030725/12/2006
INDIVIDUALLY ADAPTIVEאישית מותאמת החיאהRESUSCITATION
R. A. EREZ SYSTEMS LTDבע"מ מערכות ר.א.ארז
A23L18030825/12/2006
NATURAL SALT SUBSTITUTEלמלח טבעי תחליףGAN SHMUEL FOODS LTDבע"מ מזון שמואל גן
C07D18030913/07/2005
–2–)הטרואריל–אוקסי(–3 של נגזרות כליגנדים –אזא–ביציקלואלקיל1אלקיל–
של במחלות לטיפולNACHR–7 אלפא שלהמרכזית העצבים מערכת
3(-HETEROARYL-OXY-)2-ALKYL-1-AZA-BICYCLOALKYL DERIVATIVES AS ALPHA.7-NACHR LIGANDS FOR THE TREATMENT OF CNS DISEASESNOVARTIS AG
14/07/2004
0415746.7GB
June 3, 2007477 –התשס"ז בסיון י"ז
PCT/EP/2005/007630WO/2006/005608
C02F18031018/07/2005
לטיהור מוצק קומפקטי דו–שכבתי מוצרמים
DOUBLE-LAYERED COMPACTED SOLID WATER-PURIFICATION PRODUCTEUROTAB
19/07/20040407968FR
PCT/FR/2005/001834WO/2006/016073
C07C18031113/07/2005
–4,4 חומצה של אסטרים להכנת תהליך–אוקסובוטנואית3דיפלואורו–
PROCESS FOR THE PREPARATION OF 4,4-DIFLUORO-3-OXOBUTANOIC ACID ESTERSSYNGENTA PARTICIPATIONS AG
14/07/2004
0415764.0GB
PCT/EP/2005/007635WO/2006/005612
C07D18031228/06/2005
קרבוקסאמיד של נגזרות להכנת תהליך של בסינתזה ביניים כחומרי לשימוש פירידין
NK–1 רצפטור של אנטגוניסטים
PROCESS FOR PREPARING CARBOXAMIDE PYRIDINE DERIVATIVES USED AS INTERMEDIATES IN THE SYNTHESIS OF NK-1 RECEPOR ANTAGONISTSF. HOFFMANN-LA ROCHE AG
06/07/2004
60/585779US
23/02/2005
60/655731US
PCT/EP/2005/006919WO/2006/002860
June 3, 2007 478 –התשס"ז בסיון י"ז
C07D18031323/06/2005
THIAZOLINONE UNSUBSTITUTEDתיאזולינון של בלתי–מותמרים קוינוליניםQUINOLINESF. HOFFMANN-LA ROCHE AG
01/07/2004
60/584746US
19/11/2004
60/629495US
PCT/EP/2005/006807WO/2006/002829
C07D18031411/08/2005
בנזואיק אמינו ציקליק חומצת של נגזרותחדשה
NOVEL CYCLIC AMINO BENZOIC ACID DERIVATIVE
KYORIN PHARMACEUTICAL CO., LTD.
11/08/2004
2004-234603JP
PCT/JP/2005/014718WO/2006/016637
B65D18031528/06/2005
FLOATING MULTI-CHAMBEREDנוזל מיכלי עבור צפה תאית רב תוספתINSERT FOR LIQUID CONTAINERSBALL PACKAGING EUROPE GMBH
09/07/2004
04016274.5EP
PCT/EP/2005/006955WO/2006/005440
June 3, 2007479 –התשס"ז בסיון י"ז
C07D18031711/11/2005
AZAINDOLE CARBOXAMIDESאזאיינדולים קארבוקסאמידיםSCHWARZ PHARMA AG
12/11/2004
102004054634.7DE
PCT/EP/2005/012127WO/2006/050976
A01K18031828/06/2005
על המבוססת לסריקה כימרית מערכתיונקי ממקור שתלים והכוללת עופות
CHIMERIC AVIAN- BASED SCREENING SYSTEM CONTAINING MAMMALIAN GRAFTS
המרכז שליד תשתיות ופיתוח מחקרים קרןסוראסקי ע"ש אביב תל הרפואי
THE MEDICAL RESEARCH FUND AT THE TEL-AVIV SOURASKY MEDICAL CENTER
28/06/2004
60/582807US
PCT/IL/2005/000687WO/2006/001021
A61K18031913/07/2005
פצעים ריפוי עבור ושיטות תכשיריםדרמטולוגיים
COMPOSITIONS AND METHODS FOR DERMATOLOGICAL WOUND HEALING
MEDIWOUND LTDבע"מ מדיוונד13/07/2004
60/587057US
PCT/IL/2005/000744WO/2006/006167
F41G18034326/12/2006
הפעלה אפשרות לבדיקת בדיקה מערכת טילים מהתקרבות אזהרה מערכת של
מונחים
TEST APPARATUS FOR TESTING THE OPERABILITY OF A WARNING SYSTEM FOR APPROACHING GUIDED MISSILESRUAG AEROSPACE
June 3, 2007 480 –התשס"ז בסיון י"ז
12/01/2004
06075083.3EP
H04L18034411/05/2001
מהירה קצב להתאמת והתקן שיטה גבוה קצב בעל נתונים בשידור סגור במעגל
מארזים של
METHOD AND APPARATUS FOR FAST CLOSED-LOOP RATE ADAPTATION IN A HIGH RATE PACKET DATA TRANSMISSIONQUALCOMM INCORPORATED
12/05/2000
09/570210US
PCT/US/2001/015381WO/2001/089162
C07D18034519/07/2005
IMPROVED PROCESS FOR THEמירטאזאפין לייצור משופרת שיטהMANUFACTURE OF MIRTAZAPINEMEDICHEM, S.A.
22/07/2004
200401804ES
PCT/EP/2005/053493WO/2006/008302
F03G18034630/06/2004
TORQUE MULTIPLIERסיבובי מומנט מכפלGIL ALDRETE
28/06/2004PA/a/2004/006381MX
PCT/MX/2004/000041WO/2006/001686
A45D18034826/12/2006
June 3, 2007481 –התשס"ז בסיון י"ז
עבור שיער לייבוש מרכזית מערכתמספרות
CENTRAL HAIR DRYING SYSTEM FOR HAIR SALONS
ELIYAHU SUISSAסוויסה אליהו
C07D18034915/07/2005
מוחלפי–אריל טטראהידרואיסוקוינולינים למנוע כדי בהם והשימוש והטרואריל
נוראפינפרין, דופאמין של מחודשת קליטהוסרוטנין
ARYL-AND HETEROARYL - SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE AND SEROTONINBRISTOL-MYERS SQUIBB COMPANY
15/07/2004
60/588448US
PCT/US/2005/025193WO/2006/020049
A61K18035012/07/2005
מסיסות בעלי תרופות לאספקת תכשיריםבמים גבוהה
COMPOSITIONS FOR DELIVERING HIGHLY WATER SOLUBLE DRUGSSD PHARMACEUTICALS, INC.
12/07/2004
10/889226US
PCT/US/2005/024594WO/2006/017246
C07D18035130/06/2004
שאריתים אלכוהולים להפחתת תהליךקריסטליני הידרוכלוריד בוולציקלוויר
METHOD FOR REDUCING RESIDUAL ALCOHOLS IN CRYSTALLINE VALACYCLOVER HYDROCHLORIDE
TEVA PHARMACEUTICALבע"מ פרמצבטיות תעשיות טבעINDUSTRIES LTD.
PCT/US/2004/020903WO/2006/011874
June 3, 2007 482 –התשס"ז בסיון י"ז
C07C18035201/07/2005
–1,24( S) של קריסטליניות צורות2D ויטמין דיהידרוקסי
CRYSTALLINE FORMS OF 1,24(S) - DIHYDROXY VITAMIN D2
TEVA PHARMACEUTICALבע"מ פרמצבטיות תעשיות טבעINDUSTRIES LTD.
01/07/2004
60/584844US
23/09/2004
60/612914US
PCT/US/2005/023547WO/2006/025939
C07C18035328/06/2005
PROCESSES FOR THE PREPARATIONטומוקסטין להכנת תהליכיםOF TOMOXETINETEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.
28/06/2004
60/583641US
28/06/2004
60/583644US
28/06/2004
60/583643US
14/09/2004
60/609716US
25/10/2004
60/622065US
11/02/2005
60/652330US
11/02/2005
60/652331US
11/02/2005
60/652332US
30/03/2005
60/666666US
26/04/2005
60/675369US
09/06/2005
60/689778US
14/06/2005
60/690738US
June 3, 2007483 –התשס"ז בסיון י"ז
PCT/US/2005/023412WO/2006/068662
C07C18035428/06/2005
הידרוכלוריד אטומוקסטין להכנת תהליךPROCESS FOR THE PREPARATION OF ATOMOXETINE HYDROCHLORIDETEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.
28/06/2004
60/583641US
28/06/2004
60/583644US
28/06/2004
60/583643US
14/09/2004
60/609716US
25/10/2004
60/622065US
11/02/2005
60/652330US
11/02/2005
60/652331US
11/02/2005
60/652332US
30/03/2005
60/666666US
26/04/2005
60/675369US
09/06/2005
60/689778US
14/06/2005
60/690738US
PCT/US/2005/023419WO/2006/004976
C07C18035528/06/2005
של ומיחזור אופטית לרזולוציה תהליךטומוקסטין
PROCESS FOR THE OPTICAL RESOLUTION AND RECYCLING OF TOMOXETINE
June 3, 2007 484 –התשס"ז בסיון י"ז
TEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.
28/06/2004
60/583641US
28/06/2004
60/583644US
28/06/2004
60/583643US
14/09/2004
60/609716US
25/10/2004
60/622065US
11/02/2005
60/652330US
11/02/2005
60/652331US
11/02/2005
60/652332US
26/04/2005
60/675369US
30/05/2005
60/666666US
09/06/2005
60/689778US
14/06/2005
60/690738US
PCT/US/2005/023421WO/2006/004977
C07C18035628/06/2005
נקיים מנדלאט וטומוקסטין אטומוקסטיןאננטיומרית
ENANTIOMERICALLY PURE ATOMOXETINE AND TOMOXETINE MANDELATETEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.
28/06/2004
60/583641US
28/06/2004
60/583644US
28/06/2004
60/583643US
14/09/2004
60/609716US
June 3, 2007485 –התשס"ז בסיון י"ז
25/10/2004
60/622065US
11/02/2005
60/652330US
11/02/2005
60/652331US
11/02/2005
60/652332US
30/03/2005
60/666666US
26/04/2005
60/675369US
09/06/2005
60/689778US
14/06/2005
60/690738US
PCT/US/2005/023273WO/2006/004923
C07C18035728/06/2005
אטומוקסטין, תהליכים של מבודד אי–נקיון אטומוקסטין, של אי–נקיונות להכנת
כסטנדרט ושימושם
AN ISOLATED ATOMOXETINE IMPURITY, PROCESSES FOR THE PREPARATION OF ATOMOXETINE IMPURITIES AND THEIR USE AS REFERENCE STANDARDSTEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.
28/06/2004
60/583641US
28/06/2004
60/583644US
28/06/2004
60/583643US
14/09/2004
60/609716US
25/10/2004
60/622065US
11/02/2005
60/652330US
11/02/2005
60/652331US
11/02/2005
60/652332US
30/03/2005
60/666666US
June 3, 2007 486 –התשס"ז בסיון י"ז
26/04/2005
60/675369US
09/06/2005
60/689778US
14/06/2005
60/690738US
PCT/US/2005/023423WO/2006/004979
C07D18035829/06/2005
CRYSTALLINE FORM IV OFלינזוליד שלV I קריסטלינית צורהLINEZOLID
TEVA PHARMACEUTICALבע"מ פרמצבטיות תעשיות טבעINDUSTRIES LTD.
29/06/2004
60/584371US
30/06/2004
60/584283US
12/08/2004
60/601086US
17/08/2004
60/602227US
07/12/2004
60/633887US
24/02/2005
60/656646US
24/02/2005
60/656778US
05/05/2005
60/678440US
24/05/2005
60/684410US
PCT/US/2005/023272WO/2006/004922
C07D18035929/06/2005
ותהליכים לינזוליד של מוצקות צורותלהכנתן
SOLID FORMS OF LINEZOLID AND PROCESSES FOR PREPARATION THEREOF
TEVA PHARMACEUTICALבע"מ פרמצבטיות תעשיות טבעINDUSTRIES LTD.
29/06/2004
60/584371US
June 3, 2007487 –התשס"ז בסיון י"ז
30/06/2004
60/584283US
12/08/2004
60/601086US
17/08/2004
60/606227US
07/12/2004
60/633887US
05/05/2005
60/678440US
24/05/2005
60/684410US
PCT/US/2005/023066WO/2006/110155
C09C18036007/07/2005
יעד של זהה כמעט העתק לקביעת שיטהמידע
A METHOD FOR DETERMINING NEAR DUPLICATE DATA OBJECTS
EQUIVIO LTDבע"מ אקויויו21/07/2004
60/589596US
PCT/IL/2005/000726WO/2006/008733
A61K18036127/06/2005
ושליטה למניעה ושיטות תכשיריםאינסולין מושפעת בהיפוגליקמיה
COMPOSITIONS AND METHODS FOR THE PREVENTION AND CONTROL OF INSULIN-INDUCED HYPOGLYCEMIADIOBEX, INC.
29/06/2004
60/584449US
PCT/US/2005/022812WO/2006/004696
A61K18036308/07/2005
של אנלוגים עם וירטואלית קולונוסקופיה באופן המסומנים אתרים פוספוליפידים
רדיואקטיבי
VIRTUAL COLONOSCOPY WITH RADIOLABELLED PHOSPHOLIPID ETHER ANALOGS
June 3, 2007 488 –התשס"ז בסיון י"ז
CELLECTAR, LLC08/07/2004
60/521831US
PCT/US/2005/024259WO/2006/014589
C07K18036401/08/2005
המכיל פפטיד בתא נגד המכוונים נוגדניםבהם לשימוש ושיטות עמילן
ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE AND METHODS USING SAMERINAT NEUROSCIENCE CORPORATION
30/07/2004
60/592494US
14/02/2005
60/653197US
29/04/2005
60/676093US
PCT/US/2005/027295WO/2006/036291
A61B18036522/06/2005
CARBORANYLPORPHYRINS ANDושימושיהם קרבורנילפורפריניםUSES THEREOFBROOKHAVEN SCIENCE ASSOCIATES
28/06/2004
10/878138US
PCT/US/2005/022061WO/2006/012140
June 3, 2007489 –התשס"ז בסיון י"ז
A61M18036628/06/2005
NASAL DILATOR AND USESושימושיו נחירי מרחיבTHEREOFALEXANDRE YAZDI
28/06/20040407085FR
PCT/FR/2005/001634WO/2006/010848
A61K18036729/06/2005
נפוצה טרשת של ומניעה לטיפול שיטהלפטוספירה בזיהום טיפול באמצעות
METHOD FOR MULTIPLE SCLEROSIS TREATMENT AND PROPHYLAXIS BY TREATMENT OF LEPTOSPIRA INFECTIONKOBENHAVNS UNIVERSITET
01/07/2004PA200401042DK
PCT/DK/2005/000444WO/2006/002631
A61B18036905/07/2005
של מכונה בעזרת לעיצוב ושיטה מכשירחולייתי צווארי גוף
INSTRUMENTS AND METHOD FOR MACHINING A CERVICAL VERTEBRAL BODYCERVITECH, INC.
23/07/2004
10/897404US
12/11/2004
10/897404US
PCT/EP/2005/007253WO/2006/010444
C07K18037013/07/2005
IMPROVED APROTININ VARIANTSאפרוטינין של משופרים וריאנטיםBAYER PHARMACEUTICALS CORPORATION
13/07/2004
60/587655US
PCT/US/2005/024951
June 3, 2007 490 –התשס"ז בסיון י"ז
WO/2006/017355
C07K18037121/07/2005
METHOD OF TREATING SJOGREN'Sסג'ורגן בסינדרום לטיפול שיטהSYNDROMEGENENTECH, INC.
22/07/2004
60/590302US
PCT/US/2005/026027WO/2006/012508
C03B18037223/06/2005
והתקן שיטה וכן גלים מנחה אופטי חומרלייצורו
OPTICAL WAVEGUIDE MATERIAL AS WELL AS METHOD AND DEVICE FOR PRODUCING ITLIEKKI OY
02/07/2004
20045264FI
PCT/FI/2005/050239WO/2006/003253
C07C18037327/06/2005
–3(–3 (–R 1 ,R 2)–(–) גבישיות צורות–מתילפרופיל(–2–אתיל–1דימתילאמינו–
כלוריד הידרו פנול
CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDEGRUNENTHAL GMBH
28/06/2004
04015091.4EP
PCT/EP/2005/006884WO/2006/000441
B65C18037426/12/2006
June 3, 2007491 –התשס"ז בסיון י"ז
בלחצים גזים לאחסון רב–תאי המיכלשונים
MULTICHAMBER TANK FOR GAS STORAGE UNDER DIFFERENT PRESSURE
ANGSTORE TECHNOLOGIES LTDבע" מ טכנולוגי אגנסטור
A23L18037526/12/2006
גורמת שצריכתו אופונטיה ממין קקטוס ומפחיתה משקל והפחתת התיאבון לוויסות
ולניקוטין לקופאין החשק את
THE OPUNTIA SPECIES OF THE CACTUS FAMILY WHICH ITS CONSUMPTION CAUSES A REDUCTION OF THE APPETITE AND THE EAGERNESS FOR CAFFEINE AND NICOTINE
MOTI SHEFERשפר מוטי
B65D18037626/12/2006
יש העליון שבחלקו כלים לניקוי לנוזל מיכלהספוג להנחת שקערורית
A TANK FOR LIQUID SOAP FOR CLEANING DISHES WHICH ON TOP OF IT THERE IS A CRATER FOR LEAVING THE SPONGE
MOSHE ABAROאברו משה
B65B18037730/06/2005
VACUUM PACKAGE SYSTEM ANDבריק לאריזה ושיטה מערכתMETHODWEST PHARMACEUTICAL SERVICES, INC.
01/07/2004
60/584826US
PCT/US/2005/023138WO/2006/028562
June 3, 2007 492 –התשס"ז בסיון י"ז
A61M18037812/07/2005
אבקתיות, ומערכת תרופות למתן משאףזה משאף עם לשימוש האבקה לאחסון
INHALER FOR THE ADMINISTRATION OF POWDERED PHARMACEUTICALS, AND A POWDER CARTRIDGE SYSTEM FOR USE WITH THIS INHALERLABORATORIOS ALMIRALL, S.A.
16/07/2004
60/588382US
PCT/EP/2005/007525WO/2006/008027
A61K18037913/07/2005
מדיספונקציה ההבראה לקידום גורם נוירולוגית מחלה של התקפה לאחר
מרכזית
AGENT FOR PROMOTING THE RECOVERY FROM DYSFUNCTION AFTER THE ONSET OF CENTRAL NEUROLOGICAL DISEASEASTELLAS PHARMA INC.
14/07/2004
2004-207234JP
PCT/JP/2005/012895WO/2006/006617
A61K18038006/07/2005
בוטולינום המכיל רוקחות תכשירניורוטוקסין
PHARMACEUTICAL COMPOSITION CONTAINING BOTULINUM NEUROTOXINIPSEN LIMITED
12/07/2004
0415491.0GB
PCT/GB/2005/002653WO/2006/005910
June 3, 2007493 –התשס"ז בסיון י"ז
C07J18038101/08/2005
אסטרון של תולדות להכנת תהליך2 בעמדה המותמרים ואסטראדיאול
PROCESS FOR THE PREPARATION 2-SUBSTITUTED-DERIVATIVES OF ESTRONE AND ESTRADIOLN.V. ORGANON
04/08/2004
04103742.5EP
PCT/EP/2005/053732WO/2006/013196
C07D18038228/06/2005
מותמרים קווינאזולינון –אלקיל2 תולדותPARP כמעכבי
SUBSTITUTED 2-ALKYL QUINAZOLINONE DERIVATIVES AS PARP INHIBITORSJANSSEN PHARMACEUTICA N.V.
30/06/2004
04076887.1EP
PCT/EP/2005/053034WO/2006/003150
B65D18038320/06/2005
לשימוש ומוצר בוצי משקה להגשת שיטהזו בשיטה
METHOD OF SERVING A SLUSHY DRINK AND A PRODUCT FOR USE IN SUCHUNILEVER PLC
19/07/2004
04254314.0EP
PCT/EP/2005/006697WO/2006/007921
B23K18038814/06/2005
June 3, 2007 494 –התשס"ז בסיון י"ז
REDUCING PLASMA IGNITIONפלאזמה הצתת של בלחץ צמצוםPRESSURELAM RESEARCH CORPORATION
30/06/2004
10/883583US
PCT/US/2005/021098WO/2006/012003
H04B18038930/06/2005
METHOD OF VIDEO DATAוידיאו נתוני של לשידור שיטהTRANSMITTINGCOMET VIDEO TECHNOLOGY
30/06/2004
60/584364US
PCT/US/2005/023109WO/2006/004837
G06K18039030/06/2005
נתוני של דחיסה כולל וידיאו דחיסת שיטתוידיאו
METHOD OF DATA COMPRESSION INCLUDING COMPRESSION OF VIDEO DATACOMET VIDEO TECHNOLOGY
30/06/2004
60/584102US
PCT/US/2005/023133WO/2006/004847
B65D18039128/06/2005
של בצורה העשויה חד–פעמית אריזה עבור יציאה בפתח אוכל, מצויד כלי
ריחות
READY-MADE DISH DISPOSABLE PACKAGING, EQUIPPED OF VENT DEVICE FOR INNER VAPORSDEVELPACK S.R.L.
28/06/2004CS2004A000006IT
27/06/2005CZ2005A000011IT
PCT/IT/2005/000371June 3, 2007495 –התשס"ז בסיון י"ז
WO/2006/001048
G06Q18039227/12/2006
נכסים של חוזרת למכירה ומערכת שיטהתקשורת רשת דרך
METHOD AND SYSTEM FOR RESELLING OF ASSETS THROUGH COMMUNICATION NETWORK
YACOV KORMANוייסמן שמואל12/12/2006
11/609366US
G06F18039316/06/2005
A METHOD FOR DETECTING OFרצויים לא אקסקיוטבלים לזיהוי שיטהUNWANTED EXECUTABLES
ALADDIN KNOWLEDGE SYSTEMSבע"מ מידע מערכות אלדיןLTD.
14/07/2004
10/890170US
PCT/IL/2005/000648WO/2006/006144
A61C18039406/02/2006
הברגה, מקבל מסוג תוך–עצמיים שתלים ורכיבים אחת בחתיכה חיצונית מושחל
הקשורים ומשענות נוחות להעברה, כיסויילהם
ONE-PIECE, SCREW-RECEIVING, EXTERNALLY-THREADED ENDOSSEOUS DENTAL IMPLANTS AND RELATED TRANSFER COMPONENTS, COMFORT CAPS AND ABUTMENTSGERALD A. NIZNICK
11/02/2005
11/056578US
PCT/US/2006/004052WO/2006/088680
G01N18039601/06/2005
METHOD FOR DETECTING GLUTENגלוטן לזיהוי שיטהJune 3, 2007 496 –התשס"ז בסיון י"ז
ACADEMISCH ZIEKENHUIS LEIDEN30/06/2004
04076902.8EP
PCT/NL/2005/000400WO/2006/004394
C07C18039719/07/2005
פטריות קוטלי , תכשירים דיאמין תולדותלהכנתן ותהליכים אותן המכילים
DIAMINE DERIVATIVES, FUNGICIDAL COMPOSITIONS CONTAINING THE SAME, AND PROCESSES FOR THE PREPARATION THEREOFMITSUI CHEMICALS, INC.
21/07/2004
2004-213208JP
27/01/2005
2005-019032JP
PCT/JP/2005/013233WO/2006/009134
C09D18039907/07/2005
בעובדים קורוזיה לבקרת ציפוי תכשיר להכנתו, ועובדים מתכתיים, שיטות
איתו מצופים מתכתיים
CORROSION CONTROL COATING COMPOSITION FOR METAL WORKPIECES, METHODS FOR THE PRODUCTION THEREOF AND METAL WORKPIECES COATED THEREWITHEWALD DORKEN AG
16/07/2004
102004034645.3DE
June 3, 2007497 –התשס"ז בסיון י"ז
PCT/EP/2005/007360WO/2006/007985
H01M18040028/12/2006
בבית חשמל לייצר שיטהMETHOD FOR PRODUCING ELECTRICITY IN HOME FROM WASTE
SARAH MOGRABIמוגרבי שרה
E05C18040128/12/2006
דלתות בין ידיים לאצבעות הגנה מנגנוןומשקופים
MECHANISM, ELEMENT FOR PROTECTION OF FINGERS IN DOORS AND GATES
VICTOR BEN DAVID YOSSEFיוסף דוד בן ויקטור
H04L18040222/07/2005
מרוחקת גישה לאבטחת ומערכות שיטהפרטיות לרשתות
A METHOD AND SYSTEMS FOR SECURING REMOTE ACCESS TO PRIVATE NETWORKSCITRIX SYSTEMS, INC.
23/07/2004
60/590837US
13/08/2004
60/601431US
03/09/2004
60/607420US
07/12/2004
60/634379US
PCT/US/2005/026300WO/2006/012612
H04L18040322/07/2005
מרוחקת גישה לאבטחת ומערכות שיטהפרטיות לרשתות
A METHOD AND SYSTEMS FOR SECURING REMOTE ACCESS TO PRIVATE NETWORKS
June 3, 2007 498 –התשס"ז בסיון י"ז
CITRIX SYSTEMS, INC.23/07/2004
60/590837US
13/08/2004
60/601431US
03/09/2004
60/607420US
07/12/2004
60/634379US
PCT/US/2005/026300WO/2006/012612
H04L18040422/07/2005
מרוחקת גישה לאבטחת ומערכות שיטהפרטיות לרשתות
A METHOD AND SYSTEMS FOR SECURING REMOTE ACCESS TO PRIVATE NETWORKSCITRIX SYSTEMS, INC.
23/07/2004
60/590837US
13/08/2004
60/601431US
03/09/2004
60/607420US
07/12/2004
60/634379US
PCT/US/2005/026300WO/2006/012612
H04L18040522/07/2005
מרוחקת גישה לאבטחת ומערכות שיטהפרטיות לרשתות
A METHOD AND SYSTEMS FOR SECURING REMOTE ACCESS TO PRIVATE NETWORKSCITRIX SYSTEMS, INC.
23/07/2004
60/590837US
13/08/2004
60/601431US
June 3, 2007499 –התשס"ז בסיון י"ז
03/09/2004
60/607420US
07/12/2004
60/634379US
PCT/US/2005/026300WO/2006/012612
E02D18040628/12/2006
SCREW-PILE SYSTEMSכלונס–בורגי מערכות (1975) הנדסיים ושות' שירותים ליפסקר
בע"מLIPSKER & PARTNERS ENGINEERING SERVICES (1975) LTD.
B25G18040719/10/2004
כלי או מכשיר עבור קבוע ידית של מערכתידני
HANDLE-FIXING SYSTEM FOR HAND TOOL OR UTENSILPEDRO JOSE ZUBIAURRE ALBERDI
01/10/2004
200402342ES
01/10/2004
200402343ES
PCT/ES/2004/000449WO/2006/045855
B65D18040827/07/2005
WATER STORAGE EVAPORATIONמאוחסנים מים נידוף על בקרהCONTROLWATER INNOVATIONS PTY LTD.
28/07/2004
2004904178AU
02/08/2004
2004904282AU
04/11/2004
2004906329AU
23/03/2005
2005901415AU
PCT/AU/2005/001094WO/2006/010204
June 3, 2007 500 –התשס"ז בסיון י"ז
C07D18040928/06/2005
PARPQUINAZOLINEDIONE DERIVATES AS כמעכבות קווינאזולינדיאון תולדותPARP INHIBITORSJANSSEN PHARMACEUTICA N.V.
30/06/2004
04076885.5EP
PCT/EP/2005/053031WO/2006/003148
C07D18041028/06/2005
PARPPHTHALAZINE DERIVATIVES AS כמעכבי פטאלזין תולדותPARP INHIBITORSJANSSEN PHARMACEUTICA N.V.
30/06/2004
04076886.3EP
PCT/EP/2005/053030WO/2006/003147
C07D18041128/06/2005
PARPQUINAZOLINONE DERIVATIVES AS כמעכבי קווינאזולינון תולדותPARP INHIBITORSJANSSEN PHARMACEUTICA N.V.
30/06/2004
04076887.1EP
PCT/EP/2005/053029WO/2006/003146
A47G18041228/12/2006
DREAM SHEETחלומית וסדינית סדיןANAT BEN-DOV TZABARIצברי בן-דוב ענת
June 3, 2007501 –התשס"ז בסיון י"ז
C07C18041313/07/2005
METHOD OF CRYSTALLIZATION OFביקאלוטאמיד של התגבשות תהליךBICALUTAMIDESUMITOMO CHEMICAL COMPANY, LIMITED.
14/07/2004
2004-207709JP
PCT/JP/2005/013346WO/2006/006736
B32B18041529/06/2005
מבחינה יעילות מבודדות בניה מעטפותאנרגית
ENERGY EFFICIENT AND INSULATED BUILDING ENVELOPESASPEN AEROGELS, INC
29/06/2004
60/583940US
07/10/2004
60/616887US
PCT/US/2005/023677WO/2006/002440
A61J18041729/06/2005
TEATפטמהJACKEL INTERNATIONAL LIMITED
29/06/2004
0414560.3GB
08/02/2005
0502599.4GB
PCT/GB/2005/002532WO/2006/000816
C12Q18041830/06/2005
הכבד הצטלקות קצב לחיזוי וערכות שיטותC מסוג הכבד בדלקת כרוניים בחולים
METHODS AND KITS FOR PREDICTING LIVER FIBROSIS PROGRESSION RATE IN CHRONIC HEPATITIS C PATIENTS
June 3, 2007 502 –התשס"ז בסיון י"ז
המרכז שליד תשתיות ופיתוח מחקרים קרןסוראסקי ע"ש אביב תל הרפואי
THE MEDICAL RESEARCH FUND AT THE TEL-AVIV SOURASKY MEDICAL CENTER
01/07/2004
60/584179US
PCT/IL/2005/000700WO/2006/003654
C07K18041906/07/2005
CYCLIC PEPTIDES FOR TREATMENTבהתנוונות לטיפול ציקליים פפטידיםOF CACHEXIAPALATIN TECHNOLOGIES, INC.
06/07/2004
60/585971US
05/07/2005
11/174845US
PCT/US/2005/024125WO/2006/014552
C07K18042006/07/2005
CYCLIC PEPTIDES FOR TREATMENTבהתנוונות לטיפול ציקליים פפטידיםOF CACHEXIAPALATIN TECHNOLOGIES, INC.
06/07/2004
60/585971US
05/07/2005
11/174851US
PCT/US/2005/024138WO/2006/014559
C07F18042104/07/2005
קישור בעלי '–דיפוספינופרוצנים1,1 או אכיראלים ' לרדיקלים2, 2 בעמדה
כיראלים
1,1 -'DIPHOSPHINOFERROCENES HAVING 2, 2' - BOUND ACHIRALS OR CHIRAL RADICALSSOLVIAS AG
05/07/20041126/04CH
26/10/20041773/04CH
June 3, 2007503 –התשס"ז בסיון י"ז
10/11/20041853/04CH
PCT/EP/2005/053171WO/2006/003196
C07C18042419/07/2005
הלומתיל תרכובות של סינתזהארומטיות פוליהלוגנטיות
SYNTHESIS OF AROMATIC POLYHALOGENATED HALOMETHYL COMPOUNDS
.BROMINE COMPOUNDS LTDבע"מ ברום תרכובות19/07/2004163101IL
PCT/IL/2005/000768WO/2006/008738
C07D18042617/06/2005
הטרואריל של מותמרות תרכובותופנילסולפמואיל
SUBSTITUTED HETEROARYL - AND PHENYLSULFAMOYL COMPOUNDSPFIZER PRODUCTS, INC.
29/06/2004
60/583721US
PCT/IB/2005/002007WO/2006/003495
B60R18042728/12/2006
SYSTEM FOR ENCOURAGING USINGבטיחות בחגורת השימוש לעידוד מערכתA SEATBELT
YOSSEF COHENפרידמן ליאור
C08J18042819/07/2005
NOVEL FLAME-RETARDANTחדשים בעירה – מונעי פוליסטיריניםPOLYSTYRENES
.BROMINE COMPOUNDS LTDבע"מ ברום תרכובות19/07/2004163100IL
PCT/IL/2005/000767June 3, 2007 504 –התשס"ז בסיון י"ז
WO/2006/013554
C07F18042904/07/2005
TETRADENTATE FERROCENEושימושם פרוצין טטרהדנטאט של ליגנדיםLIGANDS AND THEIR USESOLVIAS AG
05/07/20041126/04CH
26/10/20041773/04CH
10/11/20041853/04CH
PCT/EP/2005/053170WO/2006/003195
C07D18043012/07/2005
PYRIDINE DERIVATIVESפירידין של נגזרותPFIZER INC.
23/07/2004
0416524.7GB
21/01/2005
60/646077US
PCT/IB/2005/002214WO/2006/011050
C07F18043101/07/2005
המשמשות אמינו חומצות להכנת תהליךפפטיד של לרצפטור מודולטורים בהכנת
PROCESS FOR THE PREPARATION OF AMINO ACIDS USEFUL IN THE PREPARATION OF PEPTIDE RECEPTOR MODULATORSBRISTOL-MYERS SQUIBB COMPANY
02/07/2004
60/584968US
June 3, 2007505 –התשס"ז בסיון י"ז
PCT/US/2005/023363WO/2006/014324
C07D18043201/07/2005
CETPCETP INHIBITORS מעכביMERCK & CO., INC.
02/07/2004
60/585274US
21/01/2005
60/646103US
PCT/US/2005/023546WO/2006/014357
C07F18043329/06/2005
HIVPRODRUGS OF HIV PROTEASE פרוטאזת מעכבי של פרודרגיםINHIBITORSABBOTT LABORATORIES
06/07/2004
60/585710US
PCT/US/2005/023047WO/2006/014282
C07K18043430/06/2005
גלוקאגון דמוי1 – פפטיד של מודולטורים ומצבים בסכרת בטיפול ושימושיהם אנושי
קשורים
HUMAN GLUCAGON - LIKE - PEPTIDE - 1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONSBRISTOL-MYERS SQUIBB COMPANY
02/07/2004
60/585358US
26/05/2005
60/684805US
PCT/US/2005/023076WO/2006/014287
June 3, 2007 506 –התשס"ז בסיון י"ז
H04M18043528/02/2001
בחשמל מאומת לא שימוש לגילוי שיטהכח קווי דרך מועבר
METHOD OF DETECTING UNAUTHORIZED USAGE OF ELECTRICITY TRANSMITTED OVER POWER LINESQUADLOGIC CONTROLS CORPORATION
29/02/2000
60/185832US
PCT/US/2001/006573WO/2001/065823
G06K18043630/06/2005
עזר – סוללת בעלRFID משיב – משדראחורי פיזור עם
BATTERY-ASSISTED BACKSCATTER RFID TRANSPONDER
POWERID LTDבע"מ פאואראיידי01/07/2004
60/584141US
18/08/2004
60/602342US
09/09/2004
60/608118US
01/10/2004
60/614552US
04/02/2005
60/649561US
PCT/IL/2005/000694WO/2006/003648
A61L18043730/06/2005
רכה רקמה שתל ומימדי צורה ניהולגזע תאי באמצעות
SHAPE AND DIMENSION MAINTENANCE OF SOFT TISSUE GRAFTS BY STEM CELLS
June 3, 2007507 –התשס"ז בסיון י"ז
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
30/06/2004
60/584657US
PCT/US/2005/023318WO/2006/004951
A47K18043828/12/2006
AMENITIES CASEנוחות מארז
BR-GO INTERNATIONAL TRADEמוגבלת שותפות בינלאומי סחר בר-גוLIMITED PARTNERSHIP
B65H18043930/06/2005
חומר של בליפוף לשליטה ושיטות מערכותלינארי
SYSTEMS AND METHODS FOR CONTROLLING SPOOLING OF LINEAR MATERIALGREAT STUFF, INC.
01/07/2004
60/584797US
02/07/2004
60/585042US
PCT/US/2005/023652WO/2006/007582
G21K18044028/12/2006
COMPACT SOURCE WITH VERY בהירהX קרן עם דחוס מקורBRIGHT X - RAY BEAMALCATEL LUCENT
03/01/20060650007FR
June 3, 2007 508 –התשס"ז בסיון י"ז
C07D18044122/07/2005
– איל( – פירימידינים2– – )פירידין2 פטריות על לבקרה בהם ושימוש
פתוגניות
2( - PYRIDIN - 2 - YL - )PYRIMIDINES AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGIBASF AKTIENGESELLSCHAFT
23/07/2004
102004035736.6DE
PCT/EP/2005/008039WO/2006/010570
C09D18044214/07/2005
באמצעות לריפוי הניתנים להזרקה דיובהם לשימוש ושיטות לייצור קרינה, שיטה
RADIATION CURABLE INKJET INKS, METHOD OF MANUFACTURE, AND METHODS OF USE THEREOFHEXION SPECIALTY CHEMICALS, INC.
16/07/2004
60/588921US
04/10/2004
60/615756US
02/06/2005
60/686768US
PCT/US/2005/025074WO/2006/085992
H04L18044301/07/2005
MIMOADVANCED MIMO INTERLEAVING ל מתקדם אינטרליבינגQUALCOMM INCORPORATED
01/07/2004
60/585246US
19/07/2004
60/589390US
11/08/2004
60/600962US
PCT/US/2005/023594WO/2006/007571
June 3, 2007509 –התשס"ז בסיון י"ז
H04N18044401/07/2005
קצב של בטכניקות לשימוש ומתקן שיטה לפי וידיאו בהצפנות למעלה המרה מסגרתסקלה
METHOD AND APPARATUS FOR USING FRAME RATE UP CONVERSION TECHNIQUES IN SCALABLE VIDEO CODINGQUALCOMM INCORPORATED
01/07/2004
60/585154US
22/03/2005
60/665816US
PCT/US/2005/023333WO/2006/007527
B29D18044516/07/2004
STRETCH FILMאלסטי פיליםMEGAPLAST S.A.
PCT/EP/2004/007965WO/2006/018028
G06F18044623/06/2005
לתהליך גרף אפליקציית של בקר–מציגאובייקט
OBJECT PROCESS GRAPH APPLICATION CONTROLLER-VIEWERGRAPHLOGIC INC.
16/07/2004
60/588465US
20/05/2005
10/908653US
PCT/US/2005/022192WO/2006/019506
June 3, 2007 510 –התשס"ז בסיון י"ז
C12N18044713/07/2005
MEDIUM FOR GROWING HUMANאדם בן עובר של גזע תאי לגידול מצעEMBRYONIC STEM CELLSGERON CORPORATION
13/07/2004
60/587843US
01/03/2005
60/657990US
PCT/US/2005/025179WO/2006/017370
B23B18044828/12/2006
CLAMPING APPARATUSמלחציים מתקןF-TOOL INTERNATIONAL AG
30/01/200600151/06CH
C07K18044911/12/1997
תרכובות המכילות פרמצבטיות נוסחאות תרופות להעברת במים מסיסה שאינה
מתמשכת
PHARMACEUTICAL FORMULATIONS COMPRISING A WATERINSOLUBLE COMPLEX FOR SUSTAINED DRUG DELIVERYPRAECIS PHARMACEUTICALS INCORPORATED
11/12/1996
08/762747US
PCT/US/1997/022881WO/1998/025642
C07K18045011/12/1997
תרכובות המכילות פרמצבטיות נוסחאות תרופות להעברת במים מסיסה שאינה
מתמשכת
PHARMACEUTICAL FORMULATIONS COMPRISING A WATERINSOLUBLE COMPLEX FOR SUSTAINED DRUG DELIVERYPRAECIS PHARMACEUTICALS INCORPORATED
June 3, 2007511 –התשס"ז בסיון י"ז
11/12/1996
08/762747US
PCT/US/1997/022881WO/1998/025642
A61L18045107/07/2005
בשימוש גבוהה ברמה לחיטוי ותכשיר שיטהרביעוני אמוניום הרכבי
METHOD AND COMPOSITION FOR HIGH LEVEL DISINFECTION EMPLOYING QUATERNARY AMMONIUM COMPOUNDSNANOSONICS PTY LIMITED
09/07/2004
2004903796AU
PCT/AU/2005/000997WO/2006/005108
B60H18045231/12/2006
ACTIVE VENTILATING SYSTEM FORרכב עבור פעיל אוורור מערכתVEHICLE
GIL AVRAHAMאברהם גיל
B60H18045331/12/2006
A BATHTUBאמבטיהLIAV DAVIDדויד רונלי ליאב
G06Q18045431/12/2006
METHOD & SYSTEM FORאלקטרוני תשלום לניתוב ומערכת שיטהELECTRONIC PAYMENT ROUTING
EHUD ZIEGELMANציגלמן אהוד
A47G18045505/04/2002
June 3, 2007 512 –התשס"ז בסיון י"ז
לדברי קולב עבר להסרה הניתן גודל מצייןלבוש
REMOVABLE SIZE INDICATOR FOR A GARMENT HANGERSPOTLESS PLASTICS PTY. LTD.
05/04/2001827072US
PCT/US/2002/010750WO/2002/080741
A61M18045630/06/2005
SYRINGE DEVICE HAVING VENTINGאוורור מערכת עם הזרקה התקןSYSTEMWEST PHARMACEUTICAL SERVICES, INC.
01/07/2004
60/584893US
PCT/US/2005/023754WO/2006/007592
C07K18045801/07/2005
PEPTIDE ANTIBIOTICS ANDלהכנתה ושיטות מפפטיד אנטיביוטיקהMETHODS FOR MAKING SAMEBIOSOURCE PHARM, INC.
01/07/2004
10/881160US
PCT/US/2005/023343WO/2006/083317
C07K18045901/07/2005
TREATMENT OF BACTERIALבקטרייאלים בזיהומים טיפולINFECTIONSNEUTEC PHARMA PLC
02/07/2004
0414886.2GB
PCT/GB/2005/002607WO/2006/003426
June 3, 2007513 –התשס"ז בסיון י"ז
A61K18046030/06/2005
TREATMENT OF CANCERבסרטן טיפולNEUTEC PHARMA PLC
02/07/2004
0414885.4GB
20/09/2004
0420845.0GB
30/09/2004
60/614423US
21/02/2005
0503566.2GB
22/02/2005
60/654458US
PCT/GB/2005/002545WO/2006/003384
A61L18046125/06/2005
המכילות תרחיף פורמולציות תרסיסEA 277 TGאו A 134 TGמניע כחומר
AEROSOL SUSPENSION FORMULATIONS CONTAINING TG 227 EA OR TG 134 A AS A PROPELLANTBOEHRINGER INGELHEIM INTERNATIONAL GMBH
02/07/2004
102004032322.4DE
17/05/2005
102005023334.1DE
PCT/EP/2005/006865WO/2006/002840
A47C18046231/12/2006
INTELLIGENT CHILD SAFETY SEATהילד לבטיחות חכם כסאASHER S. SABANש. סבן אשר
30/03/2006174634IL
A45D18046306/07/2004
SHAVER WITH HAIR PREHEATINGהשיער של מקדים חימום עם גילוח מכשירRADIANCY INC.
June 3, 2007 514 –התשס"ז בסיון י"ז
PCT/IL/2004/000603WO/2006/003642
A45D18046406/07/2004
להרחקת אלמנט עם חשמלי גילוח מכשירפסולת
ELECTRIC SHAVER WITH DEBRIS REMOVAL ELEMENTRADIANCY INC.
PCT/IL/2004/000602WO/2006/003641
A45D18046506/07/2004
IMPROVED ELECTRIC SHAVERמשופר חשמלי גילוח מכשירRADIANCY INC.
PCT/IL/2004/000604WO/2006/003643
B64C18046724/06/2005
HYBRID AIRCRAFTהיברידי מטוסSIMICON AS
02/07/2004
20042823NO
PCT/NO/2005/000228WO/2006/004416
June 3, 2007515 –התשס"ז בסיון י"ז
A01H18046801/07/2005
WATERMELON WITH IMPROVEDמשופרות עיבוד תכונות בעל אבטיחPROCESSING QUALITIESSEMINIS VEGETABLE SEEDS, INC.
02/07/2004
60/584964US
22/10/2004
10/972190US
31/03/2005
2005201372AU
PCT/US/2005/023902WO/2006/014463
A61F18046931/12/2006
VASCULAR ACCESS SYSTEM ANDלווריד לחדירה ושיטה מערכתMETHOD
OFER SELAסלע עופר
A61K18047029/06/2005
שימוש נגד מוגנת פומית מינון צורתלרעה
ORAL DOSAGE FORM SAFEGUARDED AGAINST ABUSEGRUNENTHAL GMBH
01/07/2004
102004032049.7DE
14/07/200410/890763US
PCT/EP/2005/006984WO/2006/002884
A61K18047126/06/2005
June 3, 2007 516 –התשס"ז בסיון י"ז
שימוש נגד מוגנת פומית מינון צורת–3(–3 (–R 1 , R 2) הכוללת לרעה
–2–אתיל–1דימתילאמינו–מתיל–פרופיל(–פניל
ORAL DOSAGE FORM SAFEGUARDED AGAINST ABUSE CONTAINING (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOLGRUNENTHAL GMBH
01/07/2004
102004032103.5DE
14/07/200410/890707US
PCT/EP/2005/006990WO/2006/002886
H01L18047201/01/2007
חשמל ליצירת הידראולית מערכתנפח שינויי באמצעות
A SYSTEM FOR ELECTRICITY CREATION BY HYDRAULIC VOLUMETRIC REPLACEMENT
KLUGERMAN VLADIMIRרומן קלוגרמן
A61M18047321/07/2005
להתקן ממשק לאספקת ומערכות שיטהאינפוזיה
METHOD AND SYSTEMS FOR PROVIDING AN INFUSION DEVICE INTERFACEANIMAS CORPORATION
21/07/2004
60/589623US
PCT/US/2005/025931WO/2006/012446
H05K18047501/01/2007
בלוח אופטי סיב של חלקי לקיבוע שיטהמודפס מעגלים
METHOD OF PARTIALLY EMBEDDING OPTICAL FIBER IN MULTILAYER PRINTED CIRCUIT BOARD
.ELTEK LTDבע"מ אלטק
June 3, 2007517 –התשס"ז בסיון י"ז
H05K18047601/01/2007
דרך אופטיים אותות לשידור ישירה דרךמודפס מעגלים לוח
STRAIGHTFORWARD OPTICAL VIA FOR SIGNAL TRANSMISSION THROUGH A PRINTED CIRCUIT BOARD
.ELTEK LTDבע"מ אלטק
G09B18047701/01/2007
דיגיטלי ותיקון להגהה ושיטה מערכתפגישה בתוך ורב–צדדי
SYSTEM AND METHOD FOR DIGITAL MULTI-LATERAL PROOFREADING DURING A MEETING
D. SIT TRADE LTDבע"מ סחר די.סיט
C07C18047930/09/2005
IMPROVED SYNTHESIS SCHEME FORללקוסאמיד משופרת סינתזה סכימתLACOSAMIDESCHWARZ PHARMA AG
02/10/2004
04023556.6EP
PCT/EP/2005/010603WO/2006/037574
D01F18048014/07/2005
של מננוטובים מרוכב סיב לעשיית תהליך מולרית מסה בעל פחמן/פוליאתילן
גבוהה אולטרה
PROCESS FOR MAKING A CARBON NANOTUBES/ ULTRA-HIGH MOLAR MASS POLYETHYLENE COMPOSITE FIBREDSM IP ASSETS B.V.
27/07/2004
04077162.8EP
PCT/EP/2005/007816WO/2006/010521
June 3, 2007 518 –התשס"ז בסיון י"ז
C07D18048120/07/2005
ARYL-PYRIDINE DERIVATIVESאריל–פירידין של נגזרותF. HOFFMANN-LA ROCHE AG
28/07/2004
04103639.3EP
PCT/EP/2005/007894WO/2006/010546
G01N18048201/01/2007
באמצעות קטנים תווים של בדיקהרנטגן קרני של פלואורסצנזיה
INSPECTION OF SMALL FEATURES USING X - RAY FLUORESCENCE
JORDAN VALLEYבע"מ סמיקונדקטורס ואלי ג'ורדןSEMICONDUCTORS LTD.
G11C18048301/07/2005
ידי על דינמי ריענון לשיפור ושיטה מערכת מוליך זיכרון בהתקן טמפרטורה מדידת
למחצה
APPARATUS AND METHOD FOR IMPROVING DYNAMIC REFRESH IN A SEMICONDUCTOR MEMORY DEVICE BY TEMPERATURE MEASUREMENTQUALCOMM INCORPORATED
02/07/2004
60/585310US
10/06/2005
11/150649US
PCT/US/2005/023334WO/2006/014315
C07D18048420/07/2005
June 3, 2007519 –התשס"ז בסיון י"ז
און, הכנתן3–ארילמורפולינ–4 תולדותהרפואי ושימושן
4-ARYLMORPHOLIN-3-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOFSANOFI-AVENTIS
23/07/20040408222FR
PCT/FR/2005/001852WO/2006/021654
H01S18048503/08/2005
SOLID-STATE SUSPENSION LASERמוצקה סוספנסיה לייזרRAYTHEON COMPANY
10/08/2004
10/915229US
PCT/US/2005/027472WO/2006/026037
C07D18048605/08/2005
אמינים עם בנזימידאזול תולדת של מלחיםלייצרה ותהליך
SALTS OF BENZIMIDAZOLE DERIVATIVE WITH AMINES AND PROCESS FOR PRODUCTION THEREOFEISAI R&D MANAGEMENT CO. LTD.
06/08/2004
2004-230094JP
PCT/JP/2005/014400WO/2006/013960
A61K18048708/07/2005
MEDICAMENTתרופהAIMSCO LIMITED
08/07/2004
0415359.9GB
21/10/2004
0423386.2GB
PCT/GB/2005/050108WO/2006/021814
June 3, 2007 520 –התשס"ז בסיון י"ז
C07D18048825/07/2005
מותמרות, הכנתן ציקליות אוריאה תולדותקינאז כמעכבי שלהן הפרמצבטי והשימוש
SUBSTITUTED CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF OF KINASE INHIBITORSAVENTIS PHARMA S.A.
27/07/2004
04291903.5EP
PCT/EP/2005/008722WO/2006/010643
H04Q18048904/07/2005
התקן של גאופרפי לאיתור ומערכת שיטהסלולרי
SYSTEM AND METHOD FOR GEOGRAPHICALLY LOCATING A CELLULAR DEVICEITIS UK LIMITED
09/07/2004
10/888631US
PCT/GB/2005/002637WO/2006/005906
C07K18049006/07/2005
CYCLIC PEPTIDESציקליים פפטידיםPALATIN TECHNOLOGIES, INC.
06/07/2004
60/585971US
05/07/2005
11/174851US
PCT/US/2005/024125WO/2006/014552
C07K18049106/07/2005
CYCLIC PEPTIDESציקליים פפטידיםPALATIN TECHNOLOGIES, INC.
June 3, 2007521 –התשס"ז בסיון י"ז
06/07/2004
60/585971US
05/07/2005
11/174851US
PCT/US/2005/024138WO/2006/014559
B65D18049215/06/2005
דרגת עם חומרים להנפקת ושיטה התקןגבוהה נקיון
APPARATUS AND METHOD FOR DISPENSING HIGH PURITY MATERIALSMALLINCKRODT BAKER, INC.
06/07/2004
60/585663US
21/10/2004
60/621030US
PCT/US/2005/021234WO/2006/014225
C07D18049330/06/2005
–5,5–מתוקסימתיל–1 להכנת תהליךברביטורית דיפניל–חומצה
A PROCESS FOR PREPARING 1-METHOXYMETHYL-5,5-DIPHENYLBARBITURIC ACID
TARO PHARMACEUTICALבע"מ רוקחית תעשיה תרוINDUSTRIES LTD.
02/07/2004
60/584955US
PCT/IL/2005/000697WO/2006/003651
C07D18049520/07/2005
רברס כמעכבי טריאזולון תרכובותנוקלאוטידים שאינם טרנסקריפטאז
BENZYLTRIAZOLONE COMPOUNDS AS NIN-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORSF. HOFFMANN-LA ROCHE AG
27/07/2004
60/591311US
PCT/EP/2005/007893
June 3, 2007 522 –התשס"ז בסיון י"ז
WO/2006/010545
G01N18049607/07/2005
מטענים ריכוז מדידת ו/או לגילוי חיישן חשמליים
לייצורו והשיטה בו אטמוספירם, שימושים
SENSOR FOR DETECTING AND/OR MEASURING CONCENTRATION OF ELECTRIC CHARGES CONTAINED IN AN ATMOSPHERE, CORRESPONDING USES AND METHOD FOR MAKING SAMEUNIVERSITE DE RENNES 1
07/07/20040407583FR
PCT/FR/2005/001761WO/2006/013289
A61B18049730/06/2005
BIOLOGICAL TISSUE CLOSUREביולוגית רקמה של לסגירה ושיטה התקןDEVICE AND METHODBRUCE D. MODESITT
10/07/2004
10/888682US
PCT/US/2005/023107WO/2006/017023
C07J18049812/07/2005
PROCESS FOR PRODUCTION OFסטרואידים ליצירת תהליךSTEROIDS
June 3, 2007523 –התשס"ז בסיון י"ז
MITSUBISHI CHEMICAL CORPORATION
13/07/2004
2004-205515JP
23/07/2004
2004-215304JP
PCT/JP/2005/013216WO/2006/006718
C09D18049905/07/2005
מים מסיסי אקריליים בקופולימרים שימושותמיסות צבעוניות מים בתמיסות
USE OF WATER-SOLUBLE ACRYLIC COPOLYMERS IN OPTIONALLY PIGMENTED AQUEOUS FORMULATIONS AND RESULTING FORMULATIONSCOATEX S.A.S.
08/07/20040407570FR
PCT/FR/2005/001714WO/2006/016035
A01G18050002/01/2007
השקיה מערכת באמצעות מנהרות הריסתבטפטוף
TUNNEL DISTRACTION WITH DRIP IRRIGATION SYSTEM
RONI BEN AVRAHAMספורטס( משפחת )לידי אברהם בן רוני
A47G18050102/07/2005
CROWN SIZERגודל ממינת כותרתMAINETTI S.P.A.
09/07/2004
VI 2004 A 000168IT
14/01/2005
VI 2005 A 000007IT
PCT/EP/2005/007172WO/2006/005467
June 3, 2007 524 –התשס"ז בסיון י"ז
C12Q18050213/12/2004
חומצות ללכידת מוצקה בפזה חומריםגרעין
SOLID PHASE MATERIALS FOR BINDING NUCLEIC ACIDSLUMIGEN, INC.
15/07/2004
10/891880US
PCT/US/2004/039762WO/2006/019388
C12Q18050330/06/2005
מחומרים גרעין חומצות לשחרור שיטותמוצקה בפזה מלכדים
METHODS FOR RELEASING NUCLEIC ACIDS FROM SOLID PHASE BINDING MATERIALSLUMIGEN, INC.
15/07/2004
10/891880US
PCT/US/2005/023916WO/2006/019568
C12Q18050413/12/2004
מפזות גרעין חומצות לבידוד שיטותלביקוע שניתנות מוצקות
METHODS FOR ISOLATING NUCLEIC ACIDS FROM CLEAVABLE SOLID PHASESLUMIGEN, INC.
15/07/2004
10/891880US
PCT/US/2004/039761WO/2006/019387
B65H18050504/07/2005
ELECTRIC HOSE WINDERחשמלי צינורות מגוללXU XIAOHUA
13/04/2005
200520101572.5CN
PCT/CN/2005/000974WO/2006/108327
June 3, 2007525 –התשס"ז בסיון י"ז
B65D18050602/01/2007
A FOLDING, STORAGE ANDונשיאה קיפול, אחסון מתקןCARRYING DEVICE
SHAY DAGANדגן שי
H01B18050702/01/2007
ומכרסמים מים בפני ועמיד גמיש כבל תקשורת ככבל לשימוש במיוחד המתאים
אופטי
HIGHLY FLEXIBLE WATER-PROOF, RODENT-PROOF CABLES PARTICULARLY USEFUL AS OPTICAL COMMUNICATION CABLES
.TELDOR WIRES AND CABLES LTDבע"מ וכבלים מוליכים טלדור
C07D18050829/06/2005
לשימוש מותמרים פירימידינים של קולטנים של כמודולטורים
גלוקוקורטיקואיד
MODIFIED PYRIMIDINE GLUCOCORTICOID RECEPTOR MODULATORSCORCEPT THERAPEUTICS, INC.
02/07/2004
60/585018US
PCT/US/2005/023675WO/2006/014394
A61N18050905/07/2005
DELIVERY SYSTEM FORהעור דרך לחיסון הולכה מערכתTRANSDERMAL IMMUNIZATION
.TRANSPHARMA MEDICAL LTDבע"מ מדיקל טראנספארמה
June 3, 2007 526 –התשס"ז בסיון י"ז
06/07/2004
60/585081US
PCT/IL/2005/000710WO/2006/003659
G06F18051004/07/2005
CRUSH MODELLINGהתנגשות מודלENGENUITY LIMITED
02/07/2004
0414992.8GB
31/08/2004
0419292.8GB
PCT/GB/2005/002627WO/2006/003438
H01M18051108/07/2005
–דלק תא של לאלקטרודות זרזים שלה, הכנה וסגסוגות פלטינה מבוסס המכילים שלהם, ותאי–דלק ושימושאותם
CATALYSTS FOR FUEL CELL ELECTRODES BASED ON PLATINUM AND ITS ALLOYS, THE PREPARATION AND USE THEREOF, AS WELL AS FUEL CELLS CONTAINING THEMACTA S.P.A.
09/07/2004FI2004A000154IT
PCT/EP/2005/053270WO/2006/005724
C07C18051207/07/2004
–4) של וניקוי לסינתזה תהליך –4מתוקסיבוטיל( )
טריפלואורומתילפניל( מתאמנון
PROCESS FOR THE SYNTHESIS AND PURIFICATION OF (4-METHOXYBUTYL)(4-TRIFLUOROMETHYLPHENYL)METHANONELUNDBECK PHARMACEUTICALS ITALY S.P.A.
PCT/EP/2004/051390WO/2006/002691
June 3, 2007527 –התשס"ז בסיון י"ז
C07C18051307/07/2004
' – דיאמינו–4 – 4 של לסינתזה תהליךסולפון – דיפניל
PROCESS FOR SYNTHESIS OF 4-4'-DIAMINO-DIPHENYL-SULFONELUNDBECK PHARMACEUTICALS ITALY S.P.A.
PCT/EP/2004/051389WO/2006/002690
C12N18051407/07/2005
ניזוק שלא חלבון של ביולוגי ארעי ביטויבצמחים
BIOLOGICALLY SAFE TRANSIENT PROTEIN EXPRESSION IN PLANTSICON GENETICS GMBH
07/07/2004
04016011.1EP
15/01/2005
60/593454US
PCT/EP/2005/007361WO/2006/003018
G01G18051502/01/2007
NETWORKED WEIGHT SCALEמרושתות מאזניםMICHAL LAORלאור מיכל
C07K18051807/07/2005
שעברEPO של חדשה תרכובתליצורה ושיטה קרבמילציה
NOVEL CARBAMYLATED EPO AND METHOD FOR ITS PRODUCTIONH. LUNDBECK A/S
07/07/2004
PA 2004 01075DK
07/07/2004
60/586370US
23/06/2005
60/693870US
PCT/DK/2005/000477WO/2006/002646
June 3, 2007 528 –התשס"ז בסיון י"ז
A61B18051902/01/2007
ביולוגית ברקמה לטיפול ושיטה מערכתפלזמה גז שחרור באמצעות
SYSTEM AND METHOD FOR TREATING BIOLOGICAL TISSUE WITH A PLASMA GAS DISCHARGE
ALMA LASERS LTDבע"מ לייזרס אלמה18/06/2006
11/333308US
G06Q18052010/08/2005
דינמית, להוספה ומערכת שיטה סטטיים לתכנים פרסומות בזמן–אמת, של
מורדים
METHOD AND SYSTEM FOR DYNAMIC, REAL-TIME ADDITION OF ADVERTISEMENTS TO DOWNLOADED STATIC CONTENT
.HIRO-MEDIA LTDבע"מ הירו-מדיה10/08/2004
60/599876US
PCT/IL/2005/000866WO/2006/016365
D06F18052103/01/2007
AN APPARATUS FOR DRYINGחיצוני כביסה מייבשCLOTHES
SHALOM REHAVIרחבי שלום
A61B18052203/01/2007
RESPIRATION MONITORנשימה מוניטורRONEN PADOWICZפדוביץ רונן
June 3, 2007529 –התשס"ז בסיון י"ז
A61P18052324/05/2000
-COMPOSITIONS FOR IAPP ושימושםIAPP מעכבות תרכובותINHIBITION AND USES THEREONQUEEN'S UNIVERSITY AT KINGSTON
24/05/1999
60/135545US
09/07/1999
60/143123US
23/05/2000
09/576677US
PCT/CA/2000/000607WO/2000/071101
C07D18052405/07/2005
–}4–הידרוקסי–N להכנת משופר תהליך–3,1–מתיל–2–איסופרופיל–5–)4–]5
–איל(–פנוקסי[–פנטוקסי{–4תיאזול–בנזאמידין
AN IMPROVED PROCESS FOR PREPARING N-HYDROXY-4-{5-[4-(5-ISOPROPYL-2-METHYL-1,3-THIAZOL-4-YL)-PHENOXY]-PENTOXY}-BENZAMIDINEDONG WHA PHARMACEUTICAL IND. CO. LTD.
05/07/2004
10-2004-0052070KR
PCT/KR/2005/002137WO/2006/004368
B65H18052707/07/2005
Z מסוג נעילה מערכת עם עטיפה חומרבו ושימוש לייצורו ושיטות
A WRAPPING MATERIAL WITH A Z-LOCK SYSTEM AND METHODS OF MAKING AND USING THE SAME
TAMA PLASTIC INDUSTRYפלסטיק תעשיות תמה
June 3, 2007 530 –התשס"ז בסיון י"ז
07/07/2004
10/884966US
PCT/IB/2005/003691WO/2006/048779
C12P18052823/02/2000
במחלות לטיפול רוקחות תכשירימיטוכונדריאליות
PHARMACEUTICAL FORMULATIONS FOR TREATING MITOCHONDRIAL DISORDERSWellstat Therapeutics Corporation
23/02/1999
60/121588US
PCT/US/2000/004663WO/2000/050043
E06B18052903/01/2007
SLAT BLIND TILTING LEVERתריסים רפרפות לכוונון מנוףYEHUDA KOSTAקוסטה יהודה
C12Q18053107/07/2005
NOVEL SEQUENCE FOR IMPROVINGגרעין חומצת ביטוי לשיפור חדש רצףEXPRESSION OF NUCLEIC ACIDCHROMAGENICS B.V.
08/07/200460/587007US
08/07/2004PCT/EP2004/51405EP
PCT/EP/2005/053251WO/2006/005718
June 3, 2007531 –התשס"ז בסיון י"ז
G03F18053201/02/2005
אל–מימיים מיקרואלקטרוניים ניקוי תכשיריפרוקטוז המכילים
NON-AQUEOUS MICROELECTRONIC CLEANING COMPOSITIONS CONTAINING FRUCTOSEMALLINCKRODT BAKER, INC.
15/07/2004
60/588248US
PCT/US/2005/003422WO/2006/019402
G01N18053311/07/2005
DROPLET DEPOSITION APPARATUSטיפונת לפליטת התקןXAAR TECHNOLOGY LIMITED
10/07/2004
0415529.7GB
PCT/GB/2005/002746WO/2006/005952
E03D18053415/06/2005
W.C. DISPENSER WITH PERFUMINGמבושם מיכל עם לאסלה דיספנסרCHAMBERRE.LE.VI-S.P.A.
14/07/2004RE2004A000084IT
PCT/EP/2005/006514WO/2006/005410
F24J18053506/07/2005
SOLAR ENERGY CONTROLסולארית אנרגיה בקרתSHEC LABS-SOLAR HYDROGEN ENERGY CORPORATION
June 3, 2007 532 –התשס"ז בסיון י"ז
06/07/20042473042CA
PCT/CA/2005/001048WO/2006/002545
A43B18053603/01/2007
PROTECTIVE GAITERולגרב לנעל מגןYUVAL SHORמקובר עינב
B65D18053804/01/2007
TRAYמגש.SARI KLEIN LTDבע"מ קליין שרי
A61B18053923/06/2005
לשימוש אופטי סיב בחון קצה לייצור שיטהרפואי בהתקן
METHOD OF MAKING A FIBER OPTIC PROBE TIP FOR USE IN A MEDICAL DEVICEONDINE INTERNATIONAL LTD.
22/07/2004
60/590420US
30/03/2005
11/094084US
PCT/US/2005/022336WO/2006/019510
A61N18054003/06/2005
יישומים עבור בסונופוטודינמיקה ריפוידנטליים
SONOPHOTODYNAMIC THERAPY FOR DENTAL APPLICATIONSONDINE INTERNATIONAL LTD.
22/07/2004
60/590421US
27/10/2004
60/622463US
June 3, 2007533 –התשס"ז בסיון י"ז
PCT/US/2005/019707WO/2006/022970
A61N18054108/07/2005
ומניעת מינירלי חומר לסילוק מערכתמוליכים רפואיים התקנים עבור קרישה
ANTI-COAGULATION AND DEMINERALIZATION SYSTEM FOR CONDUCTIVE MEDICAL DEVICESATS MEDICAL, INC.
12/07/2004
10/889328US
PCT/US/2005/024502WO/2006/017213
C07D18054309/07/2005
כקוטלי מותמר –פירולידין2 תולדותחרקים וקולטי פטריות
SUBSTITUTED 2-PYRROLIDONE DERIVATIVES AS FUNGICIDES AND INSECTICIDESBAYER CROPSCIENCE AG
12/07/2004
04016320.6EP
PCT/EP/2005/007442WO/2006/005551
C07D18054427/07/2005
פיפרזין, הכנתן דיארילמתיל של נגזרותושימושן
DIARYLMETHYL PIPERAZINE DERIVATIVES, PREPARATIONS THEREOF AND USES THEREOFASTRAZENECA AB
02/08/2004
0401968-3SE
18/08/2004
60/602363US
PCT/SE/2005/001186WO/2006/014133
C07D18054526/07/2005
June 3, 2007 534 –התשס"ז בסיון י"ז
הינוQ בהן היבריד שלA Q מולקולות אנטיביוטי, משקע הינוAו– אמינוקוינולין
נגד כחומרים שלהן והשמושים והסינתזהחיידקים
HYBRID MOLECULES QA WHERE Q IS A AMINOQUINOLINE AND A IS AN ANTIBIOTIC RESIDUE, AND THE SYNTHESIS AND USES THEREOF AS ANTIBACTERIAL AGENTSPALUMED S.A.
30/07/20040408441FR
23/12/2004
11/019450US
PCT/FR/2005/001937WO/2006/024741
C07D18054627/07/2005
בדיכאון לטיפול פיפרידין של חדשה נגזרתNOVEL PIPERIDINE DERIVATIVE FOR THE TREATMENT OF DEPRESSIONASTRAZENECA AB
02/08/2004
0401969-1SE
PCT/SE/2005/001187WO/2006/014134
C07D18054727/07/2005
של כליגנדים פיפרידין של חדשות נגזרות קולטן
בדיכאון לטיפול3H היסטמין
NOVEL PIPERIDINE DERIVATIVES AS HISTAMINE
H3 RECEPTOR LIGANDS FOR TREATMENT OF DEPRESSIONASTRAZENECA AB
02/08/2004
0401970-9SE
PCT/SE/2005/001188June 3, 2007535 –התשס"ז בסיון י"ז
WO/2006/014135
C07D18054827/07/2005
קולטן של כלינגדים פיפרידין של נגזרות3H היסטמין
PIPERIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR LIGANDSASTRAZENECA AB
02/08/2004
0401971-7SE
PCT/SE/2005/001189WO/2006/014136
G01N18054912/07/2005
FC איזור בעלי נוגדנים והנדסת זיהוילשימושם ושיטות משתנה
IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT FC REGIONS AND METHODS OF USING SAMEMACROGENICS, INC.
12/07/2004
60/587251US
28/07/2004
10/902588US
PCT/US/2005/024645WO/2006/088494
H05C18055006/07/2005
לתוך חשמלי זרם לאספקת ומערכת שיטהמדיום או אובייקט
METHOD AND APPARATUS FOR PROVIDING ELECTRIC CURRENT INTO AN OBJECT OR MEDIUM
June 3, 2007 536 –התשס"ז בסיון י"ז
THE COMMONWEALTH OF AUSTRALIA, C/O MINISTER FOR DEFENCE
07/07/2004
2004903724AU
PCT/AU/2005/000984WO/2006/002485
G01N18055208/09/2005
METHOD OF EXPLOSIVE DETECTIONנפץ חומרי וזיהוי לגילוי שיטהAND IDENTIFICATIONZAKRYTOE AKTSIONERNOE OBSCHESTVO "INTELLEKTUALNYE SKANIRUYUSCHIE SISTEMY"
09/09/2004
2004126993RU
PCT/RU/2005/000456WO/2006/031155
C07D18055306/07/2005
גידול גורם המאפננים קווינאזולין לטיפולMET –C / פעילות הפאטוציטי
בסרטן
QUINAZOLINE MODULATORS OF HEPATOCYTE GROWTH FACTOR C-MET ACTIVITY FOR THE TREATMENT OF CANCERANGION BIOMEDICA CORPORATION
06/07/2004
60/585734US
PCT/US/2005/023801WO/2006/014420
June 3, 2007537 –התשס"ז בסיון י"ז
C07K18055403/08/2005
RAGE FUSION PROTEINS ANDשימוש ושיטותRAGE אחויים חלבוניםMETHODS OF USETRANSTECH PHARMA, INC.
03/08/2004
60/598555US
PCT/US/2005/027705WO/2006/017647
C12N18055503/08/2005
RAGE FUSION PROTEINS ANDשימוש ושיטותRAGE אחויים חלבוניםMETHODS OF USETRANSTECH PHARMA, INC.
03/08/2004
60/598362US
PCT/US/2005/027694WO/2006/017643
H01S18055620/12/2005
ושיטת לייזר רכיב עבור מגן שכבת זיגוגאנקפסולציה
ARTICULATED GLAZE CLADDING FOR LASER COMPONENTS AND METHOD OF ENCAPSULATIONRAYTHEON COMPANY
23/12/2004
11/021413US
PCT/US/2005/047624WO/2006/130180
A61K18055808/07/2005
המכילים ערכיים רבVLA–4 אנטגוניסטיםפולימריים חלקים
MULTIVALENT VLA-4 ANTAGONISTS COMPRISING POLYMER MOIETIESELAN PHARMACEUTICALS, INC.
08/07/2004
60/586975US
PCT/US/2005/024369
June 3, 2007 538 –התשס"ז בסיון י"ז
WO/2006/010054
H04N18055908/07/2005
מוזיקה עבור זכויות לניהול ומערכת שיטהדיגיטלית
METHOD AND SYSTEM FOR MANAGING RIGHTS FOR DIGITAL MUSICCATCH MEDIA, INC.
16/07/2004
10/893473US
PCT/US/2005/024212WO/2006/019608
H04L18056007/07/2005
מתוזמנת להעברה תוכן לריבוד מערכתתקשורת ברשת
SYSTEM FOR LAYERING CONTENT FOR SCHEDULED DELIVERY IN A DATA NETWORKQUALCOMM INCORPORATED
09/07/2004
60/586820US
21/06/2005
11/158662US
PCT/US/2005/023980WO/2006/017099
F24H18056104/01/2007
ברז הכולל חימום או שמש לדוד אוגןמהדוד המים לריקון
A FLANGE OF A TANK OF HEATING WATER THAT INCLUDES A TAP FOR EMPTYING THE WATER
UDI RAHMANIרחמני עודי
G09B18056204/01/2007
June 3, 2007539 –התשס"ז בסיון י"ז
עם לילדים עצמי ללימוד אנגלית מקלדתדיסלקציה
A SELF TEACHING ENGLISH KEYBOARD FOR CHILDREN WITH DYSLEXIA
MARINA VIGODSKYויגודסקי מרינה
F04D18056304/01/2007
AUTOMATIC VACUUM PUMPאוטומטית ואקום משאבתDAN BRONברקוביץ( )אצל ברון דן
H01R18056404/01/2007
למכשיר שקע עם חשמלי מכשיר תקענוסף חשמלי
AN ELECTRICAL CONNECTION-REPRODUCING ELECTRICAL PLUG
YAIR MESHULAMמשולם יאיר
A61`18056504/01/2007
לתוך תרופות למתן משופר מפסיק ברזמטופל של הגוף
AN IMPROVED STOPCOCK FOR ADMINISTERING MEDICAMENTS INTO THE PATIENT'S BODY
.PLASTMED LTDבע"מ פלאסטמד
G06K18056704/07/2005
SYSTEM AND METHOD FORלהדמיה ושיטה מערכתIMAGING
.REAL IMAGING LTDבע"מ אימג'ינג ריל07/07/2004
60/586162US
PCT/IL/2005/000707WO/2006/003658
June 3, 2007 540 –התשס"ז בסיון י"ז
G01N18056806/07/2005
שקע דמות לאיתור ומכשירים שיטותשקעים נושא רכיב בתמונת
METHOD AND DEVICE FOR IDENTIFYING AN IMAGE OF A WELL IN AN IMAGE OF A WELL-BEARING COMPONENTSENG ENTERPRISES LTD.
07/07/2004
60/585571US
13/09/2004
10/938951US
15/10/2004
60/618585US
05/11/2004
60/625096US
PCT/IL/2005/000719WO/2006/003664
H04Q18056904/07/2005
אינטראקטיבית מולטימדיה שירות מערכתושיטה
AN INTERACTIVE MULTIMEDIA SERVICE SYSTEM AND METHOD THEREOFSK TELECOM CO., LTD.
05/07/2004
10-2004-0052129KR
PCT/KR/2005/002119WO/2006/004363
June 3, 2007541 –התשס"ז בסיון י"ז
C07D18057002/07/2005
מותמר דיפנילאמין נגזרות קרובות ותרכובות סליצילתיאזול
–B1 פוספטאז פוספוטירוזין כמעכבותPTP1Bהמרכיבים בהפחתת לשימוש
טיפול במסגרת בדם סוכר של הפעיליםבסכרת
DIPHENYLAMINE-SUBSTITUTED SALICYLTHIAZOLE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOTYROSINE PHOSPHATASE 1B (PTP1B) INHIBITORS FOR USING AS BLOOD-SUGAR DECREASING ACTIVE INGREDIENTS FOR TREATING DIABETESSANOFI-AVENTIS DEUTSCHLAND GMBH
17/07/2004
102004034697.6DE
PCT/EP/2005/007151WO/2006/007959
C07C18057128/06/2005
של אננטיומרית צורה לייצור שיטה–דיאמינו3,2 פרופיונית חומצה נגזרות
METHOD FOR PRODUCING ENANTIOMERIC FROM OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVESSANOFI-AVENTIS DEUTSCHLAND GMBH
10/07/2004
102004033406.4DE
PCT/EP/2005/006920WO/2006/005436
C12Q18057207/07/2005
ההגנה להגברת פעילים חומריםלמציאתם בצמחים, ושיטות הפתוגנית
ACTIVE INGREDIENTS FOR ENHANCING PATHOGEN DEFENSE IN PLANTS, AND METHODS OF FINDING THEMBAYER CROPSCIENCE GMBH
20/07/2004
102004035137.6DE
PCT/EP/2005/007344WO/2006/007981
June 3, 2007 542 –התשס"ז בסיון י"ז
A01N18057307/07/2005
SAFENING METHODלהגנה שיטהBAYER CROPSCIENCE GMBH
20/07/2004
102004035136.8DE
PCT/EP/2005/007345WO/2006/007982
A61K18057708/08/2005
הרפית לעידוד וזודילטור המכיל תכשירוסקולרי חלק שריר
A COMPOSITION CONTAINING A VASODILATOR FOR PROMOTING VASCULAR SMOOTH MUSCLE RELAXATIONFUTURA MEDICAL DEVELOPMENTS LIMITED
09/08/2004
0417675.6GB
PCT/GB/2005/003110WO/2006/016139
G06C18057807/01/2007
CREDIT PHONE SYSTEMקרדיט–פון מערכתSHLOMI AZRIELעזריאל מאיר שלמה
A61P18057907/01/2007
לקבלתם פיפירידין, תהליך נגזרותאותן הכוללים ריקחיים והרכבים
PIPERIDINE DERIVATIVES, PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSANOFI AVENTIS
10/02/199999/01593FR
07/04/199999/04429FR
PCT/FR/2000/000284WO/2000/047572
June 3, 2007543 –התשס"ז בסיון י"ז
E04C18058007/07/2005
BALLISTIC ABATEMENT BARRIERבליסטי מחסום להפחתת ומערכת שיטהMETHOD AND SYSTEMBLASHIELD, INC.
08/07/2004
10/886975US
PCT/US/2005/024073WO/2006/085980
C12Q18058114/07/2005
גרעיניות לחומצות אנליזה ושיטות מערכותקשורים ומרכיבים פולימריות
SYSTEMS AND METHODS OF ANALYZING NUCLEIC ACID POLYMERS AND RELATED COMPONENTSZS GENETICS, INC.
14/07/2004
60/587997US
PCT/US/2005/024979WO/2006/019903
G02B18058206/07/2005
INTELLIGENT INTERACTIVE LOCKנעילה ומערכת חכם הידודי מנעולAND LOCKING SYSTEM
SEGEV, EREZארז שגב06/07/2004
60/585089US
PCT/IL/2005/000715WO/2006/003661
G07F18058305/07/2004
June 3, 2007 544 –התשס"ז בסיון י"ז
ללא קופה במכונות מזומנים לקבלת שיטה תשלום בהוראת שימוש ע"י כרטיס
אס( אמ )אס טקסט הודעות באמצעות
METHOD FOR OBTAINING CASH AT CARDLESS TELLER MACHINES, USING A PAYMENT ORDER VIA SMSCAJA DE AHORROS DE GALICIA
PCT/ES/2004/000321WO/2006/013218
A61K18058412/07/2005
MSF–A תלויHIFלהורדת חומריםבסרטן לטיפול ושימושם
AGENTS CAPABLE OF DOWNREGULATING AN MSF-A-DEPENDENT HIF-1ALPHA AND USE THEREOF IN CANCER TREATMENT
המרכז שליד תשתיות ופיתוח מחקרים קרןסוראסקי ע"ש אביב תל הרפואי
THE MEDICAL RESEARCH FUND AT THE TEL-AVIV SOURASKY MEDICAL CENTER
12/07/2004
60/586697US
PCT/IL/2005/000736WO/2006/038208
G06F18058518/05/2005
הניתנת נמוכה עוצמה בעלת ארכיטקטורה של סימולטני ליישום מחדש לעיצוב
ברורים לתקשורת סטנדרטים
LOW-POWER RECONFIGURABLE ARCHITECTURE FOR SIMULTANEOUS IMPLEMENTATION OF DISTINCT COMMUNICATION STANDARDSASOCS LTD
08/07/2004
60/586353US
June 3, 2007545 –התשס"ז בסיון י"ז
08/07/2004
60/586389US
08/07/2004
60/586390US
08/07/2004
60/586391US
PCT/IB/2005/002485WO/2006/006076
G06F18058608/07/2005
אורטוגונלים שינויים ליישום ומערכת שיטהמשתנים בגדלים מהירים
A METHOD OF AND APPARATUS FOR IMPLEMENTING FAST ORTHOGONAL TRANSFORMS OF VARIABLE SIZEASOCS LTD
08/07/2004
60/586390US
08/07/2004
60/586391US
08/07/2004
60/586389US
08/07/2004
60/586353US
25/08/2004
60/604258US
03/03/2005
11/071340US
PCT/US/2005/024063WO/2006/014528
C07D18058702/08/2005
HETEROCYCLIC COMPOUNDSהטרוציקליות תרכובותPALAU PHARMA S.A.
03/08/2004
200401971ES
PCT/EP/2005/008371WO/2006/013095
June 3, 2007 546 –התשס"ז בסיון י"ז
C07K18058804/08/2005
CMETHUMANIZED ANTI-CMET נוגדי אנושי ממקור אנטגוניסטיםANTAGONISTSGENENTECH, INC.
05/08/2004
60/598991US
PCT/US/2005/027626WO/2006/015371
A61K18058929/07/2005
בסרטן – לטיפול29IL ו–IL–28ב– שימושעצמי חיסון של סדרים ואי
USE OF IL-28 AND IL-29 TO TREAT CANCER AND AUTOIMMUNE DISORDERSZymoGenetics INC.
29/07/2004
60/592069US
19/11/2004
60/629702US
29/04/2005
60/676047US
PCT/US/2005/026951WO/2006/012644
G06K18059211/07/2005
DISAMBIGUATING AMBIGUOUSמעורפלים תווים של משמעית דו הבהרהCHARACTERSAOL LLC
09/07/2004
60/586502US
PCT/US/2005/024519WO/2006/010114
E01F18059311/07/2005
ANTI-VEHICLE SECURITY SYSTEMרכב כלי נגד ביטחון מערכתVAN BIBBER, MICHAEL
June 3, 2007547 –התשס"ז בסיון י"ז
09/07/2004
10/888337US
PCT/US/2005/024537WO/2006/010122
A23B18059408/01/2007
METHOD OF PROCESSING GARLICשום לעיבוד שיטהZIVA MORENOמורנו זיוה
09/01/2006
60/757007US
G09G18059516/08/2005
תצוגה התקן מנהל מעגל של מאפייןחיי במצב הפעלה המאפשר
CURRENT MODE DISPLAY DRIVER CIRCUIT REALIZATION FEATUREIDC, LLC.
27/08/2004
60/604893US
15/07/2005
11/182389US
PCT/US/2005/029161WO/2006/026162
G09F18059622/07/2005
FIELD LABELED BUTTONשדה תיוג מתגLUTRON ELECTRONICS CO. INC.
23/07/2004
60/590627US
PCT/US/2005/026119WO/2006/012545
A61K18059725/07/2005
June 3, 2007 548 –התשס"ז בסיון י"ז
שחרור עבור שכבות רב פרמצבטית טבלית מסיסות בעלי פעילים מרכיבים של מבוקר
גבוההPHתלות– על
PHARMACEUTICAL MULTILAYER TABLET FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS WITH HIGHLY PH-DEPENDENT SOLUBILITYSANOFI-AVENTIS
29/07/2004
04291943.1EP
PCT/EP/2005/008719WO/2006/010640
G01N18060108/07/2005
שחלות סרטן לגילוי ותרכובות שיטותMETHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN CANCERTRIPATH IMAGING, INC.
09/07/2004
60/586856US
PCT/US/2005/024359WO/2006/010047
C07D18060327/03/2000
GLUCOCORTICOID RECEPTORגלוקוקורטיקואיד רצפטור של מודולטוריםMODULATORSPFIZER PRODUCTS, INC.
30/04/1999
60/132130US
PCT/IB/2000/000366WO/2000/066522
B65D18060509/01/2007
-CONTAINER WITH MULTIמשולב הושטה מכסה עם מיכלFUNCTION DISPENSING COVER
.ZEUS AVIV LTDבע"מ הטבע מן חממית
June 3, 2007549 –התשס"ז בסיון י"ז
G06F18060605/07/2000
טכני חומר של וסינטזה הצגה, ניהול, סינוןREPRESENTATION, MANAGEMENT, FILTERING AND SYNTHESIS OF TECHNICAL CONTENTCOHESIA CORPORATION
08/07/1999
09/349753US
PCT/US/2000/018422WO/2001/004812
C12Q18060703/08/2005
בסימנים המשתמשים ושיטות בחניםביולוגיים
ASSAYS AND METHODS USING BIOMARKERSGENENTECH, INC.
06/08/2004
60/599425US
PCT/US/2005/027480WO/2006/017531
C07K18060815/07/2005
HER2HER2 ANTIBODY COMPOSITION נוגדן של תכשירGENENTECH, INC.
22/07/2004
60/590202US
PCT/US/2005/025084WO/2006/033700
G06F18060912/07/2005
June 3, 2007 550 –התשס"ז בסיון י"ז
אלקטרונים מעגלים לעיצוב והתקן שיטהאופטימיזציה באמצעות
METHOD AND APPARATUS FOR DESIGNING ELECTRONIC CIRCUITS USING OPTIMIZATIONKIMOTION TECHNOLOGIES
13/07/2004
10/890349US
PCT/US/2005/024595WO/2006/017247
A61B18061009/01/2007
GRIPPING TOOLלאחיזה מכשירSHERWOOD SERVICES AG
16/01/2006
2006-7828JP
H04B18061129/06/2005
איזוריות תקשורת במערכות שכן סריקתאל–חוטיות
NEIGHBOR SCANNING IN WIRELESS LOCAL AREA NETWORKSINTERDIGITAL TECHNOLOGY CORPORATION
12/07/2004
60/587159US
PCT/US/2005/023145WO/2006/017024
C08B18061211/07/2005
המערכת להמרצת ושיטות חומריםהחיסונית
MATERIALS AND METHODS FOR IMMUNE SYSTEM STIMULATIONVARIETY CHILDREN'S HOSPITAL d/b/a MIAMI CHILDREN'S HOSPITAL
June 3, 2007551 –התשס"ז בסיון י"ז
09/07/2004
60/586548US
PCT/US/2005/024410WO/2006/010069
G05F18061305/07/2005
של האפשר ככל להקטנה ושיטות מערכותמשולב ממעגל קבוע ערך בעלת דליפה
SYSTEMS AND METHODS FOR MINIMIZING STATIC LEAKAGE OF AN INTEGRATED CIRCUITVIRTUAL SILICON TECHNOLOGY, INC.
09/07/2004
60/586565US
24/11/2004
10/996739US
PCT/US/2005/023839WO/2006/017082
B01D18061412/04/2005
Co2 הסרת הכולל בעירה גזי של ביתר ניקויULTRA CLEANING OF COMBUSTION GAS INCLUDING THE REMOVAL OF CO2EIG, INC.
06/08/2004
60/599228US
13/10/2004
60/617779US
PCT/US/2005/012794WO/2006/022885
June 3, 2007 552 –התשס"ז בסיון י"ז
G01N18061520/07/2005
פנאומטי מפעל עם להכוונה הניתן קטטרהידראולי או
STEERABLE CATHETER WITH HYDRAULIC OR PNEUMATIC ACTUATORST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC.
20/07/2004
10/895510US
PCT/US/2005/025888WO/2006/012421
H04L18061728/07/2005
שידור רב שירות וקליטת להספקת שיטה גישה במערכת עבירה בזמן לקהל ושידור
רחב פס אלחוטית
METHOD OF PROVIDING AND RECEIVING MULTICAST AND BROADCASTING SERVICE DURING HANDOVER IN BROADBAND WIRELESS ACCESS SYSTEMLG ELECTRONICS INC.
29/07/2004
10-2004-0059932KR
PCT/KR/2005/002458WO/2006/011763
H04Q18061829/07/2004
נתונים תעבורת שרות של חוקי יירוט פס אלחוטית גישה במערכת מיקום מבוסס
רחב
LAWFUL INTERCEPTION OF LOCATION BASED SERVICE TRAFFICTELEFONAKTIEBOLAGET LM ERICSSON (PUBL)
June 3, 2007553 –התשס"ז בסיון י"ז
PCT/IT/2004/000417WO/2006/011165
H04Q18061929/07/2004
IRIPROVISION OF LOCATION לתוך מיקום מידע של הספקהINFORMATION INTO IRITELEFONAKTIEBOLAGET LM ERICSSON (PUBL)
PCT/IT/2004/000418WO/2006/011166
F02K18062009/01/2007
טרוף סילון/סילון מגח קרה הצתה מערכתתכליתי רב גז גנרטור
MULTIPURPOSE GAS GENERATOR RAMJET/ SCRAMJET COLD START SYSTEMUNITED TECHNOLOGIES CORPORATION
31/01/2006
11/344764US
B60N18062111/11/2004
ממסרה, נועל לכיוון הניתן מושב מבנהדו–צירית שתי סינכרוני, שיבולת צילוב
BILATERAL, WARP-TOLERANT, CROSS-SYNCHRONIZED, GEAR-LOCK ADJUSTABLE SEAT STRUCTUREMJD INNOVATIONS, L.L.C.
18/08/2004
10/921051US
PCT/US/2004/038006WO/2006/022789
A61B18062307/07/2005
SURGICAL IMAGING DEVICEניתוח לדימות התקןPOWER MEDICAL INTERVENTIONS, INC.
June 3, 2007 554 –התשס"ז בסיון י"ז
09/07/2004
10/888285US
PCT/US/2005/024141WO/2006/017128
H04Q18062411/07/2005
או פרוטוקולים מרובתRFID מערכתהוראות מרובת
MULTI-PROTOCOL OR MULTI-COMMAND RFID SYSTEMTC LICENSE LTD.
09/07/2004
10/887320US
PCT/US/2005/024432WO/2006/010076
A61B18062510/07/2005
למדידת ושיטה לביש, מערכת מכשירחיוניים פרמטרים
WEARABLE DEVICE, SYSTEM AND METHOD FOR MEASURING VITAL PARAMETERS
.TADIRAN SPECTRALINK LTDבע"מ ספקטרלינק תדיראן09/07/2004
60/586241US
PCT/IL/2005/000732WO/2006/006158
A61B18062610/07/2005
לניטור ושיטה לביש, מערכת מכשירפיזיולוגיים פרמטרים
סביבתיים ו/או
A WEARABLE DEVICE, SYSTEM AND METHOD FOR MONITORING PHYSIOLOGICAL AND/OR ENVIRONMENTAL PARAMETERS
.TADIRAN SPECTRALINK LTDבע"מ ספקטרלינק תדיראן09/07/2004
60/586243US
09/07/2004
60/586242US
21/07/2004
60/589599US
PCT/IL/2005/000733WO/2006/006159
June 3, 2007555 –התשס"ז בסיון י"ז
B41J18062712/07/2005
הדפסה צפיפות שוני להפחתת שיטהדיו הזרקת במדפסות במדפסות, במיוחד
METHOD FOR REDUCING PRINT-DENSITY VARIATIONS IN PRINTERS, PARTICULARY IN INKJET PRINTERS
.JEMTEX INK JET PRINTING LTDבע"מ פרינטינג ג'ט אינק ג'מטקס12/07/2004
60/586712US
PCT/IL/2005/000737WO/2006/006162
C07F18062810/07/2005
מחומצנים פוספוליפידים להכנת תהליכיםIMPROVED PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS
.VASCULAR BIOGENICS LTDבע"מ ביוג'ניק וסקולר09/07/2004
60/586219US
PCT/IL/2005/000735WO/2006/006161
G06K18062924/05/2000
IDENTITY CODED SURFACEמקודדת שזהותו משטחSILVERBROOK RESEARCH PTY. LTD.
25/05/1999PQ0559AU
30/06/1999PQ1313AU
15/10/1999PQ3457AU
01/12/1999PQ4392AU
PCT/AU/2000/000570WO/2000/072250
C07D18063030/07/2005
PYRROLE DERIVATIVES ASרוקחות כגורמי פירול תולדותPHARMACEUTICAL AGENTS
June 3, 2007 556 –התשס"ז בסיון י"ז
EXELIXIS, INC.30/07/2004
60/592469US
30/07/2004
60/592439US
PCT/US/2005/026916WO/2006/012642
B41J18063310/01/2007
EFFICIENT KEYBOARDיעילה מקלדתZIV FISHERפישר זיו
A61K18063513/07/2005
זיהוי לשם זריקתי רדיו–אקטיבי צבע שימושהשומרות הלימפה בלוטות
USE OF AN INJECTABLE RADIOACTIVE DYE FOR SENTINEL LYMPH NODE IDENTIFICATIONBOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
13/07/2004
10/890420US
PCT/US/2005/024786WO/2006/010144
H01T18063608/07/2005
במחוללי בו והשימוש גבוה מתח מפסקמיקרוגל
HIGH-VOLTAGE SWITCH AND USE THEREOF IN A MICROWAVE GENERATORDIEHL BGT DEFENCE GMBH & CO. KG
19/07/2004
102004034895.2DE
PCT/EP/2005/007426WO/2006/008000
June 3, 2007557 –התשס"ז בסיון י"ז
C07D18063708/07/2005
פיראזול של טריציקליות תולדותקולטניקאנאבינואיד כמווסתי
TRICYCLIC PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORSCADILA HEALTHCARE LTD.
12/07/2004
745/MUM/2004IN
PCT/IN/2005/000237WO/2006/025069
A61K18063811/07/2005
באמצעות וכאב בדלקת לטיפול הרכבים COX–2 של סלקטיבי מעכב של שילוב
LTB4 קולטן של ואנטגוניסט
COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND PAIN USING A COMBINATION OF A COX-2 SELECTIVE INHIBITOR AND A LTB4 RECEPTOR ANTAGONISTPHARMACIA CORPORATION
22/07/2004
60/590076US
PCT/IB/2005/002203WO/2006/011048
B25B18063910/01/2007
חלקי והעמדת לתיקון הידוק מערכתעבודה
CLAMPING APPARATUS FOR POSITIONING AND FIXING WORK PIECESF-TOOL INTERNATIONAL AG
13/03/200600393/06CH
G06K18064008/07/2005
SYSTEM AND METHOD FORאשראי חשבון לאבטחת ושיטה מערכתSECURING A CREDIT ACCOUNT
June 3, 2007 558 –התשס"ז בסיון י"ז
DAVID, N. HARRIS12/07/2004
10/889227US
PCT/US/2005/024242WO/2006/017165
G01R18064114/07/2005
ורכיבים סדקים לקביעת ומערכת שיטהבשריון שבורים
METHOD AND SYSTEM FOR DETERMINING CRACKS AND BROKEN COMPONENTS IN ARMORSIMULA, INC.
16/07/2004
10/892357US
PCT/US/2005/024859WO/2006/019820
G09B18064211/01/2007
כלים יישום תוך זרה שפה להוראת שיטהרגשית אינטליגנציה מודעות של
A METHOD OF TEACHING A FOREIGN LANGUAGE BY APPLYING AWARENESS AND EMOTIONAL INTELLIGENCE TOOLS
GILA FRISCHERפרישר גילה
C07D18064324/06/2005
מצמחי פאקליטאקסל לקבלת שיטותטאקסוס
METHODS FOR OBTAINING PACLITAXEL FROM TAXUS PLANTSINDENA S.P.A.
13/07/2004
04016493.1EP
PCT/EP/2005/006846WO/2006/005429
G01N18064412/07/2005
June 3, 2007559 –התשס"ז בסיון י"ז
של אוטומטית לאנליזה ושיטה התקןדם דגימות
DEVICE AND METHOD FOR AUTOMATICALLY ANALYSING BLOOD SAMPLESVDG-VON DER GOLTZ GMBH
12/07/2004
102004033654.7DE
PCT/DE/2005/001228WO/2006/005326
H04Q18064630/06/2005
תקשורת במערכת ויעילה מהירה העברהמקומית אלחוטית
ROBUST AND FAST HANDOVER IN A WIRELESS LOCAL AREA NETWORKINTERDIGITAL TECHNOLOGY CORPORATION
12/07/2004
60/587273US
PCT/US/2005/023756WO/2006/017064
C12Q18064703/08/2005
בסימנים המשתמשים ושיטות בחניםביולוגיים
ASSAYS AND METHODS USING BIOMARKERSGENENTECH, INC.
06/08/2004
60/599393US
PCT/US/2005/029045WO/2006/017859
C09K18064803/05/2005
OXYGEN-ABSORBING PACKAGINGחמצן הסופג אריזה חומרMATERIALMULTISORB TECHNOLOGIES, INC.
13/07/2004
10/889731US
PCT/US/2005/015236WO/2006/016916
June 3, 2007 560 –התשס"ז בסיון י"ז
A61K18065008/07/2005
INFUSION AND INJECTIONולהזרקה לאינפוזיה לבודופה תמיסתSOLUTION OF LEVODOPADIZLIN MEDICAL DESIGN AB
12/07/2004
0401842-0SE
PCT/SE/2005/001135WO/2006/006929
G08B18065217/10/2005
השראה מצמדי של משורשר ארגוןנתונים לתקשורת
ARRANGEMENT OF DAISY CHAINED INDUCTIVE COUPLERS FOR DATA COMMUNICATIONAMBIENT CORPORATION
14/12/2004
11/011574US
PCT/US/2005/037463WO/2006/065340
F25B18065313/07/2005
אופף מאוויר מים לעיבוי יחידי מחזור התקןSINGLE CYCLE APPARATUS FOR CONDENSING WATER FROM AMBIENT AIRGRAEME ALLAN COLLINS
13/07/2004
2004903841AU
PCT/AU/2005/001027WO/2006/005133
C07D18065413/07/2005
June 3, 2007561 –התשס"ז בסיון י"ז
ותרופות מותמרות אוקסינדול נגזרותאותן המכילות
SUBSTITUTED OXINDOL DERIVATIVES AND MEDICAMENTS CONTAINING THE SAMEABBOTT GMBH & CO. KG
13/07/2004
102004033834.5DE
13/07/200460/587407US
PCT/EP/2005/007631WO/2006/005609
A61F18065511/01/2007
בעל אטריאלי אלקטרוגרם של מיפוימורכבות חלוקות
MAPPING OF COMPLEX FRACTIONATED ATRIAL ELECTROGRAMBIOSENSE WEBSTER, INC.
12/01/2006
60/758317US
05/01/2007
11/620370US
B21D18065612/07/2005
חסין–עייפות לגליון חתכים להכנסת שיטההנוצר והגליון
FATIGUE-RESISTANCE SHEET SLITTING METHOD AND RESULTING SHEETINDUSTRIAL ORIGAMI, LLC
12/07/2004
60/587470US
PCT/US/2005/024693WO/2006/017290
B08B18065811/01/2007
EAR PROTECTIONאוזניים מגןEDRI OFERעופר אדרי
H04L18065913/07/2005
June 3, 2007 562 –התשס"ז בסיון י"ז
אובייקט על למידע גישה להשגת שיטה ,ONS מקומי, הרשאת תווית, שרת בעל
בעל תווית, התקן יצירת תוכנית, שיטת על לשליטה תווית, תווית, ותוכנית כתיבתהתווית כתיבת בעל ההתקן
METHOD FOR ACCESSING INFORMATION ON OBJECT HAVING TAG, LOCAL SERVER, ONS PROXY, PROGRAM, TAG CREATION METHOD, DEVICE HAVING TAG WRITER, TAG, AND PROGRAM FOR CONTROLLING DEVICE HAVING TAG WRITERIBM CORPORATION
15/07/2004
2004-208935JP
PCT/JP/2005/012938WO/2006/009040
B23B18066011/01/2007
CUTTING TOOL AND CUTTINGשיבוב וכלי שיבוב שימתINSERT
.ISCAR LTDבע"מ ישקר
A61M18066114/07/2005
MATERIAL DELIVERY SYSTEMחומר לשחרור מערכתBY-PASS, INC.
14/07/2004
60/587335US
10/08/2004
60/599884US
23/08/2004
60/603262US
28/04/2005
60/675477US
PCT/IL/2005/000749WO/2006/006169
B64D18066211/01/2007
SIZE ADJUSTABLE SAFETY ANDלקסדה נוח וריפוד מתכווננת גודל ניצרתCOMFORT LINER FOR A HELMETGENTEX CORPORATION
June 3, 2007563 –התשס"ז בסיון י"ז
19/01/2006
11/337040US
F03D18066414/07/2005
מידה בקנה רוח אנרגיית אוגרת מערכתבים להתקינה שניתן תעשייתי
INDUSTRIAL-SCALE WIND-ENERGY-COLLECTION SYSTEM WHICH CAN BE INSTALLED IN THE SEAVICTORINO GONZALEZ DIAZ
14/07/2004P200401716ES
PCT/ES/2005/000403WO/2006/018467
C07D18066515/07/2005
VIRAL POLYMERASE INHIBITORSוירלי פולימראז מעכביBOEHRINGER INGELHEIM INTERNATIONAL GMBH
16/07/2004
60/588670US
PCT/CA/2005/001103WO/2006/007693
C12Q18066627/06/2005
גוונילאט פעילות לזיהוי ובחנים שיטותציקלאז
METHODS AND ASSAYS FOR DETECTING GUANYLATE CYCLASE ACTIVITYAXXAM S.R.L.
16/07/2004
04016774.4EP
PCT/EP/2005/006887WO/2006/007937
June 3, 2007 564 –התשס"ז בסיון י"ז
A01N18066713/07/2005
כחומרים פוספטים באלקנולים שימוש ליצירת המשמשים מפזרים, חומרים
הידרוטרופים, חומרי תחליבים, חומרים בתכשירים מתאימים וחומרים הרטבה
חקלאיים
USE OF PHOSPHATED ALCANOLS AS DISPERSANTS, EMULSIFIERS, HYDROTROPES, WETTING AGENTS AND COMPATABILITY AGENTS IN AGRICULTURAL COMPOSITIONSAKZO NOBEL N.V.
15/07/2004
04077043.0EP
08/09/2004
60/608167US
PCT/US/2005/024777WO/2006/019772
A23L18067027/06/2005
AERATED FOOD PRODUCTSהידרופובין המכילים מאווררים מזון תוצריCONTAINING HYDROPHOBINUNILEVER PLC
27/07/2004
04254483.3EP
03/03/2005
05251282.9EP
PCT/EP/2005/006996WO/2006/010425
A23L18067127/06/2005
AERATED FOOD PRODUCTSהידרופובין המכילים מאווררים מזון תוצריCONTAINING HYDROPHOBINUNILEVER PLC
27/07/2004
04254483.3EP
03/03/2005
05251282.9EP
PCT/EP/2005/006997WO/2006/010426
E04H18067211/01/2007
June 3, 2007565 –התשס"ז בסיון י"ז
STRUCTURE AND ACCESSORIESעבורו ואביזרים מבנהTHEREFOR
AVRAHAM SORYASסוריאס אברהם
A61B18067411/01/2007
IMPROVED SURGICAL CASSETTEמשופרת כירורגית קלטתALCON, INC.
24/01/2006
11/338491US
A61K18067518/07/2005
הפרעות או במחלות לטיפול שיטות המתווכות
CCR2 על–ידי
METHODS OF TREATING CCR2 MEDIATED DISEASES OR DISORSERSPFIZER PRODUCTS, INC.
30/07/2004
60/592683US
PCT/IB/2005/002162WO/2006/013427
C07D18067627/07/2005
טבעת עם הטרוציקליים קינז מאפננימאוחדת
FUSED RING HETEROCYCLE KINASE MODULATORSSGX PHARMACEUTICALS, INC.
27/07/2004
60/591778US
27/07/2004
60/591886US
11/05/2005
60/680091US
PCT/US/2005/026794WO/2006/015124
C07C18067918/10/2001
June 3, 2007 566 –התשס"ז בסיון י"ז
רצפטור של מודולטורים להכנת תהליךגלוקוקורטיקואיד של לא–סטרואידלי
PROCESS FOR THE PREPARATION OF NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORSPFIZER PRODUCTS, INC.
27/10/2000
60/243873US
C07D18068026/07/2005
לטיפול המשמשות פיפרזין של נגזרותומעיים קיבה של בהפרעות
PIPERAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERSGLAXO GROUP LIMITED
28/07/2004
0416844.9GB
08/07/2005
0514029.8GB
PCT/EP/2005/008263WO/2006/010629
C07D18068120/07/2005
PYRIDINE DERIVATIVES, THEIRבהן והשימוש פירידין, הכנתן תולדותPREPARATION AND USEAPPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
21/07/2004
04103483.6EP
21/07/2004
60/589621US
PCT/EP/2005/053501WO/2006/008303
C07D18068225/07/2005
June 3, 2007567 –התשס"ז בסיון י"ז
והשימוש –הידרוקסיאמיד, הכנתןN תולדותבהן
N-HYDROXAMIDE DERIVATIVES, THEIR PREPARATION AND USEAPPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
26/07/2004
04103574.2EP
26/07/2004
60/591111US
31/01/2005
05100641.9EP
01/02/2005
60/648924US
PCT/EP/2005/053616WO/2006/010751
B25J18068318/07/2005
הנע גלגילות עם רצועה של הנע מפעילשונה היקפית מהירות בעלות
DRIVE BELT ACTUATOR WITH DRIVE PULLEYS OF DIFFERENT CIRCUMFERENTIAL SPEEDTIMOTHY JOHN JONES
20/07/2004
0416186.5GB
PCT/GB/2005/002834WO/2006/008515
E02F18068422/07/2005
מטרה לעבר חפירה לניווט והתקן שיטהקבורה
METHOD AND DEVICE FOR NAVIGATING EXCAVATION TOWARDS A BURIED TARGETKEIBERG INTERNATIONAL INC.
22/07/2004
10/896333US
PCT/CA/2005/001160WO/2006/007732
June 3, 2007 568 –התשס"ז בסיון י"ז
C23C18068526/01/2006
CUTTING INSERT WITH EXCELLENTגבוהה קשיחות בעלת חיתוך תותבתTOUGHNESSSANDVIK INTELLECTUAL PROPERTY AB
31/01/2005
0500234-0SE
PCT/SE/2006/000117WO/2006/080888
C23C18068626/01/2006
עבור מודבק מקארביד מצופות תותבותחתוך מכשיר
COATED CEMENTED CARBIDE CUTTING TOOL INSERTSSANDVIK INTELLECTUAL PROPERTY AB
31/01/2005
0500235-7SE
PCT/SE/2006/000118WO/2006/080889
G06F18068814/07/2005
A METHOD AND APPARATUS FORמפתחות למסירת ומערכת שיטהDELIVERING KEYSQUALCOMM INCORPORATED
14/07/2004
60/588203US
PCT/US/2005/025151WO/2006/020015
G08B18068914/07/2005
-VEHICLE ACTIVATED MILLIMETERמכשיר מופעל מילימטרי בגל שידורWAVE INTERROGATINGSAFEVIEW, INC.
June 3, 2007569 –התשס"ז בסיון י"ז
16/07/2004
10/893017US
PCT/US/2005/025115WO/2006/019994
A61L18069014/07/2005
ליצירת הזנה ושיטת מילוי, התקן אמצעיבעצם בחלל תומך מבנה
FILLER MEANS, FEEDING DEVICE AND METHOD FOR THE FORMING OF A SUPPORT STRUCTURE IN A BONE CAVITYSIDLER, BRUNO
14/07/2004
04405451.8EP
PCT/EP/2005/007936WO/2005/094735
A61K18069111/10/2005
ORGANO-GEL FORMULATIONS FORרפואיים ליישומים אורגנו–ג'ל תכשיריTHERAPEUTIC APPLICATIONSMEDIQUEST THERAPEUTICS, INC.
08/10/2004
10/960516US
28/02/2005
11/066485US
13/06/2005
11/150254US
PCT/US/2005/036064WO/2006/042059
A01N18069230/06/2005
HERBICIDAL AGENTSעשבים קוטל תכשירBAYER CROPSCIENCE GMBH
17/07/2004
102004034571.6DE
PCT/EP/2005/007041WO/2006/007947
June 3, 2007 570 –התשס"ז בסיון י"ז
C12N18069413/01/2005
פעילות בעל רעלים מסלק חומרהגנטי קידודו ואת אפלטוקסין המשנה
A DETOXIFIZYME HAVING ACTIVITY OF TRANSFORMING AFLATOXIN AND THE GENE ENCODES THEREOFGUANGZHOU CO-WIN BIOENGINEERING CO. LTD.
17/08/2004
200410051120.0CN
PCT/CN/2005/000050WO/2006/017960
G06K18069515/07/2005
תשלום התקני לבדיקת התייחסות מיכשורמגע ללא
REFERENCE EQUIPMENT FOR TESTING CONTACTLESS PAYMENT DEVICESMASTERCARD INTERNATIONAL INCORPORATED
15/07/2004
60/588270US
PCT/US/2005/025107WO/2006/019989
G06K18069615/07/2005
באמצעות עסקאות לביצוע ומערכת שיטהמגע ללא תשלום כרטיסי
METHOD AND SYSTEM FOR CONDUCTING CONTACTLESS PAYMENT CARD TRANSACTIONSMASTERCARD INTERNATIONAL INCORPORATED
15/07/2004
60/588270US
PCT/US/2005/025119WO/2006/019997
G06K18069715/07/2005
ממנה ולהימנעות התנגשות לגילוי מערכתמגע ללא תשלום כרטיסי מערכות עבור
COLLISION DETECTION AND AVOIDANCE SCHEME FOR CONTACTLESS CARD PAYMENT SYSTEMS
June 3, 2007571 –התשס"ז בסיון י"ז
MASTERCARD INTERNATIONAL INCORPORATED
15/07/2004
60/588270US
PCT/US/2005/025317WO/2006/020144
G06K18069815/07/2005
בביטמפ המשתמשים ומערכת שיטה לעסקאות המתייחסים משתנים למסירת
במבני מגע ללא תשלום כרטיסי באמצעותתקניים נתונים
METHOD AND SYSTEM USING A BITMAP FOR PASSING CONTACTLESS PAYMENT CARD TRANSACTION VARIABLES IN STANDARDIZED DATA FORMATSMASTERCARD INTERNATIONAL INCORPORATED
15/07/2004
60/588624US
PCT/US/2005/025221WO/2006/020073
G06K18069915/07/2005
כרטיסי אותות עבור אפיון ומעגלי שיטותתשלום
PAYMENT CARD SIGNAL CHARACTERIZATION METHODS AND CIRCUITSMASTERCARD INTERNATIONAL INCORPORATED
15/07/2004
60/588270US
PCT/US/2005/025220WO/2006/020072
G06K18070015/07/2005
June 3, 2007 572 –התשס"ז בסיון י"ז
נפח עם מגע ללא תשלום כרטיסי קוראקונית–מקוטעת בצורה עבודה
CONTACTLESS PAYMENT CARD READER WITH A FRUSTO-CONICAL OPERATING VOLUMEMASTERCARD INTERNATIONAL INCORPORATED
15/07/2004
60/588270US
PCT/US/2005/025110WO/2006/019990
C07D18070213/07/2005
DIMERIC PIPERIDINE DERIVATIVESדימריים פיפרדין של תולדותJANSSEN PHARMACEUTICA N.V.
16/07/2004
60/588711US
16/07/2004
04103412.5EP
PCT/EP/2005/053351WO/2006/008260
C07D18070313/07/2005
פיפרדין, פיפראזין, של דימריות תרכובות המכילים שלהם אנלוגיים או מורפולין
המתאימות אטומים7 בעלות טבעותעצבי לניוון הקשורים סדרים באי לטיפול
DIMERIC COMPOUNDS OF PIPERIDINE, PIPERAZINE OR MORPHOLINE OR THEIR 7-MEMBERED ANALOGS SUITABLE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERSJANSSEN PHARMACEUTICA N.V.
16/07/2004
60/588446US
16/07/2004
04103413.3EP
PCT/EP/2005/053345WO/2006/008259
June 3, 2007573 –התשס"ז בסיון י"ז
G05B18070414/07/2005
PROGRAMMABLE WALLBOXלתכנות הניתן תאורה למתג עמעםDIMMERLUTRON ELECTRONICS CO., INC.
15/07/2004
10/892510US
PCT/US/2005/025002WO/2006/019918
F01K18070518/07/2005
חומנית אנרגיה המרת עבור עבודה נוזלי באמצעות וזאת דלק מתאי נפלט חום של
מעגליות ראנקין מערכות
WORKING FLUIDS FOR THERMAL ENERGY CONVERSION OF WASTE HEAT FROM FUEL CELLS USING RANKINE CYCLE SYSTEMSHONEYWELL INTERNATIONAL INC.
16/07/2004
10/892913US
PCT/US/2005/025522WO/2006/014609
A61K18070626/07/2005
PHARMACEUTICAL DOSAGE FORMSראסג'ילין הכוללות רוקחיות מינון צורותINCLUDING RASAGILINE
TEVA PHARMACEUTICALבע"מ פרמצבטיות תעשיות טבעINDUSTRIES LTD.
26/07/2004
60/591359US
01/09/2004
60/606241US
PCT/US/2005/026517WO/2006/014973
C07C18070721/07/2005
June 3, 2007 574 –התשס"ז בסיון י"ז
POLYMORPHS OF ATOMOXETINEהידרוכלוריד אטמוקסטין של פולימורפיםHYDROCHLORIDETEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.
22/07/2004
60/590851US
PCT/US/2005/026008WO/2006/020348
C07D18070822/07/2005
של חדשות קריסטליניות צורות ותהליכים המי–קלציום אטורבסטטין
להכנתן
NOVEL CRYSTAL FORMS OF ATORVASTATIN HEMI-CALCIUM AND PROCESSES FOR THEIR PREPARATION
TEVA PHARMACEUTICALבע"מ פרמצבטיות תעשיות טבעINDUSTRIES LTD.
22/07/2004
60/590945US
PCT/US/2005/026015WO/2006/012499
A61K18071024/01/2001
שחרור בעל להזרקה ניתן פרמצבטי שתלמבוקר
CONTROLLED-RELEASE, INJECTABLE PHARMACEUTICAL IMPLANTARDANA BIOSCIENCE LIMITED
27/01/2000
09/491978US
PCT/EP/2001/000733WO/2001/054662
B23B18071115/07/2005
למתאם, כלי חיתוך כלי לחיבור מערכתואביזר חיתוך
SYSTEM FOR CLAMPING A CUTTING HEAD TO AN ADAPTER, A CUTTING HEAD AND A FIXTURETEENESS ASA
22/07/2004
20043161NO
PCT/NO/2005/000264
June 3, 2007575 –התשס"ז בסיון י"ז
WO/2006/019305
H04S18071213/07/2005
קטעי ניתוח באמצעות אודיו אותות צירוףאודיו
COMBINING AUDIO SIGNALS USING AUDITORY SCENE ANALYSISDOLBY LABORATORIES LICENSING CORPORATION
03/08/2004
10/911404US
PCT/US/2005/024630WO/2006/019719
C12P18071315/07/2005
IMMUNE MODULATING COMPOUNDSמפטריות מתכווננים רכיבים חיסוןFROM FUNGIMEDIMUSH A/S
16/07/200410/892393US
15/06/2005PA200500881DK
15/06/200560/690477US
15/06/2005PA200500882DK
15/06/200560/690482US
15/06/2005PA200500880DK
15/06/200560/690496US
PCT/DK/2005/000498WO/2006/007848
A61K18071420/07/2005
מתחלבות תערובות של גלניים יישומיםליפידיים אקסיפיינטים של מעצמן
GALENIC APPLICATIONS OF SELF-EMULSIFYING MIXTURES OF LIPIDIC EXCIPIENTSAVENTIS PHARMA S.A.
June 3, 2007 576 –התשס"ז בסיון י"ז
27/07/20040408269FR
PCT/FR/2005/001853WO/2006/018501
H01L18071515/01/2007
מפסקים של אוטומטי לייצור ותהליך שיטהאלקטרים פיאזו–
A METHOD FOR THE FULLY AUTOMATED PRODUCTION OF A PIEZOELECTRIC SWITCH AND A PROCESS THEREFOR
BARAN ADVANCED TECHNOLOGIES( בע"מ86) מתקדמות טכנולוגיות ברן(86) LTD.
B01J18071602/07/2005
של הדרגתי לייצור ומתקן שיטהעיבוי בהמסת שימוש על–ידי פולימרים
METHOD AND DEVICE FOR THE GRADUAL PRODUCTION OF POLYMERS USING MELT CONDENSATIONZIMMER AKTIENGESELLSCHAFT
17/07/2004
102004034708.5DE
PCT/EP/2005/007171WO/2006/007966
A61K18071704/08/2005
ILIL-17 ANTAGONISTIC ANTOBODIES – 17 אנטגוניסטים נוגדניםNOVARTIS AG
05/08/2004
0417487.6GB
June 3, 2007577 –התשס"ז בסיון י"ז
PCT/EP/2005/008470WO/2006/013107
C07D18071801/11/2000
של אגוניסטים של חיוביים מודולטוריםניקוטיני רצפטור
POSITIVE MODULATORS OF NICOTINIC RECEPTOR AGONISTSASTRAZENECA AB
03/11/1999
9903997-6SE
PCT/SE/2000/002148WO/2001/032619
G02B18071906/07/2005
ומערך משתנה פוקלי מרחק עם עדשות הנשלטות מיקרו–מראות המכילות עדשותיחידני באופן
VARIABLE FOCAL LENGTH LENS AND LENS ARRAY COMPRISING DISCRETELY CONTROLLED MICROMIRRORSSTEREO DISPLAY, INC.
16/07/2004
10/893039US
PCT/US/2005/023920WO/2006/019571
B23K18072014/07/2005
SOLDER PASTE DISPENSER FOR Aתדמיות מדפסת עבור לחם משחת מנפקSTENCIL PRINTERSPEEDLINE TECHNOLOGIES, INC.
15/07/2004
10/891625US
PCT/US/2005/025071WO/2006/019966
C07D18072115/07/2005
June 3, 2007 578 –התשס"ז בסיון י"ז
לטיפול ניקוטין קולטני של אגוניסטיםדלקתיות במחלות
NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASESUNIVERSITE LAVAL
15/07/2004
10/890987US
PCT/CA/2005/001120WO/2006/005195
C07D18072215/07/2005
רוקחות ותכשירי תיאינופירימידין תולדותאותן המכילים
THIENOPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAMESUNESIS PHARMACEUTICALS, INC.
16/07/2004
60/588718US
01/12/2004
60/632568US
PCT/US/2005/025340WO/2006/036266
G01C18072304/01/2007
LEVELING DEVICEפלס.KAPRO INDUSTRIES LTDבע"מ תעשיות קפרו
C07K18072519/07/2005
,4דמוי–אנגיופיוטין– חלבון של מעכביםבהם ושימוש תצריפיהם
INHIBITORS OF ANGIOPOIETIN-LIKE 4 PROTEIN, COMBINATIONS, AND THEIR USEGENENTECH, INC.
20/07/2004
60/589782US
PCT/US/2005/025734
June 3, 2007579 –התשס"ז בסיון י"ז
WO/2006/014729
B23K18072627/07/2005
והלחמת אוטומטית להרכבה ומכשיר שיטהרפואי מכשור של לייזר
METHOD AND APPARATUS FOR AUTOMATED ASSEMBLY AND LASER WELDING OF MEDICAL DEVICESMEDTRONIC, INC.
28/07/2004
10/900858US
PCT/US/2005/026691WO/2006/015068
C07K18072718/08/2005
המכילים מיקרוביאליים אנטי פפטידיםליזין ו/או ארגינין של מוטיב
ANTIMICROBIAL PEPTIDES COMPRISING AN ARGININE AND/OR LYSINE -CONTAINING MOTIFNOVABIOTICS LIMITED
18/08/2004
0418414.9GB
14/03/2005
11/079795US
PCT/GB/2005/003245WO/2006/018652
G02C18072822/02/2005
June 3, 2007 580 –התשס"ז בסיון י"ז
הכוללים מסגרת חסר מסוג משקפיים מניתנות ציר צידיות, נטולות תייל זרועותלכיפוף
FRAMELESS-TYPE SPECTACLES COMPRISING HINGE-FREE, BENDABLE WIRE SIDEARMSMINIMA
19/08/20040408983FR
PCT/FR/2005/000406WO/2006/027428
C07F18072915/07/2005
COMPOUNDS AND METHODS FORבסרטן לטיפול ושיטות תרכובותTREATMENT OF CANCERTHE TEXAS A&M UNIVERSITY SYSTEM
16/07/2004
60/588596US
PCT/US/2005/025192WO/2006/020048
C07K18073315/07/2005
APOLIPOPROTEIN A1 MIMETICS ושימושיהם1A אפוליפופרוטאין מחקיAND USES THEREOFTRUSTEES OF TUFTS COLLEGE
16/07/2004
60/588722US
PCT/US/2005/025182WO/2006/020040
C12N18073415/07/2005
ושיטות דיסטרופין רטינל של טרנסגןבו לשימוש
RETINAL DYSTROPHIN TRANSGENE AND METHODS OF USE THEREOFTHE CHILDREN'S MERCY HOSPITAL
16/07/2004
60/588700US
09/09/2004
60/608252US
24/09/2004
60/613026US
04/02/2005
11/050911US
June 3, 2007581 –התשס"ז בסיון י"ז
PCT/US/2005/025375WO/2006/020184
A61L18073519/07/2005
מוליכים שטח לפני פעילים חומרים קישורשונים גופים של
MODIFIED CONDUCTIVE SURFACES HAVING ACTIVE SUBSTANCES ATTACHED THERETO
.ELUTEX LTDבע"מ אלוטקס19/07/2004
60/588749US
PCT/IL/2005/000769WO/2006/008739
C07D18073613/07/2005
במחלות לטיפול הידנטואין של נגזרותדלקתיות
HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERSSCHERING CORPORATION
16/07/2004
60/588502US
PCT/US/2005/024771WO/2006/019768
C07C18073726/08/2005
לטיפול ארילסולפונילסטילבין נגזרותקשורים ומצבים באינסומניה
ARYLSULPHONYLSTILBENE DERIVATIVES FOR TREATMENT OF INSOMNIA AND RELATED CONDITIONSMERCK SHARP & DOHME LTD
27/08/2004
0419192.0GB
PCT/GB/2005/003353WO/2006/021806
C07D18073815/07/2005
CINHIBITORS OF HCV REPLICATION הפטיטיס וירוס של שכפול מעכביBRISTOL-MYERS SQUIBB COMPANY
June 3, 2007 582 –התשס"ז בסיון י"ז
09/08/2004
60/608932US
11/03/2005
60/660555US
14/07/2005
11/181639US
PCT/US/2005/025234WO/2006/020082
A61K18073904/08/2005
ושיטות חדישות פנופיבראט פורמולציותקשורות טיפול
NOVEL FENOFIBRATE FORMULATIONS AND RELATED METHODS OF TREATMENTTRANSFORM PHARMACEUTICALS, INC.
06/08/2004
60/599320US
27/08/2004
60/604861US
24/02/2005
60/655762US
06/06/2005
60/687704US
PCT/US/2005/027806WO/2006/017692
A61K18074025/07/2005
מניעה או לטיפול תזונתיים והרכבים שיטותאוסטיאופרוזיס של
NUTRITIONAL COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSISABBOTT LABORATORIES
28/07/2004
60/591656US
PCT/US/2005/026342WO/2006/014878
B41J18074225/07/2005
METHOD OF MANUFACTUREייצור שיטתXAAR TECHNOLOGY LIMITED
June 3, 2007583 –התשס"ז בסיון י"ז
23/07/2004
0416523.9GB
PCT/GB/2005/002923WO/2006/008555
H04Q18074318/07/2005
HANDOFF עם משתנה שידור קצבSOFT
VARIABLE RATE BROADCAST WITH SOFT HANDOFFQUALCOMM INCORPORATED
20/07/2004
60/589819US
15/07/2005
11/182232US
PCT/US/2005/025523WO/2006/014610
H04L18074418/07/2005
צלילי עם והפרעה ערוץ של חוזר אומדןPILOTל מוקצים OFDMA
ITERATIVE CHANNEL AND INTERFERENCE ESTIMATION WITH DEDICATED PILOT TONES FOR OFDMAQUALCOMM INCORPORATED
16/07/2004
60/588646US
22/12/2004
60/639157US
PCT/US/2005/025609WO/2006/010159
H04L18074515/07/2005
ערוץ לאומדןPILOT של הדרגתית החרדהוהפרעה
INCREMENTAL PILOT INSERTION FOR CHANNEL AND INTERFERENCE ESTIMATIONQUALCOMM INCORPORATED
16/07/2004
60/588686US
22/12/2004
60/638536US
13/05/2005
11/128976US
June 3, 2007 584 –התשס"ז בסיון י"ז
PCT/US/2005/025157WO/2006/020021
B22D18074616/01/2007
פיזור עם מתכת בהזרקת מעוצב פריטזהה לעשייה ושיטות לקרינה אטום
METAL INJECTION MOLDED ARTICLE WITH A RADIOPAQUE DISPERSION AND METHODS OF MAKING SAMEACCELLENT, INC.
27/01/2006
11/342182US
C09D18074730/06/2005
AN INK-JET PRINTING PROCESS ANDדיו הזרקת ותהליך דיוINKSUN CHEMICAL B.V.
23/07/2004
0416571.8GB
PCT/GB/2005/002589WO/2006/008441
H04S18074915/08/2005
כל למילוי קול ערבוב להרחבת שיטההפנויים היוצאים הערוצים
METHOD FOR EXPANDING AN AUDIO MIX TO FILL ALL AVAILABLE OUTPUT CHANNELSDOLBY LABORATORIES LICENSING CORPORATION
23/08/2004
10/924757US
PCT/US/2005/029164WO/2006/023509
B65D18075014/07/2005
CONTAINERמיכלMICHAEL JAMES WARWICK
June 3, 2007585 –התשס"ז בסיון י"ז
19/07/2004
2004/5728ZA
PCT/IB/2005/052342WO/2006/011093
C07K18075219/07/2005
דמוי בחלבון לשימוש ושיטות תרכובות4 אנגיופויטין
COMPOSITIONS AND METHODS OF USING ANGIOPOIETIN-LIKE 4 PROTEINGENENTECH, INC.
20/07/2004
60/589875US
PCT/US/2005/025650WO/2006/014678
F41G18075317/01/2007
אדומה "נקודה מסוג משופר תצפית מתקןנעה"
IMPROVED "MOVING RED DOT" SIGHTING DEVICE
"FN HERSTAL" S.A.08/02/2006
2006/0078BE
A61B18075417/01/2007
לחיבור כירורגי, אליפטי, תוך–חללי מהדקרקמות
ELLIPTICAL INTRALUMINAL SURGICAL STAPLER FOR ANASTOMOSISETHICON ENDO-SURGERY, INC.
01/02/2006
11/344542US
C12N18075504/08/2005
June 3, 2007 586 –התשס"ז בסיון י"ז
לשימוש ושיטותAHASS מונוקוט רצפיבהם
MONOCOT AHASS SEQUENCES AND METHODS OF USEBASF PLANT SCIENCE GMBH
04/08/2004
60/598671US
PCT/US/2005/027729WO/2006/015376
C07D18075726/07/2005
[ פירימידינים, שימושיהםD–5 , 4אמידזו]להכנתם ושיטות
IMIDAZO[4,5-D] PYRIMIDINES, THEIR USES AND METHODS OF PREPARATIONGILEAD SCIENCES, INC.
27/07/2004
60/591726US
PCT/US/2005/026606WO/2006/033703
C07D18075901/08/2005
דם כלי במחלות לטיפול היעילים אינדזוליםולב
INDAZOLES USEFUL IN TREATING CARDIOVASCULAR DISEASESWYETH
03/08/2004
60/598573US
08/04/2005
60/669737US
PCT/US/2005/026970WO/2006/017284
C07D18076029/09/2005
ב או בהטרוציקליים מותמרים פירימידיניםHIV כמעכבי – קרבו5
HIV INHIBITING 5-CARBO- OR HETEROCYCLIC SUBSTITUTED PYRIMIDINESTIBOTEC PHARMACEUTICALS LTD.
30/09/2004
04104814.1EP
June 3, 2007587 –התשס"ז בסיון י"ז
PCT/EP/2005/054931WO/2006/035068
C07K18076219/07/2005
אוליגומרי של קוניוגטים של פורמולציותבהן ושימוש אינסולין
INSULIN-OLIGOMER CONJUGATES, FORMULATIONS AND USES THEREOFNOBEX CORPORATION
19/07/2004
60/589058US
15/10/2004
60/619153US
02/12/2004
60/632578US
24/02/2005
60/655803US
24/02/2005
60/655838US
PCT/US/2005/025644WO/2006/014673
C07D18076327/12/2005
דיאזאפן פאניל קרבוקסאמידי פאניל קרבוקסאמידי ואנאלייטד
ובשימוש חמצן המכילים דיאזאפן כאנטגוניסטים
D 3 של
PHENYL DIAZEPANE CARBOXAMIDES AND ANNELATED PHENYL PIPERAZINE CARBOXAMIDES CONTAINING OXYGEN AND USED AS DOPAMINE D3 ANTAGONISTSSCHWARZ PHARMA AG
30/12/2004
102004063797.0DE
PCT/EP/2005/014047WO/2006/072430
June 3, 2007 588 –התשס"ז בסיון י"ז
C23C18076429/07/2005
של ( לשיקועII) נחושת של קומפלקסים של שיקוע ידי על נחושת של פילמיםאוטומיות שכבות
COPPER (II) COMPLEXES FOR DEPOSITION OF COPPER FILMS BY ATOMIC LAYER DEPOSITIONE.I. DU PONT DE NEMOURS AND COMPANY
30/07/2004
60/592785US
30/07/2004
60/592816US
PCT/US/2005/027019WO/2006/015225
B29C18076502/08/2005
לעשיית נמוכה בטמפרטורה עיצוב תהליךביולוגי לפירוק הניתנים מוצקים פריטים
LOW TEMPERATURE MOLDING PROCESS FOR MAKING SOLID BIODEGRADABLE ARTICLESR&D GREEN MATERIALS, LLC
05/08/2004
60/599215US
PCT/US/2005/027380WO/2006/017481
C07D18076620/07/2005
ושימושם אמינופיפרידין, הכנתם תולדותמלנוקורטין קולטני של כאגוניסטים
AMINOPIPERIDINE DERIVATIVES , PREPARATION THEREOF AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONISTSSANOFI-AVENTIS
29/07/20040408370FR
PCT/FR/2005/001855WO/2006/021656
June 3, 2007589 –התשס"ז בסיון י"ז
H04N18076720/07/2005
FRAME מבוססת להמרה ומערכת שיטהRATE UPוידאו דחיסת עבור (FRUC–EA)
METHOD AND APPARATUS FOR ENCODER ASSISTED-FRAME RATE UP CONVERSION (EA-FRUC) FOR VIDEO COMPRESSIONQUALCOMM INCORPORATED
20/07/2004
60/589901US
PCT/US/2005/025813WO/2006/012384
C23C18076829/07/2005
של ( לשיקועII) נחושת של קומפלקסים של שיקוע ידי על נחושת של פילמיםאוטומיות שכבות
COPPER (II) COMPLEXES FOR DEPOSITION OF COPPER FILMS BY ATOMIC LAYER DEPOSITIONE.I. DU PONT DE NEMOURS AND COMPANY
30/07/2004
60/592785US
30/07/2004
60/592816US
PCT/US/2005/026953WO/2006/015200
G06F18076928/06/2005
SYSTEM FOR PROVIDING ACCESSתפעולי למידע גישה לאספקת מערכתTO OPERATION INFORMATIONNDS LIMITED
16/08/2004
60/601890US
16/08/2004
0418279.6GB
PCT/IL/2005/000685WO/2006/018827
June 3, 2007 590 –התשס"ז בסיון י"ז
C07D18077020/07/2005
והשימוש אוקסופיפרידין, הכנתן תולדותבהן הרפואי
OXOPIPERIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOFSANOFI-AVENTIS
29/07/20040408369FR
PCT/FR/2005/001854WO/2006/021655
A61K18077119/07/2005
של נורוטוקסין המכיל רפואי תכשירבוטולינום
THERAPEUTIC COMPOSITION WITH A BOUTULINUM NEUROTOXINMERZ PHARMA GMBH & CO. KGAA
26/07/2004
60/591196US
PCT/US/2005/025408WO/2006/020208
A61K18077203/08/2005
CARRIER FOR ENTERALתוך–מעי למתן נשאADMINISTRATIONVITAL HEALTH SCIENCES PTY LTD.
03/08/2004
2004904366AU
07/04/2005
2005901723AU
June 3, 2007591 –התשס"ז בסיון י"ז
PCT/AU/2005/001159WO/2006/012692
F26B18077319/07/2005
בחום וטיפול לייבוש ומערכת תהליךבחומרים
PROCESS AND SYSTEM FOR DRYING AND HEAT TREATING MATERIALSEARTHRENEW IP HOLDINGS LLC
19/07/2004
10/895030US
PCT/US/2005/025640WO/2006/014670
F26B18077418/07/2005
PROCESS AND APPARATUS OFלדישון גלם חומר לייבוש ומכשיר תהליךFEEDSTOCK DRYING FERTILIZEREARTHRENEW IP HOLDINGS LLC
19/07/2004
60/894645US
PCT/US/2005/025466WO/2006/020253
C07D18077519/07/2005
ניקוטיני אצטילכולין קולטן של מאפננים ? ושימושיהם7
MODULATORS OF ALPH7 NICOTINIC ACETYLCHOLINE RECEPTORS AND THERAPEUTIC USES THEREOFSIENA BIOTECH S.P.A.
20/07/2004
60/589003US
PCT/EP/2005/007846WO/2006/008133
A63B18077615/08/2005
FREE STANDING BALLET BARעצמאי העומד בלט לתרגול קורה מתקןEXERCISE DEVICEFLUIDITY ENTERPRISES, INC.
June 3, 2007 592 –התשס"ז בסיון י"ז
16/08/2004
10/710975US
PCT/US/2005/028988WO/2006/023446
C07D18077728/09/2005
והשימוש חדשות –און2כרומן– תולדות של חוזרת ספיגה כמעכבי בהן
מונואמיניים נוירוטרנסמיטרים
NOVEL CHROMEN-2- ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORSNEUROSEARCH A/S
30/09/200460/614052US
30/09/2004PA200401491DK
PCT/EP/2005/054861WO/2006/035034
A61B18077818/01/2007
LANCING DEVICE WITH DAMPENEDמרסן קפיץ עם ניקוב התקןSPRINGLIFESCAN, INC.
20/01/2006
60/760497US
31/03/2006
11/395908US
A61B18077918/01/2007
LANCING DEVICE WITH DAMPENERמרין עם ניקוב התקןLIFESCAN, INC.
20/01/2006
60/760497US
31/03/2006
11/395757US
June 3, 2007593 –התשס"ז בסיון י"ז
A61B18078018/01/2007
METHOD FOR DAMPENED LANCINGניקוב לריסון שיטהLIFESCAN, INC.
20/01/2006
60/760497US
31/03/2006
11/395756US
C07F18078126/07/2005
תרכובות של פוספונאטים אנלוגיםHIV מעכבות
PHOSPHONATE ANALOGS OF HIV INHIBITOR COMPOUNDSGILEAD SCIENCES, INC.
27/07/2004
60/591811US
PCT/US/2005/026504WO/2006/110157
C12N18078222/07/2005
דופאמינרגיים נוירוניים אב לתאי סמניםCORIN /4 Lrp
Lrp4/CORIN DOPAMINERGIC NEURON PROGENITOR CELL MARKERSEISAI CO. LTD.
22/07/2004
2004-213743JP
29/10/2004
2004-315060JP
PCT/JP/2005/013453WO/2006/009241
June 3, 2007 594 –התשס"ז בסיון י"ז
F01D18078318/01/2007
CERAMIC MATRIX LAMINATESקרמיות מטריצה שכבותUNITED TECHNOLOGIES CORPORATION
20/01/2006
60/760990US
17/01/2007
11/654302US
C12Q18078425/07/2005
דלקת לגילוי אימונו בדיקת ומתקן שיטההתוספתן
A METHOD AND AN IMMUNOASSAY TEST DEVICE FOR DETECTING APPENDICITISASPENBIO PHARMA, INC.
23/07/2004
60/590631US
PCT/US/2005/026218WO/2006/012588
C12N18078603/08/2005
שינוי על–ידי גנים לביטוי אפנון שיטתCPG של תוכן
METHOD FOR MODULATING GENE EXPRESSION BY ALTERING THE CPG CONTENTGENEART AG
03/08/2004
102004037611.5DE
03/08/2004
102004037652.2DE
PCT/EP/2005/008423WO/2006/015789
C07D18078725/07/2005
חלבוני של כליגנדים מותמרים טריאזנים של הסרה או לזיהוי בהם והשימוש פריון
פריונים
SUBSTITUTED TRIAZINES AS PRION PROTEIN LIGANDS AND THEIR USE TO DETECT OR REMOVE PRIONSPROMETIC BIOSCIENCES LIMITED
27/07/2004
0416699.7GB
June 3, 2007595 –התשס"ז בסיון י"ז
PCT/GB/2005/002910WO/2006/010915
C07D18078828/07/2005
וקולטןVEGF קולטן של איתות מעכביHGF
INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALINGMETHYLGENE, INC.
30/07/2004
60/592913US
20/05/2005
60/683038US
PCT/CA/2005/001177WO/2006/010264
C07K18078902/08/2005
IL –4 נגד מונוקלונליים אנושיים נוגדניםאנושי
HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN IL-4NOVARTIS AG
03/08/2004
0417301.9GB
03/08/2004
0417302.7GB
03/08/2004
0417303.5GB
03/08/2004
0417304.3GB
03/08/2004
0417305.0GB
03/08/2004
0417306.8GB
PCT/EP/2005/008361WO/2006/013087
June 3, 2007 596 –התשס"ז בסיון י"ז
C07D18079027/07/2005
PYRROLO-PYRIDINE KINASEפירולו–פירידין קינז מאפנניMODULATORSSGX PHARMACEUTICALS, INC.
27/07/2004
60/591888US
27/07/2004
60/591887US
19/05/2005
60/683510US
PCT/US/2005/026792WO/2006/015123
C07D18079127/07/2005
MAOBBENZYLOXY DERIVATIVES AS כמעכבי בנזילאוקסי נגזרותMAOB INHIBITORSF. HOFFMANN-LA ROCHE AG
02/08/2004
04103710.2EP
PCT/EP/2005/008143WO/2006/013049
A47B18079218/01/2007
תורה, תפילין )ספרי סת"ם לכתיבת שולחן גראפי, חופשית, רישום ומזוזות(, כתיבה
אפיון בעל כתיבה אופן וכל ידנית גראפיקהדומה
TABLE FOR "STAM" WRITING (TORA BOOKS, PHYLACTERIES, MEZUZAH), FREE WIRITING, GENERAL WRITING, GRAPHIC ARTS, DRAWING, WHICH HAVE SIMILAR CHARACTERISTICS.
ELIRAN ELDARאלדר אלירן
B61L18079318/01/2007
רכבת פסי על מכשולים לזיהוי שיטהרכבת תאונות ומניעת
A METHOD OF DETECTING OBSTACLES ON RAILWAYS AND PREVENTING TRAIN ACCIDENTS
TAL ISRAELIישראלי טלJune 3, 2007597 –התשס"ז בסיון י"ז
13/02/2006US60/760781US
A61B18079411/05/2005
עם מסגסוגות המיוצרים רפואיים מכשירים מרטינסיטי מעמד המופיעות צורתן זיכרון
לשימושם במאמץ, ושיטה ממושך
MEDICAL DEVICES FORMED FROM SHAPE MEMORY ALLOYS DISPLAYING A STRESS-RETAINED MARTENSITIC STATE AND METHOD FOR USE THEREOF
.NITI MEDICAL TECHNOLOGIES LTDבע"מ רפואיות טכנולוגיות ניטי30/07/2004
10/903823US
PCT/IL/2005/000492WO/2006/011127
C07D18079720/07/2005
ושימושים אמינו–טרופאן, הכנתם תולדותבהם רפואיים
AMINO-TROPANE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOFSANOFI-AVENTIS
29/07/20040408372FR
PCT/FR/2005/001856WO/2006/021657
G02B18079831/08/2005
מתח מאפייני קיזוז להתאמת תהליךאינטרפרומטרי מאפנן של חשמלי
PROCESS FOR MODIFYING OFFSET VOLTAGE CHARACTERISTICS OF AN INTERFEROMETRIC MODULATORIDC, LLC
27/09/2004
60/613499US
19/08/2005
11/208052US
PCT/US/2005/030962WO/2006/036439
June 3, 2007 598 –התשס"ז בסיון י"ז
H04L18079920/07/2005
בין סלולרית בתשורת שידור ערוצי מעברסלולרית תקשורת ומערכתSIP רשת
HANDOFF BETWEEN A SIP NETWORK AND A CELLULAR COMMUNICATION SYSTEMQUALCOMM INCORPORATED
20/07/2004
60/589821US
PCT/US/2005/025810WO/2006/012381
C12N18080220/07/2005
בררנייםSIRNAS A 5– EIFב– שימוש אנטיסנס ופולינוקלאוטידים לאפופטוזהדלקתית תגובה לעיכוב/דיכוי
USE OF APOPTOSIS-SPECIFIC EIF-5A SIRNAS AND ANTISENSE POLYNUCLEOTIDES TO INHIBIT/SUPPRESS AN INFLAMMATORY RESPONSESENESCO TECHNOLOGIES, INC.
20/07/2004
60/589073US
PCT/US/2005/025766WO/2006/014752
F41H18080308/06/2005
רכב כלי על להגנה מגנטי גלאי עם התקןמוקשים נגד אזרחי או צבאי
DEVICE FOR PROTECTING A MILITARY OR CIVILIAN VEHICLE AGAINST MINES WITH MAGNETIC DETECTIONGIAT INDUSTRIES
23/07/20040408212FR
PCT/FR/2005/001407WO/2006/021630
C07C18080402/02/2005
ZONE REACTORלמקטעים תגובה כורGRT, INC.
June 3, 2007599 –התשס"ז בסיון י"ז
19/07/2004
10/894165US
PCT/US/2005/002829WO/2006/019399
G09B18080501/06/2005
SYSTEM AND METHOD FORנהיגה על למעקב ושיטה מערכתMONITORING DRIVING
,DRIVE DIAGNOSTIC LTDבע"מ דיאגנוסטיקה דרייב20/07/2004
10/894345US
PCT/IL/2005/000566WO/2006/008731
C07D18080620/07/2005
IMIDAZOPYRAZINE AS TYROSINEקינאז טירוזין כמעכבי אימידאזופיראזיניםKINASE INHIBITORSOSI PHARMACEUTICALS, INC.
20/07/2004
60/589514US
PCT/US/2005/025891WO/2006/012422
A61B18080720/07/2005
OBSTETRIC VACUUM EXTRACTORבלידה לסיוע וואקום שולפןMONTY MEDICAL LIMITED
20/07/2004
0416172.5GB
PCT/GB/2005/002863WO/2006/008532
H01K18080818/01/2007
A LAMP AND A METHOD FORלהארה ושיטה מנורהILLUMINATING
HERSHNZON GALIגלי הירשנזוןJune 3, 2007 600 –התשס"ז בסיון י"ז
B60J18080927/05/2005
עם שכבות לו שיש שקוף למינציה מבנה של רוח במגן לשימוש לקילוף הניתן פילם
טיס כלי
TRANSPARENT LAMINATED STRUCTURE HAVING PEEL-AWAY FILM LAYERS FOR USE ON AIRCRAFT WINDSCREENSUNITED PROTECTIVE TECHNOLOGIES, LLC
30/07/2004
10/909129US
PCT/US/2005/018771WO/2006/028532
C07D18081016/08/2005
מאוחים פירימידונים של אננטיומרים של ובמניעה בטיפול ושימושים נבחרים
סרטן
ENANTIOMERS OF SELECTED FUSED PYRIMIDONES AND USES IN THE TREATMENT AND PREVENTION OF CANCERASTRAZENECA AB
18/08/2004
60/602366US
PCT/GB/2005/003207WO/2006/018628
C07D18081116/08/2005
ושימושים נבחרים מאוחים הטרוציקליםבהם
SELECTED FUSED HETEROCYCLICS AND USES THEREOFASTRAZENECA AB
18/08/2004
60/602399US
PCT/GB/2005/003202WO/2006/018627
June 3, 2007601 –התשס"ז בסיון י"ז
A61B18081320/07/2005
למדידת ושיטה לביש, מערכת מכשירסביבתיים ו/או פיסיולוגיים פרמטרים
WEARABLE DEVICE, SYSTEM AND METHOD FOR MEASURING PHYSIOLOGICAL AND/OR ENVIRONMENTAL PARAMETERS
.TADIRAN SPECTRALINK LTDבע"מ ספקטרלינק תדיראן21/07/2004
60/589581US
21/07/2004
60/589572US
PCT/IL/2005/000772WO/2006/008740
B65D18081520/07/2005
של שטח לפיסול ושיטה מודולרי מנגנוןמפרק
MODULAR APPARATUS AND METHOD FOR SCULPTING THE SURFACE OF A JOINTALEXANDRIA RESEARCH TECHNOLOGIES LLC
20/07/2004
60/589320US
20/07/2005
11/186485US
PCT/US/2005/025794WO/2006/012370
A61K18081720/07/2005
June 3, 2007 602 –התשס"ז בסיון י"ז
ומחלות אוטואימוניות של ספציפי עיכובלאוטואנטיגנים קשורות
SPECIFIC INHIBITION OF AUTOIMMUNITY AND DISEASES ASSOCIATED WITH AUTOANTIGENSISOGENIS, INC.
20/07/2004
60/589707US
29/09/2004
60/614529US
PCT/US/2005/025878WO/2006/012416
F21L18081824/10/2005
RUGGEDIZED DIGITAL LOW -LIGHTנמוך באור לראיה קשיח דיגיטלי מכשירVIEWING DEVICEXENONICS, INC.
22/10/2004
60/621415US
18/02/2005
11/060903US
PCT/US/2005/038652WO/2006/047630
B60T18081921/01/2007
INTENCITY BREAKING INDCATORבלימה עוצמת חיוויעזר ארז
B23D18082021/01/2007
ROTATABLE HOUSING DEVICEלסיבוב הניתן מעטה התקןYEFIM KERETHקרת יפים
H04L18082123/06/2005
END USER RISK MANAGEMENTסופי משתמש סיכון ניהול
June 3, 2007603 –התשס"ז בסיון י"ז
REFLECTENT SOFTWARE, INC.20/07/2004
10/894714US
PCT/US/2005/022352WO/2006/019513
F01D18082228/01/2005
FAN BLADES AND MODIFICATIONSותאומים מניפה להביDELTA T CORPORATION
21/07/2004
60/589945US
PCT/US/2005/002703WO/2006/022812
A62C18082313/06/2005
DISCHARGE OF FIREאש לכיבוי חומר של פריקהEXTINGUISHING AGENTKIDDE IP HOLDINGS LIMITED
21/07/2004
10/895729US
PCT/GB/2005/002398WO/2006/008436
H04L18082414/07/2005
במהלך פער אינדיקציית לאספקת שיטהדביקה משימה
A METHOD OF PROVIDING A GAP INDICATION DURING A STICKY ASSIGNMENTQUALCOMM INCORPORATED
June 3, 2007 604 –התשס"ז בסיון י"ז
21/07/2004
60/590112US
22/12/2004
11/022144US
PCT/US/2005/025168WO/2006/020030
H04L18082520/07/2005
תקשורת במערכות לפקטות מודע מתזמןאלחוטית
PACKET AWARE SCHEDULER IN WIRELESS COMMUNICATION SYSTEMSQUALCOMM INCORPORATED
20/07/2004
60/589820US
PCT/US/2005/025856WO/2006/012405
H04L18082611/07/2005
ערוץ אומדן לשיפור תדר תחום סינוןתקשורת אותות מרובות במערכת
FREQUENCY DOMAIN FILTERING TO IMPROVE CHANNEL ESTIMATION IN MULTICARRIER SYSTEMSQUALCOMM INCORPORATED
20/07/2004
60/589817US
22/12/2004
11/022360US
PCT/US/2005/024613WO/2006/019709
H04N18082721/07/2005
METHOD AND APPARATUS FORתנועה וקטור להעברת ומערכת שיטהMOTION VECTOR ASSIGNMENTQUALCOMM INCORPORATED
21/07/2004
60/590110US
PCT/US/2005/025897WO/2006/012428
June 3, 2007605 –התשס"ז בסיון י"ז
H04L18082819/07/2005
CONTROLLING AND MANAGINGמרובות ורשתות גישה וניהול בקרהACCESS TO MULTIPLE NETWORKSQUALCOMM INCORPORATED
20/07/2004
60/589897US
26/04/2005
60/675337US
23/06/2005
11/165081US
PCT/US/2005/025804WO/2006/012377
H04B18082919/07/2005
במערכת חוזר חיבור של כוח בקרתאורטוגונלית
REVERSE LINK POWER CONTROL IN AN ORTHOGONAL SYSTEMQUALCOMM INCORPORATED
20/07/2004
60/589823US
22/12/2004
11/022348US
PCT/US/2005/025803WO/2006/012376
H04Q18083011/07/2005
EFFICIENT SIGNALING OVERגישה ערוץ מעבר יעיל איתותACCESS CHANNELQUALCOMM INCORPORATED
21/07/2004
60/590113US
22/12/2004
11/020457US
PCT/US/2005/024614WO/2006/019710
June 3, 2007 606 –התשס"ז בסיון י"ז
A47K18083121/01/2007
METHOD AND APPARATUS FORנוזל–נוזל למיצוי ומתקן שיטהLIQUID-LIQUID EXTRACTION
LAVIE, RAMרם לביא
C07H18083221/07/2005
–2–דאוקסי–2 של תכשיר מותמר–אלקיל פלואורו–די–ריבופוראנוסיל
ונגזרותיהם ופורינים פירידינים
PREPARATION OF ALKYL-SUBSTITUTED 2-DEOXY-2 FLURO-D-RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVESPHARMASSET, INC.
21/07/2004
60/589866US
09/09/2004
60/608320US
PCT/US/2005/025916WO/2006/012440
A23L18083422/07/2005
ANTI-HYPERTENSIVE FUNCTIONALדם לחץ יתר נגד פעילים מזון תוצריFOOD PRODUCTSGLOBUS EGG SCIENCES B.V.
22/07/2004
60/589902US
27/01/2005
05100544.5EP
PCT/NL/2005/000535WO/2006/009448
G01N18083521/07/2005
משטח דוגמת לבדיקת ומכשיר שיטהפלורסטיים בחמרים ושימוש
METHOD AND APPARATUS FOR INSPECTING A SPECIMEN SURFACE AND USE OF FLUORESCENT MATERIALS
June 3, 2007607 –התשס"ז בסיון י"ז
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO
23/07/2004
04077130.5EP
PCT/NL/2005/000529WO/2006/009444
A62C18083619/07/2005
THERMOSENSITIVE SPRINKLERחום רגיש ממטירKIL, JONG-JIN
28/07/2004
10-2004-0059444KR
04/07/2005
10-2005-0059693KR
PCT/KR/2005/002319WO/2006/011725
C12Q18083728/07/2005
החוזק, הייחודיות לקביעת שיטות סינטאז2D פרודטגלנדין של והרעילות
המטופויטי
METHODS FOR DETERMINING THE POTENCY, SPECIFICITY, AND TOXICITY OF HEMATOPOIETIC PROSTAGLANDIN D2 SYNTHASEAVENTIS PHARMACEUTICALS INC.
30/07/2004
60/592501US
PCT/US/2005/026945WO/2006/015195
B60C18083821/01/2007
טבעתי חרוזי גוף להכנת תהליך חיתוך עבור חיתוך לתיל– להקצעה
יחסית קשים חומרים
PROCESS FOR MAKING AN ANNULAR ABRASION BEAD ELEMENT FOR A CUTTING WIRE FOR CUTTING RELATIVELY HARD MATERIALS
June 3, 2007 608 –התשס"ז בסיון י"ז
AROS S.R.L.23/01/2006VR2006A000016IT
H01L18084020/07/2005
EXPOSURE METHOD AND DEVICEמתקן לייצר ושיטה חשיפה שיטתMANUFACTURING METHODNIKON CORPORATION
21/07/2004
2004-212756JP
29/06/2005
2005-190728JP
PCT/JP/2005/013311WO/2006/009169
F02B18084120/07/2004
עם הידראולי באופן מונעת משאבה–מזרקפנימיים בעירה מנועי עבור בקרה מנגנון
HYDRAULICALLY DRIVEN PUMP-INJECTOR WITH CONTROLLING MECHANISM FOR INTERNAL COMBUSTION ENGINES
.MAZREK LTDבע"מ מזרק
PCT/IL/2004/000656WO/2006/008726
F02M18084220/07/2004
עבור מחט–קפיץ מנגנון עם נעילה התקן בעירה למנועי המיועדת משאבה–מזרק
פנימיים
NEEDLE-SPRING LOCKING DEVICE FOR PUMP-INJECTOR (INJECTOR) FOR INTERNAL COMBUSTION ENGINES
.MAZREK LTDבע"מ מזרק
PCT/IL/2004/000658WO/2006/008728
F02M18084320/07/2004
June 3, 2007609 –התשס"ז בסיון י"ז
עם הידראולי באופן מונעת משאבה–מזרק בעירה מנועי עבור שלבית רב לחץ הגברתפנימיים
HYDRAULICALLY DRIVEN PUMP-INJECTOR WITH MULTISTAGE PRESSURE AMPLIFICATION FOR INTERNAL COMBUSTION ENGINES
.MAZREK LTDבע"מ מזרק
PCT/IL/2004/000657WO/2006/008727
A61K18084422/07/2005
COMPOSITIONS AND METHODS FORיתר בדימום לטיפול ושיטות תכשיריםTREATING EXCESSIVE BLEEDINGALLAN D., PRONOVOST
22/07/2004
60/590214US
23/07/2004
60/590845US
PCT/US/2005/026105WO/2006/012541
G01N18084526/07/2005
VIBRATION SENSORתנודות חיישןSPIDER TECHNOLOGIES SECURITY LTD.
26/07/2004
60/590896US
PCT/IL/2005/000797WO/2006/011145
C07D18084625/07/2005
)הטרו( ארילאטאנים –טטרא2, 2, 1, 1 –טרי2,1,1 או
–הטרוציקלילאטאנים2)הטרו( אריל–אשלגן תעלות כמעכבי
1,1,2,2-TETRA (HETERO) ARYLETHANES OR 1,1,2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS POTASSIUM CHANNEL INHIBITORSMERCK & CO., INC.
29/07/2004
60/592181US
PCT/US/2005/026334
June 3, 2007 610 –התשס"ז בסיון י"ז
WO/2006/028590
G07D18084719/07/2005
DEVICE AND METHOD FOR VERIFYINGערך מסמכי לאימות ושיטה מכשירVALUE DOCUMENTSGIESECKE & DEVRIENT GMBH
22/07/2004
102004035494.4DE
PCT/EP/2005/007872WO/2006/010537
- תשכ"ז הפטנטים לחוק26 סעיף לפי הודעה1976
NOTICE UNDER SECTION 26 OF THE PATENTS LAW, 5727-1967
קובלו להלן מתפרסמים שפרטיהן הבקשות המעונין הפטנטים. כל לחוק17 סעיף לפי
מהבקשות בקשה פי על פטנט למתן להתנגד חדשים שלושה רשאי, תוך המתפרסמות
הפטנטים לרשם זה, להגיש יומן מתאריך לחוק30 סעיף לפי התנגדות הודעת
ואילך57 בתקנה הקבועה בדרך הפטנטים.1968 – הפטנטים, תשכ"ח לתקנות
The applications, particulars of which are set out below, have been accepted pursuant to Section 17 of the Patents Law. Any person wishing to oppose the grant of a patent on any of the applications published here, may, within three months from the date of this journal, give to the Commissioner of Patents notice under Section 30 of the Patents Law, in the manner prescribed in regulations 57 et seq of the Patents Regulations, 5728-1968
לפי מובאים ויישימים במידה הבקשות פרטיזה: סדר
Particulars of the applications, where applicable, are given in the following order:
Number of application [21] [11]הבקשה מספרTitle of invention [54]האמצאה שם
Application date [22]הבקשה תאריך מדינת – החוץ בקשות של ותאריך מספר
June 3, 2007611 –התשס"ז בסיון י"ז
Number and date of foreign [33] [32] [31]האגודapplication – convention country.
.Int.Cl [51]*שביעית מהדורה – בינלאומי *סיווגApplication for patent of addition [61] מוסף לפטנט בקשהDivisional application [62]חלוקה בקשת
Applicant [71]המבקשInventor [72]הממציא
International Publication Number [87]הבינלאומית בקשה של מס' פרסום Address for service [74]מסמכים למסירת מען
Abridgement of invention (in the [57]הפירוט( ערוך בה )בשפה האמצאה תקצירlanguage in which the specification is drawn up)
מס' והמדגמים הפטנטים מיומן *הערה: החל לפי הסיווג פטנטים לבקשות ציון ניתן1/06
של הבינלאומי הסיווג של השמינית המהדורה(2006 )משנה פטנטים
*Note: As from Patents and Designs Journal No.1/06, patent applications are classified according to the Eighth Edition of the International Patent Classification (2006)
June 3, 2007 612 –התשס"ז בסיון י"ז
116223]21][11[
TELECENTRIC 3D CAMERAושיטה תלת-מימד טלצנטרית מצלמהAND METHOD
]54[
01.12.1995]22[Int. Cl.8 G01S 017/00]51[
]3DV SYSTEMS LIMITED]71בע"מ, יקנעם די.וי. מערכות3]GAVRIEL IDDAN, GIORA YAHAV]72יהב עידן, גיורה גבריאלבע"מ, רוחני ושות',קניין פנסטר
, ת.ד. אריה , קרית1 כניסה12 בזל תקוה , פתח10256
FENSTER & COMPANY, INTELLECTUAL PROPERTY LTD,
12 BASEL STREETENTRANCE 1P.O.BOX 10256
PETACH TIKVA
]74[
]57 [Apparatus for creating an image indicating distances to objects (A, B) in a scene (11), comprising a modulated source of radiation (1), which directs radiation toward a scene, such that a portion of the radiation from the source is reflected from the scene and reaches the apparatus; a detector (12), which detects an image formed from the radiation that reaches the apparatus; a processor (22), which forms an image having an intensity value distribution indicative of the distance of objects from the apparatus, responsive to the intensity distribution of the detected image; and comprising a first telecentric optics comprising at least one lens (42) and an iris (40) located substantially at the
focal point of said at least one lens which receives and collimates the radiation reflected form the scene that reaches the apparatus; and a modulator (18), which modulates the collimated radiation, such that a part of the portion of the radiation which reaches the apparatus is passed by the modulator to a second telecentric optics comprising at least one image lens (44) that sends the light to pass through an iris (46) located substantially at the focal point of the image lens wherein light that passes through the iris forms the image detected by the detector, the part being dependent on the distance of respective portions of the scene from the apparatus.
June 3, 2007613 –התשס"ז בסיון י"ז
__________124728]21][11[
AURORA–2AURORA-1 AND AURORA-2 – וAURORA–1 חלבוניPROTEINS
]54[
25.11.1996]22[US]33[18.12.1995]32[60/008809]31[US14.08.199660/023943
Int. Cl.8 C07K 014/435, 014/47, C12N 009/12, 015/54]51[SUGEN, INC., U.S.A.]71[
WO/1997/022702]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [Isolated enriched or purified polypeptide, wherein said polypeptide comprises at least 100 contiguous amino
acids of the amino acid sequence depicted in SEQ IN NO:3 and SEQ.ID NO:4.
__________
124939]21][11[
בתאי המיוצרים הטרולוגיים חלבוניםלהכנתם ושיטות שמר
HETEROLOGOUS PROTEIN PRODUCTS FROM YEAST AND PROCESSES FOR PRODUCTION THEREOF
]54[
18.12.1996]22[DK]33[20.12.1995]32[1449/95]31[
Int. Cl.8 C07K 014/435, 014/62, C12N 001/19, 015/12, 015/62, 015/67, 015/81]51[NOVO NORDISK A/S, DENMARK]71[WO/1997/022706]87[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [DNA construct encoding a polypeptide and having the following
structure signal peptide-leader peptide-EEAEPK-heterologous protein.
__________
June 3, 2007 614 –התשס"ז בסיון י"ז
125855]21][11[
METHOD OF PRODUCINGמוקצפים קרמיים חומרים לייצור שיטהCERAMIC FOAMS
]54[
19.08.1998]22[IL]33[06.04.1998]32[123969]31[
Int. Cl.8 C04B 035/624]51[]CELLARIS LTD.]71בע"מ, נשר סלריס]72[גרדר גדעון
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A method of producing a ceramic foam based on foaming at least one precursor comprising a A1C13(Pri
2O) complex or a mixture of precursors comprising aluminium sec butoxide (ASB) and SiC14, the method comprising the steps of: placing said precursor or mixture
of precursors in a pressure vessel; heating and pressurizing said precursor or mixture of precursors to accelerate the transformation of the complex to a solution of isopropyl chloride and partially condensed Al-O-Al species.
__________
126552]21][11[
חכמים כרטיסים של אלחוטי שימושבטוחות גישה במערכת
REMOTE ADMINISTRATION OF SMART CARDS FOR SECURE ACCESS SYSTEMS
]54[
13.10.1998]22[Int. Cl.8 G06F 002/100000 012/14, G07F 007/10, H04L 009/32, 012/22]51[NDS LIMITED, UNITED KINGDOM]71[
]SHLOMO KIPNIS, RANNEN MEIR]72מאיר קיפניס, רענן שלמהושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A system for remote administration of at least one smart card via a communication network, the system comprising: a remote administrator having administrator identification information; at
least one user unit; at least one smart card associated with said remote administrator by storing in the least one smart card said administrator identification information of the remote administrator; and a local
June 3, 2007615 –התשס"ז בסיון י"ז
administrator other than the remote administrator, the local administrator being positioned in the communication network in a proximity to said at least one user unit and determined as a proxy administrator for administrating said at least one smart card by transmitting at least authorization information from the remote administrator to the local administrator, wherein said at least one smart card inserted in said at least
one user unit is operative to employ the administrator identification information to identify the remote administrator associated with said at least one smart card, and to establish communication via the communication network between the at least one smart card and the remote administrator in accordance with the administrator identification information.
__________
126918]21][11[
עצבי גידול להמרצתRET ליגאנדוכליני
RET LIGAND (RETL) FOR STIMULATING NEURAL AND RENAL GROWTH
]54[
07.05.1997]22[US]33[08.05.1996]32[60/017427]31[US07.06.199660/019300US16.07.199660/021859US11.04.199760/043533
Int. Cl.8 A61K 039/395, C07K 014/47, 016/18, 019/00, C12N 005/10, 015/12, 015/63]51[BIOGEN IDEC MA INC., U.S.A.]71[
WO/1997/044356]87[וגולר, וולף, ברגמן
,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
]57 [Isolated nucleic acid encoding a polypeptide with at least 80% sequence identity to an amino acid sequence selected from the group consisting of SEQ ID
NO:17 and SEQ ID NO:21, wherein said polypeptide interacts with a receptor protein Ret to trigger dimerization of the receptor protein Ret or
June 3, 2007 616 –התשס"ז בסיון י"ז
autophosphorylation of a tyrosine kinase domain of the receptor protein Ret.
__________
128058]21][11[
רוקחות ותכשירי אילודין של אנלוגיםאותם המכילים
ILLUDIN ANALOGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
]54[
14.07.1997]22[US]33[18.07.1996]32[08/683687]31[
Int. Cl.8 A61K 031/12, A61P 035/00, C07C 035/37, 039/225, 049/753, 049/757, 059/80, 062/38, 069/007, 205/45, 225/14, 225/20, 323/17, 323/22, 323/25, 323/52, C07D 233/60, 317/70, 317/72, C07F 007/08, C07H 015/18
]51[
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, U.S.A.
]71[
WO/1998/003458]87[וגולר, וולף, ברגמן
,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
]57 [A compound of the formula
wherein R1 is (CH2)n-X-Y,where n is 0 to 4;
X is O or S or NH, andY is –CH2OC(O)(C1-C4) alkyl, (C1-C8) alkyl optionally substituted with 1 OH or 1-2 halo; a monosaccharide, -CH2C(O)-O-C(CH2)2-O-C(O)CH2SH,
)-CH2(2-O-(CH2)2W where W is halo; -(C1-C8) alkyl-O-(C1-C8) alkyl, (C6-C10) aryl, (C6-C10) aryl (C1-C4) alkyl, -C(O)O(C6-C10) aryl wherein the aryl group is optionally
substituted with 1-2 OH, halo, (C1-C4) alkyl, or O(C1-C4) alkyl; -CH2CO2(C1-C4) alkyl, - CH2CO2H, Si((C1-C4) alkyl)3 or an amino acid residue;
R3 is H or (C1-C4) alkyl; R4 is SCH2(C1-C4), -S-(C6-C10) aryl optionally substituted with halo, OH or (C1-C4) alkyl, or H;R5 is H, OH or absent;R6 is (C1-C4) alkyl;
R7 is OH or –O(Si((C1-C4) alkyl)3; orR6 and R7 together are ethylenedioxy;
June 3, 2007617 –התשס"ז בסיון י"ז
R8 is (C1-C4) alkyl optionally comprising OH or halo;
the bond represented by ------ is present or absent; ora pharmaceutically acceptable salt thereof.
__________
128792]21][11[
רוקחות ותערובות הטרוציקלים קטוניםאותן המכילים
HETEROCYCLIC KETONES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
]54[
09.09.1997]22[US]33[25.09.1996]32[08/721765]31[US01.08.199708/904461
Int. Cl.8 A61K 031/40, 031/445, A61P 025/28, C07D 207/12, 207/16, 211/30, 211/60, 401/06, 409/06
]51[
GPI NIL HOLDINGS, INC., U.S.A.]71[WO/1998/013343]87[
ושותפיו, עו"פ, הס יצחק ד"ראביב , תל6451 , ת.ד. 279 הירקון רחוב
DR. YITZHAK HESS & PARTNERS, 279 HAYARKON STREET
P.O.B. 6451 TEL AVIV 61063
]74[
]57 [Compounds of the formula
or pharmaceutically acceptable salt thereof, wherein:n is 1 or 2;X is O;
Z is selected from the group consisting of CH2, CHR1 and C(R2)2;
R1 is C1-C5 straight or branched chain alkyl which is substituted with Ar1;
R2 is selected from the group consisting of:
-C1-C9 straight or branched chain alkyl,-C2-C9 straight or branched chain alkenyl,
-C3-C8 cycloalkyl,-C5-C7 cycloalkenyl, and,
-Ar1,Ar1 is phenyl, pyridyl, fluorenyl benzo[b] thiophen, or naphthyl, wherein said Ar1 is unsubstituted or substituted in one or more positions with halo, hydroxy, nitro, C1-C6 straight or branched chain alkyl, C2-C6 straight or branched chain alkenyl C1-C4 alkoxy, C2-C4 alkenyloxy, phenoxy, benzyloxy, amino, or a combination thereof.
June 3, 2007 618 –התשס"ז בסיון י"ז
מבקשה חלוקה בקשותפורסמו. שטרם זו
167896,The applications for division from this application have not yet been published
__________
129912]21][11[
PLANT COVER MATERIAL ANDבו שימוש ושיטה לצמחים כיסוי חומרMETHOD OF USING IT
]54[
19.11.1997]22[NZ]33[19.11.1996]32[299783]31[NZ18.09.1997328780
Int. Cl.8 A01G 013/02]51[JONATHAN DALLAS TOYE, NEW ZEALAND
]71[
WO/1998/021935]87[צדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
]57 [A reflective plant treatment material which reflects at least 55% of solar radiation in the UV (about 280-400 nm) range, which reflects more solar radiation than it transmits and absorbs in the UV,
visible (about 400-700 nm) and near infrared (about 700-800 nm) ranges, and which transmits at least 5% of solar radiation in the range about 800-20000 nm.
__________
131478]21][11[
בהכנתO בסטרפטוליזין שימושיםצלקת ברקמת לטיפול רפואים תכשירים
USES OF STREPTOLYSIN O IN THE PREPARATION OF MEDICAMENTS ADAPTED TO TREAT SCAR TISSUE
]54[
02.03.1998]22[US]33[04.03.1997]32[08/131478]31[
Int. Cl.8 A61K 038/00, 038/16, 038/43, 039/09, A61P 017/02, C07K 014/00, 014/315]51[MILKHAUS LABORATORY, INC., U.S.A.
]71[
WO/1998/039020]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער SANFORD T.COLB & CO,.
P.O.B. 2273 ,]74[
June 3, 2007619 –התשס"ז בסיון י"ז
REHOVOTרחובות
]57 [Use of streptolysin O for the preparation of a medicament for
eliminating or reducing the appearance of scar tissue.
__________
133032]21][11[
גנים להעברת וירליים אדנו וקטורים ו/או שריר לתאי רקמתית זיקה בעליאנדותל תאי
ADENOVIRAL GENE DELIVERY VECTORS PROVIDED WITH A TISSUE TROPISM FOR SMOOTH MUSCLE CELLS AND /OR ENDOTHELIAL CELLS
]54[
18.11.1999]22[EP]33[20.11.1998]32[98203921.
6]31[
Int. Cl.8 A61K 048/00, A61P 009/00, C07K 014/075, C12N 005/10, 015/34, 015/62, 015/861
]51[
INTROGENE B.V., THE NETHERLANDS
]71[
צדק, וכהן איתן, פרל, לצר, הרצליה12688 , ת.ד. 7 שנקר רחוב
EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
]57 [A recombinant adenoviral vector of a serotype from subgroup C, having been provided with at least a tissue tropism for smooth muscle cells and/or endothelial cells and having been deprived of at least a tissue tropism for liver cells, wherein said adenoviral vector comprises a capsid
comprising a tropism determining fragment of a fiber protein of an adenovirus of a serotype from subgroup B, and wherein said adenovirus serotype from subgroup B is selected from the group consisting of: adenovirus 11, adenovirus 16, adenovirus 35 and adenovirus 51.
__________
133693]21][11[
חדירות להגדלת ושיטות רוקחות תכשיריביולוגיות ממברנות של
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INCREASING PERMEABILITY OF BIOMEMBRANES
]54[
07.07.1998]22[IL]33[09.07.1997]32[121269]31[
Int. Cl.8 A61K 031/20, 031/21, A61P 025/00, 043/00, C07C 053/128, 057/03, 057/12, 069/003, 233/02
]51[
June 3, 2007 620 –התשס"ז בסיון י"ז
]D-PHARM LIMITED]71בע"מ, רחובות די-פארםWO/1999/002120]87[
בע"מ, די-פארם ,2313, ת.ד. ויצמן קרית המדע פארק
רחובות
D-PHARM LIMITED, KIRYAT WEIZMANN SCIENCE
PARK P.O.B. 2313
REHOVOT 76123
]74[
]57 [Use of a compound of the formula
A |
R-CH-R' (III)
wherein R denotes a saturated or unsaturated chain of between 1 to 10 carbon atoms and R' denotes a saturated or unsaturated chain of between 5 and 30 carbon atoms, and A is selected from the group consisting of COOH, COOR", CONH2, CONH-R", and COO-Y+, wherein R" is a lower alkyl group comprising 1-5 carbon atoms, and Y denotes any pharmaceutically acceptable counter-ion for the preparation of a pharmaceutical
composition for reversibly permeabilizing a biological membrane.A pharmaceutical composition for the permeabilization of biological membranes comprising a pharmaceutically effective amount of a compound of formula (III) wherein R denotes a saturated or unsaturated chain of between 4 to 10 carbon atoms, A, R', R" and Y as defined above and at least one pharmaceutically acceptable carrier is also claimed as novel.
__________
135288]21][11[
–טראיD של כרוני גלילה מתןמתילפנידט
CHRONIC BOLUS ADMINISTRATION OF D-THREO METHYLPHENIDATE
]54[
17.06.1998]22[US]33[29.09.1997]32[08/937684]31[
Int. Cl.8 A61K 031/445, A61P 025/00, C07D 211/34]51[CELGENE CORPORATION, U.S.A.]71[
WO/1999/016439]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [Use of D-threo methylphenidate or a pharmaceutically acceptable salt thereof, substantially free of both L-threo
methylphenidate and erythro methylphenidates, in the preparation of a
June 3, 2007621 –התשס"ז בסיון י"ז
medicament for treating at least one of attention deficit disorder, attention deficit hyperactivity disorder, or AIDS-related dementia, wherein said medicament is
suitable for chronic administration in single, bolus dosage of said D-threo methylphenidate in each twenty-four hour period.
__________
135332]21][11[
מערכת אל להתקשרות ושיטה מתקן מחשב משאבי לבקרת שפועלת הפעלה מימדים3ב– הדמייה ממשק בעזרת
APPARATUS AND METHOD FOR INTERACTING WITH A SIMULATED 3D INTERFACE TO AN OPERATING SYSTEM OPERATIVE TO CONTROL COMPUTER RESOURCES
]54[
01.10.1998]22[US]33[02.10.1997]32[08/946106]31[
Int. Cl.8 G06F 009/45, 009/455]51[]CLOCKWISE TECHNOLOGIES LTD.]71בע"מ, תל- אביב טכנולוגיות קלוקוייז
WO/1999/018501]87[צדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
]57 [A computer system comprising:computer resources (40); an operating system operative to control said computer resources; and a 3D interface (20) enabling a user generating camera motion to interact with the operating system and providing at least one screen display image (30) of a 3D
virtual scene including a simulated three-dimensional representation of at least a portion of the computer resources, said interface configured to be operative to monitor said camera motion and to determine which of said computer resources are visible in said display image.
June 3, 2007 622 –התשס"ז בסיון י"ז
__________
135345]21][11[
]HUMAN TOLL HOMOLOGUES]54 הומנייםTOLL הומולוגיי
07.10.1998]22[US]33[17.10.1997]32[60/062250]31[US13.11.199760/065311US28.04.199860/083322US26.06.199860/090863US26.06.199809/105413
Int. Cl.8 A61K 039/395, C07K 014/705, C12N 015/12]51[GENENTECH, INC., U.S.A.]71[
WO/1999/020756]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
] 57 [An isolated nucleic acid molecule comprising a polynucleotide sequence having at least a 95% sequence identity to
)a (a DNA molecule encoding a PRO285 polypeptide having amino acid residues 27 to 839 of Figure 1 (SEQ ID NO:1) as shown in the specification wherein the polypeptide has the ability to induce the
activation of NF-kB, or the complement of the DNA molecule; or
)b (a DNA molecule encoding the same mature polypeptide encoded by the human Toll protein cDNA in ATCC Deposit No. 209389 (DNA40021-1154) wherein the polypeptide has the ability to induce the
June 3, 2007623 –התשס"ז בסיון י"ז
activation of NF-кB, or the complement of the DNA molecule.
מבקשה חלוקה בקשותפורסמו. שטרם זו
180967,The applications for division from this application have not yet been published
__________
136310]21][11[
של ההפרשה יכולת לבדיקת שיטהפפטיד
METHOD FOR EXAMINING THE SECRETORY ABILITY OF A PEPTIDE
]54[
26.11.1998]22[JP]33[26.11.1997]32[9-324912]31[
Int. Cl.8 C12N 005/10, 015/12, 015/62, C12Q 001/68]51[CHUGAI SEIYAKU KABUSHIKI KAISHA, JAPANTOSHIO KITAMURA, JAPAN
]71[
WO/1999/026978]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A method for examining whether a peptide encoded by a test cDNA contains the secretory ability, the method comprising:
)a (providing a vector wherein the test cDNA which encodes the peptide to be
examined whether it contains the secretory ability is ligated to the 5'-upstream of the DNA which encodes a peptide capable of inducing cell proliferation through dimerization on the cell surface and lacking the secretory ability;
June 3, 2007 624 –התשס"ז בסיון י"ז
)b (introducing the vector prepared in (a) into a cell; and
)c (culturing the transformant prepared in (b), and detecting the cell proliferation ability.
__________
136455]21][11[
ATTENUATED INVASIVEהחלשה שעברה חודרנית בקטריהBACTERIA
]54[
18.12.1998]22[US]33[29.12.1997]32[08/999391]31[
Int. Cl.8 A61K 048/00, C12N 001/21, 015/74, 015/85, 015/87]51[SCHERING AKTIENGESELLSCHAFT, GERMANY
]71[
WO/1999/034007]87[וגולר, וולף, ברגמן
,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
] 57 [An attenuated invasive intracellular Listeria bacterium capable of infecting a mammalian host or host cell thereof, but having a decreased ability in intra-and intercellular movement in said host as
compared to a wild type bacterium, transformed with
)a (a promoter activated when said bacterium is present in the cytosol of a host cell, operably linked to a structural
June 3, 2007625 –התשס"ז בסיון י"ז
gene or a biologically active fragment thereof encoding a Listeria bacteriphage lysine which is lethal to the bacterium;
)b (a host cell-compatible promoter, operably linked to a structural gene or fragment thereof, encoding a polypeptide.
__________
136647]21][11[
הכנה אכינוקנדין, שיטת תולדותפטריות נגד כתכשירים ושימוש
ECHINOCANDIN DERIVATIVES, PREPARATION METHOD AND APPLICATION AS ANTI-FUNGAL AGENTS
]54[
09.12.1998]22[FR]33[10.12.1997]32[97/15628]31[FR26.10.199898/13361
Int. Cl.8 A61K 038/12, A61P 031/10, C07K 007/56]51[NOVEXEL, FRANCE]71[OLIVIER COURTIN, PATRICK FAUVEAU, ASTRID MARKUS, DOMINIQUE MELON MANGUER, JEAN-MARC MICHEL, LAURENT SCHIO
]72[
WO/1999/029716]87[ דין, עורכי עורכי לצר צדק כהן פרל
ונוטריונים, פטנטים , ת.ד.5 , רח' שנקר1 גב-ים מרכז
PEARL COHEN ZEDEK LATZER, 5 SHENKAR STREET ,
P.O.B. 12704
]74[
June 3, 2007 626 –התשס"ז בסיון י"ז
HERZLIYA 46733, הרצליה12704
]57 [A compound selected from the group consisting of all possible stereoisomeric forms of a compound of the formula
whereinR1 and R2 are individually selected from the group consisting of hydrogen, -OH, alkyl and cycloalkyl of up to 8 carbon
atoms optionally interrupted with oxygen and optionally substituted by a member selected from the group consisting of halogen, - OH and
a and b are individually hydrogen or alkyl of 1 to 8 carbon atoms or taken together with the nitrogen form a heterocycle optionally containing at least one
heteroatom selected from the group consisting of oxygen, sulfur and nitrogen, or R1 forms a double bond with the endocyclic carbon atom carrying the
wherein R2 is –XRa, X is selected from the group consisting of oxygen, -NH- and – N-alkyl radical, containing up to 8 carbon atoms, Ra is selected from the group consisting of hydrogen and alkyl and
cycloalkyl of up to 8 carbon atoms unsubstituted or substituted with at least one member of the group consisting of halogen, -OH-, -COOH, -COOAlk,
June 3, 2007627 –התשס"ז בסיון י"ז
Alk is alkyl of 1 to 8 carbon atoms,a' and b' are individually selected from the group consisting of hydrogen and alkyl of 1 to 8 carbon atoms or taken with the nitrogen form a heterocycle optionally
containing at least one heteroatom selected from the group consisting of oxygen, sulfur and nitrogen and/or substituted by a heterocycle containing at least one heteroatom or R2 is
d and e are hydrogen or alkyl of 1 to 8 carbon atoms, f and g are selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms and acyl of an organic carboxylic acid of 1 to 8 carbon atoms or e and f together with –N=C-N- form a heterocycle optionally containing at least one other heteroatom selected from the group consisting of oxygen, sulfur and nitrogen, R3 is selected from the group consisting of hydrogen, methyl and –OH,R4 is hydrogen or –OH,R representing either a linear or branched or cyclic chain containing up to 30 carbon atoms, optionally containing one or several heteroatoms, one or several heterocycles or a linear, branched or cyclic
acyl radical containing up to 30 carbon atoms optionally containing one or several heteroatoms selected from the group consisting of oxygen, sulfur and nitrogen and/or one or several heterocycles, T is selected from the group consisting of hydrogen, methyl, -CH2 –CONH2, -CH2-CN, -(CH2)2-NH2 and –(CH2)2Nalk3
+X-, alk is alkyl of 1 to 8 carbon atoms, X is halogen,Y is selected from the group consisting of hydrogen, -OH, halogen and –SO3H and salts thereof,W is hydrogen, or –OH,Z is hydrogen or methyl or a non-toxic, pharmaceutically acceptable acid addition salt thereof.
June 3, 2007 628 –התשס"ז בסיון י"ז
מבקשה חלוקה בקשותפורסמו. שטרם זו
172412,The applications for division from this application have not yet been published
__________
136833]21][11[
עצביים, פרקורסור תאי ליצירת שיטה אותם המכיל תומוריגני לא תאים הרכב
רוקחות תכשירי להכנת ושימושם
METHOD FOR GENERATING NEURAL PRECURSOR CELLS, NON-TUMORIGENIC CELL COMPOSITION CONTAINING THEM AND USES THEREOF IN PREPARATION OF PHARMACEUTICAL COMPOSITIONS
]54[
June 3, 2007629 –התשס"ז בסיון י"ז
18.12.1998]22[DE]33[19.12.1997]32[19756864.
5]31[
Int. Cl.8 A61K 048/00, C12N 005/08, 005/10]51[OLIVER BRUESTLE, GERMANY]71[WO/1999/032606]87[
לוצאטו, את לוצאטושבע , באר5352, ת.ד. תעשייה, עומר גן
LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER
P.O.B. 5352BEER-SHEVA 84152
]74[
]57 [Non-tumorigenic cell composition obtained from mammalian embryonic stem cells, containing:
)a (at least 85% isolated neural precursor cells with the ability to differentiate into neuronal or glial cells, and
)b (no more than 15% primitive embryonic and non-neural cells, obtainable by the steps of:
)a (proliferation of ES cells;)b (cultivation of the ES cells from step (a)
into neural precursor cells;)c (proliferation of the neural precursor
cells in growth factor-containing serum-free medium;
)d (proliferation of the neural precursor cells from step (c) in another growth
factor-containing serum-free medium and isolation of the purified neural precursor cells; and
)e (proliferation of the neural precursor cells from step (d) in another growth factor-containing serum-free medium and isolation of the purified precursor cells with the ability to differentiate into neuronal or glial cells, wherein the growth factor-containing, serum-free medium in step (d) comprises bFGF and EGF, and wherein the growth factor-containing, serum-free medium in step (e) comprises bFGF and PDGF, with the proviso that the method does not include the destruction of human embryos.
__________
137257]21][11[
ותוקפנות בחרדה לטיפול חומר בלוטה סביב בעור מהפרשה המתקבל
אותו המכילה ותמידה ביונק
COMPOSITION FOR THE TREATMENT OF STRESS AND AGGRESSIVE BEHAVIOR OBTAINABLE FROM A SECRETION DERIVED FROM THE SKIN AROUND MAMMALIAN GLAND AND A SOLUTION COMPRISING SAME
]54[
21.01.1999]22[EP]33[21.01.1998]32[98400117.
2]31[
Int. Cl.8 A61K 035/00, 035/55]51[FIDELINE, FRANCE]71[WO/1999/037297]87[
June 3, 2007 630 –התשס"ז בסיון י"ז
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A composition for the treatment of stress, anxiety and/or aggressive behavior in a mammal, obtainable from a secretion derived from the skin around mammalian
gland, said secretion containing, as a main active ingredient, a mixture of at least the three fatty acids palmitic acid, linoleic acid and oleic acid or derivatives thereof.
__________
137292]21][11[
תופעות המציגים ביולוגים מודליםמחלות של משניות
BIOLOGICAL MODELS EXHIBITING SECONDARY DISEASE MANIFESTATIONS
]54[
13.07.2000]22[US]33[16.07.1999]32[09/356293]31[
Int. Cl.8 A01K 067/027, C12N 005/06]51[ENZO THERAPEUTICS, INC., U.S.A.]71[
וגולר, וולף, ברגמן ,1352ב' , ת.ד. 19 היסוד קרן רחוב
ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
]57 [A Tupaia animal model for a chronic disease caused by a human viral pathogen, wherein said Tupaia animal model infected by said pathogen exhibits analogous secondary disease manifestations that are
secondary to a viral infection caused by said pathogen and said secondary disease manifestations are similar to those seen in humans with said chronic disease.
June 3, 2007631 –התשס"ז בסיון י"ז
__________
137299]21][11[
June 3, 2007 632 –התשס"ז בסיון י"ז
הניתנים צורה זיכרון בעלי פולימריםביולוגי לפירוק
BIODEGRADABLE SHAPE MEMORY POLYMERS
]54[
23.02.1999]22[US]33[23.02.1998]32[60/075523]31[
Int. Cl.8 A61L 027/00, C08L 101/12]51[MASSACHUSETTS INSTITUTE OF TECHNOLOGY, U.S.A.
]71[
WO/1999/042147]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A degradable shape memory polymer composition having at least one shape in memory, the polymer comprising
)1 (hard and soft segments or)2 (at least one soft segment, which is
crosslinked covalently or ionically, or
)3 (polymer blends,wherein the original shape of the polymer is recovered by a change in temperature or by application of another stimulus.
__________
137455]21][11[
או בחשמל הגוף ברקמות לטפול מכשירתרופות
APPARATUS FOR TREATING BODY TISSUES WITH ELECTRICITY OR MEDICAMENTS
]54[
23.07.2000]22[US]33[26.07.1999]32[09/360893]31[
Int. Cl.8 A61N 007/00]51[]ZULI HOLDINGS LTD.]71השרון בע"מ, רמת החזקות זולי
איתן, מהולל, פאפו, קוגלר,, הרצליה11המנופים
EITAN, MEHULAL, PAPPO, KUGLER,
11 HAMENOFIM ST .HERZLIYA 46120
]74[
]57 [A device (3) to be inserted into the body for treating body tissue, comprising:
)a (a device (8) capable of generating electrical current at a therapeutic voltage and amperage, for treating body issue, in response to ultrasonic vibrations;
)b (sensor means (11), the sensor means adapted to receive preselected stimuli generated by the body tissue, and
)c (means (10) for selectively generating and transmitting ultrasonic vibrations to the device for a location outside the device,
June 3, 2007633 –התשס"ז בסיון י"ז
)d (wherein the sensor means is adapted to communicate with and selectively energize the means for selectively generating and
transmitting ultrasonic vibrations to the device in response to the preselected stimuli generated by the body tissue.
__________
137617]21][11[
,1] – [ – טריאזולו4, 2, 1] – – פניל65 – a7 בקבוצה מותמרים [ פירימידינים
ציקלואליפטית, הכנתן או – אריל נגד למלחמה אותם המכילים ותכשירים
בצמחים פטוגניות פטריות
6 - PHENYL - [1, 2, 4] - TRIAZOLO - [1, 5 - A]-PYRIMIDINES SUBSTITUTED BY A 7 - ARYL OR (CYCLO) ALIPHATIC GROUP, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM FOR COMBATING PHYTOPATHOGENIC FUNGI
]54[
09.02.1999]22[US]33[11.02.1998]32[022288]31[US03.02.1999243851
Int. Cl.8 C07D 487/04]51[WYETH HOLDINGS CORPORATION, U.S.A.
]71[
WO/1999/041255]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
June 3, 2007 634 –התשס"ז בסיון י"ז
]57 [A compound of the formula
whereinR1 represents an optionally substituted alkyl, alkenyl, alkynyl, alkadienyl, or aryl group, or an optionally substituted cycloalkyl or cycloalkenyl group wherein one CH2 group of said cycloalkyl or cycloalkenyl group may also be replaced by O, S or NR2, in which R2 represents a hydrogen atom or an alkyl group; X
represents a hydrogen or halogen atom, or a hydroxy, alkoxy, aryloxy, aralkyloxy, haloalkoxy, alkylthio, cyano, amino, alkylamino, azido or dialkylamino group; L1, L2, L3, L4 and L5 each independently represent an hydrogen or halogen atom or an optionally substituted alkyl or alkoxy group or a nitro or cyano group.
__________
137893]21][11[
– ידי על זירוז באמצעות נוטקאטון יצורלקאז
PRODUCTION OF NOOTKATONE BY LACCASE CATALYSIS
]54[
16.08.2000]22[US]33[08.09.1999]32[09/391785]31[
Int. Cl.8 A23L 001/222, C07C 049/653, 409/14, C12P 007/26]51[GIVAUDAN SA, SWITZERLAND]71[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A process for producing nootkatone comprising:
)a (reacting valencene and a composition having laccase activity, wherein valencene is at a concentration of greater than 0.1%,
in the presence of an oxygen source to form valencene hydroperoxide,
)b (degrading the hydroperoxide to form nootkatone, and
)c (recovering nootkatone.
__________June 3, 2007635 –התשס"ז בסיון י"ז
137954]21][11[
מותמרים פירידינו–אריפיפרזינים תאים התרבות ביתר בטיפול היעילים
בפרוסטטה סרטנית לא
SUBSTITUTED PYRIDINO ARYLPIPERAZINES USEFUL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
]54[
19.02.1999]22[US]33[20.02.1998]32[60/075321]31[
Int. Cl.8 A61K 031/44, A61P 043/00, C07D 401/12]51[ORTHO-MCNEIL PHARMACEUTICAL, INC., U.S.A.
]71[
WO/1999/042448]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A compound of the formula
R1 is hydrogen, halogen, C1-5 alkoxy, hydroxyl, or C1-5 alkyl;
R2 is C1-6 alkyl, substituted C1-6 alkyl where the alkyl substituents are independently selected from one or more halogens, phenyl, substituted phenyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-5 alkyl, C1-5 alkoxy, and trihalo C1-5 alkyl, phenyl C1-5 alkyl, or substituted phenyl C1-5 alkyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-5 alkyl, halogen, C1-5
alkoxy, and trihalo C1-5 alkyl; R3 is hydrogen, hydroxy or C1-5 alkoxy if the dashed line is absent or is oxygen if the
dashed line is present; R4 is hydrogen, C1-5 alkyl, phenyl C1-5 alkyl or substituted phenyl C1-5 alkyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-5 alkyl, C1-5 alkoxy, and trihalo C1-5 alkyl;
R5 is C1-6 alkyl, substituted C1-6 alkyl where the alkyl substituents are independently selected from one or more halogens, phenyl, substituted phenyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-8 alkyl, hydrogen, halogen, hydroxy, C1-8 alkyl, substituted C1-8 alkyl where the alkyl substituents are independently selected from one or more
June 3, 2007 636 –התשס"ז בסיון י"ז
halogens, C1-5 alkoxy, amino, C1-5 alkylamino, di C1-5 alkylamino, C1-5 alkylcarbonyl, C1-5 alkoxycarbonyl, arylcarbonyl, nitrile, aminosulfonyl, C1-5 alkylsulfonyl, phenylsulfonyl, and substituted phenylsulfonyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-8 alkyl, hydrogen, halogen, hydroxy and nitro;
phenyl C1-5 alkyl, substituted phenyl C1-5 alkyl
where the phenyl substituents are independently selected from one or more members of the group consisting of C1-8 alkyl, hydrogen, halogen, hydroxy, C1-8 alkyl, substituted C1-8 alkyl where the alkyl substituents are independently selected from one or more halogens, C1-5 alkoxy, amino, C1-5 alkylamino, di C1-5 alkylamino, C1-5 alkylcarbonyl, C1-5 alkoxycarbonyl, and nitro; X is oxygen, sulfur or NH; pharmaceutically acceptable salts thereof; and stereoisomers, racemic mixtures, as well as enantiomers thereof.
__________
138090]21][11[
זימון בסביבת סתגלני מחדש רכישה זמןמקומות מרובת
ADAPTIVE REACQUISITION TIME IN A SLOTTED PAGING ENVIRONMENT
]54[
16.03.1999]22[US]33[16.03.1998]32[09/039985]31[
Int. Cl.8 H04B 007/216, H04Q 007/32]51[QUALCOMM INCORPORATED, U.S.A.
]71[
WO/1999/048221]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A method for adaptively determining a pilot signal reacquisition time, the method comprising the steps of: measuring a magnitude of a shift in phase of said pilot signal; comparing said measured
magnitude to a shift threshold; and decreasing said reacquisition time if said measured magnitude is not greater than said shift threshold.
June 3, 2007637 –התשס"ז בסיון י"ז
__________
138199]21][11[
LOW-PASS FILTER FOR Aדיפלקסר יחידה עבור איטי מעבר מסנןDIPLEXER
]54[
02.03.1999]22[DE]33[03.03.1998]32[19809021.
8]31[
Int. Cl.8 H03H 007/01]51[VACUUMSCHELZE GMBH, GERMANY
]71[
JORG PETZOLD, JOHANNES BEICHLER, DIRK HEUMANN
]72[
WO/1999/045643]87[לביא, שמעון
, ירושלים21 רח' הרצוג SIMON LAVIE,
21 HERZOG ST.JERUSALEM
]74[
]57 [Low-pass filter (8) for a diplexer for separating low-frequency signals of analogue communication systems from high-frequency signal of digital communication systems, comprising a plurality of series inductors (9) formed
with the aid of magnetic cores, characterised in that the magnetic cores are produced from an amorphous or manocrystalline alloy in such a manner that the series inductors display saturation induction of Bs > 0.6 T, a saturation to
June 3, 2007 638 –התשס"ז בסיון י"ז
remanence ratio of Br/Bs < 0.2 and substantially constant permeability to more than 10kHz.
__________
138336]21][11[
תימרוסל המכילים פרמצבטיים תכשיריםהרפס וירוס בזיהומי לטיפול
PHARMACEUTICAL COMPOSITIONS COMPRISING THIMEROSAL FOR TREATMENT OF HERPES VIRUS INFECTIONS
]54[
06.02.1998]22[Int. Cl.8 A61K 031/305, 031/555, 038/00, 039/20, A61P 009/10, 025/16, 025/28, 031/22, C07F 003/10, 003/12, C07K 014/00
]51[
DIVISION FROM 123206]62[MILKHAUS LABORATORY, INC., U.S.A.
]71[
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [Use of effective amount of thimerosal free of association with influenza virus and optionally in addition a rubella virus vaccine to make a pharmaceutical
composition for treating subjects suffering from herpes virus infections, wherein said composition is adapted to be administered systemically.
June 3, 2007639 –התשס"ז בסיון י"ז
__________
138767]21][11[
המתחלבים טקסיין של טרום–תרכיזיםבאיחסון ויציבים
STORAGE-STABLE SELF- EMULSIFYING PRECONCENTRATES OF A TAXANE
]54[
30.03.1999]22[US]33[01.04.1998]32[60/080272]31[US01.04.199860/080273
Int. Cl.8 A61K 009/107, 045/00, 047/26, 047/44, A61P 035/00, C07D 305/14]51[RTP PHARMA INC., U.S.A.]71[
ISKANDAR MOUSSA, INDU PARIKH, ALAIN CARRIER
]72[
WO/1999/049848]87[ושות' בע"מ, מ. בן-דוד ירמיהו
,45087, ת.ד. חוצבים המרפא, הר רחוב ירושלים
JEREMY M. BEN-DAVID & CO. LTD,.
HAR HOTZVIM HI-TECH PARK ,P.O. B. 45087 ,
JERUSALEM 91450
]74[
]57 [A storage-stable, self-emulsifying preconcentrate of a taxane in a microemulsion, composed of:
)i (10 to 80% w/w of at least one hydrophobic component selected from triglyceride, diglyceride, monoglyceride, free fatty acid, fatty acid ester, fish oil, vegetable oil, or mixtures thereof;
)ii (20 to 80% w/w of a surfactant phase comprising at least one non-ionic surfactant;
)iii (0 to 35% w/w of diethylene glycol monoethylether; and
)iv (0 to 40% w/w of at least one hydrophilic component selected from hydroxyalkane, dihydroxyalkane, a polyethylene glycol having an average molecular weight of less than or equal to 1000, and mixtures thereof; said preconcentrate producing an average particle size of less than or equal to 10 μm when mixed with an aqueous medium.
__________
139297]21][11[
המעכבים פירידין אמידו של נגזרותגסטרית חומצה הפרשת
IMIDAZO PYRIDINE DERIVATIVES WHICH INHIBIT GASTRIC ACID SECRETION
]54[
June 3, 2007 640 –התשס"ז בסיון י"ז
23.04.1999]22[SE]33[29.04.1998]32[9801526-6]31[
Int. Cl.8 A61K 031/437, 045/00, A61P 001/04, C07D 471/04]51[ASTRAZENECA AB, SWEDEN]71[KOSRAT AMIN, PETER NORDBERG, INGEMAR STARKE, MICHAEL DAHLSTROM
]72[
WO/1999/055706]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A compound of the formula
or a pharmaceutically acceptable salt thereof, whereinR1 is H, CH3, or CH2 OH; R2 is CH3 or CH2
CH3; R3 is H, C1-C6 alkyl, hydroxylated
C1-C6 alkyl or halogen; R4 is H, C1-C6 alkyl, hydroxylated C1-C6 alkyl, or halogen;
R5 is H, or halogen, R6 and R7 are the same or different and selected from H, C1-C6 alkyl, hydroxylated C1-C6 alkoxy-substituted C1-C6 alkyl; and X is NH, or O.
__________
139813]21][11[
OLIGONUCLEOTIDEריריתית חסינות לגרימת ומוצרים שיטותCOMPRISING COMPOSITION FOR INDUCING MUCOSAL IMMUNITY
]54[
21.05.1999]22[US]33[22.05.1998]32[60/086393]31[
Int. Cl.8 A61K 039/39]51[
June 3, 2007641 –התשס"ז בסיון י"ז
COLEY PHARMACEUTICALS, INC., U.S.A.
THE OTTAWA HEALTH RESEARCH INSTITUTE, CANADA
]71[
WO/1999/061056]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A composition for inducing a mucosal immune response in a subject, also exposed to an antigen that is not encoded in a nucleic acid vector, on administration to a mucosal surface of the
subject, wherein the composition comprises an oligonucleotide having a sequence including at least the following formula:
5'X1X2CGX3X43;'
wherein C is unmethylated, and X1, X2, X3 and X4 are nucleotides; and a pharmaceutically acceptable carrier.
__________
140028]21][11[
]PATIENT SPECIFIC DOSIMETRY]54לחולה ספציפי מינון מדידת
04.06.1999]22[US]33[04.06.1998]32[60/088327]31[
Int. Cl.8 A61K 051/00, 051/12]51[THE REGENTS OF THE UNIVERSITY OF MICHIGAN, U.S.A.
SMITHKLINE BEECHAM CORPORATION, U.S.A.
]71[
WO/1999/062565]87[איתן, מהולל, פאפו, קוגלר,
, הרצליה11המנופים EITAN, MEHULAL, PAPPO, KUGLER,
11 HAMENOFIM ST .HERZLIYA 46120
]74[
]57 [A method of establishing a patient-specific optimally effective dose for
administration of a radiopharmaceutical to a patient, the method comprising: determining a maximum tolerated dose for
June 3, 2007 642 –התשס"ז בסיון י"ז
the radiopharmaceutical for the patient population; determining a desired total body dose of the radiopharmaceutical for the patient; determining the clearance profile for the radiopharmaceutical or radiopharmaceutical analog; determining the patient's mass and maximum effective mass; selecting the lower of the patient's mass and maximum effective mass; determining the activity hours for the radiopharmaceutical or radiopharmaceutical analog based on the
lower of the patient's mass or maximum effective mass and the desired total body dose; administering a tracer dose of the radiopharmaceutical or the radiopharmaceutical analog to the patient; determining the residence time for the radiopharmaceutical or the radiopharmaceutical analog; and establishing the optimally effective dose of the radiopharmaceutical for the patient by solving for therapeutic dose in the following equation:
Activity Hours desired total body dose therapeutic dose= –––––––––––––––– X––––––––––––––––––––
Residence time maximum tolerated dose.
__________
140367]21][11[
תקשורת עבור ושיטה התקן, מערכתגישה ובקרת מאובטחת
DEVICE, SYSTEM AND METHOD FOR SECURE COMMUNICATION AND ACCESS CONTROL
]54[
23.06.1999]22[US]33[24.06.1998]32[09/104014]31[US11.05.199909/309873
Int. Cl.8 G06F 007/58, H04L 009/12, 017/22]51[
אביב רון, תל בינימיןWARCOP INVESTMENT LTD., BRITISH VIRGIN ISLANDSBENYAMIN RON
]71[
]ADAM SHEFI]72שפי אדםWO/2000/067548]87[
( בע"מ,1995) ג'י.אי.ארליך בגין מנחם ,רחוב15 אילון, קומה מגדל
גן , רמת11
G.E. EHRLICH (1995) LTD,. AYALON TOWER 15TH FLOOR
11 MENACHEM BEGIN STREET
]74[
June 3, 2007643 –התשס"ז בסיון י"ז
52521 RAMAT GAN
]57 [A method for generating a practically unlimited quantity of true random numbers, the true random numbers being identical in a plurality of locations, the method being operable by a data processor and the method comprising the steps of:
)a (providing an identical table of true random numbers, an identical pointer, an identical seed and an identical pseudorandom number generator at each of the plurality of locations;
)b (obtaining an obtained true random number from said identical table of true
random numbers according to said pointer, said obtained true random number being identical at the plurality of locations;
)c (generating a generated pseudorandom number by said pseudorandom number generator, said generated pseudorandom number being identical at the plurality of locations; and
)d (combining said obtained true random number and said generated pseudorandom number to form at least one of the quantity of true random numbers, said at least one of the quantity of true random numbers being identical at the plurality of locations.
__________
140429]21][11[
June 3, 2007 644 –התשס"ז בסיון י"ז
כסופגי השימושיים פוליאוריתן תכשירילהכנתן ושיטה אנרגיה
POLYURETHANE COMPOSITIONS USEFUL AS SHOCK ABSORBERS AND A METHOD FOR THEIR PREPARATION
]54[
20.12.2000]22[Int. Cl.8 C08G 018/48, 071/00, C08J 009/00, C08L 075/08]51[
]ORYCLE APPLICATIONS LTD.]71גת בע"מ, קרית יישומים אוריקלעו"פ, ברסלר דר' אייל
- גן , רמת11 תובל DR. EYAL BRESSLER,
11 TOVAL ST .RAMAT GAN 52522
]74[
]57 [A polyurethane foam composition comprising: at least one polyether polyol having an average molecular weight from
100-20,000; an aromatic polyisocyanate; a tackifying resin; a surfactant; a blowing agent, and a catalyst.
__________
140553]21][11[
דהידרוגנז לפורמאלדיהיד גניםמתילטרופיים משמרים
FORMALDEHYDE DEHYDROGENASE GENES FROM METHYLOTROPHIC YEASTS
]54[
02.07.1999]22[US]33[03.07.1998]32[60/091699]31[
Int. Cl.8 C12N 015/53]51[RESEARCH CORPORATION TECHNOLOGIES, INC., U.S.A.
]71[
WO/2000/001829]87[וגולר, וולף, ברגמן
,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
]57 [An isolated nucleic acid comprising a promoter that is inducible by methanol, methylamine, and a mixture of both methanol and methylamine in a
methylotrophic yeast, wherein said isolated nucleic acid is derivable from Pichia pastoris.
__________
140669]21][11[
המכיל הרירית דרך למתן אבקתי תכשירפולימרית תרופה
POWDERY PREPARATION FOR MUCOSAL ADMINISTRATION CONTAINING
]54[
June 3, 2007645 –התשס"ז בסיון י"ז
POLYMERICMEDICINE
01.07.1999]22[JP]33[08.07.1998]32[10-192722]31[JP25.03.199911-81549
Int. Cl.8 A61K 009/00, 009/14, 038/00]51[KIRIN-AMGEN INC., U.S.A.]71[
WO/2000/002574]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A preparation in powder form for administration through mucosa, comprising a medicine of high molecular weight selected from the group consisting
of bioactive peptides and proteins, antibodies, vaccines, and antigens, and aminoalkylmethacrylate copolymer or polyvinyl acetal diethylaminoacetate.
__________
141410]21][11[
להכנתם, ארילפיפראזינים, תהליך אותם המכילים רוקחות תכשירי
לטיפול תרופות להכנת בהם והשימוש ידי על המתווכים מחלה במצבי
(MMP) מטאלופרוטאינזות
ARYLPIPERAZINES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR TREATING DISEASE CONDITIONS MEDIATED BY METALLOPROTEINASES (MMP)
]54[
25.08.1999]22[EP]33[31.08.1998]32[98402144.
4]31[
EP04.06.199999401351.4Int. Cl.8 A61K 031/495, A61P 043/00, C07D 401/00, 403/12, 405/12, 409/12, 413/12, 417/12
]51[
ASTRAZENECA AB, SWEDEN]71[WO/2000/012478]87[
ושות', ש. הורוביץ , תל41-45 רוטשילד שדרות ציון בית
אביב
S. HOROWITZ & CO,. ZION HOUSE,
41-45 ROTHSCHILD BLVD,.TEL AVIV 65784
]74[
]57 [A compound of the formula
June 3, 2007 646 –התשס"ז בסיון י"ז
wherein ring B is a monocyclic or bicyclic alkyl, aryl, aralkyl, heteroaryl or heteroaralkyl ring comprising up to 12 ring atoms and containing one or more heteroatoms independently chosen from N, O, and S; alternatively ring B may be biphenyl; ring B may optionally be linked to ring A by a C1-4 alkyl or a C1-4 alkoxy chain linking the 2-position of ring B with a carbon atoms alpha to X2; each R3 is independently selected from hydrogen, halogen, NO2, COOR wherein R is
hydrogen or C1-6 alkyl, CN, CF3, C1-6 alkyl, -S-C1-6 alkyl, -SO-C1-6 alkyl, -SO2-C1-6 alkyl, C1-6 alkoxy and up to C10 aryloxy, n is 1, 2 or 3; P is –(CH2)n- wherein n=0, 1, 2: or P is an alkene or alkyne chain of up to six carbon atoms; or P may be selected from –CO-N(R6)-, -N(R6)-CO-, -SO2-N(R6)- and- N(R6)-SO2-, and R6 is hydrogen, C1-6 alkyl, up to C10 aralkyl or up to C9 heteroalkyl; Ring A is piperazine and may optionally be mono- or di-substituted by optionally
substituted C1-6 alkyl or C1-6 alkoxy, each substituent being independently selected from halogen, C1-6 alkyl or an oxo group.X1 and X2 are each N;Y is selected from –SO2- and –CO;-
Z is –N(OH)HO and Q is selected from –CH(R6)-, -CH(R6)-CH2-, and- N(R6)-
CH2;-R1 is H, C1-6 alkyl, C5-7 cycloalkyl, up to C10 aryl, up to C10 heteroaryl, up to C12 aralkyl, or up to C12 heteroarylalkyl, all optionally substituted by up to three groups independently selected from NO2, CF3, halogen, C1-4 alkyl, carboxyl (C1-4) alkyl, up to C6 cycloalkyl, -OR4, -SR4, C1-4 alkyl substituted with –OR4, SR4 (and its oxidized analogues), or C1-4 alkyl-Y-NR4, or R1 is 2,3,4,5,6-pentafluorophenyl; R4 is hydrogen, C1-6 alkyl, up to C10 aryl or up to C10 heteroaryl or up to C9 aralkyl, each independently optionally substituted by halogen, NO2, CN, CF3, C1-6 alkyl, -S-C1-6 alkyl, -SO-C1-6 alkyl, -SO2-C1-6 alkyl or C1-6 alkoxy;
R2 is H, C1-6 alkyl, or together with R1 forms a carbocyclic or heterocyclic spiro 5, 6 or 7 membered ring, the latter containing at least one heteroatom selected from N, O, and S; also the group Q can be linked to either R1 or R2 to form a 5, 6 or 7 membered alkyl or heteroalkyl ring comprising one or more of O, S and N; and wherein any alkyl groups outlined above may be straight chain or branched, or a pharmaceutically-acceptable salt or in vivo hydrolysable precursor thereof.
__________
141458]21][11[
MORPHOLOGICALמורפולוגית הבהרהDISAMBIGUATION
]54[
June 3, 2007647 –התשס"ז בסיון י"ז
15.02.2001]22[US]33[29.06.2000]32[09/606326]31[
Int. Cl.8 G06F 017/27]51[IBM CORPORATION, U.S.A.]71[
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A method for morphological disambiguation, comprising: building a statistical base by morphologically analyzing a corpus of text comprising multiple words having lemmas so as to find respective linguistic patterns of the words independently of the lemmas to which the linguistic patterns are applied, each pattern comprising a specification of at least one characteristic selected from a set of characteristics including a part of speech, prefix, number, gender and person,
and finding relative frequencies of occurrence of the linguistic patterns in the corpus; receiving an input string; morphologically analyzing the string to generate a list of candidate analyses of the string, each candidate analysis comprising a respective word, having a linguistic pattern and a lemma; and evaluating the
pattern in each of the analyses using the statistical base so as to determine a relative frequency of occurrence of the pattern in each of the analyses, independent of the
lemma to which the pattern is applied; and selecting from the list one or more of the analyses that comprise respective patterns whose frequency of occurrence is above a predetermined threshold.
__________
141710]21][11[
OBJECT DETECTION METHODאובייקט לגילוי ומערכת שיטהAND SYSTEM
]54[
28.02.2001]22[June 3, 2007 648 –התשס"ז בסיון י"ז
Int. Cl.8 G01S 017/02]51[ בע"מ, לחימה אמצעי לפיתוח רפאל-רשות
חיפהRAFAEL-ARMAMENT DEVELOPMENT AUTHORITY LTD.
]71[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A method for monitoring a region of interest, the method comprising:
)i (transmitting incident radiation towards the region of interest with a certain transmitting angle to define a plane of propagation of the incident radiation, and with a predetermined angular intensity distribution, I(θ), of the incident radiation, the region of interest being located within said plane;
)ii (collecting reflections of the incident radiation with a solid angle of collection intersecting with said plane, a region of intersection being a detecting window of a
predetermined geometry containing at least a portion of said region of interest; detecting the collected radiation coming from within said detecting window utilizing a detector having a sensing surface configured with a predetermined geometry and with a spatially variable sensitivity within this surface selected in accordance with the geometry of the detecting window and the angular intensity distribution of the incident radiation; and generating output signals indicative of the detected radiation.
__________
141743]21][11[
דימולטיפלקסר בקרת עבור ושיטה ציוד קצב להתאמת בשימוש ומולטיפלקסר
ניידת תקשורת במערכת
APPARATUS AND METHOD FOR CONTROLLING A DEMULTIPLEXER AND A MULTIPLEXER USED FOR RATE MATCHING IN A MOBILE COMMUNICATION SYSTEM
]54[
08.07.2000]22[KR]33[08.07.1999]32[1999/2740
7]31[
KR23.07.19991999/30095KR30.08.19991999/37496
Int. Cl.8 H03M 013/03, H04B 007/02, 007/216]51[SAMSUNG ELECTRONICS CO., LTD., REPUBLIC OF KOREA
]71[
WO/2001/005059]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
June 3, 2007649 –התשס"ז בסיון י"ז
]57 [An uplink transmitting device in a mobile communication system, comprising: an encoder for receiving a first information bit stream and for outputting three streams, a second information bit stream, a first parity stream, and a second parity stream, by encoding the first information bit stream; an interleaver for interleaving the encoded streams by a predetermined interleaving rule; a radio frame segmenter for receiving the interleaved stream from the interleaver and mapping the received interleaved stream
onto at least one consecutive radio frame; a demultiplexer for separating each of the at least one radio frames received from the radio frame segmenter into a third information bit stream, and first and second parity streams from the demultiplexer; and a rate matcher for bypassing the third information bit stream and for puncturing a part of the first and second parity streams from the demultiplexer according to a given rate matching rule.
מבקשה חלוקה בקשותפורסמו. שטרם זו
180083,The applications for division from this application have not yet been published
__________
141761]21][11[
CONTACTLESS ACCESS TICKETלייצורו ושיטה מגע ללא לגישה כרטיסAND METHOD FOR MAKING SAME
]54[
07.07.2000]22[FR]33[07.07.1999]32[99/08802]31[
Int. Cl.8 G06K 019/06]51[ASK, FRANCE]71[WO/2001/004834]87[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A ticket (10) providing access to a zone with controlled access when said
ticket is presented without contact in front of a ticket reader authorizing access to the zone, said ticket having an Edmonson
June 3, 2007 650 –התשס"ז בסיון י"ז
format and comprising a paper ticket body (12) covered on both surfaces with a protective coating (18, 20), said paper ticket body being provided with a through-hole wherein is located an electronic module (14) comprising an integrated circuit (22) and an antenna (24), said antenna being formed by at least one turn obtained by screen printing with silvery powder in a polymerisable composition
before being heat-cured, wherein said electronic module also includes an overlay having a thickness slightly greater than that of said electronic circuit and provided with an opening whose dimensions are slightly greater than that of said electronic circuit such that said electronic circuit fits into said opening, so that said module has a substantially constant thickness.
__________
142265]21][11[
לא גישה בעלת נתונים עיבוד מערכת ( המקדימהNUMA) לזכרון אחידה על מרוחק עיבוד לענף קריאה בקשתמשוער בסיס
NON-UNIFORM MEMORY ACCESS (NUMA) DATA PROCESSING SYSTEM THAT SPECULATIVELY FORWARDS A READ REQUEST TO A REMOTE PROCESSING NODE
]54[
10.12.1999]22[US]33[15.12.1998]32[09/211351]31[
Int. Cl.8 G06F 012/08, 013/00]51[INTERNATIONAL BUSINESS MACHINES CORPORATION, U.S.A.
]71[
WO/2000/036514]87[ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
]74[
June 3, 2007651 –התשס"ז בסיון י"ז
REHOVOT
]57 [A computer system, comprising: a node interconnect; and at least a local node and a remote node that are each coupled to said node interconnect, said local node including a local interconnect and said local and remote nodes each including one or more snoopers, wherein said one or more snoopers of said local node include a node controller insterposed between said local interconnect and said node interconnect, wherein said node controller speculatively transmits a request transaction received from said local
interconnect to said remote node via said node interconnect prior to determination of a local response, wherein snoopers at the local node and the remote node independently process the request transaction to obtain the local node response at the local node and a remote node response at the remote node, and wherein said node controller of the local node handles the remote node response to said request transaction in accordance with the local node response.
__________
142572]21][11[
מודלים שני בין ההבדלים לקביעת שיטהיותר או
METHOD FOR DETERMINING DIFFERENCES BETWEEN TWO OR MORE MODELS
]54[
15.10.1999]22[US]33[16.10.1998]32[60/104682]31[
Int. Cl.8 G06F 017/30]51[COMPUTER ASSOCIATES THINK, INC., U.S.A.
]71[
WO/2000/023863]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER]74[
June 3, 2007 652 –התשס"ז בסיון י"ז
P.O.B. 5352BEER-SHEVA 84152
]57 [A method for comparing a first model and a second model, comprising: identifying metadata in the first model and in the second model; calculating a first set of signatures for objects of the metadata of the first model and a second set of signatures for objects of the metadata of the second model, wherein the objects to the first model and the objects of the second model corresponding with each
other have the same signatures; determining which signatures of the first set of signatures match signatures of the second set of signatures; and determining for the matched signatures whether the objects associated with the signatures of the first set of signatures equal the objects associated with the signatures of the second set of signatures.
__________
142650]21][11[
או מרה חומצת של קוניוגטים של שימוש או שומנית וחומצה מרה מלח של
רוקחות תכשירי להכנת שומניות חומצות שומני בכבד כולסטרול, לטיפול להורדתוסכרת בהיפרגליקמיה ולטיפול
USE OF BILE ACID OR BILE SALT FATTY ACIDS CONJUGATES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR REDUCING CHOLESTEROL, TREATING FATTY LIVER AND
]54[
June 3, 2007653 –התשס"ז בסיון י"ז
TREATING HYPERGLYCEMIA AND DIABETES
17.04.2001]22[Int. Cl.8 A61K 031/575, C07J 009/00, 041/00]51[GALMED INTERNATIONAL LIMITED, MALTA
]71[
( בע"מ,1995) ג'י.אי.ארליך בגין מנחם ,רחוב15 אילון, קומה מגדל
גן , רמת11
G.E. EHRLICH (1995) LTD,. AYALON TOWER 15TH FLOOR
11 MENACHEM BEGIN STREET52521 RAMAT GAN
]74[
]57 [Use of a bile acid or bile salt fatty acid conjugate of the formula W-X-Gin which G is a bile acid or bile salt radical, which, if desired, is conjugated in position 24 with a suitable amino acid, W stands for one or two fatty acid radicals
having 14-22 carbon atoms, and X stands for a suitable bonding member or for a direct C=C bond between said bile acid or bile salt radical and the fatty acid(s) or of a pharmaceutical composition comprising same for the manufacture of a medicament for the reduction of the cholesterol in blood and body, wherein said suitable bonding member provides a solid bond that is not substantially deconjugated during the absorption process of the conjugate, with the proviso that said bond is not an ester bond.
__________
142787]21][11[
גבישי איבופרופאן של מצופים חלקיקיםמגורען
COATED PARTICLES OF GRANULATED CRYSTALLINE IBUPROFEN
]54[
03.11.1999]22[FR]33[06.11.1998]32[98/14033]31[
Int. Cl.8 A61K 009/28, 009/50, 031/19]51[ETHYPHARM, FRANCE]71[WO/2000/027368]87[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [Coated particles based on granulated microcrystals of ibuprofen, its isomers and its pharmaceutically acceptable salts,
characterized in that they have a coating consisting of a mixture comprising
June 3, 2007 654 –התשס"ז בסיון י"ז
)a (from 5 to 50% by weight, preferably from 10 to 30% by weight, of ethyl cellulose, based on the ibuprofen,
)b (from 10 to 60% by weight, preferably from 15 to 50% by weight, of hydroxypropyl methyl cellulose, based on the ethyl cellulose, and
)c (from 0.1 to 40% by weight, preferably from 3 to 25% by weight, of silica with antistatic and permeabilizing properties, based on the ethyl cellulose,
said coating – of which at least one of the constituents can be used for the granulation of the ibuprofen microcrystals to produce said particles – masking the unpleasant taste of the ibuprofen, significantly reducing its irritant effect on the throat after swallowing, and releasing the ibuprofen substantially immediately when the particles are placed in an aqueous medium.
__________
142876]21][11[
–חומצה5 של נאנו–אמולסיהאמינולוולינית
NANO-EMULSION OF 5-AMINOLEVULINIC ACID
]54[
12.11.1999]22[DE]33[12.11.1998]32[19852245.
2]31[
Int. Cl.8 A61K 009/107]51[BIOFRONTERA BIOSCIENCE GMBH, GERMANY
]71[
WO/2000/028971]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [Composition characterized in that it contains a nanoemulsion which comprises an active substance selected from 5-aminolevulinic acid, or a salt, a complex or an addition compound thereof, and/or precursors and/or metabolites thereof
which can be converted into protoporphyrin IX, and a carrier in an aqueous phase, with the carrier being formed from one or more lipids and from one or more emulsifiers including soybean lecithin.
__________
143013]21][11[
בעל מעצמו המתיישרMOSFET שבבנפרדים שערים עם כפול שער
SELF-ALIGNED DOUBLE GATE MOSFET WITH SEPARATE GATES
]54[
June 3, 2007655 –התשס"ז בסיון י"ז
07.05.2001]22[US]33[15.05.2000]32[60/204131]31[US07.07.200009/612260
Int. Cl.8 H01L 029/76]51[IBM CORPORATION, U.S.A.]71[
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A transistor comprising: a channel region (5); a first gate (16) on top of said channel region; a second gate (22) below said channel region; and source and drain regions (8) laterally adjacent said channel region, wherein said channel region
includes an extension into said source and drain regions, and wherein said first gate comprises the same material as said second gate, and has a different doping concentration than said second gate.
__________
June 3, 2007 656 –התשס"ז בסיון י"ז
143014]21][11[
TRANSDERMAL DRUGתת–עוריים אנליט והוצאת תרופה מתןDELIVERY AND ANALYTE EXTRACTION
]54[
01.11.1999]22[US]33[09.11.1998]32[09/189170]31[
Int. Cl.8 A61N 001/30]51[]TRANSPHARMA MEDICAL LTD.]71בע"מ, יהוד מדיקל טראנספארמה
WO/2000/027473]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A device (20) for ablating stratum corneum epidermidis of skin on the body of a subject, comprising; a plurality of electrodes (60), which are adapted to be applied to the skin of the subject at respective points; and a power source,
(52) which is adapted to apply electrical energy between two or more of the plurality of electrodes, to cause ablation of an area of the stratum corneum during a first time period, so as to facilitate passage of a substance through the ablated area during a second time period, subsequent to the first time period.
__________
143202]21][11[
COMPUTERIZED ADAPTIVEמסתגלת ממוחשבת הדמיהIMAGING
]54[
30.11.1999]22[IL]33[01.12.1998]32[127359]31[US27.01.199909/238225
June 3, 2007657 –התשס"ז בסיון י"ז
Int. Cl.8 G01N 021/17, 021/64, G02B 021/00, G06T 001/00]51[ YEDA RESEARCH ANDבע"מ, רחובות ופיתוח למחקר חברה ידע
DEVELOPMENT CO. LTD.THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, U.S.A.
]71[
WO/2000/033250]87[סקמסקי, אפרים
, ירושלים4500, ת.ד. EPHRAIM SECEMSKI,
P.O.BOX 4500JERUSALEM 91045
]74[
]57 [Apparatus for three-dimensional image processing, comprising: an imaging system reading a three dimensional map of variations in the refractive characteristics in a volume; a ray tracer, utilizing said three dimensional map to analytically trace a multiplicity of rays from a multiplicity of locations in said volume through said
volume, thereby providing a location dependent point spread function; and a three dimensional deconvolver, utilizing the location dependent point spread function, to provide an output image corrected for distortions due to three dimensional variations in the refractive characteristics in said volume.
__________
143229]21][11[
מבחינה פעילות נגזרות לייצור שיטה –4–אמינו–1 של אופטית
– אין2)הידרוקסימתיל(– ציקלופנט–
METHOD FOR PRODUCING OPTICALLY ACTIVE 1-AMINO-4-(HYDROXYMETHYL)-CYCLOPENT-2-ENE DERIVATIVES
]54[
23.12.1999]22[EP]33[23.12.1998]32[98124570.
7]31[
June 3, 2007 658 –התשס"ז בסיון י"ז
Int. Cl.8 C07C 235/30, 235/40, C12P 041/00]51[LONZA AG, SWITZERLAND]71[WO/2000/039324]87[
לוצאטו, את לוצאטושבע , באר5352, ת.ד. תעשייה, עומר גן
LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER
P.O.B. 5352BEER-SHEVA 84152
]74[
]57 [Process for preparing enantiomerically enriched 1-amino-4-
(hydroxymethyl) cyclopent-2-ene derivatives of the formulae
in which R1 is hydrogen or an optoionally substituted C1-8-alkyl radical, aryl radical
or cycloalkyl radical and R2 is an optionally substituted acyl, in that a racemic 1-amino-4-(hydroxymethyl) cyclopent-2-ene derivative of the formula
in which R1 is as defined above is reacted using a hydrolase in the presence of an acylating agent.
__________
143253]21][11[
נקודות בעל בטיפטוף להשקייה זרנוקשונה בקצב מים טיפטוף
DRIP IRRIGATION HOSE WITH EMITTERS HAVING DIFFERENT DISCHARGE RATES
]54[
19.11.1999]22[US]33[20.11.1998]32[60/109667]31[
Int. Cl.8 A01G 025/02]51[T-SYSTEMS INTERNATIONAL, INC., U.S.A.
]71[
WO/2000/030433]87[
June 3, 2007659 –התשס"ז בסיון י"ז
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A drip irrigation hose (10) having a water supply passage (26) and a plurality of flow regulating channels (24) manufactured into the hose that are smaller than the water supply passage, the flow regulating channels each comprising: a predesignated geometry to provide a desired discharge rate at a given pressure, an inlet section (32) comprising one or more openings connecting the water
supply passage to that flow regulating channel, and an outlet section (28) comprising one or more openings (36) connecting that flow regulating channel to the exterior of the hose, wherein the plurality of flow regulating channels have at least two different geometries to provide at least two different discharge rates at the given pressure.
__________
143270]21][11[
חיות של פעילות הגברת עבור שיטהמחמד
METHOD FOR INCREASING PET ACTIVITY
]54[
21.09.2000]22[US]33[22.09.1999]32[60/155451]31[
Int. Cl.8 A23K 001/14, 001/18]51[SOCIETE DES PRODUITS NESTLE S.A., SWITZERLAND
]71[
June 3, 2007 660 –התשס"ז בסיון י"ז
WO/2001/021008]87[ושותפיו, עו"פ, הס יצחק ד"ר
אביב , תל6451 , ת.ד. 279 הירקון רחוב DR. YITZHAK HESS & PARTNERS,
279 HAYARKON STREET P.O.B. 6451
TEL AVIV 61063
]74[
]57 [A method for improving activity in a pet, the method comprising administering to the pet a nutritional agent which
promotes the growth of bifido-and lactic-bacteria in the gastro-intestinal tract of the pet.
__________
143693]21][11[
לקבצים דינמית לגישה ומערכת שיטהשרת – לקוח במערכת
CLIENT-SERVER DYNAMIC FILE ACCESS SYSTEM AND METHOD
]54[
29.12.1999]22[US]33[31.12.1998]32[09/224622]31[
Int. Cl.8 G06F 015/173, 019/00]51[COMPUTER ASSOCIATES THINK, INC., U.S.A.
]71[
WO/2000/039698]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A system for dynamically viewing updates to a data file, comprising: a file access client operable to request dynamic access to a data file; and a file access server coupled to the file access client, the file access server operable to transmit an
initial content of the data file to the file access client and data file modifications dynamically occurring over time, wherein the file access client is enabled to dynamically view the updates to the data file as they occur.
June 3, 2007661 –התשס"ז בסיון י"ז
__________
143709]21][11[
ANDROGEN RECEPTORאנדרוגן לקולטני מעכביםSUPPRESSORS
]54[
12.11.1999]22[US]33[18.12.1998]32[09/215351]31[
Int. Cl.8 A61K 031/145, 031/165, 031/275, 031/40, C07C 237/04, 237/22, 255/56, 255/58, 275/30, 317/46, 323/51, 335/06, 335/16, C07D 207/40, 233/66
]51[
BIOPHYSICA, INC., U.S.A.]71[WO/2000/037430]87[
( בע"מ,1995) ג'י.אי.ארליך בגין מנחם ,רחוב15 אילון, קומה מגדל
גן , רמת11
G.E. EHRLICH (1995) LTD,. AYALON TOWER 15TH FLOOR
11 MENACHEM BEGIN STREET52521 RAMAT GAN
]74[
]57 [A compound of the formula:
June 3, 2007 662 –התשס"ז בסיון י"ז
wherein:X is nitro, cyano or halogen;V is CF3, halogen or H;
W is OH when T is H and is methyl when T and T1 are taken together to form a C=Z bridge; U is N when T and T1 are taken together to form a C=Z bridge or is taken together with T1 to form a bond or O or N; Q is a chalcogen; n is 1 or 2 and d is 0 or 1;when d is 0, T and T1 are hydrogen;when d is 1, then:
when n is 1, Y is a bond or linking group of from 1 to 10 carbon atoms and from 0 to 6 heteroatoms in the chain, where the
heteroatoms are N, O, or S; Z, when other than taken together with Y, is an aliphatic group of from 1 to 6 carbon atoms, a polyfluoroacylamido group of from 2 to 8 carbon atoms and having at least 2 fluorines and not more than 2m-1 fluorines, wherein m is the number of carbon atoms, or haloanilino, where halo is of atomic number 9 to 80; and when n is 2, Y and Z are taken together to form a bond or a linking group of from 1 to 10 carbon atoms and from 0 to 6 heteroatoms, with from 0 to 4 heteroatoms in the chain, where the heteroatoms are N,O, and S.
__________
143780]21][11[
PROCESS FORאלקטרודה לייצור תהליךMANUFACTURING ELECTRODE
]54[
14.06.2001]22[Int. Cl.8 H01G 009/052]51[
קרמיקה( בע"מ, יקנעם )טכנולוגיות קראלעילית
CEREL (CERAMIC TECHNOLOGIES) LTD.
]71[
צ'רניאק, טלי שוסטר, לודמילה ישראלכהן פלד, ניסים
ISRAEL SCHUSTER, LUDMILA CHERNIAK, TALI PELED, NISSIM COHEN
]72[
לוצאטו, את לוצאטושבע , באר5352, ת.ד. תעשייה, עומר גן
LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER
P.O.B. 5352BEER-SHEVA 84152
]74[
June 3, 2007663 –התשס"ז בסיון י"ז
]57 [An electrophoretic process for producing a tantalum electrode having a substantially uniform layer of deposited tantalum particles thereon, comprising the steps:
)a (providing a suspension of tantalum particles in a polar organic solvent;
)b (immersing a temporary tantalum foil deposition electrode and a counter electrode in said suspension;
)c (providing an electric field to charge said particles using said temporary
deposition electrode and said counter electrode;
)d (replacing said temporary deposition electrode with a new deposition electrode; and,applying a suitable direct current to said new deposition electrode and said counter electrode, such as to cause electrophoretic homogeneous deposition of tantalum particles onto the surface of said deposition electrode.
__________
143886]21][11[
וגרירה גלילה מערכת הכולל תרמילאינטגרלית
RUCKSACK WITH INTEGRATED ROLLING AND TRACTION SYSTEM
]54[
01.10.1999]22[BE]33[02.10.1998]32[9800714]31[
Int. Cl.8 A45F 003/04]51[ROGER DE LATHOUWER, BELGIUM
]71[
WO/2000/019862]87[ושות' בע"מ, מ. בן-דוד ירמיהו
,45087, ת.ד. חוצבים המרפא, הר רחוב ירושלים
JEREMY M. BEN-DAVID & CO. LTD,.
HAR HOTZVIM HI-TECH PARK ,
]74[
June 3, 2007 664 –התשס"ז בסיון י"ז
P.O. B. 45087 ,JERUSALEM 91450
[57] Rucksack with supple material walls comprising a retractable handle (7) and an incurvated base plate, such plate made to be integrated with the base of at least one telescopic housing of the rod(s) of the retractable handle, said base plate comprising openings at the incurvation, openings receiving projecting wheels, characterized in that the upper extremity of the telescopic housing(s) is connected to a
supporting plate of the supple material extending perpendicular to the telescopic system and in that the base plate is an interior base plate and the telescopic housing provided internally in the baggage along one face, and in that the face in contact with the back and provided with straps (31) is opposite the face adjacent to the telescopic housing.
__________
143940]21][11[
של דינמית לקורלציה ושיטה מערכתאירועים
SYSTEM AND METHOD FOR DYNAMIC CORRELATION OF EVENTS
]54[
29.12.1999]22[US]33[31.12.1998]32[09/224487]31[
Int. Cl.8 G06F 009/44, 017/30]51[COMPUTER ASSOCIATES THINK, INC., U.S.A.
]71[
WO/2000/039674]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352
]74[
June 3, 2007665 –התשס"ז בסיון י"ז
BEER-SHEVA 84152
[57] An event management system comprising: ane event manager, the event manager receiving on or more subscription requests for one or more event data from one or more subscribers, the event manager receiving one or more events and if the one or more events matches an existing condition, applying the one or more events as an update to the existing condition, the event manager further routing the one or more event data to the one or more subscribers; an alarm rule store, the alarm rule store storing alarm
rules; an event correlator coupled to the event manager and to the alarm rule store, the event correlator correlating the one or more event data provided by the event manager based on the alarm rules, the event correlator further dynamically determining whether a rule has changed, added or deleted to dynamically execute the added or modified rule; and a response engine coupled to the event manager, the response engine executing a response policy based on the correlation of events by the event correlator.
__________
143952]21][11[
רקבוביות, תכונות בעל אורגני דשןושימושו לייצורו שיטה
ORGANIC FERTILIZER HAVING HUMIC PROPERTIES, ITS METHOD OF PRODUCTION AND ITS USE
]54[
17.12.1999]22[DE]33[22.12.1998]32[19859068.
7]31[
Int. Cl.8 C05F 011/02, C05G 003/00]51[TECHNISCHE UNIVERSITAT DRESDEN, GERMANY
]71[
KLAUS FISCHER, RAINER SCHIENE, JOACHIM KATZUR
]72[
June 3, 2007 666 –התשס"ז בסיון י"ז
WO/2000/037394]87[בע"מ, פרידמן מרק ד"ר
אביב , תל7 שמואלוב, רח' האומנים בית DR. MARK FRIEDMAN LTD,.
BEIT SAMUELOFF, 7 HAOMANIM STREET,
TEL AVIV
]74[
[57] A method for the production of organic fertilizer having humic properties, comprising suspending lignite in an aqueous-ammoniacal medium of pH greater than about 9 and up to about 12, dissolving partially and oxidizing the lignite at a temperature of about 20 to
about 100oC, under atmospheric pressure thereby to obtain the organic fertilizer as a dispersion in aqueous medium and thickening or drying the dispersion, the organic fertilizer having a C/N ratio of about 9 to about 15.
__________
144067]21][11[
SYSTEM AND METHOD OFמתועלים נתונים להצגת ושיטה מערכתPRESENTING CHANNELIZED DATA
]54[
20.01.2000]22[US]33[20.01.1999]32[09/233870]31[
Int. Cl.8 G06F 015/16, 017/30]51[COMPUTER ASSOCIATES THINK, INC., U.S.A.
]71[
WO/2000/043917]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
[57] A method of channelising data within a system having a user interface and a server, characterized by: identifying, at the user interface, data to be published as published content; sending a request to the server identifying the data to the server;
generating, at the server, an object key to the the data to be published; storing the object key into a content directory as a function of values stored in a virtual directory; associating the object key with a channel; and displaying the channel on the user interface.
June 3, 2007667 –התשס"ז בסיון י"ז
__________
144290]21][11[
]ANTITACHYCARDIAL PACING]54אנטיטכיכרדיאלית הקצבה
14.01.2000]22[US]33[14.01.1999]32[231570]31[
Int. Cl.8 A61N 001/37]51[THE MOWER FAMILY CHF TREATMENT IRREVOCABLE TRUST, U.S.A.
]71[
MORTON M. MOWER]72[WO/2000/041766]87[
ושות' בע"מ, מ. בן-דוד ירמיהו ,45087, ת.ד. חוצבים המרפא, הר רחוב
ירושלים
JEREMY M. BEN-DAVID & CO. LTD,.
HAR HOTZVIM HI-TECH PARK ,P.O. B. 45087 ,
JERUSALEM 91450
]74[
[57] A method for setting up an implantable cardiac stimulator preparatory to the stimulator's use on the human body
to perform cardioverting, the cardiac stimulator having output means for delivering electrical stimulation of a
predetermined polarity, amplitude, shape and duration, the method comprising: selecting a first intensity level for application of pulses of biphasic pacing
stimulation, upon sensing the onset of tachycardia, each pulse of biphasic pacing stimulation comprising a first stimulation phase with a first phase polarity, a first phase amplitude, a first phase shape and a first phase duration; and a second stimulation phase with a second phase polarity, a second phase amplitude, a second phase shape and a second phase duration wherein said first phase amplitude is less than said second phase amplitude, said selecting comprising selection from the group consisting of at the diastolic
June 3, 2007 668 –התשס"ז בסיון י"ז
depolarization threshold, below the diastolic depolarization threshold or above the diastolic depolarization threshold.
__________
144411]21][11[
]HUMAN LIVER PROGENITORS]54אנושי מכבד אב תאי
19.01.2000]22[US]33[19.01.1999]32[60/116331]31[
Int. Cl.8 A61K 035/407, C12N 005/08]51[UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, U.S.A.
]71[
WO/2000/043498]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] A method of preparing a composition comprising a mixture of cells derived from human liver tissue, which mixture comprises an enriched population of human liver progenitors, the method comprising:(a) providing a cell suspension of human liver tissue comprising a mixture of cells of varying sizes, including immature cells and mature cells;(b) debulking the suspension based upon cell size, buoyant density, or a combination thereof to remove mature cells under conditions that permit the removal of mature cells and those of
relatively larger size, while retaining immature cells and those cells of less than about 15 micrometer in diameter; and(c) selecting those cells that express alpha-fetoprotein and one or more markers selected from the group consisting of CD14, CD34, CD38,ICAM, CD117, and albumin.
__________
June 3, 2007669 –התשס"ז בסיון י"ז
144756]21][11[
METHOD FOR CONTROLLINGהליפוזום גודל על לשליטה שיטהLIPOSOME SIZE
]54[
June 3, 2007 670 –התשס"ז בסיון י"ז
03.02.2000]22[US]33[08.02.1999]32[60/119229]31[
Int. Cl.8 A61K 009/00, 009/127, 009/133]51[ALZA CORPORATION, U.S.A.]71[
WO/2000/045791]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
[57] A method for preparing a liposome composition comprising liposomes having a desired size, the method comprising (i) determining an amount of lipid solvent required to achieve the desired liposome size from a profile of liposome size as a function of amount of lipid solvent in a hydration mixture of the lipid solvent and a
second solvent with which the lipid solvent is miscible, and (ii) hydrating a vesicle-forming lipid dissolved in said determined amount of lipid solvent with the second solvent to form the hydration mixture, said determined amount of lipid solvent being between 10-50 weight percent.
__________
144966]21][11[
פי על מחשב פעולות להפעלת שיטהלחוצים המחשב מקלדת מקשי בו הזמן
METHOD FOR EXECUTING COMPUTER OPERATIONS ACCORDING TO COMPUTER KEYBOARD'S KEYS DOWN TIME
]54[
19.08.2001]22[Int. Cl.8 G06F 003/02]51[
]ISRAEL ELIEZEROV]71אביב אליעזרוב, תל ישראלאליעזרוב, ישראל
אביב , תל16 רח' בלוך ISRAEL ELIEZEROV,
16 BLOCH ST. TEL AVIV]74[
[57] A method for enabling users of computer keyboards to generate different characters using the same keyboard keys said method comprising timing the keydown time of said key whereby a predetermined short duration results with
the character that a regular keystroke would generate being outputted, and a predetermined longer duration results with the character that would have been generated if the shift key was pressed while the key was pressed.
June 3, 2007671 –התשס"ז בסיון י"ז
__________
145069]21][11[
משטח דרך לנתינה רוקחות תכשירהגוף של חלל או מעבר של חצוני
PHARMACEUTICAL COMPOSITIONS FOR DELIVERY TO AN EXTERNAL WALL OF A BODY PASSAGEWAY OR CAVITY
]54[
June 3, 2007 672 –התשס"ז בסיון י"ז
23.02.2000]22[US]33[23.02.1999]32[60/121424]31[
Int. Cl.8 A61K 009/00, 009/70]51[UNIVERSITY OF BRITISH COLUMBIA, CANADAANGIOTECH INTERNATIONAL AG., SWITZERLAND
]71[
WO/2000/050016]87[וגולר, וולף, ברגמן
,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
[57] Use of a factor that induces fibrosis for the manufacture of a medicament for improving or increasing body passageway or cavity integrity, when said factor is
delivered to a non-luminal surface of said body passageway or cavity substantially as described in the specification.
__________
145090]21][11[
בערוץ המתקבלים נתונים לעיבוד שיטהאריתמטית אפליקציה בצורת תקשורת
APPROACH FOR PROCESSING DATA RECEIVED FROM A COMMUNICATION CHANNEL IN FINITE PRECISION ARITHMETIC APPLICATIONS
]54[
02.01.2001]22[US]33[30.12.1999]32[60/173785]31[US30.12.199960/173778
Int. Cl.8 H04B 003/06, H04J 011/00, H04L 027/01, 027/26]51[BANDSPEED, INC., U.S.A.]71[
WO/2001/050697]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] An apparatus for processing data received from a communications channel comprising: an equalizer configured to equalize received data from the
communications channel and generate equalized data, wherein the received data
is based upon both modulated data and distortion introduced by the communications channel, and the modulated data is the result of original data modulated onto one or more carriers, and wherein the equalizer is configured to use an algorithm with a set of one or more
June 3, 2007673 –התשס"ז בסיון י"ז
coefficients selected to account for a frequency domain response of the equalizer and to reduce the distortion introduced by the communications
channel; and a demodulator configured to generation an estimate of the original data by demodulating the equalized data.
__________
145125]21][11[
ההעברה לצימצום ושיטה מערכתTCP/IP בסביבת הודעות של החוזרת
SYSTEM AND METHOD OF REDUCING RETRANSMISSION OF MESSAGES ON A TCP/IP ENVIRONMENT
]54[
27.08.2001]22[US]33[13.09.2000]32[661402]31[
Int. Cl.8 H04L 012/56, 029/06]51[HARRIS CORPORATION, U.S.A.]71[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] In a radio network using TCP as the transport protocol for acknowledging message packets successfully received at a destination station and retransmitting message packets from the source station
which are not acknowledged within a predetermined period of time, a method of reducing the unnecessary retransmission of
message packets characterized by the steps of:(a) receiving a TCP retransmission packet at a source radio from a source station for retransmission to a destination station and maintaining the packet in a message queue until retransmission;(b) receiving a TCP acknowledgment packet at the source radio from a destination station;
June 3, 2007 674 –התשס"ז בסיון י"ז
(c) comparing the received acknowledgment packet from the destination station with the retransmission packet in the message queue; and
(d) discarding the retransmission packet from the message queue if the retransmission packet corresponds to the acknowledgment packet.
__________
145150]21][11[
June 3, 2007675 –התשס"ז בסיון י"ז
–a10 , 8הקסאהידרו– נגזרותמתאנופירידו
אזפין,d–3,2]] ' פיראנו2',6,5:3]] ותכשיריאותן המכילים רוקחות
HEXAHYDRO-8, 10A-METHANO PYRIDO
[2,'3:'5,6 ]PYRANO [2,3-D] AZEPINE
DERIVATIVES AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THEM
]54[
01.03.2000]22[FR]33[05.03.1999]32[99/02784]31[
Int. Cl.8 A61K 031/439, A61P 001/00, 025/30, 029/00, C07D 491/22]51[SANOFI AVENTIS, FRANCE]71[WO/2000/053608]87[
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] A compound in the form of pure geometrical or optical isomers or a mixture of such isomers, of the formula
in whichR1 is a hydrogen atom, a (C1-C4) alkyl group, a phenyl (C1-C4) alkyl group, a phenylhydroxy (C1-C4) alkyl group, a furanyl (C1-C4) alkyl group, or a furanylhydroxy (C1-C4) alkyl group,R2 is either a hydrogen or halogen atom or a trifluoromethyl, cyano, hydroxyl, nitro, acetyl, (C1-C6) alkyl or (C1-C6) alkoxy group or a group of general formula NR4R5
in which R4 is a hydrogen atom or a (C1-C4) alkyl or (C1-C4) alkanoyl group and R5 is a hydrogen atom or a (C1-C4) alkyl
group, or else R4 and R5 form, with the nitrogen atom which carries them, a C4-C7 ring, or a phenyl or naphthyl group optionally subsituted by a halogen atom or a trifluoromethyl, trifluoromethoxy, cyano, hydroxyl, nitro, acetyl, (C1-C6) alkyl, (C1-C6) alkoxy or methylenedioxy group linked in the 2 and 3 positions of the phenyl ring, and R3 is a hydrogen or halogen atom or a (C1-C4) alkyl group, in the state of a base or an addition salt to an acid.
__________
145325]21][11[
]SYSTEM AND METHOD FOR ]54 אינדקס מפתח לחילוץ ושיטה מערכת
June 3, 2007 676 –התשס"ז בסיון י"ז
EXTRACTING INDEX KEY DATAנתונים שדות שלFIELDS
24.03.2000]22[US]33[26.03.1999]32[09/276994]31[
Int. Cl.8 G06F 007/08, 017/30]51[COMPUTER ASSOCIATES THINK, INC., U.S.A.
]71[
WO/2001/038952]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
[57] A system (100) for extracting index key data fields, comprising: a definition interrogator (102) operable to extract index definitions and column definitions from a database; a code generator (104) coupled to the definition interrogator, the code generator operable to build computer code for extracting index key data fields based upon the index definitions and the column
definitions, the computer code including instructions to skip reading a selected number of characters in a data table (108) to read index key data fields; and a table analyzer (106) coupled to the code generator, the table analyzer operable to use the computer code to extract index data from a data table.
__________
145362]21][11[
June 3, 2007677 –התשס"ז בסיון י"ז
מיצוי עבור סולפיד מחצבי גיפור ומתכות נחושת של הידרומטלורגי
אחרות
SULPHIDISATION OF SULPHIDE ORES FOR HYDROMETALLURGICAL EXTRACTION OF COPPER AND OTHER METALS
]54[
14.12.2000]22[DE]33[14.12.1999]32[19960132.
1]31[
Int. Cl.8 C22B 001/00, 015/00]51[ALEXANDER BECKMANN, GERMANY
]71[
WO/2001/044524]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
[57] A process for extracting metals from chalcopyrite-containing ores comprising leaching steps of microbiological or chemical nature for leaching out the metals, characterized in that(a) the ores are converted in an inert atmosphere to a reaction product
compriusing covelline, pyrite, and accompanying sulfides by adding sulfur and additives in a conversion step interposed prior to the leaching steps, and(b) copper and other metals, precious metals, and rare earths contained in the reaction product are extracted.
__________
145470]21][11[
ALKYLATED RESORCINOLאלקיל קבוצות עם ריסורצינול תולדותDERIVATIVES
]54[
22.03.2000]22[US]33[22.03.1999]32[60/125674]31[US30.08.199960/151595
Int. Cl.8 C07C 039/10, 039/19, 043/20, 043/23]51[IMMUGEN PHARMACEUTICALS, INC., U.S.A.
]71[
WO/2000/056303]87[וגולר, וולף, ברגמן
,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
June 3, 2007 678 –התשס"ז בסיון י"ז
[57] An alkylated resorcinol derivativeof the formula:
wherein,R1 is: OH, OCH3
R2 is: HR3 is: 1, 1,5-trimethylhexyl, 1,1,5,5-tetramethylhexyl, or 1,1,5-trimethyl-hept-
4-enyl,R4 is: HR5 is: OH, or OCH3; andR6 is: H, OH, methyl, or ethyl.
__________
145483]21][11[
ביציקליות הטרוארומטיות תרכובות בטיפול לשימוש פעמים ארבע מותמרות
אותן הכוללים רוקחות תרופתי, תכשיריחדשות תרכובות וכמה
TETRASUBSTITUTED BICYCLIC HETEROAROMATIC COMPOUNDS FOR USE IN THERAPY, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND SOME NOVEL COMPOUNDS
]54[
03.04.2000]22[EP]33[08.04.1999]32[99201152.
8]31[
Int. Cl.8 A61K 031/395, A61P 005/06, C07D 471/04, 487/04, 491/04, 495/00]51[N.V. ORGANON, THE NETHERLANDS
]71[
WO/2000/061586]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
[57] A bicyclic heteroaromatic derivative compound of the formula
June 3, 2007679 –התשס"ז בסיון י"ז
or a pharmaceutically acceptable salt thereof whereinR1 is NR5R6, OR5, SR5 or R7;R5 and R6 are independently selected from H, (1-8C) alkyl, (2-8C) alkenyl, (2-8C) alkynyl, (3-8C) cycloalkyl, (2-7C) heterocycloalkyl, alkyl (1-8C) carbonyl, (6-14C) arylcarbonyl, (6-14C) aryl or (4-13C) heteroaryl, or R5 and R6 together are joined in a (2-7C) heterocycloalkyl ring and wherein the alkyl group, alkenyl group or alkynyl group, if present in R5 and/or R6
optionally are substituted with one or more substituents selected from hydroxyl, (6-14C) aryl, (1-8C) alkoxy, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (1-8C) alkoxycarbonyl, (6-14C) aryloxycarbonyl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, amino, (1-8C) alkylaminocarbonyl, (6-14C) arylaminocarbonyl, (1-8C) alkylcarbonylamino, (6-14C) arylcarbonylamino, (6-14C)(di) arylamino and/or (1-8C) (di) alkylamino;R7 is (3-8C) cycloalkyl, (2-7C) heterocycloalkyl or (6-14C) aryl or (4-13C) heteroaryl, both optionally substituted at the ortho and/or meta position with one or more substituents selected from R8, (6-14C) aryl, (4-13C) heteroaryl, (2-7C) heterocycloalkyl, (3-8C) cycloalkyl, NHR8, OR8 and/or SR8 in which R8 is (6-14C) aryl, (4-13C) heteroaryl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, (1-8C) alkyl, (2-8C) alkenyl, (2-8C) alkynyl, the alkyl group of which may be optionally substituted with one or more substituents selected from hydroxyl, (1-8C) alkoxy, (2-7C) heterocycloalkyl (1-8C) alkoxy, (3-8C) cycloalkyl (1-8C) alkoxy, (6-14C) aryl (1-8C) alkoxy, (4-
13C) heteroaryl (1-8C) alkoxy, (2-7C) heterocycloalkyl, (3-8C) cycloalkyl, (6-14C) aryl, (4-13C) heteroaryl, (1-8C) alkoxycarbonyl, (6-14C) arylyloxycarbonyl, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, amino, 1-8C) alkylamino-carbonyl, (6-14C) arylaminocarbonyl, (1-8C) alkylarbonylamino, (6-14C) aryl-carbonylamino, (6-14C) (di) arylamino and/or (1-8C) (di) alkylamino; R2 is (1-8C) alkyl, (2-8C) alkenyl or (2-8) alkynyl, all optionally substituted with one or more substituents selected from (6-14C) aryl, (4-13C) hetdroaryl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (6-14C) aryloxcarbonyl and/or (1-8C) alkoxycarbonyl or R2 is (6-14C) aryl or (4-13C) heteroaryl, both optionally substituted with one or more substituents selected from (1-8C) alkyl, (1-8C) alkylthio, (1-8C) (di) alkylamino, (1-8C) alkoxy, (2-8C) alkenyl, or (2-8C) alkynyl;R3 is (1-8C) alkyl, (2-8C) alkenyl or (2-8C) alkynyl, all optionally substituted with one or more substituents selected from hydroxyl, (1-8C) alkoxy, (6-14C) aryloxy, (3-8C) cycloalkyl (1-8C) alkoxy, (2-7C) heterocycloalkyl (1-8C) alkoxy, (6-14C) aryl (1-8C) alkoxy, (4-13C) heteroaryl (1-8C) alkoxy, (2-7C) heterocycloalkyl, (6-14C) aryl, (4-13C) heteroaryl, (1-8C) alkoxycarbonyl, (6-14C) aryloxycarbonyl, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, amino, (1-8C) alkylaminocarbonyl, (6-
June 3, 2007 680 –התשס"ז בסיון י"ז
14C) arylaminocarbonyl, (1-8C) alkylcarbonylamino, (6-14C) arylcarbonylamino, (6-14C)(di) arylamino or (1-8C)(di) alkylamino, or R3 is (3-8C cycloalkyl, (2-7C) heterocycloalkyl, or (6-14C) aryl or (4-13C) heteroaryl, both optionally substituted with one or more substituents selected from (1-8C) alkyl, (1-8C) (di) alkylamino or (1-8C) alkoxy;X is S, O or N(R4);
R4 is H, (1-8C) alkyl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl or (6-14C) aryl (1-8C) alkyl;Y is CH or N;Z is NH2 or OH;A is S, N(H), N(R9), O or a bond;R9 can be selected from the same groups as described for R2;B is N(H), O, or a bond;for use in therapy.
__________
145553]21][11[
BONE SCREW FOR USE INאורטופדי בניתוח לשימוש עצמות בורגORTHOPAEDIC SURGERY
]54[
03.04.2000]22[EP]33[08.04.1999]32[99830204.
6]31[
Int. Cl.8 A61B 017/86]51[ORTHOFIX INTERNATIONAL B.V., THE NETHERLANDS
]71[
DANIELE VENTURINI]72[WO/2000/061022]87[
בע"מ, פרידמן מרק ד"ראביב , תל7 שמואלוב, רח' האומנים בית
DR. MARK FRIEDMAN LTD,. BEIT SAMUELOFF, 7 HAOMANIM
STREET, TEL AVIV
]74[
[57] A bone screw for use in orthopaedic surgery, in particular with external fracture fixation devices, comprising a head (3), a shank (4), and a threaded portion (5) tapering towards a tip (2) at the opposite end from the head, wherein said threaded portion has at least one constant pitch
section comprising threads (9) with an acute angle or cusp-like triangular profile in cross-section, characterised in that said threads are separated from each other by a shaped bottom land having a concave profile (10) defined by two countersloping planes.
June 3, 2007681 –התשס"ז בסיון י"ז
__________
145572]21][11[
USER INTERFACE FORזמן של נתונים להזנת משתמש ממשקINPUTTING TIME-RELATED DATA
]54[
23.09.2001]22[Int. Cl.8 G04B 027/08, G04C 009/00]51[
שבע ברמן, באר ראובןשבע ברמן, באר אנה
REUBEN BERMANANNA BERMAN
]71[
ברמן, ראובןשבע , באר16 ארן זלמן
REUBEN BERMAN, 16 ZALMAN ARAN ST .
BEER-SHEBA
]74[
[57] A non-virtual apparatus for inputting time-related data, comprising: an analog clock whose notches and/or the surrounding thereof is sensitive to a touch of a rigid object, inputting said time via said apparatus being carried out by:(a) inputting the hour of said time by touching the corresponding notch or its surrounding with a rigid object;
(b) inputting the minute of said time by touching the corresponding notch or its surrounding with a rigid object;(c) optionally, setting the second of said time by touching the corresponding notch or its surrounding with a rigid object.
June 3, 2007 682 –התשס"ז בסיון י"ז
__________
145668]21][11[
]NEEDLELESS SYRINGE]54מחט חסר מזרק
14.04.2000]22[US]33[16.04.1999]32[293320]31[
Int. Cl.8 A61M 005/30]51[POWDERJECT RESEARCH LIMITED, UNITED KINGDOM
]71[
WO/2000/062846]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] A needleless syringe device for accelerating particles into a target tissue of a vertebrate subject, said syringe comprising: an elongate, tubular duct (1) having a lumen (2) for delivering the particles towards the target tissue, the duct having an upstream end and a downstream
end; a receptacle (10) holding the particles to be accelerated; and a gas discharge chamber (4), upstream of the receptacle for the controlled discharge therefrom of pressurized gas to accelerate the particles from the receptacle down the duct lumen towards the target tissue; wherein the
June 3, 2007683 –התשס"ז בסיון י"ז
pressurized gas discharged from the gas discharge chamber has a maximum total pressure which is less than 10 bar, and which is sufficient to accelerate the
particles down the duct such that the particles are configured to exit the duct with sufficient energy to penetrate into the target tissue.
__________
146058]21][11[
]FUSE SWITCH]54נתיך של מתג
20.04.2000]22[AT]33[20.04.1999]32[A702/99]31[
Int. Cl.8 H01H 085/54]51[MOELLER GEBAUDEAUTOMATION KG, AUSTRIA
]71[
WO/2000/063940]87[ושותפיו, עו"פ, הס יצחק ד"ר
אביב , תל6451 , ת.ד. 279 הירקון רחוב DR. YITZHAK HESS & PARTNERS,
279 HAYARKON STREET P.O.B. 6451
TEL AVIV 61063
]74[
[57] A fuse switch with an insulating housing (1) in which two live housing contacts (14) are arranged in a stationary fashion and with a switching slide (22) which is guided in a displaceable or swivelable manner between an on position and an off or exchange position in the
insulating housing for receiving a cartridge fuse link (20), which switching slide is also formed from an insulating material and whose final contact caps (21) rest in the on position directly on the stationary housing contacts and in the off or exchange position are spaced from the
June 3, 2007 684 –התשס"ז בסיון י"ז
stationary housing contacts, characterized by a carriage (24) with a pin (27), which carriage is held displaceably in the switching slide and holds the cartridge fuse-link and engages in a connecting link (28) arranged on the insulating housing, with the connecting link being shaped in
such a way that the carriage is displaced during the displacement or swiveling of the switching slide to such an extent from the the same that the cartridge fuse-link projects in sections beyond the switching slide.
__________
146098]21][11[
של הפה דרך למתן מינון צורת12,7,6,3,2, 12a–2 – הקסאהידרו–
–4, 3 – )6 – דימתיל( –3, 2 מתיל)ו– :1,'2]' מתילנדיאוקסיפניל( פיראזינו
–4, 1 – [ אינדולb – 4,3] [ פירידו1,6דיאון
UNIT DOSAGE FORM OF 2,3,6,7,12, 12A - HEXAHYDRO - 2 - METHYL - (AND 2,3 - DIMETHYL) -6 - (3,4 - METHYLENEDIOXYPHENYL) PYRAZINO [2',1',: 1,6] PYRIDO [3,4-B] INDOLE - 1,4 - DIONE FOR ORAL ADMINISTRATION
]54[
26.04.2000]22[US]33[30.04.1999]32[60/132036]31[
Int. Cl.8 A61K 031/4985, A61P 015/10, C07D 471/14]51[LILLY ICOS LLC, U.S.A.]71[
WO/2000/066099]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.]74[
June 3, 2007685 –התשס"ז בסיון י"ז
, P.O.B. 4060אביבTEL AVIV 61040
[57] A pharmaceutical unit dosage composition comprising about 1 to about 20 mg of a compound of the formula
said unit dosage form being suitable for oral administration.
__________
146211]21][11[
רעלן כקושרי אניוניים פולימריםאנטיבקטריאליים וחומרים
ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS
]54[
11.05.2000]22[US]33[13.05.1999]32[60/133975]31[US03.04.200009/541268
Int. Cl.8 A61K 031/74, 047/00, A61P 001/12]51[GENZYME CORPORATION, U.S.A.]71[
WO/2000/069428]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
[57] Use of a therapeutically effective amount of a polymer comprising pendant acid functional groups or a salt thereof with a pharmaceutically acceptable cation
in the preparation of a medicament for inhibiting a pathogenic toxin in a patient, said polymer being substantially free of acid anhydride groups.
__________
June 3, 2007 686 –התשס"ז בסיון י"ז
146232]21][11[
D3 דופאמין לקולטן בליגנדות שימושכליה במחלות לטיפול תרופות לייצור
USE OF DOPAMINE D3 RECEPTOR LIGANDS FOR PRODUCING MEDICAMENTS FOR TREATING KIDNEY DISORDERS
]54[
28.04.2000]22[DE]33[07.05.1999]32[19922443.
9]31[
Int. Cl.8 A61K 045/00, C07D 403/14]51[ABBOTT GMBH & CO. KG, GERMANY
]71[
WO/2000/067847]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] Use of dopamine D3 receptor antagonists for the production of drugs for the treatment of renal function disorders.
__________
146276]21][11[
ספירואמידזולידין, הכנתם, של תולדות המכילות רפואיות והכנות שימושם
אותם
SPIROIMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM
]54[
06.05.2000]22[DE]33[17.05.1999]32[19922462.
5]31[
June 3, 2007687 –התשס"ז בסיון י"ז
Int. Cl.8 A61K 031/4184, A61P 009/00, 043/00, C07D 235/00, 235/02]51[SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY
]71[
WO/2000/069831]87[ דין, עורכי עורכי לצר צדק כהן פרל
ונוטריונים, פטנטים , ת.ד.5 , רח' שנקר1 גב-ים מרכז
, הרצליה12704
PEARL COHEN ZEDEK LATZER, 5 SHENKAR STREET ,
P.O.B. 12704 HERZLIYA 46733
]74[
[57] A compound of the formula
in whichR1 is hydrogen or methyl;R2 is unsubsituted phenyl, phenyl which is substituted by a methylenedioxy residue or an ethylenedioxy residue, phenyl which is substituted by one or two (C1-C4) – alkoxy groups, or (C1-C4) – alkyl; X is –CH2-CH2- or –CH2-CH2-CH2-, where one of the CH2 groups in these two residues can be replaced by a carbonyl group C=O;W is isopropyl or cyclopropyl;V is hydrogen or methoxy;E is –CO-R3, -CO-H, -CH2-O-R4, -CH2-O-CO-R4, -CH2-O-CO-O-R5 or 5-tetrazolyl; R3 is hydroxy, (C1-C10)-alkoxy, phenyl-(C1-C8) – alkoxy-, phenyloxy –,(C1-C8)- alkylcarbonyloxy-(C1-C6)-alkoxy-, phenylcarbonyloxy – (C1-C6)-alkoxy-, phenyl-(C1-C6)- alkylcarbonyloxy-(C1-C6)-alkoxy-, (C1-C8)-alkoxycarbonyloxy-(C1-C6)-alkoxy-phenyloxycarbonyloxy- (C1-
C6)-alkoxy-, phenyl-(C1-C6)-alkoxycarbonyloxy-(C1-C6)-alkoxy-, amino, mono-((C1-C10)-alkyl)-amino-, di-((C1-C10)-alkyl-amino-or R4R4N-CO-(C1-C6)-alkoxy-in which the residues R4 are independent of one another and can be identical or different;R4 is hydrogen, (C1-C10) – alkyl, phenyl or phenyl-(C1-C8)-alkyl-; R5 has one of the meanings of R4 with the exception of hydrogen; phenyl present in the groups R3, R4 and R5 is an unsubstituted phenyl residue or a phenyl residue which is substituted by one or more identical or different substituents from the group consisting of (C1-C4)-alkyl, (C1-C4)-alkoxy, methylenedioxy, ethylenedioxy, halogen, trifluoromethyl and trifluoromethoxy; in all its stereosiomeric forms and mixtures thereof in all ratios, and its physiologically tolerable salts.
__________
June 3, 2007 688 –התשס"ז בסיון י"ז
146420]21][11[
1,7,7[ – PHENYL – ]2 – [(ETHOXY – ( DIMETHYLAMINO – N, N) – '2)] – 2 – (–) –(4R, 2S, 1R) HEPTANE HIGH
PURITY [2.2.1]BICYCLO – [METHYL] – TRIתוספה ומלחי גבוהה –באיכות
שלהם, רפואיות למטרות חומציות ותרופות התרכיבים להכנת תהליך
אותם המכילות
HIGH PURITY (1R,2S,4R) - (-) - 2 - [(2' - (N, N - DIMETHYLAMINO) - ETHOXY)] - 2- [PHENYL] - 1,7,7 -TRI - [METHYL]-BICYCLO [2.2.1] HEPTANE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, PROCESS FOR THE PREPARATION OF THESE COMPOUNDS AND MEDICAMENTS CONTAINING THEM
]54[
10.05.2000]22[HU]33[11.05.1999]32[P9901559]31[
Int. Cl.8 C07C 217/00]51[EGIS GYOGYSZERGYAR RT., HUNGARY
]71[
GYULA LUKACS, GYULA SIMIG, TIBOR MEZEI, ZOLTAN BUDAI, MARTA PORCS-MAKKAY, GYORGY KRASZNAI, KALMAN NAGY, GYORGYI DONATH VERECZKEY, TIBOR SZABO, NORBERT NEMETH, JANOS SZYLAGYI
]72[
WO/2000/068183]87[בע"מ, פרידמן מרק ד"ר
אביב , תל7 שמואלוב, רח' האומנים בית DR. MARK FRIEDMAN LTD,.
BEIT SAMUELOFF, 7 HAOMANIM STREET,
TEL AVIV
]74[
June 3, 2007689 –התשס"ז בסיון י"ז
[57] (1R, 2S, 4R)-(-)-2-[(2'-(N, N-dimethylamino)-ethoxy)]-2-[phenyl]-
1,7,7,-tri-[methyl]-bicyclo [2.2.1] heptane of formula
and pharmaceutically acceptable acid addition salts thereof, charactgerised by that they contain not more than 0.2% of
(1R, 3S, 4R)-3-[(2'-(N, N-dimethylamino)-ethyl)]-1,7,7-tri-[methyl]-bicyclo (2.2.1) heptane-2-one of formula
or of a pharmaceutically acceptable acid addition salt thereof.
__________
146432]21][11[
רוקחות ותכשירי טטראפפטידאותן המכילים
TETRAPEPTIDE AND PHARMACEUTICALCOMPOSITION CONTAINING THE SAME
]54[
20.01.2000]22[RU]33[11.05.1999]32[99108841]31[
Int. Cl.8 A61K 038/07, A61P 011/06, 039/06, 043/00, C07K 005/10, 005/103]51[OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIJU "KLINIKA INSTITUTA BIOREGUL YATSII I GERONTOLOGII", RUSSIA
]71[
WO/2000/068255]87[וגולר, וולף, ברגמן
ב' , ת.ד.19 היסוד קרן רחוב , ירושלים1352
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,
]74[
June 3, 2007 690 –התשס"ז בסיון י"ז
JERUSALEM 91013
[57] A tetrapeptide L-alanyl-L-glutamyl-L-aspartyl-glycine of the general formula L-Ala-L-Glu-L-Asp-Gly.
__________
146471]21][11[
– איל3 – – אוקסולאןN אגוניסטים2,'3,'5( ,'Oאדנוזינים )מותמר–
בפה, הפעיליםA1 לאדנוזין לקולטניםאותם המכילים רוקחיים
ORALLY ACTIVE A1 ADENOSINE RECEPTOR AGONIST N- OXOLAN - 3 - YL - 2`,3`,5` - TRIS (O- SUBSTITUTED) ADENOSINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
]54[
19.05.2000]22[US]33[24.05.1999]32[09/317523]31[
Int. Cl.8 C07H 019/00]51[CV THERAPEUTICS, INC., U.S.A.]71[
WO/2000/071558]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] A compound of the formula:
June 3, 2007691 –התשס"ז בסיון י"ז
wherein R2, R2' and R2" are independently selected from the group of C1-5 alkyl, C3-6 cycloalkyl, and 2-, 3-, 4-pyridinyl, which alkyl, cycloalkyl, and pyridinyl are optionally substituted with 1 to 3 substituents independently selected from
the group consisting of OR20 and N(R20)2; and R20 is selected from the group consisting of hydrogen and C1-5 alkyl, which alkyl group is optionally substituted with 1 to 3 phenyl groups.
__________
146619]21][11[
METHOD AND SYSTEM FORפקס למשלוח ומערכת שיטהDELIVERY OF FACSIMILE
]54[
24.05.2000]22[AU]33[25.05.1999]32[PQ0559]31[AU30.06.1999PQ1313
Int. Cl.8 G06F 013/00, 015/00, H04N 001/00]51[SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA
]71[
WO/2000/072576]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] A method of enabling composition of a facsimile by a user and delivery thereof, the method including the steps of:providing a form to the user, the form printed onto at least one paper surface, the form including visible information relating to the user and at least one area for the user to enter a message, the at least one paper surface having invisible coded data indicative of an identity of the form and of the at least one area, wherein the visible information and the invisible coded data are printed substantially simultaneously and wherein at the time of printing a computer system associates the type and spatial extent of the coded data with the spatial extent of at least some of the visible
information; receiving, in a computer system, interaction data from a sensing device used to compose the message, the interaction data being indicative of an identity of the form and a position of the sensing device relative to the area on the paper surface, the sensing device, when placed operatively relative to the area in order to compose the message, generating the interaction data based at least partially on sensing at least some of the coded data in the vicinity of the position; capturing electronically, in the computer system and from the interaction data, at least the message, and transmitting the message to a designated recipient address for facsimile delivery.
June 3, 2007 692 –התשס"ז בסיון י"ז
__________
146688]21][11[
METHOD AND APPARATUS FORדמויות והשוואת לחיפוש והתקן שיטהSEARCHING FOR AND COMPARING IMAGES
]54[
23.05.2000]22[US]33[04.06.1999]32[09/326362]31[
Int. Cl.8 G06K 009/68, G06T 007/00]51[LOOK DYNAMICS, INC., U.S.A.]71[
WO/2000/075867]87[וגולר, וולף, ברגמן
,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
[57] A search method for locating particular content or similar content that has been converted to a digital format for storage in a digital file at a location somewhere in at least one of a plurality of database and/or server devices, which are connected to and accessible via a computer network, comprising: producing a reference image in an optical pattern that is characteristic of the particular content; accessing and downloading a plurality of digital candidate files from their respective storage locations in one or more of the plurality of database and/or server devices along with location information that is
indicative of said respective storage locations;producing a plurality of candidate images in optical patterns that are characteristic of content in the respective downloaded digital candidate files; comparing the candidate image to the reference image by optical correlation to detect degree of correlation between the reference image and the candidate images, and reporting results based on the degree of correlation for the digital candidate files from the storage locations that are determined by the degree of correlation to have content that is closest to or matches the particular content.
June 3, 2007693 –התשס"ז בסיון י"ז
__________
146707]21][11[
– ציאנואינדול5 – )4 – ]1 של שימוש– YL– 3 – ]קרבמואיל2 – )4 (בוטיל – ( – פיפרזיןYL – 5 – בנזופורן –
שלו פיזיולוגית המקובלים והמלחיםתרופות להכנת
USE OF 1 - [4 - (5 - CYANOINDOL - 3 - YL) BUTYL] - 4 - (2 - CARBAMOYL - BENZOFURAN - 5 - YL) - PIPERAZINE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS FOR THE MANUFACTURE OF MEDICAMENTS
]54[
16.05.2000]22[EP]33[27.05.1999]32[99109295.
8]31[
Int. Cl.8 A61K 031/00, A61P 005/00, 009/10, 009/12, 025/00, 025/06, C07D 405/00]51[MERCK PATENT GMBH, GERMANY
]71[
WO/2000/072832]87[צדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
[57] Use of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbamoyl-benzofuran-5-yl)- piperazine or a physiologically acceptable salt thereof, for the manufacture of a medicament for the treatment of sub-type anxiety disorders chosen from the the sub-
types: panic disorder with or without agoraphobia, agoraphobia, obsessive-compulsive spectrum disorders, social phobia, posttraumatic stress disorder, acute stress indication and/or generalized-anxiety disorder.
June 3, 2007 694 –התשס"ז בסיון י"ז
__________
146758]21][11[
PROCESS FOR PRODUCTION OFאמית חומצת של אסטר לייצור תהליךAMIC ACID ESTER
]54[
02.04.2001]22[JP]33[03.04.2000]32[2000-
100786]31[
Int. Cl.8 C07D 277/64]51[IHARA CHEMICAL INDUSTRY CO., LTD., JAPAN
]71[
WO/2001/074795]87[ושות', גבריאלי זליגסון
אביב , תל1426 , ת.ד. 31 רח' יבנה SELIGSOHN GABRIELI & CO,.
31 YAVNE ST.P.O.B. 1426
TEL AVIV 61013
]74[
[57] A process for producing anamic acid ester of the formula:
(wherein A is a substituted or unsubstituted lower alkylene group, a substituted or unsubstituted cycloalkylene group, a substituted or unsubstituted arylene group, a substituted or unsubsituted cycloalkylalkylene group, or a substituted or unsubstituted aralkylene group; R1 is a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted cycloalkyl group, a
substituted or unsubstituted aryl group, a substituted or unsubstituted cycloalkylalkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted heterocyclic alkyl group; and R3 is a hydrogen atom or a lower alkyl group), which process comprises reacting, in the presence of water, an amino acid of the formula:
June 3, 2007695 –התשס"ז בסיון י"ז
(wherein A has the same definition as given above) with a halogenated carbonic acid ester of the formula
(wherein R1 has the same definition as given above and X is a halogen atom) to
form a carbamate compound of the the formula
(wherein A and R1 have the same definitions as given above), then reacting the carbamate compound with a
halogenated carbonic acid ester of the formula
(wherein R2 is a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted cycloalkylalkyl group, a substituted or
unsubstituted aralkyl group, a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted heterocyclic alkyl group; and X is a halogen atom) to form, in the system, a mixed acid anhydride of the formula
(wherein A, R1 and R2 and R2 have the same definitions as given above), and
reacting the mixed acid anhydride with an amine compound of the formula
(wherein R3 has the same definition as given above and Het is a substituted or unsubstituted heterocyclic group).
June 3, 2007 696 –התשס"ז בסיון י"ז
__________
146810]21][11[
–10,11 של נגזרות להכנת תהליךמתנובנזוסבראן
PROCESS FOR PREPARING 10,11-METHANOBENZOSUBERANE DERIVATIVES
]54[
26.05.2000]22[US]33[03.06.1999]32[60/137283]31[
Int. Cl.8 C07D 241/12, 295/088, 401/12]51[ELI LILLY AND COMPANY, U.S.A.]71[
WO/2000/075121]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
[57] A process for preparing a compoundof the formula
wherein A is –CH2-CH2-, -CH2-CHRa-CH2-, -CH2-CHRa-CH2-CH2-, and Ra is OH;R1 is H, F, Cl, or Br;R2 is H, F,Cl, or Br; and
R3 is heteroaryl or phenyl, each optionally substituted with F, Cl, Br, CF3, CN, NO2, or OCHF2; or the pharmaceutically acceptable salts thereof, comprising the steps of:
June 3, 2007697 –התשס"ז בסיון י"ז
(a) reacting a compound of the formula
with a nucleophile source to form a compound of the formula
wherein X is a leaving group;(b) reacting a compound of formula (5) with pyrazine to provide a compound of the formula
(c) reducing the compound of formula (6) to provide a compound of the formula
June 3, 2007 698 –התשס"ז בסיון י"ז
(d) reacting a compound of formula (8) with either:
(i) an epoxy compound of the formula
wherein R3 is as defined above, and n is an integer 1 or 2; or
(ii) a halo compound of the formula
X1-(CH2)m-O-R3
wherein R3 is as defined above, X1 is halo, and m is 2, 3 or 4; and(e) optionally forming a pharmaceutically acceptable salt from the compound produced in step (d).
Claimed as novel are intermediate compounds of formula (6)wherein R1 and R2 are as above defined and X is selected from the group consisting of I, Br, Cl, OMs, and OTs.
__________
146923]21][11[
חומצות של פולימרים ו– אוליגומריםציקליות אימנו קרבוקסיליות
OLIGOMERS AND POLYMERS OF CYCLIC IMINO CARBOXYLIC ACIDS
]54[
13.06.2000]22[US]33[14.06.1999]32[60/138972]31[
Int. Cl.8 A61K 031/40, 031/445, 031/495, A61P 043/00, C07D 207/16, 211/00, 211/60, 241/04, 401/06, 403/06, G01N 033/53
]51[
WISCONSIN ALUMNI RESEARCH FOUNDATION, U.S.A.
]71[
SAMUEL H. GELLMAN, BAYARD R. HUCK, MICHELE R. RICHARDS
]72[
June 3, 2007699 –התשס"ז בסיון י"ז
WO/2000/076974]87[בע"מ, פרידמן מרק ד"ר
אביב , תל7 שמואלוב, רח' האומנים בית DR. MARK FRIEDMAN LTD,.
BEIT SAMUELOFF, 7 HAOMANIM STREET,
TEL AVIV
]74[
[57] Compound of the formula:
X-{A}n-Y
wherein n is an integer greater than 1; andeach A, independent of every other A, is selected from the group consisting of:
wherein R1, R2, and R5 are independently selected from the group consisting of hydrogen, linear or branched C1-C6-alkyl, alkenyl, or alkynyl; mono-or di-C1-C6 alkylamino, mono- or bicyclic aryl, mono- or bicyclic heteroaryl having up to 5 heteroatoms selected from N, O, and S; mono- or bicyclic aryl-C1-C6-alkyl, mono-or bicycle heteroaryl- C1-C6-alkyl, -(CH2)1-
6-OR3, -(CH2)1-6-SR3,-(CH2)1-6-S(=O)-CH2-R3, -(CH2)1-6-S(=O)2-CH2-R3, -(CH2)1-6-NR3R3,-(CH2)1-6-NHC(=O)R3, -(CH2)1-6-NHS(=O)2-CH2-R3, -(CH2)1-6-O-(CH2)2-6-R4,-(CH2)1-6-S-(CH2)2-6-R4, -(CH2)1-6-S(=O) -(CH2)2-6-R4, -(CH2)1-6-S(=O)2-(CH2)2-6-R4,-(CH2)1-6-NH-(CH2)2-6-R4, -(CH2)1-6-N- {(CH2)2-6-R4}2, -(CH2)1-6-NHC(=O) -(CH2)2-6-R4,and -(CH2)1-6 –NHS=(=O)2-(CH2)2-6-R4; whereinR3 is independently selected from the group consisting of hydrogen, C1-C6-alkyl, alkenyl, or alkynyl; mono- or bicyclic aryl,
mono-or bicyclic heteraryl having up to 5 heteroatoms selected from N, O, and S; mono- or bicyclic aryl- C1-C6-alkyl, mono- or bicyclic heteroaryl- C1-C6 – alkyl; and R4 is selected from the group consisting of hydroxy, C1-C6-alkyloxy, aryloxy, heteroaryloxy, thio, C1-C6- alkylthio, C1-C6
- alkylsulfinyl, C1-C6 – alkylsulfonyl, arylthio, arylsulfinyl, arylsulfonyl, heteroarylthio, heteroarylsulfinyl, heteroarylsulfonyl, amino, mono-or di- C1-C6 – alkylamino, mono – or diarylamino, mono-or diheteroarylamino, N-alkyl-N-arylamino, N-alkyl-N-heteroarylamino, N-aryl-N-heteroarylamino, aryl- C1-C6 – alkylamino, carboxylic acid, carboxamide, mono- or di- C1-C6 – alkylcarboxamide, mono- or diarylcarboxamide, mono- or diheterarylcarboxamide, N-alkyl-N-arylcarboxamide, N-alkyl-N-heteroarylcarboxamide, N-aryl-N-heteroarylcarboxamide, sulfonic acid, sulfonamide, mono- or di- C1-C6
alkylsulfonamide, mono- or diarylsulfonamide, mono- or diheteroarylsulfonamide, N-alkyl-N-
June 3, 2007 700 –התשס"ז בסיון י"ז
arylsulfonamide, N-alkyl-N-heteroarylsulfonamide, N-aryl-N-heteroarylsulfonamide, urea; mono- di- or tri-substituted urea, wherein the subsitutent(s) is selected from the group consisting of C1-C6 - alkyl, aryl, heteroaryl; O-alkylurethane, O-arylurethane, and O-heteroarylurethane;R6 is selected from the group consisting of hydrogen, linear or branched C1-C6 – alkyl, alkenyl, or alkynyl; mono-or di- C1-C6
alkylamino, mono- or bicyclic aryl, mono- or bicyclic heteroaryl having up to 5 heteroatoms selected from N, O, and S; mono- or bicyclic heteroaryl- C1-C6 – alkyl, -S(=O)2-(CH2)1-6-(CH2)1-6-R3, -C(=O)R3, -S(=O)2-(CH2)2-6R4, and –C(=O)-(CH2)1-6-R4;wherein R3 and R4 are as defined above; R7
and R8 are selected from the group listed above for R1, R2, and R5, and are further selected from the group consisting of hydroxy, C1-C6 – alkyloxy, aryloxy, heteroaryloxy, thio, C1-C6 – alkylthio, C1-C6 – alkylsulfinyl, C1-C6 –alkylsulfonyl, arylthio, arylsulfinyl, arylsulfonyl, heteroarylthio, heteroarylsulfinyl, heteroarylsulfonyl, amino, mono – or di-
C1-C6 – alkylamino, mono- or diarylamino, mono-or diheteroarylamino, N-alkyl-N-arylamino, N-alkyl-N-heteroarylamino, N-aryl-N-heteroarylamino, aryl- C1-C6 - alkylamino, carboxylic acid, carboxamide, mono-or di- C1-C6 - alkylcarboxamide, mono – or diarylcarboxamide, mono- or diheteroarylcarboxamide, N-alkyl-N-arylcarboxamide, N-alkyl-N-heteroarylcarboxamide, N-aryl-N-heteroarylcarboxamide,sulfonic acid, sulfonamide, mono- or di- C1-C6 – alkylsulfonamide, mono- or diarylsulfonamide, mono- or diheteroarylsulfonamide, N-alkyl-N-arylsulfonamide, N-alkyl-N-heteroarylsulfonamide, N-aryl-N-heteroarylsulfonamide, urea; mono-di- or tri- substituted urea, wherein the subsitutent(s) is selected from the group consisting of C1-C6 – alkyl, aryl, heteroaryl; O-alkylurethane, O-arylurethane, and O-heteroarylurethane; one of X or Y is hydrogen or an amino-terminal capping group; the other of X or Y is hydroxy or a carboxy-terminal capping group; and salts thereof.
לתקנות35 לתקנה בהתאם נבחן זה פירוט1968 – הפטנטים, תשכ"ח
This specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968
__________
146993]21][11[
וכבל גבוהים ביצועים בעל נתונים כבל מעטה בעל גבוהים ביצועים נתוניםפלאור מכיל שאינוUL 910 קיבול
HIGH PERFORMANCE DATA CABLE AND A UL 910 PLENUM NON-FLUORINATED JACKET HIGH PERFORMANCE DATA CABLE
]54[
14.06.2000]22[US]33[22.07.1999]32[60/144998]31[
Int. Cl.8 H01B 007/18]51[BELDEN WIRE & CABLE COMPANY, U.S.A.
]71[
June 3, 2007701 –התשס"ז בסיון י"ז
WO/2001/008167]87[וגולר, וולף, ברגמן
,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
[57] An individual bound lateral shielded twisted pair data cable comprising:an insulated twisted pair cable (10); a shielding tape selected from the group consisting of a metal tape (16), a first composite tape having a non-metal base and a layer of metal on one side of said base, and a second composite tape having a non-metal base and a layer of metal on both sides of said base; said shielding tape being laterally wrapped with at least a 10% overlap around said individual twisted pair cable; a fabric or metal binder (18) being wrapped around said shielding tape to provide a bound lateral shielded twisted
pair cable; said shielding tape having a metal thickness of 0.33 to 2.00 mils; said shielding tape and binder being wrapped around said twisted pair at a tension to eliminate a substantial amount of the air and to leave a cross-sectional void area of less than 25% of the cross-sectional area of the shielded twisted pair cable to provide said bound lateral shielded twisted pair data cable, and to provide said bound lateral shielded twisted pair data cable with an adjusted to 20o C standard impedance deviation of 4.5 or less when said standard deviation is calculated around a mean or average impedance of 50 to 200 ohms.
__________
147012]21][11[
רוקחות אינדול, תכשירי של תולדות תרופה בהכנת ושימושן אותן המכילים יתר לפעילות הקשורות במחלות לטיפול
אוסטאוקלאסטס של
INDOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE THEREOF FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH OVER ACTIVITY OF OSTEOCLASTS
]54[
16.06.2000]22[GB]33[18.06.1999]32[9914371.1]31[
Int. Cl.8 A61K 031/404, 031/435, A61P 019/10, C07D 401/12, 403/12]51[NIKEM RESEARCH S.R.L., ITALY]71[
June 3, 2007 702 –התשס"ז בסיון י"ז
WO/2001/002388]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
[57] Compounds selected from the list consisting of:4-(5,6-dichloro-1H-indol-2-yl) 3-ethoxy-N(2,2,6,6-tetramethylpiperidin-4-yl)-benzamide;4-(5,6-dichloro-1H-indol-2-yl)-3-benzyloxy-N-(2,2,6,6-tetramethylpiperidin-4-yl)-benzamide;4-(5,6-dichloro-1H-indol-2yl)-3-propoxy-N-(2,2, 6,6-tetramethylpiperidin-4-yl) benzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-[3-[4-(3-methoxyphenyl) piperazin-1-yl]propyl]-3-methoxybenzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-[3-[4-(2-pyrimidiyl) piperazin-1yl]propy]-3-methoxybenzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-methoxybenzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(1,2,2,6,6-pentamethylpiperidin-4-yl)-3-ethoxybenzamide;4-(5, 6-dichloro-1H-indol-2-yl)-N(3-pyridyl)-3-ethoxybenzamide,4-(5,6,-dichloro-1H-indo-2-yl)-N-(3-(6-methoxypyridyl)-3-ethoxybenzamide;4-(5,6-dichloro-1H-indol-2yl)-N-(1-benzylpiperidin-4-yl)-3-ethoxybenzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-2,5-dimethoxybenzamide;
4-(5, 6-dichloro-1H-indol-2-yl)-N-(1,2,2,6,6-pentamethylpiperidin-4-yl)2,5-dimethoxybenzamide;4-(5-methoxy-6-chloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-ethoxybenzamide;4-(5,6-dichloro-1H-indol-2-yl)-3-methoxy-N-((1-ethoxycarbonylpentyl) piperidin-4-yl) benzamide;4-(5,6-dichloro-1H-indol-2-yl)-3-methoxy-N-((carboxybutyl) piperidin-4-yl)benzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-(hydroxycarbonylmethoxy) benzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethypiperidin-4-yl)-3-(2-hydroxyethoxy) benzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-(3-aminopropoxy) benzamide;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-(2-dimethylamino-ethoxy) benzamide, and;4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-3-(2, 3-dihydroxypropoxy) benzamide;or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof.
June 3, 2007703 –התשס"ז בסיון י"ז
__________
147091]21][11[
משטח לקילוף משוב בקרת מערכת מים ניהול של משולבת מערכת עם אויר
חומצה ומיחזור
FEEDBACK CONTROLLED AIRFOIL STRIPPING SYSTEM WITH INTEGRATED WATER MANAGEMENT AND ACID RECYCLING SYSTEM
]54[
June 3, 2007 704 –התשס"ז בסיון י"ז
13.12.2001]22[US]33[15.12.2000]32[09/738449]31[
Int. Cl.8 B22D 029/00]51[UNITED TECHNOLOGIES CORPORATION, U.S.A.
]71[
וגולר, וולף, ברגמן ,1352ב' , ת.ד. 19 היסוד קרן רחוב
ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
[57] A coating removal system comprising: a stripping tank (12) containing an electrolyte bath stripping solution for removing a coating from at least one workpiece immersed in said electrolyte bath while a controlled absolute electrical potential is maintained on said at least one workpiece with respect to a reference electrode immersed in said electrolyte bath; a rinse tank (14)
containing a rinse solution for rinsing said at least one workpiece after completion of removal of said coating from said at least one workpiece; and a distillation unit (16) for receiving electrolyte from said stripping tank containing dissolved metals, for purifying said electrolyte received from said stripping tank, and for returning said electrolyte in a purified form to said stripping tank.
__________
147118]21][11[
בשרת מקור שרתי למספר דינמי חיבורמעבר מקודד פרוקסי
DYNAMIC CONNECTION TO MULTIPLE ORIGIN SERVERS IN A TRANSCODING PROXY
]54[
28.06.2000]22[US]33[30.06.1999]32[09/343454]31[
June 3, 2007705 –התשס"ז בסיון י"ז
Int. Cl.8 H04L 009/08, 012/22, 012/66, 029/00, 029/06]51[INTERNATIONAL BUSINESS MACHINES CORPORATION, U.S.A.
]71[
WO/2001/003398]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] A method of enabling a proxy (15) to participate in secure communication between a client (10') and a first origin server (12a'), comprising the step of:(a) establishing (20, 22) a first secure session between the client and the proxy;(b) upon verifying the first secure session, establishing (24, 26) a second secure session between the client and the proxy, the second secure session requesting the proxy to act as a conduit to the first origin server;(c) having the client and the first origin server negotiate (30) a session master secret;
(d) having the client deliver (32) the session master secret to the proxy using the first secure session to enable the proxy to participate in the secure communication;(e) responsive to a client request to the first origin server, establishing a third secure session between the client and the proxy, the third secure session requesting the proxy to act as conduit to the second origin server;(f) having the client and the second origin server negotiate a new session master secret; and(g) having the client deliver the new session master secret to the proxy using the first secure session generated in step (a).
June 3, 2007 706 –התשס"ז בסיון י"ז
__________
147169]21][11[
לשם קוד בר ליצירת אוטומטית שיטהנתונים והעברת איחזור
AUTOMATIC BARCODE CREATION FOR DATA TRANSFER AND RETRIEVAL
]54[
11.06.2000]22[US]33[18.06.1999]32[335838]31[
Int. Cl.8 G06K 007/10]51[]I.C. CODE LTD.]71בע"מ, מתן איי.סי. קוד
WO/2000/079468]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
[57] A system for automatically printing an at least two-dimensional barcode onto a printable substrate (24); the barcode featuring a pattern of a plurality of marks, the system comprising:(a) an output device (16) for receiving a plurality of printing commands and for printing a printable substrate according to said plurality of printing commands;(b) a computational device (12) for receiving data to be printed; and(c) a printer driver module (14) for being operated by said computational device and for automatically translating into the at
least two dimensional barcode, at least a portion of said data to be printed including at least one selected from a group including: substantially all text and substantially all graphical images, and for automatically determining at least one command for printing the barcode onto said printable substrate to form a printed barcode, said printer driver module passing said at least one command to said output device, so that said output device is enabled to print the barcode in addition to said data to be printed.
June 3, 2007707 –התשס"ז בסיון י"ז
__________
147199]21][11[
המשוקעים יסודות לאריזת שיטהאלקטרוכימית
METHOD FOR PACKING ELECTROCHEMICALLY-DEPOSITED ELEMENTS
]54[
20.12.2001]22[Int. Cl.8 A61N 005/10, G21G 004/06]51[
למחקר בנגב, הרשות בן-גוריון אוניברסיטתשבע ופיתוח, באר
BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
]71[
שני, משה לסטר, גד גולן, ברנדה יובלטולמן פרג'י, רוברטו
YUVAL GOLAN, BRENDA H. LASTER, GAD SHANI, MOSHE FARAGGI
]72[
עו"פ, רוטמן פיירניק ,10012 , ת.ד. 91 רח' הרצל עציון בית
שבע באר
PYERNIK RUTMAN, BEIT ETSION
HERZL ST. 91P.O.B. 10012
BEER SHEVA
]74[
[57] A method for densely packaging an element inside a casing, such that the element-containing casing is suitable for use in the preparation of a radiation source, comprising providing a solution containing ions of said element, positioning a working electrode and at least one counter electrode in contact with said solution, connecting said working electrode and said at least one counter electrode to the negative and
positive poles of a power source, respectively, passing an electrical current between said electrodes to electrochemically deposit said element on said working electrode in a geometrical form corresponding to the form of the interior of the casing and concurrently or sequentially loading said casing with said element.
__________June 3, 2007 708 –התשס"ז בסיון י"ז
147265]21][11[
דרך למתן תכשיר המספק התקן אורגנוסילוקסאן שרף הפה, המכיל
להסרה ניתן בפסתומך ומשתמש
DELIVERY SYSTEM FOR ORAL CARE COMPOSITIONS COMPRISING ORGANOSILOXANE RESINS USING A REMOVABLE BACKING STRIP
]54[
30.06.2000]22[WO]33[02.07.1999]32[PCT/US99/15131]31[WO02.07.1999PCT/US99/15130WO09.06.2000PCT/US00/15890WO09.06.2000PCT/US00/15891
Int. Cl.7 A61K 000/889000 009/00]51[THE PROCTER & GAMBLE COMPANY, U.S.A.
]71[
WO/2001/001958]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
[57] A delivery system for delivering an oral care substance to the oral cavity, the delivery system comprising:(a) a removable backing strip having sufficient flexibility so as to be readily conformable to an oral surface when the delivery system is placed thereagainst; and
(b) an oral care composition applied to the backing strip such that when the delivery system is placed on the oral surface the oral care composition contacts the oral surface, the oral care composition comprising:(i) an organosiloxane resin;
June 3, 2007709 –התשס"ז בסיון י"ז
(ii) a rheology modifier; and(iii) at least one oral care substance;
wherein the oral care composition remains on the oral surface after the backing strip is removed.
__________
147319]21][11[
פגמים של אל–הרס לגילוי והתקן שיטהחבויים
METHOD AND APPARATUS FOR NON-DESTRUCTIVE DETECTION OF HIDDEN FLAWS
]54[
10.05.2000]22[US]33[14.05.1999]32[09/311442]31[
Int. Cl.8 G01B 015/06]51[SCANNEX TECHNOLOGIES, LLC, U.S.A.
]71[
WO/2000/070306]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] A method for non-destructive examination a test sample comprising the steps of:(a) directing radiation into said test sample;(b) directing radiation into an unflawed standard sample;(c) detecting radiation emanating from said test sample to obtain a set of responses R;
(d) detecting radiation emanating from said standard sample to obtain a set of responses S;(e) utilizing said set of responses R and said set of responses S to obtain a single figure-of-merit; and(f) determining the deviation of said single figure-of-merit from a reference value.
June 3, 2007 710 –התשס"ז בסיון י"ז
__________
147327]21][11[
ואימידאזופירידינים, בנזאימידיאזולים להכנתם, תכשירי ביניים וחומר תהליך
בהם והשימוש אותם המכילים רוקחות זיהום מניעת או לטיפול תרופות להכנתסינסיציאלי נשמתי ויראלי
BENZIMIDAZOLES AND IMIDAZOPYRIDINES, A PROCESS AND AN INTERMEDIATE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE FOR TREATING OR PREVENTING RESPIRATORY SYNCYTIAL VIRUS
]54[
20.06.2000]22[EP]33[28.06.1999]32[99202088.
3]31[
Int. Cl.8 A61K 031/395, A61P 031/00, C07D 401/00, 471/02, 491/02, 495/02]51[JANSSEN PHARMACEUTICA N.V., BELGIUM
]71[
WO/2001/000612]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
June 3, 2007711 –התשס"ז בסיון י"ז
[57] A compound of the formula
a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein-a1=a2-a3=a4-represents a bivalent radical of formula-CH=CH-CH=CH- (a-1);-N=CH-CH=CH- (a-2);-CH=N-CH=CH- (a-3);-CH=CH-N=CH- (a-4); or
-CH=CH-CH=N- (a-5);wherein each hydrogen atom in the radicals (a-1), (a-2), (a-3), (a-4) and (a-5) may optionally be replaced by halo, C1-6 alkyl, nitro, amino, hydroxy, C1-6 alkyl-oxy, polyhalo C1-6 alkyl, carboxyl, amino C1-6 alkyl, mono- or di(C1-4 alkyl)- amino C1-6 alkyl, C1-6 alkyloxycarbonyl, hydroxy C1-6 alkyl, or a radical or formula
wherein =Z is =O, =CH-C(=O)-NR5aR5b, =CH2, =CH-C1-6 alkyl, =N-OH or =N-O-C1-6 alkyl;
Q is a radical of formula
wherein Alk is C1-6 alkanediyl;Y1 is a bivalent radical of formula –NR2- or –CH(NR2R4)-;
X1 is NR4, S, S(=O), S(=O)2, O, CH2, C(=O), C(=CH2), CH(OH), CH(CH3),CH(OCH3), CH(SCH3), CH(NR5aR5b), CH2-NR4 or NR4-CH2;
June 3, 2007 712 –התשס"ז בסיון י"ז
X2 is a direct bond, CH2, C(=O), NR4, C1-4 alkyl-NR4, NR4 –C1-4 alkyl;t is 2, 3 4 or 5;u is 1, 2, 3, 4 or 5;v is 2 or 3; andwhereby each hydrogen atom in Alk and the carbocycles and the heterocycles defined in radicals (b-3), (b-4), (b-5), (b-6), (b-7) and (b-8) may optionally be replaced by R3; with the proviso that when R3 is hydroxy or C1-6 alkyloxy, then R3 can not replace a hydrogen atom in the α position relative to a nitrogen atom;G is C1-10 alkanediyl substituted with one or more hydroxy, C1-6 alkyloxy, aryl C1-6 alkyloxy, C1-6 alkylthio, aryl C1-6 alkylthio, HO(-CH2-CH2-O)n-, C1-6 alkyloxy-(-CH2-CH2-O)n- or aryl C1-6 alkyloxy (-CH2-CH2-O)n-;R1 is a monocyclic heterocycle or aryl; said heterocycle being selected from piperidinyl, piperazinyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, tetrahydrofuranyl, thienyl, pyrrolyl, thiazolyl, oxazolyl, imidazolyl, isothiazolyl, pyrazoly l, isoxazolyl, oxadiazolyl; and each heterocycle may optionally be substituted with1 or where possible more, such as 2, 3 or 4, substituents selected from halo, hydroxy, amino, cyano, carboxy, C1-6 alkyl, C1-6 alkyloxy, C1-6 alkylthio, C1-6 alkyloxy C1-6 alkyl, aryl, aryl C1-6 alkyl, aryl C1-6 alkyloxy, hydroxy C1-6 alkyl, mono-or di(C1-6 alkyl) amino, mono-or di(C1-6 alkyl) amino C1-6 alkyl, polyhalo C1-6 alkyl, C1-6 alkylcarbonylamino, C1-6 alkyl-SO2-NR5c-, aryl-SO2-NR5c-, -C1-6 alkyloxycarbonyl, -
C(=O)-NR5cR5d, HO(-CH2-CH2-O)n-, halo (-CH2-CH2-O)n-, C1-6 alkyloxy (-CH2-CH2-O)n-,aryl C1-6 alkyloxy (-CH2-CH2-O)n- and mono-or di(C1-6 alkyl) amino (-CH2-CH2O)n-;each n independently is 1, 2, 3 or 4;
R2 is hydrogen, formyl, C1-6 alkylcarbonyl, Hetcarbonyl, pyrrolidinyl, piperidinyl, homopiperidinyl,C3-7 cycloalkyl substituted with N(R6)2, or C1-10 alkyl substituted with N(R6)2 and optionally with a second, third or fourth substituent selected from amino, hydroxy, C3-7 cycloalkyl, C2-5 alkanediyl, piperidinyl, mono-or di(C1-6 alkyl) amino, C1-6
alkyloxycarbonylamino, aryl and aryloxy;R3 is hydrogen, hydroxy, C1-6 alkyl, C1-6 alkyloxy, aryl C1-6 alkyl or aryl C1-6 alkyloxy;R4 is hydrogen, C1-6 alkyl or aryl C1-6 alkyl;R5a, R5b, R5c and R5d each independently are hydrogen or C1-6 alkyl; orR5a and R5b, or R5c and R5d taken together form a bivalent radical of formula –(CH2)s- wherein s is 4 or 5;R6 is hydrogen, C1-4 alkyl, formyl, hydroxy C1-6 alkyl, C1-6 alkylcarbonyl or C1-6 alkyloxycarbonyl;aryl is phenyl or phenyl substituted with 1 or more, such as 2, 3 or 4, substituents selected from halo, hydroxy, C1-6 alkyl, hydroxy C1-6 alkyl, polyhalo C1-6 alkyl, and C1-6 alkyloxy;Het is pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl.
__________
147328]21][11[
ואימידזופירידין בנזימידזול תרכובות או לטיפול תרופה להכנת בהן והשימוש
וירליים זיהומים מניעת
BENZIMIDAZOLE AND IMIDAZOPYRIDINE COMPOUNDS AND THEIR USE FOR PREPARING A MEDICINE FOR TREATMENT OR
]54[
June 3, 2007713 –התשס"ז בסיון י"ז
PREVENTION OF VIRAL INFECTIONS
20.06.2000]22[EP]33[28.06.1999]32[99202089.
1]31[
Int. Cl.8 A61K 031/395, A61P 031/00, C07D 401/00, 471/02, 491/02, 495/02]51[JANSSEN PHARMACEUTICA N.V., BELGIUM
]71[
WO/2001/000615]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
[57] A compound of the formula
a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein-a1=a2-a3=a4-represents a bivalent radical of formula-CH=CH-CH=CH- (a-1);-N=CH-CH=CH- (a-2);-CH=N-CH=CH- (a-3);
-CH=CH-N=CH- (a-4); or-CH=CH-CH=N- (a-5);wherein each hydrogen atom in the radicals (a-1), (a-2), (a-3), (a-4) and (a-5) may optionally be replaced by halo, C1-6 alkyl, nitro, amino, hydroxy, C1-6 alkyl-oxy, polyhalo C1-6 alkyl, carboxyl, amino C1-6 alkyl, mono- or di(C1-4 alkyl)- amino C1-6 alkyl, C1-6 alkyloxycarbonyl, hydroxy C1-6 alkyl, or a radical of formula
wherein =Z is =O, =CH-C(=O)-NR5aR5b, =CH2, =CH-C1-6 alkyl, =N-OH or =N-O-C1-6 alkyl;
Q is a radical of formula
June 3, 2007 714 –התשס"ז בסיון י"ז
wherein Alk is C1-6 alkanediyl;Y1 is a bivalent radical of formula –NR2- or –CH(NR2R4)-;X1 is NR4, S, S(=O), S(=O)2, O, CH2, C(=O), C(=CH2), CH(OH), CH(CH3),CH(OCH3), CH(SCH3), CH(NR5aR5b), CH2-NR4 or NR4-CH2;X2 is a direct bond, CH2, C(=O), NR4, C1-4 alkyl-NR4, NR4 –C1-4 alkyl;t is 2, 3 4 or 5;u is 1, 2, 3, 4 or 5;v is 2 or 3; andwhereby each hydrogen atom in Alk and the carbocycles and the heterocycles defined in radicals (b-3), (b-4), (b-5), (b-
6), (b-7) and (b-8) may optionally be replaced by R3; with the proviso that when R3 is hydroxy or C1-6 alkyloxy, then R3 can
not replace a hydrogen atom in the α position relative to a nitrogen atom;G is C1-10 alkanediyl substituted with one or more hydroxy, C1-6 alkyloxy, aryl C1-6 alkyloxy, C1-6 alkylthio, aryl C1-6 alkylthio, HO(-CH2-CH2-O)n-, C1-6 alkyloxy-(-CH2-CH2-O)n- or aryl C1-6 alkyloxy (-CH2-CH2-O)n-; aryl C1-6 alyloxy (-CH2-CH2-O)n-, amino, mono-or-di(C1-6 alkyl) amino, C1-6 alkyloxycarbonylamino and aryl; R1 is a bicyclic heterocycle selected from quinolinyl, quinoxalinyl, benzofuranyl,
benzothienyl, benzimidazolyl, benzoxazolyl, benzthiazolyl, pyridopyridyl, naphthiridinyl, 1H-imidazo [4, 5-b] pyridinyl, 3H-imidazo [4,5] pyridinyl, imidazo [1,2-a] pyridinyl, 2, 3-dihydro-1,4-dioxino [2,3-b] pyridyl or a radical of the formula
June 3, 2007715 –התשס"ז בסיון י"ז
and said bicyclic heterocylces may optionally be substituted in either of the two cycles with 1 or where possible more, such as 2, 3 or 4, substituents selected from halo, hydroxy, amino, cyano, carboxyl, C1-6 alkyl, C1-6 alkyloxy, C1-6 alkylthio, C1-6 alkyloxy-C1-6 alkyl, aryl, aryl C1-6 alkyl, aryl C1-6 alkyloxy, hydroxy C1-6 alkyl, mono-or di(C1-6 alkyl)-amino, mono-or di(C1-6 alkyl) amino C1-6 alkyl, polyhalo C1-6 alkyl, C1-6 alkycarbonylamino, C1-6 alkyl –SO2-NR5c-, aryl-SO2-NR5c-, C1-6 alkyloxycarbonyl, -C(=O)-NR5CR5d, HO(-CH2-CH2-O)n-, halo (-CH2-CH2-O)n-, C1-6 alkyloxy (-CH2-CH2-
O)n-, aryl C1-6 alkoxy (-CH2-CH2-O)n- and mono-or di(C1-6 alkyl) amino(-CH2-CH2-O)n-; each n independently is 1, 2, 3 or 4; each m independently is 1 or 2; each p independently is 1 or 2;each R2 indepdnently is hydrogen, formyl, C1-6 alkylcarbonyl, Hetcharbonyl, pyrrolidinyl, piperidinyl, homopiperidinyl, C3-7 cycloalkyl substituted with N(R6)2, or C1-10 alkyl substituted with N(R6)2 and
optionally with a second, third or fourth substituent selected from amino, hydroxy, C3-7 cycloalkyl, C2-5 alkanediyl, piperidinyl, mono-or di (C1-6 alkyl) amino, C1-6 alkyloxycarbonylamino, aryl and aryloxy; R3 is hydrogen, hydroxy, C1-6 alkyl, C1-6 alkyloxy, aryl C1-6 alkyl or aryl C1-6 alkyloxy; R4 is hydrogen, C1-6 alkyl or aryl C1-6 alkyl;R5a, R5b, R5c and R5d each independently are hydrogen or C1-6 alkyl; orR5a and R5b, or R5c and R5d taken together form a bivalent radical of formula –(CH2)s-wherein s is 4 or 5; R6 is hydrogen, C1-4 alkyl, formyl, hydroxy C1-6 alkyl, C1-6 alkylcarbonyl or C1-6 alkyloxycarbonyl; aryl is phenyl or phenyl substituted with 1 or more, such as 2, 3 or 4, substituents selected from halo, hydroxy, C1-6 alkyl, hydroxy C1-6 alkyl, polyhalo C1-6 alkyl, and C1-6 alkyloxy;Het is pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl.Intermediates of formula
June 3, 2007 716 –התשס"ז בסיון י"ז
with P being a protective group, and Q1 being defined as, Q above defined but
being devoided of the R2 or R6 substituent, and of the formula
with (O=)Q3 being a carbonyl derivative of Q provided that it is devoided of the NR2R4
or NR2 substituent.
and of the formula
with (O=)G2 being a carbonyl derivative of G are claimed as novel.
__________
147418]21][11[
כיסוי קצה לזיהוי ושיטה מערכתאלחוטי תקשורת במכשיר
SYSTEM AND METHOD FOR EDGE OF COVERAGE DETECTION IN A WIRELESS COMMUNICATION DEVICE
]54[
06.07.2000]22[US]33[07.07.1999]32[09/348442]31[
Int. Cl.8 H04Q 007/38]51[QUALCOMM INCORPORATED, U.S.A.
]71[
WO/2001/003464]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] In a wireless telephone communication system having more than one service provider system a method to enhance performance of a mobile phone,
comprising: when the mobile phone that is communicating with a first service provider system is in an idle mode, monitoring a first performance level and a second performance level;
June 3, 2007717 –התשס"ז בסיון י"ז
if the first performance level falls below a first threshold and the second performance level falls below a second threshold. starting a timer; if, while the timer is running, either the first or second performance levels exceed their respective thresholds, resetting the timer and continue
monitoring the first and second performance levels; and if the timer exceeds a predetermined duration, switching the mobile telephone from the first service provider system to a second service provider system.
__________
147441]21][11[
[N-[4-(1-SUBSTITUTED ]54[June 3, 2007 718 –התשס"ז בסיון י"ז
[פנילN[–4(–1– תולדות–5–איל[אלקיל[–1מותמר(פיפראזין–
[פיראן–B–2,3–אוקסו–תיאנו]7מותמר– רוקחות ותכשירי –קרבוקסאמיד3
אותן המכילים
PHENYL)PIPERAZIN-1-YL]ALKYL-]5-SUBSTITUTED-7-
OXO-THIENO[3,2-B]PYRAN-3-CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
28.07.2000]22[IT]33[30.07.1999]32[MI99A001704]31[
Int. Cl.8 A61K 031/396, A61P 013/00, 025/00, 027/02, C07D 495/00, 495/04]51[RECORDATI IRELAND LIMITED, IRELAND
]71[
WO/2001/009140]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
[57] A compound of the formula
whereinR represents an aryl, cycloalkyl or polyhaloalkyl group,R1 represents an alkyl, alkoxy, polyfuoroalkoxy, hydroxy or trifluoromethanesulphonyloxy group, each
of R2 and R3 independently represents a hydrogen or halogen atom or an alkoxy or polyfluoroalkoxy group, and n is 0, 1 or 2, or an N-oxide or a pharmaceutically acceptable salt of such a compound.
__________
June 3, 2007719 –התשס"ז בסיון י"ז
147510]21][11[
TASTE MASKEDמוסווה טעם בעל נוזלי רוקחות תכשירPHARMACEUTICAL LIQUID FORMULATIONS
]54[
June 3, 2007 720 –התשס"ז בסיון י"ז
21.06.2000]22[US]33[09.07.1999]32[60/143019]31[
Int. Cl.8 A61K 009/00, 009/14, 009/16]51[ORTHO-MCNEIL PHARMACEUTICAL, INC., U.S.A.
]71[
WO/2001/003698]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] An orally consumable liquid composition comprising a pharmaceutically active agent wherein the active agent is levofloxacin in particle form contained in a liquid suspension having a pH greater than about 6.0, each particle comprising a core of the pharmaceutically active agent, optionally associated with inactive pharmaceutical adjuvants; the core being coated with a
taste masking effective amount of a polymer blend of (a) dimethylaminoethyl methacrylate and neutral methacrylic acid ester (MM/MAE) and (b) a cellulose ester, in an aqueous vehicle, wherein the cellulose ester and the MM/MAE are present in a polymer weight ratio of the cellulose ester to the MM/MAE of about 40:60 to about 90:10.
__________
147628]21][11[
בקרה ערוץ של ניידת תחנה פיקוחמקוטע שידור במצב יעודי קדמי
MOBILE STATION SUPERVISION OF THE FORWARD DEDICATED CONTROL CHANNEL WHEN IN THE DISCONTINUOUS TRANSMISSION MODE
]54[
20.07.2000]22[US]33[21.07.1999]32[09/358634]31[
Int. Cl.8 H04B 007/185, H04J 003/12, H04Q 007/20, 007/38]51[QUALCOMM INCORPORATED, U.S.A.
]71[
WO/2001/008439]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] An apparatus used to supervise a dedicated control channel transmitted operating in a discontinuous transmission (DTX) mode, comprising: transceiver
means for transmitting and receiving transmissions; count means communicatively coupled to said transceiver means for counting a number
June 3, 2007721 –התשס"ז בסיון י"ז
of bad, good, and empty frames received in a transmission, wherein said count means is reset when a new transmission is received, and wherein said count means counts the number of bad frames received (COUNT1), the number of good frames received (COUNT2), and the number of empty frames received (COUNT3), and where said COUNTs may be incremented when:COUNT1 is incremented if a bad frame is received;COUNT2 is incremented if a good frame is received, and reset to zero if a bad frame is received; andCOUNT3 is incremented if an empty frame is received, and reset to zero if a
good frame is received; a fade timer, wherein said fade timer is set for a designated period if COUNT2 exceeds a third threshold (TH3); disabling/enabling means for disabling said transceiver, wherein said transceiver is enabled if COUNT2 exceeds a second threshold (TH2), and wherein said transceiver is disabled if said fade timer expires before COUNT1 is reset to zero, and wherein said transceiver is disabled if COUNT3 exceeds a fourth threshold (TH4); and terminating means for terminating a transmission, wherein said transmission is terminated if said fade timer expires before COUNT1 is reset to zero, or if COUNT3 exceeds a fifth threshold (TH5).
June 3, 2007 722 –התשס"ז בסיון י"ז
מבקשה חלוקה בקשותפורסמו. שטרם זו
179708,The applications for division from this application have not yet been published
__________
147672]21][11[
ושיטת הקלטה וידאו, מערכת מצלמתמשופר דינמי טווח בעלות הקלטה
DYNAMIC RANGE VIDEO CAMERA, RECORDING SYSTEM AND RECORDING METHOD
]54[
June 3, 2007723 –התשס"ז בסיון י"ז
16.08.2000]22[US]33[17.08.1999]32[60/149237]31[
Int. Cl.8 G03B 007/00, H04N 003/14, 005/225, 005/235, 005/238]51[APPLIED VISION SYSTEMS, INC., U.S.A.
]71[
WO/2001/013171]87[ושות', ש. הורוביץ
, תל41-45 רוטשילד שדרות ציון בית אביב
S. HOROWITZ & CO,. ZION HOUSE,
41-45 ROTHSCHILD BLVD,.TEL AVIV 65784
]74[
[57] A method of producing a video recording with improved dynamic range comprising: providing a video camera comprising a video detector capable of converting an optical image into a sequence of video fields or frames, and an electronic shutter for adjusting the amount of light received by said detector from an optical image viewed by said camera; operating said camera to capture an optical image; commanding said electronic shutter to vary the amount of light received by said video detector from said captured optical image whereby to produce from said detector an output video signal constituting a sequence of video fields or frames representing the captured optical image, with said sequence comprising at least first and second fields or frames representing different exposure values of
the captured image occurring repetitively in said sequence according to a predetermined repetition frequency; recording said output video signal in a recording medium; subsequently playing said output video signal out of said recording medium; processing said output video signal played out of said recording medium so as to produce a modified video signal consisting of a continuous sequence of said first fields or frames or a continuous sequence of said second fields or frames; and selectively applying said modified video signal as an input signal to a video display apparatus whereby to cause said apparatus to display said captured optical image according to the first or second fields or frames contained in said modified video signal.
June 3, 2007 724 –התשס"ז בסיון י"ז
__________
147761]21][11[
שידור אנרגיית לבקרת ומערכת שיטה שמבקר שער בעלת תקשורת במערכת
משתנה מהירות על
METHOD AND SYSTEM FOR CONTROLLING TRANSMISSION ENERGY IN A VARIABLE RATE GATED COMMUNICATION SYSTEM
]54[
27.07.2000]22[US]33[29.07.1999]32[09/363545]31[
Int. Cl.8 H04B 007/005, 007/216, 007/26]51[QUALCOMM INCORPORATED, U.S.A.
]71[
WO/2001/010056]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] In a wireless communication device, a method for controlling transmission energy of a remote station in response to received closed loop power control commands, comprising the steps of:(a) identifying ones of said received closed loop power control commands generated based upon gated out portions of a reverse link signal wherein said step of identifying is performed by receiving a predetermined number of power control bit estimates
requesting said remote station to increase its transmission energy in a set of said received closed loop power control commands consisting of alternating power control commands; and(b) adjusting transmission energy in response to said step of identifying ones of said received closed loop power control commands generated based upon gated out portions of a reverse link signal.
__________
June 3, 2007725 –התשס"ז בסיון י"ז
147767]21][11[
– ארילויניל2 תרכובות להכנת תהליכים –2 – – דיאריל1, 4 ו– אתר אלקיל
– בוטן2 – פלורורו
PROCESSES FOR THE PREPARATION OF 2 - ARYLVINYL ALKYL ETHER AND 1,4 - DIARYL - 2 - FLUORO - 2 - BUTENE COMPOUNDS
]54[
07.08.2000]22[US]33[12.08.1999]32[373262]31[
Int. Cl.8 C07C 017/263, 022/08, 025/24, 041/01, 041/28, 041/30, 043/00, 043/176, 043/215, 043/225, 043/29, 069/773, C07D 213/24, 213/62
]51[
BASF AKTIENGESELLSCHAFT, GERMANY
]71[
WO/2001/012578]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] A process for the preparation of a 2-arylvinyl alkyl ether compound of the formula
whereinR is hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl or C3-C6 halocycloalkyl;R1 is C1-C6 alkyl; andAr is phenyl optionally substituted with any combination of from one to three halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy groups, 1-or 2-naphthyl optionally substituted with any
combination of from one to three halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy groups, or a 5- or 6-membered heteroaromatic ring optionally substituted with any combination of from one to three halogen, C1-C4 alkyl, C1-C4
haloalkyl, C1-C4 alkoxy or C1-C4
haloalkoxy groups, in the absence of phosphonium halide compounds, which process comprises reacting a first acid with either(a) an aldehyde compound of the formula
June 3, 2007 726 –התשס"ז בסיון י"ז
wherein R and Ar are as described above and an alkanol compound of the formula
R1OHwherein R1 is as described above, or(b) an acetal compound of the formula
in the presence of an aprotic solvent at an elevated temperature.
__________
147791]21][11[
של רבים בתים לייצור והתקן שיטה על שעון דופק בכל רעש דמויי רצפים
במקביל הבתים חישוב ידי
METHOD AND APPARATUS FOR GENERATING MULTIPLE BITS OF A PSEUDONOISE SEQUENCE WITH EACH CLOCK PULSE BY COMPUTING THE BITS IN PARALLEL
]54[
30.08.2000]22[US]33[31.08.1999]32[09/386600]31[
Int. Cl.8 G06F 007/58, H04B 007/216]51[QUALCOMM INCORPORATED, ]71[
June 3, 2007727 –התשס"ז בסיון י"ז
U.S.A.WO/2001/016699]87[
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] An apparatus for generating multiple bits of a pseudonoise sequence by computing the bit in parallel, comprising:(a) a state memory;(b) a next state generator communicatively connected with said state memory, said
next state generator being configured to provide next state pre-determined number of states apart from a current state by a single operation; and(c) an output generator communicatively connected with said state memory.
__________
147795]21][11[
חיפוש זמני להפחתת והתקן שיטה תחנות איכון מידע באמצעות ראשוניים
ניידות
METHOD AND APPARATUS FOR REDUCING PILOT SEARCH TIMES UTILIZING MOBILE STATION LOCATION INFORMATION
]54[
30.08.2000]22[US]33[31.08.1999]32[09/387102]31[
Int. Cl.8 H04B 001/707, H04J 013/00, H04Q 007/22, 007/32, 007/34, 007/38]51[QUALCOMM INCORPORATED, U.S.A.
]71[
WO/2001/017125]87[
June 3, 2007 728 –התשס"ז בסיון י"ז
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] A method for conducting pilot signal search in a wireless communications system, comprising: determining a location of a mobile station within said wireless
communications system; determining a plurality of search window sizes corresponding to a plurality of pilot signals.
מבקשה חלוקה בקשותפורסמו. שטרם זו
179313,The applications for division from this application have not yet been published
__________
147916]21][11[
בעלת אלחוטית לתקשורת והתקן שיטהמשתנים מידע קצבי
METHOD AND APPARATUS FOR WIRELESS COMMUNICATIONS HAVING VARYING DATA RATES
]54[
28.07.2000]22[US]33[04.08.1999]32[09/368637]31[
Int. Cl.8 H04B 007/005, H04J 003/16, H04L 001/00, 012/28, H04Q 007/00]51[ATHEROS COMMUNICATIONS, INC., U.S.A.
]71[
WO/2001/011815]87[
June 3, 2007729 –התשס"ז בסיון י"ז
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] A method of dynamically allocating a data rate for wireless communication between a first transceiver and a second transceiver, the method comprising: transmitting initial first data at a first predetermined power level and at an initial first data rate from a first transceiver to a second transceiver; receiving the initial first data at the second transceiver; sensing the received power level of the received initial first data; determining a modified
first data rate greater than said initial first data rate at which to transmit further first data, said modified first data rate having a maximum data rate that is determined based upon the received power level of the received initial first data; transmitting the further first data at the modified first data rate and at the first predetermined power level from the first transceiver to the second transceiver; and receiving the further first data at the second transceiver.
__________
148003]21][11[
פעולה המכיל מורחף רוקחות תכשירפעילה לא ופאזה
FLOATING PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE PHASE AND A NON-ACTIVE PHASE
]54[
June 3, 2007 730 –התשס"ז בסיון י"ז
02.08.2000]22[FR]33[06.08.1999]32[99/10285]31[
Int. Cl.8 A61K 009/00, 009/20, 009/50]51[GALENIX DEVELOPPEMENT, FRANCE
]71[
WO/2001/010417]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] Floating pharmaceutical composition characterized in that is it constituted by at least:(a) a first phase, termed active phase, comprising at least one active ingredient and at least one disintegrating agent selected from hydroxypropylmethylcellulose, highly substituted hydroxy propylcellulose and ethylcellulose, the at least one disintegrating agent being in quantities less
than 15% by weight of the active phase and in a form making it possible to obtain a disintegrating effect while preventing the formation of a continuous network;(b) a second phase, termed inactive phase, comprising at least one gas-generating system and at least one hydrophilic polymer or a porous mineral compound,the active phase comprising a quantity of active ingredient(s) constituting at least 80% by weight of the active phase.
לתקנות35 לתקנה בהתאם נבחן זה פירוט1968 – הפטנטים, תשכ"ח
This specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968
__________
148042]21][11[
METHOD FOR PREPARING–דיאונים5,8קינולין– להכנת שיטהQUINOLINE-5,8-DIONES
]54[
10.08.2000]22[FR]33[13.08.1999]32[99/10491]31[
Int. Cl.8 C07D 215/20]51[LABORATOIRE L. LAFON, FRANCE]71[WO/2001/012597]87[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
June 3, 2007731 –התשס"ז בסיון י"ז
[57] A process for preparing quinoline-5, 8-diones of the formula:
in which:R1, R2 and R3 are chosen from hydrogen, a halogen atom, a C1-C6 alkyl group, -CHO,
-OH, -OR, -COOH, -CN, -CO2R, -CONHR, -CONRR'-, -NH2, -NHCOR,
morpholino and SO3H, Rand R' being chosen from C1-C6 alkyl groups and Ar being a C6-C14 aryl group, in
which an 8-hydroxyquinoline of the formula:
in which R1, R2 and R3 have the meaning given above, is oxidized with oxygen under the action of actinic radiation in solution in an organic solvent and in the
presence of a catalytic amount of a sensitizer, and the hydroperoxide formed, of the formula:
June 3, 2007 732 –התשס"ז בסיון י"ז
is then decomposed to a compoundof formula I.
__________
148068]21][11[
או ליפואית אלפא– בחומצה שימוש בתרופות פעיל כמרכיב בנגזרותיה
מיגרנה מניעת או לטיפול
USE OF ALPHA- LIPOIC ACID OR DERIVATIVES THEREOF AS AN ACTIVE INGREDENT IN THE MANUFACTURE OF MEDICAMENTS FOR TREATING OR PREVENTING MIGRAINE
]54[
26.08.2000]22[DE]33[30.08.1999]32[19941217.
0]31[
Int. Cl.8 A61K 031/385, 031/405, A61P 025/06, C07D 209/04, 339/00, 339/04]51[MEDA PHARMA GMBH & CO. KG, GERMANY
]71[
JEAN SCHOENEN, JURGEN ENGEL, KLAUS WESSEL, MANFRED PEUKERT, MICHAEL LOBISCH, HARALD BORBE
]72[
WO/2001/015693]87[( בע"מ,1995) ג'י.אי.ארליך
בגין מנחם ,רחוב15 אילון, קומה מגדל גן , רמת11
G.E. EHRLICH (1995) LTD,. AYALON TOWER 15TH FLOOR
11 MENACHEM BEGIN STREET52521 RAMAT GAN
]74[
[57] Use of racemic α-lipoic acid or its enantiomers or pharmaceutically
acceptable salts, amides, esters or thioesters thereof, in reduced or oxidized
June 3, 2007733 –התשס"ז בסיון י"ז
form, as an active ingredient for the manufacture of a medicament for prevention or treatment of migraine.
__________
148137]21][11[
באמצעות מסונכרנת מעגל סינתזהאסינכרוני פירוט
SYNCHRONOUS CIRCUIT SYNTHESIS USING AN ASYNCHRONOUS SPECIFICATION
]54[
18.08.2000]22[US]33[19.08.1999]32[377372]31[US09.11.199960/164201
Int. Cl.8 G06F 017/50, H04L 012/66]51[MASSACHUSETTS INSTITUTE OF TECHNOLOGY, U.S.A.
]71[
WO/2001/013285]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] A method for designing a synchronous digital system according to an asynchronous system specification for a first system comprising:accepting the asynchronous system specification, including accepting specifications of a plurality of data elements whose values define a state of the first system and accepting specifications of a plurality of state transition rules, wherein application of any of the state transition rules atomically updates values of the data element according to the specification of said state transition rule; and processing
the asynchronous system specification to form a specification of the synchronous digital system; wherein: processing the asynchronous system specification includes identifying a sequence of two or more of the state transition rules of the asynchronous system specification for application in a single state transition of the synchronous digital system; and at least some state transition of said synchronous digital system corresponds to sequential application of two or more of the state transition rules of the identified sequence.
June 3, 2007 734 –התשס"ז בסיון י"ז
__________
148162]21][11[
באמצעות אדמה בחרקי להלחם שיטהפניל–פירזולים
METHOD FOR FIGHTING SOIL INSECTS WITH PHENYL-PYRAZOLES
]54[
07.09.2000]22[FR]33[07.09.1999]32[99/11312]31[
Int. Cl.8 A01N 043/56, C07D 231/14, 401/02]51[BAYER CROPSCIENCE S.A., FRANCE
]71[
WO/2001/017354]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER]74[
June 3, 2007735 –התשס"ז בסיון י"ז
P.O.B. 5352BEER-SHEVA 84152
[57] Insecticidal compositions comprising:(a) between 0.001 and 5%, preferably between 0.05 and 1% and still more
advantageously between 0.05 and 0.5% of a compound of the formula
in which:R1 is a halogen atom or a CN group or a methyl group or a CH3CO group;R2 is S(O)nR3;R3 is alkyl or haloalkyl;R4 represents a hydrogen or halogen atom, or an NR5R6, S(O)mR7, C(O)R7 or C(O)-R7, alkyl, haloalkyl or OR8 radical or an –N=C(R9)(R10) radical; R5 and R6 independently represent a hydrogen atom or an alkyl, haloalkyl, C(O) alkyl or S(O) rCF3 radical, or R5 and R6 can together form a divalent alkylene radical which may be interrupted by one or two divalent heteroatoms such as oxygen or sulphur; R7 represents an alkyl or haloalkyl radical; R8 represents an alkyl or haloalkyl radical or a hydrogen atom; R9 represents an alkyl radical or a hydrogen atom; R10 represents a phenyl or heteroaryl group optionally substituted with one or more halogen
atoms or groups such as OH, -O-alkyl, -S-alkyl, cyano or alkyl; X represents a trivalent nitrogen atom or a C-R12 radical; R11 and R12 represent, independently of each other, a hydrogen or halogen atom; R13 represents a halogen atom or a haloalkyl, haloalkoxy, S(O)qCF3 or SF5 group; m, n, q, r represent, independently of each other, an integer equal to 0, 1 or 2; with the proviso that when R1 is methyl, then R3 is haloalkyl, R4 is NH2, R11 is Cl, R13 is CF3 and X is N;(b) between 0.05 and 10%, preferably between 0.1 and 5% of one (or more) moisture-retaining agents, preferably a moisture-retaining agent of an organic nature; and(c) between 40 and 99%, preferably between 50 and 98% (and more preferably between 70 and 97%) of vegetable meal.
__________
148325]21][11[
של רצפטור של אנטגוניסטיםויטרונקטין
VITRONECTIN RECEPTOR ANTAGONISTS
]54[
June 3, 2007 736 –התשס"ז בסיון י"ז
07.09.2000]22[US]33[07.09.1999]32[60/152780]31[
Int. Cl.8 A61K 031/4375, 031/4439, A61P 003/14, 009/00, 019/10, 035/00, C07D 213/74, 401/06, 413/12, 417/12, 471/04
]51[
SMITHKLINE BEECHAM CORPORATION, U.S.A.
]71[
WO/2001/017959]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
[57] A compound of the formula:
wherein:R1 is Het-or Ar;R2 is
or a pharmaceutically acceptable salt thereof.
__________
148375]21][11[
]AIR DUCT DAMPER]54אויר לתעלת אויר וסת
25.02.2002]22[Int. Cl.8 F24F 007/06]51[
]TWITOPLAST LTD.]71בע"מ, פתח-תקוה טויטופלסטצדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
June 3, 2007737 –התשס"ז בסיון י"ז
[57] An air damper particularly useful in air conditioning ducts, comprising a plurality of radial blades, each blade being pivotally supported between an outer housing ring and a central hub member, said blades being rotatable about a radial pivot axis between a fully closed position blocking air flow in a duct containing said
damper to a fully open position allowing substantially free air flow in said duct, and including any desired intermediate position, said radial blades being interlinked so that the rotation of one blade causes the same degree of rotation in all remaining blades.
__________
148406]21][11[
PHARMACEUTICAL TRAMADOLרוקחי לשימוש טרמדול מלחיSALTS
]54[
03.08.2000]22[DE]33[31.08.1999]32[19940740.
1]31[
Int. Cl.8 C07D 215/00]51[GRUNENTHAL GMBH, GERMANY]71[WO/2001/015682]87[
June 3, 2007 738 –התשס"ז בסיון י"ז
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
[57] A pharmaceutically acceptable salt of tramadol and a sugar substitute, wherein
the solubility of the salt in water or aqueous body fluids is <100 mg/ml.
__________
148521]21][11[
הודעות סידרת לשידור ומערכת שיטהנתונים בסיס עבור
METHOD AND SYSTEM FOR TRANSMITTING A CHAIN OF MESSAGES FOR DATABASE
]54[
14.09.2000]22[CH]33[17.09.1999]32[1713/99]31[
Int. Cl.8 G06F 009/445, H04L 012/18, 029/06, H04N 007/24]51[NAGRACARD S.A., SWITZERLAND]71[WO/2001/022684]87[
וגולר, וולף, ברגמן ,1352ב' , ת.ד. 19 היסוד קרן רחוב
ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
[57] Method of transmission of chain of database managing messages between a management centre and a plurality of subscriber databases, each management message comprising a chain header (HD), a chain identifier (FM) allowing the simultaneous transmission of several chains and a chain index (FI) allowing to identify the message in the chain,
characterized in that it consists in adding to each message a conditional block (CD) which determines if this message is to be processed without references to all or part of elements of the chain or to be processed according to the conditions linked to the previous processing of all or part of elements of the chain.
June 3, 2007739 –התשס"ז בסיון י"ז
__________
148568]21][11[
במערכת לשימוש דבק, במיוחד סרטיטרנסדרמלית או דרמלית
PLASTIC FILMS, ESPECIALLY FOR USE IN A DERMAL OR TRANSDERMAL THERAPEUTIC SYSTEM
]54[
June 3, 2007 740 –התשס"ז בסיון י"ז
26.08.2000]22[DE]33[10.09.1999]32[1994317.8]31[
Int. Cl.8 A61K 035/00]51[LTS LOHMANN THERAPIE-SYSTEME AG, GERMANY
]71[
WO/2001/019351]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
[57] Dermal or transdermal therapeutic system comprising a sheet-like substrate or reservoir containing readily volatile auxiliary agents or active agents, which substrate or reservoir is covered on one of its sides with a backing layer impermeable to the ingredients and on the opposite side
with a detachable, likewise impermeable protective layer to prevent loss of ingredients during prolonged storage, characterized in that both the backing layer and the protective layer are made of plastic film which is impermeably coated on both sides with vapour-deposited metal.
__________
148619]21][11[
לזכרון לאפשר ושיטה מערכת תפקוד כדי תוך קוד בצע לא–וולטיליל
מידע ועיבוד אגירה כמתקן
SYSTEM AND METHOD FOR ENABLING NON-VOLATILE MEMORY TO EXECUTE CODE WHILE OPERATING AS A DATA STORAGE/PROCESSING DEVICE
]54[
18.06.2001]22[US]33[31.07.2000]32[09/629966]31[
Int. Cl.8 G06F 012/00, 015/78]51[
June 3, 2007741 –התשס"ז בסיון י"ז
M-SYSTEMS FLASH DISKבע"מ פיונירס דיסק פלאש אם-סיסטמסPIONEERS LTD.
]71[
,AMIR BAN, MOSHE GEFENזרנוויצקי גפן, שוקה בן, משה אמירSHUKA ZERNOVIZKY
]72[
WO/2002/010921]87[בע"מ, פרידמן מרק ד"ר
אביב , תל7 שמואלוב, רח' האומנים בית DR. MARK FRIEDMAN LTD,.
BEIT SAMUELOFF, 7 HAOMANIM STREET,
TEL AVIV
]74[
[57] A method for executing code while processing data on a non-volatile memory device, comprising the following steps:(i) adding at least one logic circuit to the non-volatile memory device;(ii) sensing a read request while the device is in program/erase mode/operation, by said at least one logic circuit;(iii) in response to said sensing, entering of program and/or erase operations into suspended mode, by said at least one logic circuit;(iv) signaling to CPU/Bus to delay executing said read request, by said at least one logic circuit;
(v) turning off signal to allow CPU/Bus to execute said read request, by said at least one logic circuit; and(vi) exiting of said device from said suspended mode to continue program/erase operation, by said at least one logic circuit.A single flash memory device comprising:a suspend logic circuit for enabling hardware initiated suspending of data processing operations in response to at least one read request received by the memory device from a host; and a resume logic circuit for enabling hardware initiated resuming of data processing operations.
__________
148683]21][11[
נמתח, מחיצה בד לקיבוע מסילה מקטע קיר או מדומה תקרה כגון מדומהממנו המורכב מדומה
RAIL SECTION FOR FIXING A STRETCHED WEB, FALSE PARTITION SUCH AS A FALSE CEILING OR FALSE WALL COMPRISING SAME
]54[
June 3, 2007 742 –התשס"ז בסיון י"ז
11.07.2001]22[FR]33[13.07.2000]32[00/09186]31[
Int. Cl.8 E04B 009/30]51[NEWMAT, S.A., FRANCE]71[WO/2002/006604]87[
לוצאטו, את לוצאטושבע , באר5352, ת.ד. תעשייה, עומר גן
LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER
P.O.B. 5352BEER-SHEVA 84152
]74[
[57] A rail section (3) for stretched fabric false partitions affixed to a mounting surface (4), said rail section comprising: a groove (3) defined by an internal wing (7), an external wing (5) and a base (6); an interval adjacent to the external wing and separating the external wing from a mounting surface; a joint (12) including a lip (13), and a flap (14) outside the groove, said flap extending outward from said
external wing toward said mounting surface; said lip being shaped and configured to pinch the fabric of the false partition between said lip and said internal wing; wherein the lip is approximately flat, an internal face (16) of the lip being approximately parallel to an external face of the lip; wherein the lip has a free edge that is disposed inside the groove.
__________
148953]21][11[
]HORMONAL COMPOSITION AND ]54בו ושימוש הורמונלי תכשיר
June 3, 2007743 –התשס"ז בסיון י"ז
USE THEREOF
24.10.2000]22[WO]33[25.10.1999]32[PCT/FR99/02588]31[
Int. Cl.8 A61K 045/00, C07J 005/00]51[LABORATOIRE THERAMEX, MONACO
]71[
WO/2001/030357]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
[57] Use of a combined estroprogestative association to be administered by the oral route for the preparation of a medicament intended to correct estrogen deficiencies in women, more particularly in menopausal women, wherein the association contains an estrogen at a dose ranging from 0.3 to 3
mg, and a progestative selected from nomegestrol and esters thereof at a dose ranging from 0.3 to 1.25 mg, in combination or admixture with one or more non-toxic, inert, pharmaceutically acceptable excipient(s).
__________
149209]21][11[
Nאלקילאמידים, הכנתם, –גואנידינו המכילים רוקחות ותכשירי בהם השמוש
אותם
N-GUANIDINOALKYLAMIDES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM
]54[
21.10.2000]22[EP]33[30.10.1999]32[99121623.
5]31[
Int. Cl.8 A61K 031/16, 031/395, A61P 007/02, 009/00, C07C 279/14, C07D 213/30, 213/40, 215/48, 239/28
]51[
SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY
]71[
WO/2001/032611]87[צדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
[57] Compounds of the formula
June 3, 2007 744 –התשס"ז בסיון י"ז
in whichone or two of the groups Y are carbonatoms carrying a group of the formula
Ro-(CH2)n-O-
and zero, one, two or three of the groups Y are nitrogen atoms, and the remaining groups Y are carbon atoms carrying a group R1, where the groups Y are independent of each other and can be identical or different; L is chosen from hydrogen, (C1-C6)-alkylcarbonyl, (C6-C14)-aryl-(C1-C4) – alkylcarbonyl, (C6-C14)-arylcarbonyl, (C1-C6)-alkyloxycarbonyl,
(C6-C14)-aryl-(C1-C4)- alkyloxycarbonyl and (C6-C14)-aryloxycarbonyl, where the aryl groups present in L are unsubstituted or substituted by one or more identical or different substituents R13, and where all groups L are independent of each other and can be identical or different;A is chosen from R3O- and R4R6N-;k is 1, 2, 3 or 4;
n is 0, 1, 2, 3 or 4;Ro is chosen from phenyl and monocyclic 6-membered heteroaryl containing one or two nitrogen atoms as ring heteroatoms, where the group Ro is unsubstituted or substituted by one or more identical or different groups R2;R1 is chosen from hydrogen, halogen, nitro, hydroxy, (C1-C6)-alkyloxy-, (C6-C14)-
aryl, (C1-C8)-alkyl, hydroxycarbonyl-(C1-C8)-alkylureido-, (C1-C8)-alkyloxycarbonyl-(C1-C8)-alkylureido-, (C1-C8)-alkylsulfonyl-and R11R12N-, where the groups R1 are independent of each other and can be identical or different, and where alkyl and aryl groups present in R1 are unsubstituted or substituted by one or more identical of different substituents R13,or two groups R1 bonded to adjacent ring carbon atoms together with the carbon atoms to which they are bonded form an aromatic ring condensed to the ring depicted in formula l, where the ring formed by the two groups R1 is unsubstituted or substituted by one or more identical or different substituents R13;R2 is chosen from halogen, nitro, (C1-C8)-alkyl, cyano, hydroxy, amino and (C1-C8)- alkyloxy-, where alkyl groups present in R2 are unsubstituted or substituted by one or more identical or different halogen atoms; R3, R4 and R5 are chosen from hydrogen, (C1-C12)-alkyl, (C6-C14)-aryl-(C1-C4)-alkyl-, (C6-C14)-aryl-, Het-and Het-(C1-C4)-alkyl, where R4 and R5 are independent of each other and can be identical or different, and where the groups alkyl, aryl and Het present in R3, R4 and R5 are
June 3, 2007745 –התשס"ז בסיון י"ז
unsubstituted or substituted by one or more identical or different substituents R13, or R4
and R5 together with the nitrogen atom to which they are bonded form a saturated 3-membered to 8-membered monocyclic ring which in addition to the nitrogen atom carrying R4 and R5 can contain one or two identical or different ring heteroatoms chosen from oxygen, sulfur and nitrogen; R11 and R12 which are independent of each other and can be identical or different, are chosen from hydrogen, (C1-C8)-alkyl, (C6-C14)- (C1-C4)-alkyl, -Het-(C1-C4)-alkyl-, hydroxycarbonyl-(C1-C8)-alkyl-, (C1-C8)-alkyloycarbonyl-(C1-C8)-alkyl-, hydroxycarbonyl-(C1-C8)-alkyloxcarbonyl-(C1-C8)- alkylcarbonyl- and (C1-C8)-alkylcarbonyl-, where alkyl and aryl groups present in R11 and R12 are unsubstituted or substituted by one or more identical or different substituents R13,or R11 and R12 together with the nitrogen atom to which they are bonded form a
saturated or unsaturated 5-membered to 8-membered monocyclic heterocyclic ring which in addition to the nitrogen atom carrying R11 and R12 can contain one or two identical or different ring heteroatoms chosen from oxygen, sulfur and nitrogen, and in which one or two of the ring carbon atoms can be substituted by oxo to form C=O group(s); R13 is chosen from halogen, nitro, cyano, hydroxy, (C1-C8)-alkyl, (C1-C8)-alkyloxy, trifluoromethyl and amino; Het is a residue of a saturated, partially unsaturated or aromatic monocyclic or bicyclic, 3-membered to 10-membered heterocyclic ring system containing one, two, three or four identical or different heteroatoms chosen from nitrogen, oxygen and sulfur; in all their stereoisomeric forms and mixtures thereof in any ratio, and their physiologically tolerable salts.
__________
149324]21][11[
דיספרסיה של סימן לאיתור שיטהאופטיים תקשורת בקווי אופטית
TECHNIQUE FOR DETERMINING SIGN OF OPTICAL DISPERSION IN OPTICAL COMMUNICATION LINES
]54[
24.04.2002]22[Int. Cl.8 G02B 006/34]51[
]ECI TELECOM LTD.]71תקוה בע"מ, פתח אי.סי.איי. טלקוםבע"מ, אי. סי. איי. טלקום
תקוה , פתח30הסיבים רחוב ECI TELECOM LTD,
30 HASIVIM ST.PETACH TIKVA 49517
]74[
[57] A method for determining the sign of chromatic dispersion in an optical communication line suitable for transmitting an optical signal at a
predetermined optical wavelength, the method comprising steps of: introducing controlled changes of wavelength around said predetermined wavelength,
June 3, 2007 746 –התשס"ז בסיון י"ז
monitoring the optical signal that has passed said line, and obtaining a first signal reflecting changes of the carrier wavelength of said optical signal, a second signal reflecting changes of delay of the optical signal transmitted via said line,
comparing the first signal with the second signal, and determining the chromatic dispersion sign based on the phase difference between the compared first and second signals.
__________
149356]21][11[
המאפשרת תקשורת מערכת רשת להשתמש רשת ספקי של רב למספרמשותף רשת במבנה
DISTRIBUTED NETWORK COMMUNICATION SYSTEM WHICH ENABLES MULTIPLE NETWORK PROVIDERS TO USE A COMMON DISTRIBUTED NETWORK INFRASTRUCTURE
]54[
03.11.2000]22[US]33[03.11.1999]32[433818]31[US18.04.2000551291
Int. Cl.8 H04L 012/14, 012/28, 029/06, 029/12]51[WAYPORT, INC., U.S.A.]71[
WO/2001/037517]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] A method for providing access to a network system, wherein the network system includes a plurality of access points coupled to a network, the method comprising: a first access point receiving identification information from a portable computing device, wherein the identification information indicates a
network provider of a plurality of possible network providers; determining the network provider for the portable computing device after receiving the identification information; the first access to the portable computing device through the network provider determined in said determining.
June 3, 2007747 –התשס"ז בסיון י"ז
__________
149439]21][11[
יותר או אחת לבקרת ושיטה מערכת כיחידה כניסות מרובות בקרה יחידותאחת כניסות מרובת
SYSTEM AND METHOD FOR CONTROLLING ONE OR MORE MULTIPOINT CONTROL UNITS AS ONE MULTIPOINT CONTROL UNIT
]54[
08.11.2000]22[US]33[08.11.1999]32[60/164298]31[
Int. Cl.8 H04L 012/18, 029/06, H04N 007/00, 007/15]51[]POLYCOM ISRAEL LTD.]71תקווה בע"מ, פתח ישראל פוליקום
WO/2001/035655]87[צדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
[57] A method for multimedia communication, comprising the steps of:communicatively interconnecting a plurality of multimedia terminals to a plurality of corresponding multipoint control units, wherein each multimedia terminal is connectable to two or more of said plurality of multipoint control units; communicatively interconnecting the plurality of corresponding multipoint control units to a central control unit; identifying capability factors for each of the plurality of multimedia terminals and
each of the plurality of corresponding multipoint control units; responsive to a command to initiate a multimedia communication between at least two of the plurality of multimedia terminals, evaluating the capability factors for each of the at least two multimedia terminals;comparing the capability factors for each of the at least two multimedia terminals to the capability factors of the multipoint control units communicatively interconnected to the central control unit to determine an optimum assignment of
June 3, 2007 748 –התשס"ז בסיון י"ז
resources for a multimedia interconnection between the at least two participating multimedia terminals and responsive to the comparing of capability factors, the central control unit assigning the multimedia control unit to be used for the multimedia interconnection of the participating
multimedia terminals to one of said plurality of multimedia control units and directing a communicative interconnection between the at least two multimedia terminals via at least one of the plurality of multipoint control units.
__________
149538]21][11[
של הדדי אופטי לחיבור אפיק תצורתחישוב יחידות מספר
BUS CONFIGURATION FOR OPTICALLY INTERCONNECTING A PLURALITY OF CALCULATION UNITS
]54[
29.09.2000]22[
June 3, 2007749 –התשס"ז בסיון י"ז
US]33[11.11.1999]32[09/438345]31[Int. Cl.8 G02B 006/28]51[INTEL CORPORATION, U.S.A.]71[
WO/2001/035137]87[וגולר, וולף, ברגמן
,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
[57] A method for optically interconnecting a plurality of devices, comprising: splitting a first optical signal beam received from a first device; optically coupling a second device and a third device to receive the first optical signal beam; splitting a second optical signal beam received from the second device; optically coupling the first device and the third device to receive the second
optical signal beam; splitting a third optical signal beam received from the third device; optically coupling the first device and the second device to receive the third optical signal beam, and deflecting a portion of at least one of the first, second, and third optical signal beams directed from a first beam splitter back to the first beam splitter.
__________
149659]21][11[
SYSTEM FOR TRACKING Aכלי אחרי למעקב מערכתCRAFT
]54[
17.10.2001]22[FR]33[20.10.2000]32[00/13484]31[
Int. Cl.8 G01S 001/04, 005/14]51[THALES, FRANCE]71[WO/2002/033437]87[
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
[57] A system for tracking a craft from a monitoring station by means of signals transmitted by satellites of a positioning system and frequency-transposed and relayed by a transponder placed onboard the craft, said signals transmitted by the satellites of the positioning system each resulting from the modulation of a carrier by a spreading code, this craft tracking system comprising: onboard the craft, a transponder retransmitting the signals from the satellites of the positioning system
after an infradyne frequency transposition by means of a transposition carrier of higher frequency KFQ than F0 of the satellite signals, by associating a transposition driver FQ representative of the phase and frequency of the carrier used for the transposition KFQ, and at the monitoring station; a receiver responsive to the signals retransmitted by the transponder, with: a signal processing part incorporating a demodulation stage with a spreading code recovery loop nested within a carrier recovery loop each slaved
June 3, 2007 750 –התשס"ז בסיון י"ז
to its own error signal, the error signal of the code recovery loop being representative of the delay affecting, on reception, the spreading code of the signal undergoing demodulation and the error signal of the carrier recovery loop being representative of the frequency gap affecting, on reception, the carrier of the signal undergoing demodulation; a part for determining the frequency gap K∆F2, with respect to its preset value, of the transposition carrier used by the transponder, operating on the basis of the transposition driver received from the transponder; means for correcting the error signal of the carrier recovery loop, of the bias caused by the frequency gap ∆F2 determined by the part for determining frequency gap, and a part for signal utilization, extracting information regarding the position and the speed of the
craft from the error signals of the code recovery loop and of the carrier recovery loop of the processing part, the error signal of the carrier recovery loop being corrected beforehand of the frequency gap K∆F2 delivered by the frequency gap determining part, said craft tracking system being characterized in that it comprises: at the level of the monitoring station, means for interpreting the error signal of the carrier recovery loop, after correction of the bias caused by the frequency gap K∆F2 determined by the frequency gap determining part (40, 41) as a measurement representative of the Doppler effect caused, on the initial frequency F0 of the signal relayed by the transponder, by an approach speed corresponding to the sum of the craft/satellite Vos and craft/receiver VOR relative retreat speeds.
__________
149730]21][11[
מסוג וירטואלי מסך רקע עיצובVMEbusלפגמים עמיד
FAULT TOLERANT VIRTUAL VMEBUS BACKPLANE DESIGN
]54[
15.11.2000]22[US]33[18.11.1999]32[442702]31[
Int. Cl.8 G06F 011/20, 013/40]51[
June 3, 2007751 –התשס"ז בסיון י"ז
HONEYWELL INC., U.S.A.]71[WO/2001/037102]87[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
[57] A fault tolerant virtual VMEbus backplane for computer systems, the apparatus comprising: at least two VMEbus backplanes, each VMEbus backplane comprising a power supply and
a fault detection apparatus; and at least two bridge modules, each bridge module comprising a switch for connecting and disconnecting each of said VMEbus backplanes.
__________
149738]21][11[
רוטור על להבים של צורה שינוירוחבי סאונד אולטרה באמצעות
TRANSVERSE ULTRASOUND PEENING OF BLADES ON A ROTOR
]54[
20.09.2001]22[FR]33[21.09.2000]32[00/12017]31[
Int. Cl.8 B24B 039/00]51[June 3, 2007 752 –התשס"ז בסיון י"ז
SNECMA MOTEURS, FRANCE]71[BENOIT JEAN HENRI BERTHELET, GERARD MICHEL ROLAND GUELDRY, CLAUDE MARCEL MONS, MARIE-CHRISTINE NTSAMA-ETOUNDI
]72[
WO/2002/024411]87[ דין, עורכי עורכי לצר צדק כהן פרל
ונוטריונים, פטנטים , ת.ד.5 , רח' שנקר1 גב-ים מרכז
, הרצליה12704
PEARL COHEN ZEDEK LATZER, 5 SHENKAR STREET ,
P.O.B. 12704 HERZLIYA 46733
]74[
]57 [A method for ultrasonic peening of parts lying radially at a periphery of a wheel, comprising: setting the wheel in rotation about its geometric axis; creating a mist of microbeads in a fixed active chamber arranged to a side of said wheel, by a first vibrating surface arranged in a lower part of said active chamber, said active chamber comprising an opening
shaped to allow the parts to be put in and removed as the wheel rotates and being sized to accommodate at least three adjacent parts; wherein the wheel is rotated about said geometric axis which is substantially vertical, and the first vibrating surface is arranged under a path of the parts in the active chamber.
__________
149748]21][11[
3 ,1 – –ניטרוגואנידינים2 להכין שיטה– דימותמרים
METHOD FOR PRODUCTION OF 1,3 - DISUBSTITUTED 2-NITROGUANIDINES
]54[
08.12.2000]22[DE]33[21.12.1999]32[19961604.
3]31[
June 3, 2007753 –התשס"ז בסיון י"ז
Int. Cl.8 C07D 213/36, 213/61, 277/28, 277/32, 307/14]51[BAYER AKTIENGESELLSCHAFT, GERMANY
]71[
WO/2001/046160]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
]57 [A process for the preparation of a compound of the formula
wherein R1 is hydrogen or alkyl,R2 is hydrogen, alkyl, cycloalkyl or –CH2R3,R3 is alkenyl, alkinyl, or aryl or heteroaryl each of which is optionally substituted,
Het is an unsubstituted or substituted aromatic or non-aromatic, monocyclic or bicyclic heterocyclic radical, comprising the step of: reacting a compound of the formula
wherein R1, R2 and Het are as defined above, and R4 is alkyl, cycloalkyl, aryl, arylalkyl or heterocyclylalkyl, each of which may be unsubstituted or substituted,
with anhydrous hydrogen chloride or with one or more compounds which can generate hydrogen chloride in the presence or absence of a diluent.
June 3, 2007 754 –התשס"ז בסיון י"ז
__________149812]21][11[
טרנסדרמליות תרופתיות מערכותוייצורן משופרת יציבות בעלות
TRANSDERMAL THERAPEUTIC SYSTEMS HAVING IMPROVED STABILITY AND THEIR PRODUCTION
]54[
24.11.2000]22[DE]33[29.11.1999]32[19957401.
4]31[
June 3, 2007755 –התשס"ז בסיון י"ז
DE04.11.200010054713.3Int. Cl.8 A61K 009/00, 009/70]51[LTS LOHMANN THERAPIE-SYSTEME AG, GERMANY
]71[
WALTER MULLER]72[WO/2001/039753]87[
צדק, וכהן איתן, פרל, לצר, הרצליה12688 , ת.ד. 7 שנקר רחוב
EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
]57 [A transdermal therapeutic system (TTS) in which the formation of oxidative degradation products of at least one active substance present in this system and oxidizable by hydroperoxides is reduced during storage of the TTS, wherein the
sum of the peroxide numbers (PON) of the formulation constituents in contact with the active substance or substances in the proportionate weighting dictated by the formula for the TTS is not more than 20.
__________
149816]21][11[
מוזיקה תצוגת לתיאום ושיטה מערכתבתזמורת נגנים בין
SYSTEM AND METHOD FOR COORDINATING MUSIC DISPLAY AMONG PLAYERS IN AN ORCHESTRA
]54[
22.11.2000]22[US]33[23.11.1999]32[447916]31[
Int. Cl.8 G09B 015/00, 015/02]51[HARRY CONNICK, JR., U.S.A.]71[
WO/2001/039158]87[ושות', גבריאלי זליגסון
אביב , תל1426 , ת.ד. 31 רח' יבנה SELIGSOHN GABRIELI & CO,.
31 YAVNE ST.P.O.B. 1426
TEL AVIV 61013
]74[
June 3, 2007 756 –התשס"ז בסיון י"ז
]57 [In a network of computerized devices each containing programming for displaying music on a display device, the computerized devices being used by each of a plurality of players in an orchestra under direction of a conductor, a method for facilitating leading of the orchestra, the method comprising: registering an identity of an instrument in use by each player and the corresponding computerized device being used by the player; receiving at a computerized device in use by the conductor a change to a musical arrangement represented in a handwritten format, the conductor's format to electronic
music type format; allowing the conductor to select whether the change is to be sent to all players in the orchestra or only to one or more players using an instrument impacted by the change; if the conductor selects to send the change only to the player or players using an instrument impacted by the change, determining which instrument or instruments are impacted by the change and identifying the corresponding computerized device or devices registered for that instrument; allowing the conductor to select whether the change should be converted to electronic music type format before transmission to the one or more players; and transmitting the change to one or more players in accordance with the conductor's selections.
__________
June 3, 2007757 –התשס"ז בסיון י"ז
149822]21][11[
MULTI-SERVER FILEשרתים ממספר קובץ הורדתDOWNLOAD
]54[
23.11.2000]22[US]33[24.11.1999]32[09/448179]31[
Int. Cl.8 G06F 011/00, 013/00]51[]SPEEDBIT LTD.]71בע"מ ספידביט
WO/2001/039002]87[עו"פ, בע"מ עמיתים אלפאפטנט
שמש , בית55 רח' ראובן ALPHAPATENT LTD,.
55 REUVEN ST,.BET-SHEMESH 99544
]74[
]57 [A method for downloading a file to a client, the method comprising the steps of:
)a (determining the presence of said file on each of a plurality of secondary servers;
)b (retrieving a plurality of portions of said file from any of said servers, wherein at
least a first of said portions is retrieved from a first on any of said servers and at least a second of said portions is retrieved from a second on any of said servers; and
)c (assembling said file at said client from said plurality of portions.
__________
June 3, 2007 758 –התשס"ז בסיון י"ז
149823]21][11[
METHODS AND APPARATUS FORמשרת קובץ להורדת והתקן שיטהDOWNLOADING A FILE FROM A SERVER
]54[
18.01.2001]22[US]33[19.01.2000]32[09/487338]31[
Int. Cl.8 G06F 011/00, 013/00]51[]SPEEDBIT LTD.]71בע"מ ספידביט
WO/2001/053953]87[עו"פ, בע"מ עמיתים אלפאפטנט
שמש , בית55 רח' ראובן ALPHAPATENT LTD,.
55 REUVEN ST,.BET-SHEMESH 99544
]74[
]57 [A method for downloading files, the method comprising the steps of: at a client:
)a (requesting a proxy server to initiate a first download of a file from a first server, said first server determined by said client to lack download resume capability and said proxy server possessing download resume capability; at said proxy server:
)b (initiating said first download of said file from said first server; and at said client:
)c (initiating at least a second download of at least a portion of said file from said proxy server, said portion not being downloaded to said client directly from said first server.
June 3, 2007759 –התשס"ז בסיון י"ז
__________
149880]21][11[
ELECTRONIC PARKING METERאלקטרונית חניה מד מערכתSYSTEM
]54[
28.05.2002]22[US]33[30.05.2001]32[09/866919]31[
Int. Cl.8 G07C 001/30, G08G 001/14]51[INNOVAPARK, LLC, U.S.A.]71[
וגולר, וולף, ברגמן ,1352ב' , ת.ד. 19 היסוד קרן רחוב
ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
]57 [An electronic parking meter system comprising: an electronic parking meter (4, 6) for determining the time a parking space associated with the parking meter is occupied by a vehicle and receiving coins denoting desired parking time and indicating said time; an inductive loop vehicle detection sensor (8, 10) located to detect both the physical presence or absence of a vehicle in said parking space and emitting a respective signal indicative
thereof, a microprocessor controller (14) coupled to the sensor and the electronic parking meter for selectively controlling the electronic parking meter and the controller responsive to the sensor signal; the electronic parking meter indicating time provided upon payment with a vehicle occupying said space to obtain a fixed amount of time in accordance with the amount of payment, said electronic parking meter decrementing the indicated
June 3, 2007 760 –התשס"ז בסיון י"ז
time; said controller initializing said electronic parking meter to zero when the sensor signals the controller that a vehicle no longer occupies the parking space; said detection sensor includes a variable oscillator circuit oscillating at a base frequency and responsive to the inductance of the inductive loop for providing said signals to the microprocessor indicating the presence or absence of a vehicle in the parking space; said microprocessor controller including a crystal oscillator producing pulses and operating at approximately 50 times the base frequency of the variable oscillator circuit and initiating a 12.5 ms long charge to said variable oscillator circuit every 2.5 seconds for the purpose of measuring the operating frequency of said circuit while conserving power as needed for the practical application of the technology in
parking control; the presence or absence of a vehicle in the parking space causing a respective decrease or increase in the inductance of the inductive loop and a respective commensurate increase or decrease in the operating frequency and a respective decrease or increase in the period of the variable oscillator circuit, thereby decreasing or increasing the number of crystal oscillator pulses in each period of the variable oscillator circuit; said oscillator providing an output signal including said crystal oscillator pulses to said microprocessor controller, and said microprocessor controller superimposes the signals received from the variable oscillator circuit during each 12.5 ms time frame in which the variable oscillator circuit is charged with the crystal oscillator pulses to determine the presence or absence of a vehicle in the parking space.
__________
149898]21][11[
BUTT-ENDED BAG WITH Aבולט סגירה אלמנט בעלת שקיתBUCKLE-OVER CLOSING ELEMENT
]54[
June 3, 2007761 –התשס"ז בסיון י"ז
20.10.2000]22[DE]33[30.11.1999]32[19957563.
0]31[
Int. Cl.8 B65D 075/00, 075/58]51[SPS VERPACKUNGS-SYSTEM GMBH, GERMANY
]71[
WO/2001/040074]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [Stand-up pouch (1) made of heat-sealable or weldable plastic foil for receiving liquid and/or paste-like substances, having two side walls (2, 3), which are joined to one another at their longitudinal edges, wherein disposed at the bottom stand-up pouch end between the bottom transverse edges (8, 9) is a foldable bottom part, which lies between the side wall and serves as a standing base (10) ,
and situated at the top stand-up pouch end between the side walls is a foldable top part, and having a discharge opening (12)
between the upper transverse edge (13, 20) of a first side wall and the associated top-part edge (21, 22), wherein a closure element (20) is inserted into the discharge opening, the stand-up pouch in the first side wall in a region below the closure element comprising a means (33) of
stabilizing and supporting the closure element in a forward-tilted position, wherein the means of stabilizing and supporting the closure element is formed by at least one embossing (33, 34).
__________
149984]21][11[
June 3, 2007 762 –התשס"ז בסיון י"ז
TIOTROPIUM-CONTAININGטיאוטרופיום המכילה לשאיפה אבקהINHALATION POWDER
]54[
28.09.2001]22[DE]33[12.10.2000]32[10050635.
6]31[
Int. Cl.8 A61K 009/00, 009/72, C07D 451/02]51[BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, GERMANY
]71[
WO/2002/030389]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [Inhalable powder containing 0.04 to 0.8% by weight of tiotropium in admixture with a physiologically acceptable excipient, characterized in that the excipient consists of a mixture of coarser excipient with an average particle size of
15 to 80 μm and finer excipient with an average particle size of 1 to 9 μm, the proportion of finer excipient constituting 3 to 15% by weight of the total amount of excipient.
__________
150159]21][11[
בפולשנות פגע ללא רקמה הנצלתמזערית
MINIMALLY INVASIVE INTACT RECOVERY OF TISSUE
]54[
01.09.2000]22[US]33[27.12.1999]32[09/472673]31[
Int. Cl.8 A61B 010/00]51[NEOTHERMIA CORPORATION, U.S.A.
]71[
WO/2001/047409]87[( בע"מ,1995) ג'י.אי.ארליך
בגין מנחם ,רחוב15 אילון, קומה מגדל גן , רמת11
G.E. EHRLICH (1995) LTD,. AYALON TOWER 15TH FLOOR
11 MENACHEM BEGIN STREET52521 RAMAT GAN
]74[
]57 [Apparatus (10) for retrieving a tissue volume of predetermined peripheral extent, comprising a delivery cannula (12) having an outer surface surmounting an interior channel and extending from a proximal end portion along a longitudinal axis to a
forward region, having a distal end positionable in confronting adjacency with said tissue volume; a capture component positioned within said delivery cannula interior channel, having an expansible forward portion extending to a forwardly
June 3, 2007763 –התשס"ז בסיון י"ז
disposed electrically conducting electrosurgical cutting leading edge portion and being extendible and expandable toward an outer peripheral dimension selected for the circumscriptive engagement of said tissue volume peripheral extent when moved along said longitudinal axis to egress from said delivery cannula; and a deployment assembly (18) extending within said interior channel, drivably coupled with
said capture component and actuable to effect said movement of said capture component along said longitudinal axis, and for effecting a subsequent contraction of said leading edge portion to provide closure of said capture component leading edge portion, and including a terminal assembly for simultaneously effecting the conduction of electrical energy to said leading edge portion.
__________
150173]21][11[
METHOD FOR PRODUCTION OF–פוספונומתילגליציןN להכנת שיטהN-PHOSPHONOMETHYLGLYCINE
]54[
22.12.2000]22[DE]33[23.12.1999]32[19962601.
4]31[
Int. Cl.8 C07F 009/00, 009/28, 009/38, 009/40, 009/50]51[BASF AKTIENGESELLSCHAFT, GERMANY
]71[
WO/2001/047938]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
]57 [A process for the preparation of N-phosphonomethylglycine, wherein
)a (a hexahydrotriazine derivative of the formula
June 3, 2007 764 –התשס"ז בסיון י"ז
in which X is CN, COOZ, CONR1R2 or CH2OY,Y is H or a radical which is readily exchangeable for H,Z is H, an alkali metal, alkaline earth metal, C1-C18-alkyl or aryl, which is
unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl,R1 and R2 can be identical or different and are H or C1-C4-alkyl, is reacted with a triacyl phosphate of the formula
P(OCOR3)3
in which the radicals R3, which can be identical or different, are C1-C18-alkyl or aryl, which is unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl, and
)b (the product obtained is hydrolyzed, and, if X is CH2OY, oxidized.Claimed as novel is the phosphono compound of the formula
in which the radicals R3, which can be identical or different, are C1-C18-alkyl or aryl which is unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl, andX is CN, COOZ, CONR1R2 or CH2OY,Y is H or a radical which is readily exchangeable for H:
Z is H, and alkali metal, alkaline earth metal, C1-C18-alkyl or aryl, which is unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl;
R1 and R2, which can be identical or different, are H or C1-C4-alkyl, or a salt thereof.
__________
June 3, 2007765 –התשס"ז בסיון י"ז
150177]21][11[
המגבירים הידרוקסיד משחררי אמצעיםהעור חדירות את
HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS
]54[
15.12.2000]22[US]33[16.12.1999]32[465098]31[US11.05.2000569889
June 3, 2007 766 –התשס"ז בסיון י"ז
US30.06.2000607892US14.12.2000738410US14.12.2000738395
Int. Cl.8 A61K 009/70, 047/02]51[DERMATRENDS, INC.]71[
WO/2001/043775]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
] 57 [Use of (a) a drug selected from the group consisting of amino acids, analgesic agents, anesthetic agents, anti-acne agents, antiarthritic agents, antiarrhythmic agents, antiasthmatic agents, antibiotic agents, anticancer agents, anticholinergic agents, anticonvulsant agents, antidepressant agents, antidiabetic agents, antidiarrheal agents, antifugal agents, antiglaucoma agents, antihelminthic agents, antihistamines, antihyperlipidemic agents, antihypertensive agents, antimigraine preparations, antinauseants, antineoplastic agents, antiparkinsonism drugs, antipruritic agents, antipsoriatic agents,antipsychotic agents, antipyretic agents, antispasmodic agents, antitubercular agents, antiulcer agents, antiviral agents, anxiolytic agents, appetite suppressants, attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD) drugs, beta-blockers, calcium channel blockers, central nervous system stimulants, decongestants, diuretics, fatty acids, genetic materials, herbal remedies, hormonolytics, hypnotic agents, hypoglycemic agents, immunosuppressive agents, leukotriene inhibitors, mitotic inhibitors, muscle relaxants, narcotic antagonists, nicotine, parasympatholytic agents, peptide drugs, psychostimulants, sedatives, steroids, sympathomimetics,
tranquilizers, vasodilators, vitamins, and combinations thereof, wherein the drug is
)i (a basic drug in the form of a free base,)ii (an acidic drug in the form of a free
acid,)iii (an acidic drug in the form of a basic
addition salt, or)iv (a nonionizable compound; and
)b (an amount of an inorganic hydroxide effective to enhance the flux of the drug through the body surface without causing damage thereto, wherein the inorganic hydroxide is selected from the group consisting of monovalent metal hydroxides, divalent metal hydroxides, and ammonium hydroxide wherein the amount of inorganic hydroxide in the formulation applied to the body surface is the total of (a) the amount required to neutralize any acidic species in the formulation plus (b) an amount equal to 0.5 wt.% to 4.0% of the formulation;
for the preparation of a pharmaceutical formulation suitable for topical or transdermal drug administration for administering the drug to a localized region of a human patient's body surface for enhancing the flux of a drug through a body surface, and wherein following application to the body surface, the formulation provides a pH at the interface between the body surface and the
June 3, 2007767 –התשס"ז בסיון י"ז
__________
150251]21][11[
SCREENING SYSTEM FORשינוע בתהליך פריטים בדיקת מערכתOBJECTS IN TRANSIT
]54[
16.06.2002]22[Int. Cl.8 B61J 001/02]51[
]SECURELOGIC LTD.]71בע"מ, נתניה ספייסלוג'יקצדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
]57 [An automated security inspection and conveying system for in-transit objects, comprising means for identifying the sender of each object and to profile the security status data of said sender into said system, and a plurality of various cargo security screening machines in combination with conveying and storing components, to route and track said objects from a reception point through said screening machines to reach a storing junction, via a user-adjustable screening process, said conveying and storing components being interfaced with said
security status data for assigning a risk assessment factor to object of said sender, whereby each object is routed via an appropriate number of screening devices, the output of said screening devices being processed and said risk assessment factor being adjusted accordingly, the new risk assessment factor being sent to a control system of said conveying and storing components, whereby object is accordingly diverted to a track leading to a "reject" bay, or to a track for further screening of doubtful object, or to a loading track for objects cleared for transportation.
__________
150301]21][11[
June 3, 2007 768 –התשס"ז בסיון י"ז
METHOD AND SYSTEM FORלבלב מחלות של לבקרה ושיטה מערכתMONITORING PANCREATIC PATHOLOGIES
]54[
07.01.2001]22[US]33[06.01.2000]32[60/174663]31[
Int. Cl.8 A61B 005/04]51[ YEDA RESEARCH ANDבע"מ, רחובות ופיתוח למחקר חברה ידע
DEVELOPMENT CO. LTD.]71[
מרגלית, ליאור כהן, רענן דגני, ירון הדסהברוקר
HADASSA DEGANI, IRUN COHEN, RAANAN MARGALIT, LIOR BRUKER
]72[
WO/2001/049161]87[ושות', וב ד"ר
, רחובות2189 , ת.ד. 2 רח' פקריס WEBB & ASSOCIATES,
2 PEKERIS STREET P.O.B. 2189 REHOVOT 76121
]74[
]57 [A method for monitoring a pancreatic pathology in a patient comprising the steps of: obtaining a first magnetic resonance image of an internal body organ using defined sequence parameters; injecting a contrast agent to the patient; obtaining a plurality of subsequent contrast enhancement images of the internal body organ using the defined sequence parameters; creating an intensity curve, by plotting intensity over time, from the
plurality of subsequent contrast enhancement images, converting the intensity curve to an enhancement curve, said enhancement curve having a linear portion and a plateau portion; extracting an enhancement value at plateau from the enhancement curve; and comparing the enhancement value at plateau to a standard, thereby monitoring the pancreatic pathology in the patient.
__________
150306]21][11[
לטיפול ושיטות פרוסטגלנדין תרכובותגברית זיקפה באי–תפקוד
PROSTAGLANDIN COMPOSITIONS AND METHODS OF TREATMENT FOR MALE ERECTILE DYSFUNCTION
]54[
10.01.2001]22[US]33[10.01.2000]32[09/480738]31[
Int. Cl.8 A61K 031/5575, A61P 015/10, C07C 405/00]51[NEXMED HOLDINGS, INC., U.S.A.]71[
WO/2001/051053]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
June 3, 2007769 –התשס"ז בסיון י"ז
]57 [Use of prostaglandin E1; a skin penetration enhancer which is a member of the group consisting of an alkyl-2-(N, N-disubstituted amino)-alkanoate, an (N, N-disubstituted amino)-alkanol alkanoate, pharmaceutically acceptable salts thereof and a mixture thereof; a polysaccharide gum or a polyacrylic acid polymer; a lipophilic compound which is a member of the group consisting of an aliphatic C1 to
C8 alcohol, an aliphatic C8 to C30 ester, and a mixture thereof; and an acidic buffer system for the preparation of a pharmaceutical composition for treating erectile dysfunction in a patient needing such treatment, whereby the pharmaceutical composition is to be supplied in the fossa navicularis of the patient.
__________
150403]21][11[
–4–2אלפא–) להכנת תהליך בוטילניטרון –טרט–Nדיסולפופניל(–
שלהם מקובלים רוקחות ומלחי
PROCESS FOR THE PREPARATION OF ALPHA-(2-4-DISULFOPHENYL)-N-TERT- BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
]54[
04.01.2001]22[SE]33[10.01.2000]32[0000055-4]31[
Int. Cl.8 C07C 303/02, 303/32, 309/46]51[ASTRAZENECA AB, SWEDENCENTAUR PHARMACEUTICALS,
]71[
June 3, 2007 770 –התשס"ז בסיון י"ז
INC., U.S.A.JORGEN BLIXT, HENRY KRUK, JOHN MCGINLEY, SERGEI POUHOV, JOHN VAJDA
]72[
WO/2001/051460]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A process for the preparation of a compound of the formula
wherein each R independently represents SO3H or a salt thereof, which process
involves reaction of an aldehyde of the formula
wherein R is as defined above, with N-tert-butylhydroxylammonium acetate in a liquid reaction solvent.
__________
150549]21][11[
בהזרקה להושטה רוקחות תכשירביפוספונאט המכיל
PHARMACEUTICAL PARENTERAL COMPOSITION CONTAINING A BIPHOSPHONATE
]54[
16.01.2001]22[EP]33[20.01.2000]32[00101044.
6]31[
Int. Cl.8 A61K 031/66, 031/675, A61P 019/00, C07F 009/00, 009/38, 009/572, 009/58, 009/6558
]51[
F. HOFFMANN-LA ROCHE AG, SWITZERLAND
]71[
June 3, 2007771 –התשס"ז בסיון י"ז
WO/2001/052859]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A parenteral composition having pH from about 6 to about 8 comprising (1) a bisphosphonate, selected from the group consisting of
)a (N-methyl-4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid,
)b (4-(N,N-dimethylamino)-1-hydroxybutylidene-1,1-bis-phosphonic acid,
)c (3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid (pamidronate),
)d (3-(N-methyl-N-pentyl) amino-1-hydroxypropane-1,1-bisphosphonic acid (ibandronic acid),
)e (3-(N-methyl-N-pentyl) amino-1-hydroxypropane-1,1-bisphosphonic acid, monosodium salt, monohydrate (ibandronate),
)f (1-hydroxy-3-(N-methyl-N-pentylamino) propylidene-1,1-bisphosphonic acid,
)g (1-hydroxy-2-[3-pyridinyl] ethylidene-1,1-bisphosphonic acid (risedronate),
)h (4-(hydroxymethylene-1,1-bisphosphonic acid) piperidine,
)i (cycloheptylaminomethylene-1,1-
bisphosphonic acid (cimadronate),
)j (1,1-dichloromethylene-1,1-diphosphonic acid and the disodium salt (clodronate),
)k (1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonic acid (EB-1053),
)l (1-hydroxyethane-1,1-diphosphonic acid (etidronic acid),
)m (6-amino-1-hydroxyhexylidene-1,1-bisphosphonic acid (neridronate),
)n (3-(dimethylamino)-1-hydroxypropylidene-1,1-bisphosphonic acid (olpadronate),
)o] (2-(2-pyridinyl) ethylidene-[1,1-bisphosphonic acid (piridronate),
)p) (4-chlorophenyl (thiomethane-1,1-diphosponic acid (tiludronate),
)q (1-hydroxy-2-(1H-imidazol-1-yl) ethylidene-1,1-bisphosphonic acid (zolendronate),
)r)] (cycloheptylamino-(methylene-[bisphosphonic acid (icadronate), and
)s] (1-hydroxy-2-imidazo-(1,2-a) pyridine-3-ylethylidene-[bisphosphonic acid and
pharmaceutically acceptable salts thereof;)2 (a pharmaceutically acceptable
chelating agent selected from EDTA and DTPA and pharmaceutically acceptable salt thereof; and
)3 (a pharmaceutically acceptable excipient.
__________
150560]21][11[
תרכובות של פולימרים נושאים מצעים קשורות קואורדינציה סנדוויץ צמודות
בהן לשימוש ותהליכים
SUBSTRATES CARRYING POLYMERS OF LINKED SANDWICH COORDINATION COMPOUNDS AND METHODS OF USE THEREOF
]54[
June 3, 2007 772 –התשס"ז בסיון י"ז
05.01.2001]22[US]33[14.01.2000]32[09/483500]31[US28.06.200009/605587
Int. Cl.8 C08F 026/06, G11C 013/00]51[NORTH CAROLINA STATE UNIVERSITY, U.S.A.
]71[
WO/2001/052266]87[ושותפיו, עו"פ, הס יצחק ד"ר
אביב , תל6451 , ת.ד. 279 הירקון רחוב DR. YITZHAK HESS & PARTNERS,
279 HAYARKON STREET P.O.B. 6451
TEL AVIV 61063
]74[
]57 [An apparatus for storing data, said apparatus comprising: a fixed electrode (103, 101) electrically coupled to a storage medium (102) having a plurality of different and distinguishable oxidation states wherein data is stored in said oxidation states by the addition or withdrawal of one or more electrons from said storage medium via the electrically
coupled electrode; said storage medium comprising a polymer; said polymer comprising a plurality of covalently joined monomeric units, each of said monomeric units comprising an independently selected sandwich coordination compound; and wherein said storage medium comprises a plurality of double-decker or triple-decker sandwich coordination compounds.
__________
150669]21][11[
תאי המכיל אלקטרוכימי בדיקה פסלשימושו ושיטות רבים תגובה
ELECTROCHEMICAL TEST STRIP HAVING A PLURALITY OF REACTION CHAMBERS AND METHODS FOR USING THE SAME
]54[
09.07.2002]22[Int. Cl.8 G01N 027/327]51[LIFESCAN, INC., U.S.A.]71[
June 3, 2007773 –התשס"ז בסיון י"ז
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [An electrochemical test strip (20) comprising:
)a (a plurality of reaction zones (22) defined by opposing working and reference electrodes separated by a spacer layer, wherein each of said reaction zones is defined by a bore through said spacer layer and further wherein each of said
reaction zones has its own fluid ingress channel to provide for fluid communication between said reaction zones and the external environment of said test strip; and
)b (a reagent composition present in each of said reaction zones.
__________
150811]21][11[
נצנוץ מבני לשיוור ושיטה מערכת ממוחשבת הדמיה עבור גבישיים
טומוגרפית
SYSTEM AND METHOD OF ALIGNING SCINTILLATOR CRYSTALLINE STRUCTURES FOR COMPUTED TOMOGRAPHY IMAGING
]54[
18.12.2001]22[US]33[19.12.2000]32[09/681067]31[
Int. Cl.8 G01T 001/00]51[GE MEDICAL SYSTEMS GLOBAL TECHNOLOGY COMPANY, LLC,
]71[
June 3, 2007 774 –התשס"ז בסיון י"ז
U.S.A.WO/2002/050569]87[
ושות', גבריאלי זליגסוןאביב , תל1426 , ת.ד. 31 רח' יבנה
SELIGSOHN GABRIELI & CO,. 31 YAVNE ST.
P.O.B. 1426 TEL AVIV 61013
]74[
]57 [A method of CT imaging comprising the steps of: providing a plurality of scintillators forming a scintillator array wherein each scintillator comprises a plurality of crystallites; aligning the crystallites of each scintillator in a uniform direction to receive high frequency electromagnetic energy from a projection
source; directing high frequency electromagnetic energy toward the scintillator array; converting the high frequency electromagnetic energy to light energy; transmitting signals indicative of light energy intensity to a data acquisition system; and generating a CT image from the transmitted signals.
__________
150855]21][11[
INTRATUBULAR ANASTOMOSISתוך–טובולרי אנסטומוזה מתקןAPPARATUS
]54[
22.07.2002]22[Int. Cl.8 A61B 017/11]51[
NITI MEDICAL TECHNOLOGIESבע"מ, נתניה רפואיות טכנולוגיות ניטיLTD.
]71[
ספנסר, מיכאל מונסביץ, בנימין לאונידנאמן ערד, רונן
LEONID MONASSEVITCH, BENJAMIN SPENSER, MICHAEL ARAD, RONEN NE'EMAN
]72[
ושות' בע"מ, מ. בן-דוד ירמיהו ,45087, ת.ד. חוצבים המרפא, הר רחוב
ירושלים
JEREMY M. BEN-DAVID & CO. LTD,.
HAR HOTZVIM HI-TECH PARK ,P.O. B. 45087 ,
JERUSALEM 91450
]74[
]57 [An intratubular anastomosis apparatus for joning organ portions of a hollow organ after intussusception thereof, said apparatus including:
)a (an anastomosis ring (50), and)b (a crimping support element (52) for use
therewith, wherein said anastomosis ring includes a length of a wire having a predetermined cross-sectional configuration and formed of a shape memory alloy defining a closed generally
circular shape, having a central opening, and having overlapping end portions, said anastomosis ring for crimping adjacent organ portions against said crimping support element so as to cause anastomosis therebetween, wherein said anastomosis ring and said shape memory alloy assume
)i (a plastic state, when at a first, lower temperature and
)ii (an elastic state, when reaching at least a second, higher temperature, thereby enabling said anastomosis ring to retain a
June 3, 2007775 –התשס"ז בסיון י"ז
preselected configuration at the first, lower temperature, and an elastic crimping configuration upon reverting to the second, higher temperature; and wherein said crimping support element for intratubular insertion so as to provide a support for crimping said organ portions against said support element, said crimping support element having
)i (a generally cylindrical side-wall (54);)ii (proximal and distal end walls formed
generally transversely to said side-wall,
thereby to define therewith said crimping support element;
)iii (a generally axial aperture (60) for providing flow communication therethrough; and
)iv (attachment means for operationally engaging said crimping support element to a crimping applicator member so as to position said crimping support element adjacent to said anastomosis ring for facilitating crimping of preselected wall portions of a hollow organ therebetween.
__________
150880]21][11[
ממכשיר שידור לשינוי ושיטה מערכתגופית תוך לחישה
SYSTEM AND METHOD FOR CHANGING TRANSMISSION FROM AN IN VIVO SENSING DEVICE
]54[
23.07.2002]22[US]33[23.07.2001]32[60/306872]31[
Int. Cl.8 A61B 005/05]51[]GIVEN IMAGING LTD.]71בע"מ, יקנעם אימג'ינג גיוון
June 3, 2007 776 –התשס"ז בסיון י"ז
ARKADY GLUKHOVSKY, BARUCHארליך ארקדי, ברוך גלוקחובסקיERLICH
]72[
דין, עורכי עורכי לצר צדק כהן פרלונוטריונים, פטנטים
, ת.ד.5 , רח' שנקר1 גב-ים מרכז , הרצליה12704
PEARL COHEN ZEDEK LATZER, 5 SHENKAR STREET ,
P.O.B. 12704 HERZLIYA 46733
]74[
]57 [A system for obtaining in vivo data, the system comprising: a swallowable capsule; and a receiving unit; said swallowable capsule comprising at least one in vivo sensor, or at least one signal transmitter and at least one power level
receiver to receive a command to adjust the power level of said at least one signal transmitter; and said receiving unit comprising at least one receiver and at least one power level transmitter.
__________
150888]21][11[
ידי על מזיקים חרקים לסילוק שיטהכימי אידוי
DEBUGGING METHOD OF EXPELLING HARMFUL INSECTS BY CHEMICAL VOLATILIZATION
]54[
30.01.2001]22[JP]33[13.04.2000]32[2000-
111596]31[
Int. Cl.8 A01N 025/18, 053/00, 061/00]51[FUMAKILLA LIMITED, JAPAN]71[WO/2001/078508]87[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A method for repelling or expelling a harmful or noxious insect comprising:
)a (providing a pyrethroid chemical, said pyrethroid chemical having the following characteristics:
)i (a higher vapour pressure than d,d-T80-prallethrin, determined when the
pyrethroid chemical is heated at 60 to 250˚ C, the retention time of the pyrethroid chemical in minutes being 24.5 to 26.4; and
)ii (a higher debugging potency than transfuluthrin, determined when the pyrethroid chemical is spontaneously volatilized for 70 days in a room having a volume of 33m3, the pyrethroid chemical having an average KT50 in minutes of 7.92 to 10.86; and
June 3, 2007777 –התשס"ז בסיון י"ז
)b (contacting the pyrethroid chemical with the harmful or noxious insect or a locus thereof.
__________
151000]21][11[
DEVICE FOR EXTRACTINGמרימונים מיץ שקיקי למיצוי התקןJUICE SACS FROM POMEGRANATES
]54[
31.07.2002]22[Int. Cl.8 A47J 019/02]51[
]ITZHAK GVILI]71גוילי, נתניה יצחקושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A device for extracting juice sacs from at least a portion of a pomegranate, comprising:
)a (a mallet having a mallet arm and a mallet head;
)b (a driving mechanism operatively connected to the mallet configured to position the mallet at one or more positions and to swing the mallet when the mallet is positioned at each of the one or more positions.
__________
151011]21][11[
June 3, 2007 778 –התשס"ז בסיון י"ז
FOREIGN BODY RETRIEVALזר גוף לשליפת התקןDEVICE
]54[
02.02.2001]22[US]33[02.02.2000]32[09/496482]31[
Int. Cl.8 A61B 017/50]51[BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, U.S.A.
]71[
WO/2001/056484]87[ דין, עורכי עורכי לצר צדק כהן פרל
ונוטריונים, פטנטים , ת.ד.5 , רח' שנקר1 גב-ים מרכז
, הרצליה12704
PEARL COHEN ZEDEK LATZER, 5 SHENKAR STREET ,
P.O.B. 12704 HERZLIYA 46733
]74[
]57 [A retrieval device comprising: a first catheter having a distal end, a proximal end, a lumen system configured to accept at least one wire such that the at least one wire may extend beyond either end of the first catheter, and an opening system through which a loop may be formed, the opening system positioned between the distal end and the proximal end, the lumen system having an opening separate from the opening system, the opening of the
lumen system configured to accept the at least one wire such that the at least one wire may extend beyond the distal end of the first catheter; and a wire having a distal end attached to the first catheter, and a proximal end; wherein the proximal end of the wire may be manipulated to cause a portion of the wire to form a loop external of the first catheter, the loop being capable of grasping foreign bodies within a patient.
June 3, 2007779 –התשס"ז בסיון י"ז
__________
151182]21][11[
ותנורים עמיד–בחום חומרבו המשתמשים גבוהי–טמפרטורה
HEAT-RESISTANT MATERIAL BASED ON SILICIDES AND HIGH-TEMPERATURE HEATERS USING SAID MATERIAL
]54[
30.01.2001]22[RU]33[17.02.2000]32[200010364
9]31[
Int. Cl.8 C04B 035/505, C22C 029/02, H05B 003/14]51[INSTITUT FIZIKI TVERDOGO TELA ROSSIISKOI AKADEMII NAUK, RUSSIA
]71[
BORIS ABRAMOVICH GNESIN, PAVEL ARTEMOVICH GURZGIYANTS
]72[
WO/2001/061421]87[בע"מ, פרידמן מרק ד"ר
אביב , תל7 שמואלוב, רח' האומנים בית DR. MARK FRIEDMAN LTD,.
BEIT SAMUELOFF, 7 HAOMANIM STREET,
TEL AVIV
]74[
]57 [A heat-resistant material comprising molybdenum and tungsten silicides Me5Si3
and MeSi2 and silicon carbide, characterized in that it comprises silicides in the form of solid solutions (Mo, W)5Si3,
(Mo, W)5Si3C and (Mo, W)Si2 with the following ratio of the components (in vol. %):
)Mo, W(5Si3 and/or (Mo, W)5Si3C 5-98,)Mo, W (Si2 2-95, the ratio of
molybdenum and tungsten in the total mass of the refractory metals in the heat-resistant material ranging within (in wt. %)Mo 2-90,W 10-98,the material comprising silicon carbide 0-
55 vol.%
__________
151212]21][11[
]FOAMED STARCH SHEET]54מוקצף עמילן גליון
14.02.2001]22[IT]33[15.02.2000]32[TO2000A000141]31[
Int. Cl.8 B32B 017/12, C08J 009/12, C08L 003/12]51[
June 3, 2007 780 –התשס"ז בסיון י"ז
NOVAMONT S.P.A., ITALY]71[WO/2001/060898]87[
לוצאטו, את לוצאטו , באר5352, ת.ד. תעשייה, עומר גן
שבע
LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER
P.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A foamed article, in particular in the form of a foamed sheet useful as a partly-finished product adapted to be further processed into a finished article of manufacture, comprising destructured or complexed starch foamed as a continuous phase, having a density lying between 20 and 150 kg/m3, cell dimensions in a range
lying between 20 and 700 μm with a cell distribution such that at least 80% of them have, in the absence of stretching, a dimension lying between 20 and 400 μm, in which the material from which the foam is made has an intrinsic viscosity in DMSO at 30˚ lying between 1.5 and 0.3 dl/g.
__________
151314]21][11[
ותכנתן להכנתן מיצלות, שיטותאותן המכילים רוקחות ותכשירי
MICELLES, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
]54[
20.02.2001]22[US]33[18.02.2000]32[60/183768]31[
Int. Cl.8 A61K 031/70, 038/00, A61P 043/00, C07D 407/12, C07F 009/00, 009/655, C07H 005/00, 019/00, 021/00
]51[
EISAI CO.,LTD., JAPAN]71[WO/2001/060382]87[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
]74[
June 3, 2007781 –התשס"ז בסיון י"ז
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]57 [A method for preparing at least one micelle comprising Compound (1), a pharmaceutically acceptable salt thereof, and/or a stereoisomer thereof, which method comprises: adding an amount of Compound (1), a pharmaceutically
acceptable salt thereof and/or a stereoisomer thereof to a first aqueous alkaline solution comprising at least one basic metal salt, at least one neutral salt, and a predetermined concentration of metal ion; wherein Compound (1) is:
thereby forming a second aqueous alkaline solution comprising at least one micelle having a preselected hydrodynamic diameter, wherein the at least one micelle
comprises Compound (1), a pharmaceutically acceptable salt thereof, and/or a stereoisomer thereof.
__________
151390]21][11[
סילאן, על המבוססים ציפויים הרכבי ושיטות מהם המופקים מצופים פריטיםבהם לשימוש
SILANE-BASED COATING COMPOSITIONS, COATED ARTICLES OBTAINED THEREFROM AND METHODS OF USING SAME
]54[
08.02.2001]22[US]33[28.02.2000]32[60/185354]31[US29.02.200060/185367US29.09.200060/236158
Int. Cl.8 C09D 183/06]51[ADSIL, LC, U.S.A.]71[
WO/2001/064804]87[
June 3, 2007 782 –התשס"ז בסיון י"ז
ושות', כהן שלמה ד"ראביב , תל11490 , ת.ד. 124 גבירול אבן
DR. SHLOMO COHEN & CO,. 124 IBN GABIROL ST,.
P.O.B. 11490 ,TEL AVIV 62038
]74[
]57 [An aqueous coating composition formed by admixing
)A (at least one silane of the formula
R1Si(OR2)3
wherein R1 is a C1-C6 alkyl group, a phenyl group or a functional group containing at least one of vinyl, acrylic, amino, mercapto, or vinyl chloride functional group; andR2 is a C1-C6 alkyl group;
)C (acid component comprising a member selected from the group consisting of water-soluble organic acids, H3BO3 and H3PO3; and
)D (water and further comprising a silane compound of the formula
X[R1Si(OR2)3]2
wherein R1 and R2 are as defined above, and X represents an amino group or keto group
O||
C >
__________
151586]21][11[
-PREPARATION OF 4,4'-DIKETO–קרוטןβ'–דיקטו–4,4 נגזרות הכנתΒ-CAROTENE DERIVATIVES
]54[
03.09.2002]22[US]33[13.09.2001]32[953007]31[
Int. Cl.8 C07C 403/24]51[DSM IP ASSETS B.V., THE NETHERLANDS
]71[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
]74[
June 3, 2007783 –התשס"ז בסיון י"ז
TEL AVIV 61040
]57 [A method of preparing 4,4'-diketo derivatives from β-carotene or β-carotene derivatives comprising contacting the β-carotene or β-carotene derivatives in an organic solvent with a solution of an oxidizing agent, wherein said oxidizing
agent is formed by mixing acidified aqueous solutions of the sodium or potassium salts of sulfite, hydrogen sulfite, or bisulfite solutions and sodium or potassium bromate solutions in water to produce 4,4'-diketo derivative products.
__________
151789]21][11[
CONTAINER FOR LINEZOLIDתוך–ורידית לינזוליד לתמיסת מיכלINTRAVENOUS SOLUTION
]54[
15.03.2001]22[US]33[22.03.2000]32[60/191383]31[
Int. Cl.8 A61J 001/00, A61L 002/16]51[PHARMACIA & UPJOHN COMPANY LLC, U.S.A.
]71[
WO/2001/070170]87[צדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688, HERZLIYA 46733
]74[
] 57 [A container containing an IV aqueous solution of a Gram-positive oxazolidinone agent, wherein the container
surface that contacts the solution is made of at least 50% polyolefin.
מבקשה חלוקה בקשותפורסמו. שטרם זו
181368,The applications for division from this application have not yet been published
__________
151825]21][11[
OXYGEN REDUCED NIOBIUMחמצן מופחתות הניוביום תחמוצותOXIDES
]54[
22.03.2001]22[US]33[23.03.2000]32[09/533430]31[US01.09.200060/229668US11.01.200109/758705
Int. Cl.8 G01G 001/02, H01G 009/04]51[CABOT CORPORATION, U.S.A.]71[
WO/2001/071738]87[
June 3, 2007 784 –התשס"ז בסיון י"ז
ושות', גבריאלי זליגסוןאביב , תל1426 , ת.ד. 31 רח' יבנה
SELIGSOHN GABRIELI & CO,. 31 YAVNE ST.
P.O.B. 1426 TEL AVIV 61013
]74[
]57 [The method of forming an anode comprising the steps of pressing a mixture of niobium oxide powder with at least one binder or lubricant to form the pressed
anode, wherein the niobium oxide has an atomic ratio of niobium to oxygen of 1:less than 2.5.
__________
151953]21][11[
ACCESSORY MOUNT FOR Aנשק כלי עבור אביזרים מחברFIREARM
]54[
26.09.2002]22[Int. Cl.8 F41A 029/00]51[
]T.D.I. ARMS SYSTEMS LTD.]71בע"מ, יבנה נשק טי.די.אי. מערכותושות', בלום, גדור עו"ד גדור דבורה
, גבעתיים23 , קומה53 השלום דרך DEBORAH GADOR, BLUM,
GADOR & CO,. 53 DERECH HASHALOM
23 RD FLOORGIVATAYIM 53454
]74[
]57 [An accessory mount for a hand held firearm having a barrel and a mounting rail coupled beneath the barrel, the accessory mount comprising: a frame, defining a substantially flattened bottom surface, and a track for mounting along the mounting
rail, the frame having a cavity for receiving a light, and a bipod mount coupled adjacent the track and behind the light cavity and arranged to hold a bipod having legs which can be folded substantially adjacent the barrel.
June 3, 2007785 –התשס"ז בסיון י"ז
__________
152305]21][11[
ושיטה מחוזק רב–שכבתי אריגלהכנתו
REINFORCED MULTILAYER FABRIC AND METHOD OF PREPARATION
]54[
12.04.2001]22[IT]33[17.04.2000]32[MI2000A000860]31[
Int. Cl.8 B32B 005/08, D04H 003/04, F41H 005/04]51[F. LLI CITTERIO S.P.A., ITALY]71[WO/2001/078975]87[
לוצאטו, את לוצאטו , באר5352, ת.ד. תעשייה, עומר גן
שבע
LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER
P.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A finished reinforced multilayer fabric (18), comprising at least a first layer (12) of threads (13) parallel with each other, superimposed on at least one second layer (12) of threads also parallel with each other, the threads of said first layer being set in various directions as regards the threads of the second layer; a binding layer (14) interposed between said first and second layer to keep said layers together
and to prevent one layer sliding over the other, wherein the binding layer impregnates only a portion of a single thread which is placed on the upper layer and next to each thread of the lower layer, the remaining portion of said threads are made up of fibrils which are impregnated with a resin matrix which keeps said fibrils firmly together.
__________
June 3, 2007 786 –התשס"ז בסיון י"ז
152333]21][11[
]COATING COMPOSITION]54לציפוי תכשיר
20.04.2001]22[AU]33[20.04.2000]32[PQ7079]31[
Int. Cl.8 C09D 005/00, 007/12]51[WORLDWIDE THERMAL MANAGEMENT IP PTY LTD., AUSTRALIAWORLDWIDE FIRE RETARDANT IP PTY LTD., AUSTRALIAWORLDWIDE COATINGS IP PTY LTD, AUSTRALIA
]71[
WO/2001/081482]87[צדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
]57 [A coating composition comprising)i (a supporting medium, and
)ii (a plurality of cellulose particles, having an average dry particle size of less than 10
μm, dispersed in the supporting medium in an amount of less than about 10 g/L, excluding aqueous coating compositions adapted for application to paper.
__________
152972]21][11[
]FULL-CALIBER PROJECTILE]54מלא קוטר בעל קליע
20.11.2002]22[DE]33[23.11.2001]32[10157563.
7]31[
Int. Cl.8 F42B 014/00]51[RHEINMETALL W & M GMBH, GERMANY
]71[
צדק, וכהן איתן, פרל, לצר, הרצליה12688 , ת.ד. 7 שנקר רחוב
EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
]57 [A full-caliber projectile (1) comprising: a projectile body having a cylindrical guide region (5) and an ogival
projectile tip (7), connected to a front end of the guide region; a cylindrical guide ring (8), which is divided at its
June 3, 2007787 –התשס"ז בסיון י"ז
circumference into at least two shell-like guide-ring segments (9), mounted on an outer surface of the projectile tip, with an outer diameter of the ring being smaller than an inner diameter of a gun barrel (2) of the same caliber as the projectile; and means (10) securing the guide ring to the outer surface of the projectile tip such that the guide-ring segments detach from the
projectile and move rapidly outwardly when a predetermined firing acceleration is attained in the corresponding gun barrel, so that the guide-ring segments are pushed rearwardly toward the cylindrical guide region of the projectile in an axial direction until the guide ring segments rest against the inside wall of the gun barrel and against the projectile.
__________
153136]21][11[
]PIPE REPAIR CLAMP]54צינורות תיקון חבק
27.11.2002]22[Int. Cl.8 F16L 021/06]51[
KRAUSZ METAL INDUSTRIESאביב בע"מ, תל מתכת תעשיות קראוסLTD.
]71[
ELIEZER KRAUSZ, AVIצ'יפרוט קראוס, אבי אליעזרCHIPROOT
]72[
צדק, וכהן איתן, פרל, לצר, הרצליה12688 , ת.ד. 7 שנקר רחוב
EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
June 3, 2007 788 –התשס"ז בסיון י"ז
]57 [A wide-range pipe repair clamp (10) for temporary or permanent repair of pipes (12, 12') comprising:
)a (a metal clamping band (14) to surround said pipe, said band being extended at both ends to form a hollow shape (16) including a flat base (18), a wedge-shaped section (20) and a convex rounded section (22), elongated apertures (24) being provided to allow passage for screw fasteners (26) through said hollow shape, narrow edges of said wedge-shaped sections being in contact with each other to form a substantially triangularly shaped space (28) between said formed ends;
)b (a flexible inner sealing sleeve (30) disposed inside said clamping band;
)c (a pair of profile strips (32) each having a major face for contacting the outer
surface of said convex rounded section, and an opposite seating face for shoulder support of a plurality of screw fasteners, said strips having apertures (40) to allow passage of said fasteners, said profile strips sliding over said convex rounded section when said fasteners are tightened or loosened to maintain said seating face perpendicular to the axes of said fasteners; and
)d (said plurality of screw fasteners inserted into said apertures wherein the tightening of said screw fasteners reduces the size of said triangularly shaped space and tightens said metal clamping band to compress said flexible inner sleeve sealingly against the outer diameter of said pipes.
__________
153892]21][11[
KIT FOR MOISTURIZING THEהעין שטח פני של הליחלוח עבור ערכהSURFACE OF THE EYE
]54[
06.07.2001]22[US]33[12.07.2000]32[09/614790]31[US30.03.200109/823385
June 3, 2007789 –התשס"ז בסיון י"ז
Int. Cl.8 A61K 009/00, A61P 027/02, C07D 311/00]51[ROGUE VALLEY NATURAL SPRINGS, INC., U.S.A.
]71[
WO/2002/003924]87[ושותפיו, עו"פ, הס יצחק ד"ר
אביב , תל6451 , ת.ד. 279 הירקון רחוב DR. YITZHAK HESS & PARTNERS,
279 HAYARKON STREET P.O.B. 6451
TEL AVIV 61063
]74[
]57 [A kit for moisturizing the surface of the eye comprising a sealed container, an aqueous fluid within said container, and an
actuator that sprays a mist of said fluid from said container.
__________
154133]21][11[
COMPRESSOR COOLER AND ITSהרכבתו ותהליך מדחס מקררASSEMBLY PROCEDURE
]54[
26.01.2003]22[NL]33[29.01.2002]32[1019858]31[
Int. Cl.8 F04B 017/04]51[THALES NEDERLAND B.V., THE NETHERLANDS
]71[
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [Assembly procedure of a cooler compressor comprising the following steps:
coating at least one piston with a material; placing each piston in a cylinder; and raising the temperature to a predetermined
temperature so that the coated piston expands to occupy substantially all the cylinder; wherein each piston is fixed in the cylinder in this position until the temperature returns to ambient temperature.
June 3, 2007 790 –התשס"ז בסיון י"ז
__________
154303]21][11[
סוספנסיה תרכיז להכנת רציף תהליך תכשיר בצורת עשבים קוטלת מימית
יציב
CONTINUOUS PROCESS FOR THE PREPARATION OF A STABLE HERBICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITION
]54[
24.08.2001]22[US]33[25.08.2000]32[60/228316]31[
Int. Cl.8 A01N 025/04, 033/18]51[BASF AKTIENGESELLSCHAFT, GERMANY
]71[
WO/2002/015690]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
June 3, 2007791 –התשס"ז בסיון י"ז
]57 [A process for the preparation of a stable aqueous suspension concentrate composition which comprises mixing a molten pendimethalin stream having a temperature of about 57˚ to 75˚C with an
aqueous stream containing coformulants plus seed crystals of orange pendimethalin, said aqueous stream having a temperature of about -3˚C to 5˚C.
__________
154360]21][11[
גז התרחבות אנרגיות של לשימוש שיטהזו שיטה לממש כח במתקן ושימוש
METHOD FOR UTILIZATION OF GAS EXPANSION ENERGY AND UTILIZATION OF POWER INSTALLATION FOR IMPLEMENTATION OF THIS METHOD
]54[
15.08.2001]22[RU]33[16.08.2000]32[200012136
1]31[
Int. Cl.8 F02C 001/02, F25B 011/02]51[ALLA PAVLOVNA TUZOVA, RUSSIA
]71[
VLADIMIR YAROSLAVOVICH VASILEV, OLEG MICHAILOVICH KISELEV
]72[
WO/2002/014662]87[בע"מ, פרידמן מרק ד"ר
אביב , תל7 שמואלוב, רח' האומנים בית DR. MARK FRIEDMAN LTD,.
BEIT SAMUELOFF, 7 HAOMANIM STREET,
TEL AVIV
]74[
]57 [Method of utilization of the natural gas expansion energy during the process of reduction of gas pressure from high to the required one by conversion of natural gas expansion energy to mechanical energy with the aid of the gas cooled down in the process of pressure reduction as a cooling
agent characterized in that natural gas pressure is reduced in two or more successive stages (1, 2) simultaneously, wherein at least a part of natural gas after the first and/or each successive stage of natural gas pressure drop is used as a cooling agent for generation of cold.
June 3, 2007 792 –התשס"ז בסיון י"ז
__________
154569]21][11[
טורבינת למערכת אוויר לסינון שיטותגז
METHODS FOR FILTERING AIR FOR A GAS TURBINE SYSTEM
]54[
10.08.2001]22[US]33[05.09.2000]32[60/230138]31[US31.05.200109/871169
Int. Cl.8 B01D 039/16, 046/24, 046/52]51[DONALDSON COMPANY, INC., U.S.A.
]71[
WO/2002/020134]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A filter structure for filtering air in a gas turbine intake system, the turbine operating at an intake air demand greater than 8000 cu.ft./min. the intake air having an ambient temperature and a humidity of at least 50% RH, the structure comprising, in an air intake of a gas turbine system, at least one filter element (242), the filter element having a media pack (260, 262) forming a tubular construction defining a open filter interior (268, 276), the open filter interior being a clean air plenum, the
media pack including a pleated construction of a media composite, the media composite including a substrate at least partially covered by a layer of fine fibers, the fine fibers comprising a polymeric composition comprising an addition polymer or a condensation polymer other than a copolymer formed from a cyclic lactam and a C6-10 diamine monomer or a C6-10 diacid monomer combined with an additive material.
June 3, 2007793 –התשס"ז בסיון י"ז
__________
154570]21][11[
שכבות יותר או שתיים בעל מסנן מבנה שימושי חיים אורך בעל עדין סיב של
משופר
FILTER STRUCTURE WITH TWO OR MORE LAYERS OF FINE FIBER HAVING EXTENDED USEFUL SERVICE LIFE
]54[
21.08.2001]22[US]33[05.09.2000]32[60/230138]31[US31.05.200109/871156
Int. Cl.8 B01D 039/00, 046/12]51[DONALDSON COMPANY, INC., U.S.A.
]71[
WO/2002/020130]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A fine filter media comprising a single layer of filter substrate, the substrate having a first surface and a second surface,
the substrate having a permeability of about 0.03 to 15 m/sec and an efficiency greater than 10%, the first surface and the second surface each comprising a layer of fine fiber having a diameter of about 0.001
to 0.5 microns, the layer of fine fiber having a thickness of less than 5 microns, the layer of fine fiber formed in an amount effective to obtain a pore size of about 0.0001 to 5 microns, an overall efficiency under ASTM-1215-89 with monodisperse 0.78 micron polystyrene latex particles at 6.1 m/min velocity of about 50% to 90% in any one layer and to obtain an efficiency
June 3, 2007 794 –התשס"ז בסיון י"ז
of greater than 90% in the layers combined.
__________
154653]21][11[
מפולימרים סטריליים פריטים הכנת פולי על המבוסס מייצב המכילים
)אוקסיאלקילין(
PREPARATION OF STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE)
]54[
30.08.2001]22[US]33[01.09.2000]32[09/654359]31[
Int. Cl.8 A61L 002/14, C08K 005/12]51[OCCIDENTAL CHEMICAL CORPORATION, U.S.A.
]71[
WO/2002/017972]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A method of preparing a sterile article comprising:
)A (preparing a polymer having a halogen-containing repeating unit, where said polymer contains about 0.005 to about 65 phr (as defined in the specification) of a stabilizer having the general formula TGOT', where each T is independently selected from R-, R-CO-, -P(OR)2, -Si(OR)3 or –Si(OR)3, T' is T or A[GOT]n, each A is independently selected from LS-Sn(R)3-q(SLJ)q, L-O-Sn(R)3-q (OLJ)q, (CH2)pS-Sn(R)3-q(S(CH2)p-J)q, LCO2SN(R)3-q(OLCO-J)q, or LSn(Y)3-
q(LJ)q when n is 0, from CO, E ,
CO-E-CO, Si(R)2, Si(OR)2, (Si(R)2G)r, (CO-E-CO-G)r, or (E-G)r when n is 1, and from P, PO, and trimellitate when n is 2, Y
is –SLJ, -SLOR, -OLJ, -OLR, -S(CH2)p-J, -S(CH2)pR, OLCO-J, or OLCOOR, G is (O-CH2-R'CH)n, J is O-(CH2CR'HO)T, L is CO(CH2)p, each R is independently selected from R', aralkyl from C6 to C12, and alkaryl from C6 to C12 each R' is independently selected from hydrogen, alkyl from C1 to C12 and aryl from C6 to C12, E is alkylene from C1 to C12, aralkylene from C6 to C12, alkarylene from C6 to C12, arylene from C6 to C12, m is 1 to
20 ,n is 0 to 2, p is 0 to 10, q is 0 to 3 and r is 1 to 20;
)B (making said article from said polymer; and
)C (sterilizing said article with ionizing radiation.
June 3, 2007795 –התשס"ז בסיון י"ז
__________
154957]21][11[
אטומים למצנחים גמישה חיבור מערכתאחרים בטיחות ומתקני מהסביבה
FLEXIBLE LINKAGE SYSTEM FOR ENVIRONMENTALLY SEALED PARACHUTES AND OTHER SAFETY DEVICES
]54[
June 3, 2007 796 –התשס"ז בסיון י"ז
21.09.2001]22[US]33[22.09.2000]32[09/667678]31[
Int. Cl.8 B64D 017/40]51[SIMULA, INC., U.S.A.]71[
WO/2002/024528]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A flexible linkage system for removably connecting an environmentally sealed apparatus (40) to an external apparatus, said flexible linkage system comprising:
)a (a flexible internal link (10) attachable at a first end to the environmentally sealed apparatus, said flexible internal link comprising an internal loop at a second end; and
)b (a flexible external link (20) comprising an external loop (23) at a third end and a removable fastener (24) anchored to a mid-section of the external link, wherein said flexible external link is attachable to the external apparatus at a fourth end, and wherein the external loop is routed through the internal loop and removably connected to the removable fastener.
__________
155006]21][11[
יעילות בעלי פולימריים הרכביםלאופרוליד למתן משופרת
POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY
]54[
21.09.2001]22[June 3, 2007797 –התשס"ז בסיון י"ז
US]33[21.09.2000]32[09/666174]31[US13.11.200009/711758
Int. Cl.8 A61K 009/00, 038/09, 047/34]51[QLT USA, INC., U.S.A.]71[
WO/2002/030393]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A flowable composition suitable for use as a controlled release implant, the composition comprising: (a) a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid; (b) a biocompatible polar aprotic solvent
selected from the group consisting of an amide, an ester, a carbonate, a ketone, an ether, and a sulfonyl; wherein the biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid; and (c) leuprolide acetate.
__________
155138]21][11[
GEL TRAP FORאלקטרופורזיס עבור ג'ל מלכודתELECTROPHORESIS
]54[
29.10.2001]22[IL]33[02.11.2000]32[139446]31[IL02.11.2000139447
Int. Cl.8 G01N 027/447]51[]GENE BIO-APPLICATION LTD.]71בע"מ בביולוגיה יישומים גן
WO/2002/037093]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [Apparatus for electrophoresis comprising a suitable housing (100) accommodating a first gel matrix (38) adapted for performing an electrophoretic process on at least one sample of interest therein in a first direction, characterized in comprising at least a first trap (90) comprising a second gel matrix (48) having at least one suitable absorption material capable of trapping and retaining
therein at least one target substance migrating thereto from the first gel matrix in an opposite direction to said first direction when an electrophoretic process is performed in said first matrix in said first direction, wherein said first gel matrix is in ionic communication with said second gel matrix, and wherein said target substance is different from said at least one sample of interest.
June 3, 2007 798 –התשס"ז בסיון י"ז
__________
155357]21][11[
]LOADING MEMBER]54העמסה יחידת
13.11.2001]22[DK]33[13.11.2000]32[PA200001694]31[
Int. Cl.8 B65D 019/40, 071/00, B65G 001/00]51[INTER IKEA SYSTEMS B.V., THE NETHERLANDS
]71[
WO/2002/038471]87[וגולר, וולף, ברגמן
,1352ב' , ת.ד. 19 היסוד קרן רחוב ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
]57 [A loading member (7), which is adapted to be handled by a fork lift truck, which further has a substantially L-shaped cross section and which jointly with a corresponding loading member may be arranged at the bottom of a box (3), each member being provided at one of two respective parallel lower edges (3a, 3b) of
the box and retained in close abutment with the box by means of circumferential straps (5) or packaging film, whereby the members may form the feet of the box, one web (2) of the L-section being provided with at least two pressed hollow projections (7', 7'', 7''') on the surface intended to face a supporting surface of the
June 3, 2007799 –התשס"ז בסיון י"ז
loading member, characterized in that the two outermost of these projections (7', 7''), which are arranged in one row, have an interspacing of at least half the length of the member and a width being less than or equal to half the width of the web and
further that the projections substantially abut the edge (4), at which the web (2, 6) of the L-section converge, and that the interspacing between the projections is such as to allow the insertion therebetween of forks of a fork-lift truck.
__________
155372]21][11[
מידע לרכישת פריפריאלי מכשיר להכנת אישי, במיוחד ביומטריומזהים מסמכים
PERIPHERAL DEVICE FOR ACQUIRING BIOMETRIC AND PERSONAL DATA, PARTICULARLY FOR PREPARING RECOGNITION DOCUMENTS
]54[
11.10.2001]22[IT]33[16.10.2000]32[RM2000A000549]31[IT29.01.2001RM2001U000012
Int. Cl.8 G07C 009/00]51[ITALDATA INGEGNERIA DELL'IDEA S.P.A., ITALY
]71[
WO/2002/033664]87[לוצאטו, את לוצאטו
, באר5352, ת.ד. תעשייה, עומר גן שבע
LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER
P.O.B. 5352BEER-SHEVA 84152
]74[
]57 [Peripheral device for acquiring biomertric and personal data, which, in particular, acts as an interface device with a main computer for the preparation of recognition documents such as identity cards, comprising, in a single casing: a smart card reader/writer device (20); a first
video camera (3) for the live photography of a person requesting the document; an external lighting unit (63) adjacent to the first video camera; a second video camera (4), acting as a scanner, located inside the casing, for the acquisition of personal characteristics shown on a backing card for
June 3, 2007 800 –התשס"ז בסיון י"ז
video digitization, which can be inserted into a guide and support frame in front of the second camera, through an entry slot formed in the casing; an internal lighting unit (69) adjacent to the second video camera, for illuminating the backing card; a video source switch (65), for switching the signals from the first video camera and the second video camera; a power supply unit (60) operated by a switch (61) and
connected to a distributor of power (6) to the first and second video cameras; one USB data connector (1) for the connection to the main computer; characterized in that: said video source switch receives signals from said first video camera and said second video camera, said signals are sent to said USB data connector through a video digitizer (7).
__________
155408]21][11[
DUAL-STAGE FILTRATIONדו–שלבית סינון מחסניתCARTRIDGE
]54[
30.10.2001]22[US]33[30.10.2000]32[60/244317]31[US02.01.200160/259889
Int. Cl.8 A61M 001/34, B01D 061/14, 063/00]51[NEPHROS, INC., U.S.A.]71[
WO/2002/036246]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [In a blood dialysis system including a source of substitution fluid and a blood
dialysis machine, a hemodiafiltration cartridge (10) comprising: a housing (12) including a blood inlet (20) which receives blood, a blood outlet (60) which discharges
June 3, 2007801 –התשס"ז בסיון י"ז
diafiltered blood, a dialysate inlet (12) for receiving a dialysate fluid and a dialysate outlet (64) for discharging the dialysate fluid, the housing further including a plurality of semi-permeable filtering elements; a member for dividing the housing into a first hemodiafiltration stage (14) and a second hemodiafiltration stage (16) a first portion of the plurality of semi-permeable filtering elements being associated with the first stage and a second portion of the plurality of semi-permeable filtering elements being associated with the second stage, the blood inlet being in fluid communication only with the first stage, while the blood outlet is in fluid communication only with the second stage;
and an inter-stage section for providing fluid communication between the first and second stages, the inter-stage section including an inlet for receiving a substitution fluid, wherein blood entering the blood inlet is partially diafiltered as it flows within the semi-permeable filtering elements of the first stage before being discharged into the inter-stage section where it is mixed with substitution fluid to form a blood/substitution mixture which then flows within the semi-permeable filtering elements of the second stage where further diafiltration occurs, wherein the housing includes only one dialysate fluid compartment that is common to both the first and second stages.
__________
155700]21][11[
]CONTAINER AND CONTAINER ]54למיכל ואביזר מיכלJune 3, 2007 802 –התשס"ז בסיון י"ז
ACCESSORY
21.11.2001]22[GB]33[06.12.2000]32[0029752.3]31[GB10.08.20010119484.4GB28.08.20010120767.9
Int. Cl.8 B65D 023/08, 077/04]51[ELI LILLY AND COMPANY, U.S.A.]71[
WO/2002/064438]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A protective container (1) for housing a fragile article (100) comprising: a container portion (3) and a base portion (5), said container portion comprising: an upper end, a lower end, and a generally cylindrical side surface extending lengthwise along a longitudinal axis from said upper end to said lower end, said cylindrical side surface forming a cavity therein for housing the fragile article, wherein said cylindrical side surface comprises an inner wall surface and an outer wall surface, said inner wall surface comprising a configuration of inner wall ribs and inner wall depressions, said outer wall surface comprising a configuration of
outer wall ribs (37) and outer wall depressions (39), wherein said outer wall depressions correspond with said inner wall ribs and said outer wall ribs correspond with said inner wall depressions, and wherein said container portion further comprises an upper end collar (45) and a lower end collar (47), both extending laterally beyond the outer wall ribs; wherein each collar is adapted to absorb impact energy in the event of an impact thereon to protect the fragile article from breakage; and wherein said base portion is releasably securable to said container portion.
June 3, 2007803 –התשס"ז בסיון י"ז
__________
155711]21][11[
תרתיל של ופליטה להוצאה מכשירירי מכלי כדור של
DEVICE FOR EXTRACTING AND EJECTING A CARTRIDGE CASE AWAY FROM A FIREARM
]54[
01.05.2003]22[IT]33[13.05.2002]32[MI2002A001016]31[
Int. Cl.8 F41A 015/12]51[FABBRICA D'ARMI PIETRO BERETTA S.P.A., ITALY
]71[
לוצאטו, את לוצאטו , באר5352, ת.ד. תעשייה, עומר גן
שבע
LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER
P.O.B. 5352BEER-SHEVA 84152
]74[
]57 [Device for extracting and ejecting a cartridge case in a firearm applied to a breechblock equipped with windows (17) on opposite sides, characterized in that it comprises an extraction element (19), equipped with an engagement means (28) suitable for holding a cartridge case (15), and an ejector element (20), equipped with a thrusting plane (33) suitable for taking
away said cartridge case from the firearm through one of said windows, as well as in that it comprises a removable retainer element (27) of said extraction and ejector element, said extraction and ejector elements being housed equally effectively on opposite sides of a breechblock (12) in seats (18).
June 3, 2007 804 –התשס"ז בסיון י"ז
_________
156103]21][11[
VALVE MECHANISM FORנוזלים עירוי למערכות שסתום מנגנוןINFUSION FLUID SYSTEMS
]54[
07.12.2001]22[US]33[08.12.2000]32[60/254230]31[
Int. Cl.8 A61L 002/24, B01D 012/00, 017/12, 061/24]51[NEPHROS, INC., U.S.A.]71[
WO/2002/045813]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A method of ensuring sterility and preventing contamination of a first fluid delivered through a first conduit (90) from a supply source that contains fresh, unused fluid to a point of use, wherein the first fluid is filtered before the point of use to produce sterile first fluid, the method comprising: disposing valve mechanism (110) along the first conduit, the valve mechanism being positionable between an open position in which the first fluid flows through the first conduit to the point of use and a closed position in which the first fluid is prevented from flowing through the valve mechanism to the point of use; sensing a first flow pressure of the fresh, unused first fluid in the first conduit at a location upstream of the valve mechanism; combining the first fluid with a second fluid to form a third fluid at a location
downstream of the valve mechanism; opening the valve mechanism when the first flow pressure exceeds a reference flow pressure by a predetermined value; and closing the valve mechanism under a preselected condition to prevent the first fluid from flowing to the point of use, the closing of the valve mechanism also preventing retrograde flow of the second and third fluids from the point of use to a location upstream of the valve mechanism, thereby ensuring that the first fluid is sterile and substantially free of contamination, wherein the fluid in the first conduit is divided into a first stream that delivers fresh, unused first fluid to a location where the first fluid is filtered and a second stream that delivers the first fluid directly to the point of use and the valve mechanism is disposed along the first
June 3, 2007805 –התשס"ז בסיון י"ז
stream of the first conduit between a location where the first fluid is filtered and the point of use of the sterile first fluid such that the valve mechanism acts on and
controls flow of the sterile first fluid in the first conduit downstream of the location where the first fluid is filtered.
__________
156952]21][11[
FOLDABLE PUSHCHAIR FORתינוקות עבור מתקפלת טיול עגלתBABIES
]54[
16.07.2003]22[ES]33[10.09.2002]32[20020218
9]31[
Int. Cl.8 B62B 007/06]51[JANE, S.A., SPAIN]71[
ושותפיו, עו"פ, הס יצחק ד"ראביב , תל6451 , ת.ד. 279 הירקון רחוב
DR. YITZHAK HESS & PARTNERS, 279 HAYARKON STREET
P.O.B. 6451 TEL AVIV 61063
]74[
June 3, 2007 806 –התשס"ז בסיון י"ז
]57 [A foldable pushchair for babies comprising: a central front wheel (1) being a castoring wheel, and a footrest (5) being formed by a plate, wherein said footrest is linked by a pin-jointed connection to a lower portion of converging front legs (3, 4) by a cross pin (8), said footrest comprising: a rearward portion of said footrest defining two recesses (6), the front legs being fitted to said recesses by the
cross-pin, an extension (9) provided with a cylindrical bore at a forward portion of said footrest to fit a fork (12) to which the castoring wheel is fitted, and means (15) for locking the footrest in a position when in use and allowing for folding said footrest, said means being gripped to a plate (26) being fixed to the lower portion of the front legs.
__________
157258]21][11[
METHOD FOR REMOVING Aממעטפתו כבל מרכז להסרת שיטהCABLE CORE FROM A CABLE SHEATH
]54[
20.02.2002]22[AT]33[20.02.2001]32[PCT/AT01/00041]31[AT28.06.2001A 1010/2001
Int. Cl.8 H01B 015/00, H02G 001/08]51[ALOIS PICHLER, AUSTRIA]71[WO/2002/067397]87[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
]57 [A method for removing a cable core from a cable sheath of a cable, which cable core comprises an envelope, wherein, at an end of the cable – the so-called proximal
cable end – a flowable medium is introduced under pressure into the cable tube so as to reduce friction,and a tensile
June 3, 2007807 –התשס"ז בסיון י"ז
force is exerted on the cable core at an end of the cable, characterized in that the flowable medium is introduced precisely
targeted into an annular space between the inner side of the cable sheath and the envelope of the cable core.
__________
157290]21][11[
CHEMICAL MECHANICALפנים שטח וגימור מכני כימי עיבודMACHINING AND SURFACE FINISHING
]54[
07.02.2002]22[US]33[08.02.2001]32[60/267756]31[
Int. Cl.8 B24B 037/04]51[REM TECHNOLOGIES, INC., U.S.A.]71[
WO/2002/062528]87[צדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
]57 [A process comprising:)a (providing a tool;
)b (introducing an active chemistry onto a workpiece, the active chemistry being capable of reacting with the workpiece to form a conversion coating on the workpiece, the conversion coating being insoluble in the active chemistry such that the conversion coating protects the workpiece from further reaction; and
)c (contacting the tool with the workpiece with a relative motion therebetween, until a desired surface property of the workpiece is reached; wherein the contact between the tool and the workpiece removes the conversion coating from the workpiece, thereby exposing the workpiece to further reaction with the active chemistry such that the conversion coating is allowed to re-form on the workpiece.
June 3, 2007 808 –התשס"ז בסיון י"ז
__________
157506]21][11[
דיאלקטריות שכבות לייצור שיטה נמוך, עבור דיאלקטרי מקדם בעלות
בעלות סיליקון, שהן שבבי על מוליכיםנמוכה פגמים וצפיפות משופרת אדהזיה
METHOD OF FABRICATING LOW-DIELECTRIC CONSTANT INTERLEVEL DIELECTRIC FILMS FOR BEOL INTERCONNECTS WITH ENHANCED ADHESION AND LOW-DEFECT DENSITY
]54[
19.02.2002]22[US]33[21.02.2001]32[09/789422]31[
Int. Cl.8 H01L 021/312]51[IBM CORPORATION, U.S.A.]71[
WO/2002/069381]87[יבמ, מעבדות
הכרמל, חיפה הר חיפה אוניברסיטת IBM LABORATORIES,
HAIFA UNIVERSITYHAIFA 31905
]74[
]57 [A method of fabricating an integrated circuit comprising the steps of: (a) applying a silane coupling agent containing at least one polymerizable group to a surface of a substrate to provide a substantially uniform coating of said silane-coupling agent on said substrate; (b) heating said substrate containing said coating of said silane-coupling agent at a
temperature of about 90º or above to provide a modified surface layer to said substrate containing Si—O bonds, said modified surface layer having a greater water contact angle than a non-heated substrate containing a coating of said silane-coupling agent; (c) rinsing said heated substrate with a suitable solvent that is effective in removing any unreacted
June 3, 2007809 –התשס"ז בסיון י"ז
silane-coupling agent to provide a modified surface that is substantially free of particular matter; and (d) applying a
dielectric material to said rinsed surface containing said Si—O.
__________
157663]21][11[
במערכת נע גוף של מיקום לזיהוי התקןלכך ושיטה ניווט
APPARATUS FOR DETECTING LOCATION OF MOVABLE BODY IN NAVIGATION SYSTEM AND METHOD THEREOF
]54[
29.08.2003]22[KR]33[14.03.2003]32[16090/200
3]31[
Int. Cl.8 G01C 021/26, G08G 001/0968]51[SAMSUNG ELECTRONICS CO., LTD., REPUBLIC OF KOREA
]71[
ושות', ט. קולב סנפורד ,2273, ת.ד. , מרמורק4 הגיא שער
רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
June 3, 2007 810 –התשס"ז בסיון י"ז
]57 [An apparatus for detecting location of a movable body in a navigation system, the apparatus comprising: a map data detector (420) for detecting a width of a road, road linear information, and map information of a region corresponding to a location information in an external digital map storage on the basis of location information of the movable body, said location information being transmitted by sensors sensing location coordinates and traveling direction information of the movable body; a memory (430) for storing said width of the road, road linear information, and map information detected from the map data detector; a filter (440)
for computing an optimum location information of the movable body including the width of a road and the road linear information included in said map information on the basis of the location coordinates and traveling direction information of the movable body transmitted by said sensors; and a map-matching unit (450) for receiving the optimum location information of the movable body from the filter and correcting the optimum location information by matching the optimum location information and the map information stored in the memory.
__________
157691]21][11[
קו פרופיל של א–סימטרית מדידהסקטרומטריה בעזרת
LINE PROFILE ASYMMETRY MEASUREMENT USING SCATTEROMETRY
]54[
28.02.2002]22[US]33[02.03.2001]32[60/273039]31[
Int. Cl.8 G01B 011/02]51[ACCENT OPTICAL TECHNOLOGIES, INC., U.S.A.
]71[
WO/2002/070985]87[צדק, וכהן איתן, פרל, לצר
, הרצליה12688 , ת.ד. 7 שנקר רחוב EITAN, PEARL, LATZER AND COHEN ZEDEK,
P.O.B. 12688 ,HERZLIYA 46733
]74[
June 3, 2007811 –התשס"ז בסיון י"ז
]57 [A method of measuring line profile asymmetries in microelectronic devices, the method comprising the steps of: directing light at an array of microelectronic features of a microelectronic device; detecting light scattered back from the array comprising
one or more features selected from the group consisting of one or more angles of reflection and one or more wavelengths; and comparing one or more characteristics of the back-scattered light by performing an operation comprising examining data from complementary angles of reflection.
__________
157789]21][11[
METHODS AND APPARATUSחומרים לעיבוד והתקן שיטותFOR MATERIALS PROCESSING
]54[
21.02.2002]22[US]33[07.03.2001]32[802037]31[
Int. Cl.8 B01F 007/12, B01J 019/10]51[KREIDO LABORATORIES, U.S.A.]71[
WO/2002/072251]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
June 3, 2007 812 –התשס"ז בסיון י"ז
]57 [A method for processing materials, comprising: passing materials to be processed in a flow path through an annular processing passage (44) between two closely spaced smooth surfaces provided by respective cylindrical apparatus members (30), at least one rotating relative to the another; wherein the material forms material boundary layers
against both the surfaces; wherein the radial spacing between the two surfaces is equal to or less than the back-to-back radial thicknesses of the two boundary layers; and wherein the smoothnesses of the surfaces are such that formation of Taylor vortices in the processing passage is inhibited.
__________
158429]21][11[
METHOD FOR CROSS-LINKING Aפולימרי פריט לצילוב שיטהPOLYMER ARTICLE
]54[
21.03.2002]22[EP]33[11.05.2001]32[01111570.
6]31[
Int. Cl.8 C08F 008/42]51[BOREALIS TECHNOLOGY OY, FINLAND
]71[
WO/2002/096962]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
]74[
June 3, 2007813 –התשס"ז בסיון י"ז
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]57 [Method for cross-linking a polymer article comprising a cross-linkable polymer which has been produced by the use of a single-site catalyst with hydrolysable silane groups and a
crystallinity level of at least 30% wherein the cross-linking is performed in the presence of a silanol condensation catalyst comprising a compound of the formula
ArSO3H
or a precursor thereof, Ar being a hydrocarbyl substituted aromatic group comprising at least 14 carbon atoms.
__________
158662]21][11[
התפרצות מקטעי קובץ תגובת מערכותמעורבים אנוקסית
SURGE ANOXIC MIX SEQUENCING BATCH REACTOR SYSTEMS
]54[
03.03.1999]22[US]33[04.03.1998]32[09/034512]31[US02.10.199860/102864
Int. Cl.8 C02F 003/12, 003/20, 003/30]51[DIVISION FROM 138198]62[MIKKEL G. MANDT, U.S.A.]71[
WO/1999/044951]87[ושות', ט. קולב סנפורד
,2273, ת.ד. , מרמורק4 הגיא שער רחובות
SANFORD T.COLB & CO,. P.O.B. 2273 ,
REHOVOT
]74[
]57 [A surge anoxic mix sequencing batch reaction method for treating wastewater to reduce its solids content, biological oxygen demand (BOD) and nitrogenous content in an overall sequencing batch-reaction treatment cycle time of less than 20 hours, comprising the steps of: providing an anaerobic pretreatment zone, an anoxic waste liquid treatment zone and one or more separate aerobic sequencing waste liquid treatment zones wherein the ratio of the volume of the anoxic waste liquid treatment zone to
the volume of the one or more aerobic sequencing waste liquid treatment zones is in the range of from about 0.2: to about 1:1; and wherein the anaerobic treatment zone has a treatment volume in the range of from about 20 percent to about 300 percent of the treatment volume of the anoxic treatment zone; introducing influent wastewater containing wastewater solids content, BOD and nitrogenous content to be treated into the anaerobic pretreatment zone containing waste solids including treatment microorganisms under
June 3, 2007 814 –התשס"ז בסיון י"ז
anaerobic conditions; introducing waste water from said anaerobic treatment zone into the anoxic waste liquid treatment zone containing waste solids including treatment microorganisms under anoxic conditions; introducing wastewater and treatment microorganisms from said anoxic waste liquid treatment zone in to the one or more aerobic sequencing waste liquid treatment zones containing waste solids including treatment microorganisms under aerobic conditions; mixing and aerating the waste liquid in the one or more aerobic sequencing batch aeration treatment zones to reduce the biological oxygen demand of the wastewater and to convert at least a portion of the nitrogenous wastewater content to inorganic nitrate or nitrite components; introducing and mixing waste liquid and treatment microorganisms from the one or more aerobic sequencing waste liquid treatment zones into the anoxic waste liquid treatment zone at a rate of at least about 0.1 of the total volume of anoxic zone per hour during an interaction time period, to provide nitrate or nitrite oxidizing components from the one or more aerobic sequencing batch reaction treatment zones for the anoxic treatment microorganism metabolism and to convert the nitrate or nitrite components to nitrogen for removal from the wastewater in the anoxic mix treatment zone; subsequently to said mixing and aeration steps, maintaining the waste liquid in the one or more aerobic sequential batch wastewater treatment zones in a quiescent state without said mixing and aerating, to form in the respective one or more sequencing batch aeration zones, a clarified upper layer and a stratified lower waste liquor layer containing waste solids including treatment microorganisms; recycling waste solids from the stratified lower waste liquor layer including treatment microorganisms from said one or
more aerobic sequential batch waste water treatment zones directly into the anaerobic pretreatment zones or indirectly into the anoxic zone and subsequently into the anaerobic pretreatment zone at a flow rate in the range of from about 50/1 to about 1/300 of the influent wastewater flow rate to the anaerobic treatment zone, wherein at least a portion of the total suspended solids of the influent wastewater to be treated is settled to an anaerobic settled solids zone in the lower portion of the anaerobic treatment zone, wherein at least 50 percent by weight of the microbial and other solids content (TSS) of the waste liquor directly or indirectly recycled to the anaerobic zone is settled to the anaerobic settled solids zone in the lower portion of the anaerobic treatment zone together with settled influent wastewater solids, wherein at least about 10 percent by weight of the organic solids which settle in the settled solids zone are anaerobically biologically digested to produce anaerobically digested solid, soluble and gas components, wherein wastewater from the anaerobic treatment zone which includes both influent wastewater and recycled waste liquor wastewater, is conducted from the anaerobic zone to the anoxic zone, and wherein at least the soluble anaerobic digestion components produced by anaerobic digestion in the anaerobic treatment zone are conducted in the wastewater flow from the anaerobic treatment zone to the anoxic treatment zone for anoxic biotreatment, and to the aerobic treatment zone for aerobic biotreatment; and removing a predetermined portion of the clarified upper layer from the respective one or more sequencing aeration treatment zones as a treated effluent stream having reduced solids content BOD and nitrogenous content with respect to said influent wastewater.
The applications for division,178656 מבקשה חלוקה בקשות
June 3, 2007815 –התשס"ז בסיון י"ז
from this application haveפורסמו. שטרם זוnot yet been published
__________
159091]21][11[
HIGH TEMPERATUREגבוהה בטמפרטורה סיכה חומר הרכבLUBRICANT COMPOSITION
]54[
31.05.2002]22[US]33[01.06.2001]32[09/872191]31[
Int. Cl.8 C10M 169/04]51[ANDEROL, INC., U.S.A.]71[
MICHAEL A. MCHENRY, DALE D. CARR, JEFFREY A. HUTTER
]72[
WO/2002/099021]87[בע"מ, רוחני ושות',קניין פנסטר
, ת.ד. אריה , קרית1 כניסה12 בזל תקוה , פתח10256
FENSTER & COMPANY, INTELLECTUAL PROPERTY LTD,
12 BASEL STREETENTRANCE 1P.O.BOX 10256
PETACH TIKVA
]74[
]57 [A synthetic polyol ester based lubricant, comprising
)A (a polyol ester base stock that is the reaction product of:
)i (a polyol mixture including a major proportion of dipentaerythritol, and
)ii (at least one C5 to C12 monocarboxylic acid, wherein the resulting mixture of esters has a viscosity at 40˚C of at least about 120 cSt, and
)B (an additive package including an effective amount of at least one oligomeric amine antioxidant, extreme pressure/anti-wear agents and a minor effective amount of a corrosion inhibitor.
__________
159109]21][11[
–4–אמינו–3–)7 של נגזרות–Aארילבוטנואיל(טטרהידרואימידזו)
–3,4וטטרהידרוטריאזולו) (פיראזין2,1Aפפטידז דיפפטידיל של כמעכבים (פיראזין
אותן המכילים רוקחות ותכשירי
DIPEPTIDYL PEPTIDASE INHIBITING 7-(3-AMINO-4-ARYLBUTANOYL)TETRAHYDROIMIDAZO (1,2-A) PYRAZINE AND TETRAHYDROTRIAZOLO (4,3-A) PYRAZINE DERIVATIVES AND PHARMACEUTICAL
]54[
June 3, 2007 816 –התשס"ז בסיון י"ז
COMPOSITIONS CONTAINING THEM
05.07.2002]22[US]33[06.07.200
1]32[60/303474]31[
Int. Cl.8 A61K 031/4985, A61P 001/00, 003/00, 003/10, 005/00, 009/00, 015/16, 019/10, 025/00, 031/18, 035/00, 037/06, C07D 487/04, 519/00, C12P 017/18
]51[
MERCK & CO., INC., U.S.A.]71[WO/2003/004498]87[
ושות', כהן שלמה ד"ר , תל11490 , ת.ד. 124 גבירול אבן
אביב
DR. SHLOMO COHEN & CO,. 124 IBN GABIROL ST,.
P.O.B. 11490 ,TEL AVIV 62038
]74[
]57 [A compound of the formula
wherein: Ar is phenyl which is unsubstituted or substituted with 1-5 of R3, wherein R3 is independently selected from the group consisting of:
)1 (halogen,)2 (C1-6 alkyl, which is linear or branched
and is unsubstituted or substituted with 1-5 halogens,
)3 (OC1-6 alkyl, which is linear or branched and is unsubstituted or substituted with 1-6 halogens, and
)4 (CN;X is selected from the group consisting of:
)1 (N, and)2 (CR3;
R1 and R2 are independently selected from the group consisting of:
)1 (hydrogen,)2 (CN,
)3 (C1-10 alkyl, which is linear or branched and which is unsubstituted or substituted with 1-5 halogens or phenyl, which is unsubstituted or substituted with 1-5
substituents independently selected from halogen, CN, OH, R4, OR4, NHSO2R4, SO2R4, CO2H, and CO2C1-6 alkyl, wherein the CO2C1-6 alkyl is linear or branched,
)4 (phenyl which is unsubstituted or substituted with 1-5 substituents independently selected from halogen, CN, OH, R4, OR4, NHSO2R4, SO2R4, CO2H, and CO2C1-6 alkyl, wherein the CO2C1-6 alkyl is linear or branched, and
)5 (a 5- or 6-membered heterocycle which may be saturated or unsaturated comprising 1-4 heteroatoms independently selected from N, S and O, the heterocycle being unsubstituted or substituted with 1-3 substituents independently selected from oxo, OH, halogen, C1-6 alkyl, and OC1-6 alkyl, wherein the C1-6 alkyl and OC1-6 alkyl are linear or branched and optionally substituted with 1-5 halogens;
R4 is C1-6 alkyl, which is linear or branched and which is unsubstituted or substituted
June 3, 2007817 –התשס"ז בסיון י"ז
with 1-5 groups independently selected from halogen, CO2H, and CO2C1-6
alkyl, wherein the CO2C1-6 alkyl, wherein the
CO2C1-6 alkyl is linear or branched; and pharmaceutically acceptable salts thereof and individual diastereomers thereof.
35 לתקנה בהתאם נבחן זה פירוט1968 – הפטנטים, תשכ"ח לתקנות
This specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968
חלוקה בקשות שטרם זו מבקשהפורסמו.
178307,The applications for division from this application have not yet been published
__________
160163]21][11[
מעגל מיקרו טורבינה של להב קצהלצינון
TURBINE BLADE TIP WITH MICROCIRCUIT COOLING
]54[
02.02.2004]22[US]33[05.02.2003]32[10/358646]31[
Int. Cl.8 F01D 005/18]51[UNITED TECHNOLOGIES CORPORATION, U.S.A.
]71[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A turbine blade (24) comprising: a hollow airfoil (54) into which cooling flow is flowable from an end of said airfoil, said airfoil including pressure (42) and suction (44) sidewalls joined together at leading (46) and trailing (48) edges and extending from a root (50) to a tip (36);
at least one micropassage (80) disposed within said tip, said micropassage includes an inlet (70) and an outlet (72), said inlet
and said outlet in flow communication with said micropassage; a means for providing cooling flow to said airfoil wherein said cooling flow enters said inlet from said airfoil, transitions through said micropassage and exits at said outlet into a region outside said airfoil; and at least one pedestal (88), said pedestal radially extends at least in part in the path of said cooling flow flowing in said micropassage.
June 3, 2007 818 –התשס"ז בסיון י"ז
June 3, 2007819 –התשס"ז בסיון י"ז
__________
161371]21][11[
PANEL WITH SOUNDייצור ושיטת קול בידוד שכבת עם לוחINSULATION LAYER AND PRODUCTION METHOD
]54[
28.06.2002]22[DE]33[23.10.2001]32[10151614.
2]31[
Int. Cl.7 B32B 021/08, 025/04, E04F 015/20]51[M. KAINDL, AUSTRIA]71[WO/2003/035396]87[
וגולר, וולף, ברגמן ,1352ב' , ת.ד. 19 היסוד קרן רחוב
ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
]57 [A method for the production of a panel (P) having a sound insulation layer (5) mounted thereon, in which several layers are pressed in a press by supplying pressure and heat, wherein single layers
are made of wood, derived timber product or paper, at least one layer being provided with aminoplast, characterized in that: the layers are pressed together with the sound insulation layer; wherein the sound insulation layer is connected to the paper
June 3, 2007 820 –התשס"ז בסיון י"ז
that is impregnated with aminoplast, and after pressing, the panel is provided with locking elements (6, 7).
__________
161917]21][11[
מערכת עבור קרינה מפני מגן–חוםסולרית
RADIATION HEAT SHIELD FOR SOLAR SYSTEM
]54[
13.11.2002]22[US]33[13.11.2001]32[987106]31[
Int. Cl.8 F24J 002/05, 002/10]51[]SOLEL SOLAR SYSTEMS LTD.]71בע"מ, ירושלים סולריות מערכות סולל
WO/2003/042609]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A solar system (60) comprising a reflector and a heat collecting element (HCE) received at the focus of the reflector, said HCE having a longitudinal axis extending between a first end and a second end; the HCE comprising a coated tube (16) received within a coaxial evacuated enveloping glass tube (24); said enveloping glass tube being secured at respective ends thereof to the coated tube by a coaxially deformable connector element (30) having a distal end thereof
sealingly secured to the coated tube and a proximal end thereof sealingly attached to a respective end of the enveloping glass tube by a glass to metal connection (46) (GMC), wherein a radiation shield assembly (62, 64) extends over the connector element and over the GMC; said radiation shield assembly is secured to the connector element by support legs (70, 72) engaging the connector element adjacent the proximal end.
June 3, 2007821 –התשס"ז בסיון י"ז
__________
163286]21][11[
–2מותמר(פירולידין– –)גליציל1 רוקחות ותכשירי קרבוניטרילים, הכנתם
אותם המכילים
1(-SUBSTITUTED GLYCYL)PYRROLIDINE-2-CARBONITRILES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
]54[
04.03.2003]22[HU]33[06.03.2002]32[P0200849]31[
Int. Cl.8 A61K 031/395, A61P 001/00, 003/00, 009/00, 015/06, 017/00, 025/00, 029/00, 035/00, 037/00, C07D 401/14, 413/14, 417/14, 451/04, 451/14
]51[
SANOFI AVENTIS, FRANCE]71[WO/2003/074500]87[
ושותפיו, עו"פ, הס יצחק ד"ראביב , תל6451 , ת.ד. 279 הירקון רחוב
DR. YITZHAK HESS & PARTNERS, 279 HAYARKON STREET
P.O.B. 6451 TEL AVIV 61063
]74[
]57 [Dipeptidyl peptidase –IV- enzyme inhibition compounds of the formula
June 3, 2007 822 –התשס"ז בסיון י"ז
wherein R1 means a nitrogen-containing aromatic moiety consisting of one or two aromatic rings, preferably a pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxidazolyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, benzimidazolyl, indazolyl, benzthiazolyl, benzisothiazolyl, benzoxazolyl or benzisoxazolyl, tetrazolyl, triazinyl ring; which is, in a given case, independently from each other mono- or disubstituted by one or two of the following groups: C1-4 alkyl groups, C1-4 alkoxy groups, halogen atom, trihalogenomethyl group, methylthio group, nitro group, cyano group, amino group or phenyl group; or thienyl, furyl or
benzyl group; or p-toluenesulfonyl group; or acyl group of formula R1a-CO, wherein R1a means C1-4 alkyl group, phenyl group; phenyl, pyridyl or phenylethenyl group substituted with one or more alkyl- and/or alkoxy- or nitro-group or halogen atom; phenylethenyl or phenylethyl group substituted with alkylene-dioxy group; piperidin-1-yl, 4-methylpiperazin-1-yl, pyrrolidin-l-yl group,B stands for a group of formula (1) or (2) or (3) or (4) or (5) or (6) or (7) as shown in the specification;
R2 stands for hydrogen atom or fluorine atom;R3 stands for fluorine atom ;
and salts, isomers, tautomers, solvates and hydrates thereof.
__________
163398]21][11[
MICROCIRCUIT COOLING FORטורבינה של להב עבור קירור מערכתA TURBINE BLADE
]54[
05.08.2004]22[US]33[08.08.2003]32[637448]31[
Int. Cl.8 F01D 005/18]51[UNITED TECHNOLOGIES CORPORATION, U.S.A.
]71[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A turbine rotor blade (27) comprising: an external wall (24), said external wall including an inner surface (65); an internal cavity (32a-c) into which cooling air is flowable; a first cooling circuit (22) embedded within said wall, said first cooling circuit including: a first inlet (61c), said first inlet connects said first cooling circuit with said cavity and provides a cooling air flow path into said
first cooling circuit; and an exit aperture (63), said exit aperture provides a cooling air flow path out of said first cooling circuit, said first cooling circuit configured to increase the temperature of the cooling air as it travels from said inlet to said exit aperture of said second cooling circuit; and a third cooling circuit (22) embedded within said wall, said third cooling circuit
June 3, 2007823 –התשס"ז בסיון י"ז
includes: a first inlet (61a), said first inlet of said second cooling circuit connects said second cooling circuit with said cavity and provides a cooling air flow path into said second cooling circuit; and an exit aperture (63), said exit aperture of said third cooling circuit provides a cooling air flow path out of said third cooling circuit, said third cooling circuit configured to increase the temperature of the cooling air
as it travels from said inlet of said third cooling circuit to said exit aperture of said third cooling circuit; wherein said first inlets are aligned with the direction of counter-rotating flow circulations (104, 106) experienced by said inner surface of said wall of said cavity caused by Coriolis forces on the cooling air flow inside said cavity.
__________
June 3, 2007 824 –התשס"ז בסיון י"ז
163443]21][11[
-INNER AIR SEAL ANTIפנימי אטם של סיבוב המונע התקןROTATION DEVICE
]54[
10.08.2004]22[US]33[13.08.2003]32[10/640225]31[
Int. Cl.8 F01D 009/04, 011/00, F04B 017/00, F16B 039/00]51[UNITED TECHNOLOGIES CORPORATION, U.S.A.
]71[
וגולר, וולף, ברגמן ,1352ב' , ת.ד. 19 היסוד קרן רחוב
ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
]57 [An anti-rotation device for preventing rotation of a damper spring and an inner air seal (1) in a stator assembly (10), said device comprising a lug (8) positioned within a slot at a center of an inner air seal arc segment, said lug
engaging a slot in said damper spring and a cutout (18) in a stator segment so as to prevent rotation of said damper spring and said inner air seal in either direction relative to the stator assembly.
__________
June 3, 2007825 –התשס"ז בסיון י"ז
163624]21][11[
QUICK DISCONNECT WITHעוצר קפיץ בעל מהיק מנתקRETAINING SPRING
]54[
19.08.2004]22[US]33[29.08.2003]32[60/499166]31[
Int. Cl.8 H01R 004/00, 004/50]51[TRIUMPH BRANDS, INC., U.S.A.]71[
וגולר, וולף, ברגמן ,1352ב' , ת.ד. 19 היסוד קרן רחוב
ירושלים
WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST .
P.O.B. 1352,JERUSALEM 91013
]74[
]57 [A quick disconnect (100), comprising: a front coupling (10, 70) and a rear coupling (10) each for connection to a respective cable end; a hinge latch (20) comprising at least one finger pivotally mounted at a first end (18) of the rear coupling, the finger having a retention
groove (24) disposed at a second end and having a coupling groove for receiving the front coupling; a compression sleeve (40) slidably disposed over the hinge latch; a biasing member disposed at a first end of the compression sleeve for engagement with the retention groove of the finger.
__________
June 3, 2007 826 –התשס"ז בסיון י"ז
164542]21][11[
BALER GATE LINKAGE ANDהסגר ומבנה חבילה שער חיבורLATCH STRUCTURE
]54[
13.10.2004]22[US]33[15.10.2003]32[687256]31[
Int. Cl.8 A01D 046/08]51[DEERE & COMPANY, U.S.A.]71[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [A baler having a bale forming chamber with first and second upright frame sections (46, 48), the second frame section movable relative to the first frame section for releasing a formed bale from the chamber, linkage structure (50) connecting the first and second frame sections including a control linkage having an upper link (82) connecting an upper portion of the first frame section with an upper portion of the second frame section, a second link (86) pivotally connected between first and second frame sections at a location below the upper link, and cylinder structure (76) connected between the frame sections and rocking the second frame section relative to the first frame section between a closed position for
forming a bale and an open position for releasing the bale, wherein in the closed position, the upper portions of the frame sections generally abut, wherein the upper link moves the second frame section over the upper portion of the first frame section as the cylinder rocks the second frame member towards the open position; and further including a latch member (100) connected to the second frame section and securing the second frame section to the first frame section in the closed position, wherein the operation of the cylinder structure with the frame sections in the closed position initially moves the first frame section to release the latch member without need for a separate unlatching mechanism.
June 3, 2007827 –התשס"ז בסיון י"ז
__________
164842]21][11[
COTTON FEEDING ROLLERכותנה להזנת מגלל מבנהSTRUCTURE
]54[
26.10.2004]22[US]33[28.10.2003]32[695096]31[
Int. Cl.8 A01D 046/08]51[DEERE & COMPANY, U.S.A.]71[
ושותפיו, כהן ריינהולד , תל4060 , ת.ד. 21 העם אחד רחוב
אביב
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST ,.P.O.B. 4060 ,
TEL AVIV 61040
]74[
]57 [In a mobile cotton harvester having selectively operable processing structure connected to the harvester for processing harvested cotton in a field, accumulator structure comprising: an upright storage area having side walls (30g) and having a lower discharge area (124), the upright storage area receiving the harvested cotton and facilitating continuous harvester operation; a cotton metering structure (32) including upper and lower rotatable spaced rollers (92, 96), the metering structure defining an inclined accumulator floor
angling downwardly towards the lower discharge area; a drive (14) connected to the metering structure for rotating the spaced rollers in a same direction to urge the received cotton from the storage area towards the lower discharge area; and a discharge roller (120) located above the lower roller and discharge area, the discharge roller intercepting the cotton urged towards the lower discharge area to break up cotton clumps and meter cotton to the discharge area.
June 3, 2007 828 –התשס"ז בסיון י"ז
__________
164924]21][11[
דיו דוחף הכולל דיו הזרקת נחיר מכלולהזזה בר
INK JET NOZZLE ASSEMBLY INCLUDING DISPLACEABLE INK PUSHER
]54[
21.08.2002]22[US]33[28.06.2002]32[10/183175]31[
Int. Cl.8 B41J 002/05]51[SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA
]71[
WO/2004/002744]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [An ink jet printhead chip that comprises a substrate (116); drive circuitry (156) positioned in the substrate; and a plurality of nozzle arrangements (122) positioned on the substrate, each nozzle arrangement comprising nozzle chamber walls (150) and a roof wall (130) that define a nozzle chamber and an ink ejection port in the roof wall in fluid communication with the nozzle chamber; an ink pusher that is operatively positioned
with respect to the nozzle chamber and is displaceable through a range of between 1 micron and 5 microns to eject ink from the ink ejection port; and an actuator (128) that is connected to the drive circuitry and the ink pusher to displace the ink pusher on receipt of an electrical signal from the drive circuitry, each nozzle arrangement being the product of a MEMS fabrication technique.
June 3, 2007829 –התשס"ז בסיון י"ז
__________
165463]21][11[
MULTI-LAYER CARBONLESSפחם נטול רב–שכבתי דף מוצרSHEET PRODUCT
]54[
19.05.2003]22[GB]33[29.05.2002]32[0212358.6]31[
Int. Cl.8 B41M 005/00]51[ARJO WIGGINS LIMITED, UNITED KINGDOM
]71[
DAVID JOHN TAYLOR, RICHARD DAVID SAUNDERS, MICHAEL ERIC HOBSON
]72[
WO/2003/101744]87[ושות' בע"מ, מ. בן-דוד ירמיהו
,45087, ת.ד. חוצבים המרפא, הר רחוב ירושלים
JEREMY M. BEN-DAVID & CO. LTD,.
HAR HOTZVIM HI-TECH PARK ,P.O. B. 45087 ,
JERUSALEM 91450
]74[
]57 [A magnetically-activatable sheet product comprising a pair of laminated outer sheets between which is a magnetic layer comprising magnetically-activatable particles in a binder matrix, the outer sheets having sufficient opacity to mask the appearance of the magnetic layer; at least one of the outer sheets being provided
on its outward facing surface with a coating which comprises either microcapsules containing a solution of at least one chromogenic material, or dispersed droplets containing at least one chromogenic material in a pressure-rupturable matrix, or a colour developer composition, or both microcapsules
June 3, 2007 830 –התשס"ז בסיון י"ז
containing at least one chromogenic
__________
165884]21][11[
METHOD FORמשטחים שלUV לטיהור שיטהPHOTOSENSITIZED ULTRAVIOLET DECONTAMINATION OF SURFACES
]54[
08.11.1999]22[US]33[09.11.1998]32[60/107617]31[
Int. Cl.8 A61L 002/10]51[DIVISION FROM 143058]62[CLEAN EARTH TECHNOLOGIES, LLC, U.S.A.
]71[
WO/2000/028552]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
]57 [A method of decontaminating a contaminated surface, the method comprising: spraying a photosensitizer onto the contaminated surface, the photosensitizer comprising an aqueous
solution containing hydrogen peroxide and peracetic acid; and applying UV light in an intensity sufficient to destroy contaminants on the surface.
June 3, 2007831 –התשס"ז בסיון י"ז
__________
165885]21][11[
METHOD FORמשטחים של לטיהור והתקן שיטהPHOTOSENSITIZED DECONTAMINATION OF SURFACES
]54[
08.11.1999]22[US]33[09.11.1998]32[60/107617]31[
Int. Cl.8 A61L 002/10]51[DIVISION FROM 143058]62[CLEAN EARTH TECHNOLOGIES, LLC, U.S.A.
]71[
WO/2000/028552]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
]57 [A method of decontaminating the surface of a contaminated object, the method comprising: surrounding the contaminated object with a barrier having an entrance and an exit therein;
establishing an air flow into the exit and out of the entrance; spraying a photo sensitizer onto the surface of the object; and illuminating the sprayed surfaces of the object with light.
June 3, 2007 832 –התשס"ז בסיון י"ז
__________
165886]21][11[
METHOD FORמשטחים של לטיהור שיטהPHOTOSENSITIZED DECONTAMINATION OF SURFACES
]54[
08.11.1999]22[US]33[09.11.1998]32[60/107617]31[
Int. Cl.8 A61F 002/10]51[CLEAN EARTH TECHNOLOGIES, LLC, U.S.A.
]71[
WO/2000/028552]87[ושותפיו, כהן ריינהולד
, תל4060 , ת.ד. 21 העם אחד רחוב אביב
REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST ,.
P.O.B. 4060 ,TEL AVIV 61040
]74[
]57 [A method of decontaminating a contaminated non-conducting surface, the method comprising: providing a conducting backing for the non-conducting surface; spraying photosensitizer onto the
contaminated surface, the photosensitizer being electrically charged so that it is attracted to the contaminated surface; and illuminating the sprayed surface with light.
June 3, 2007833 –התשס"ז בסיון י"ז
__________
166724]21][11[
תכונות עם מיקרו–אלקטרומכני מפעילמתנגד אבזם של
MICRO-ELECTROMECHANICAL ACTUATOR WITH BUCKLE-RESISTANT PROPERTIES
]54[
30.06.2000]22[Int. Cl.8 B41J 002/45]51[SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA
]71[
WO/2002/002328]87[לוצאטו, את לוצאטו
שבע , באר5352, ת.ד. תעשייה, עומר גן LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMERP.O.B. 5352BEER-SHEVA 84152
]74[
]57 [A micro-electromechanical actuator (7) that includes a substrate (2); drive circuitry positioned on the substrate; an active beam member (10) that is anchored to the substrate at one end and electrically connected to the drive circuitry, the active
beam member defining an electrical heating circuit that is spaced from and overlies the substrate to heat resistively and expand when a current from the drive circuitry is set up in the active beam member; a passive beam member (12) that
June 3, 2007 834 –התשס"ז בסיון י"ז
is also anchored to the substrate at one end and electrically isolated from the drive circuitry, the active beam member being interposed between the substrate and the passive beam member; a longitudinally extending lever arm (6) that is fast at one end to an opposite end of the active and
passive beam members, such that expansion and subsequent contraction of the active beam member causes reciprocal movement of the lever arm away from and towards the substrate; and a working member fast with an opposite end of the lever arm.
__________
167283]21][11[
מודפסים וספרים ספרים להדפסת שיטותאלו בשיטות
METHODS FOR PRINTING BOOKLETS AND BOOKLETS PRINTED THEREBY
]54[
07.03.2005]22[Int. Cl.8 B42C 001/00, B42D 009/00]51[
מרמורשטיין, אשדוד ישראלכץ, אשדוד אליעזר
ISRAEL MARMORSTEINELIEZER KATZ
]71[
וגולר, וולף, ברגמן ,1352ב' , ת.ד. 19 היסוד קרן רחוב
ירושלים
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST .P.O.B. 1352,
JERUSALEM 91013
]74[
]57 [A method for preparing a protable booklet of multi-column textual material, comprising reformatting the textual layout of said material in order to create substantial alignment between the lines of text I all of the columns in an area
predetermined for horizontal subdivision of the sheet containing the same, creating at least one space horizontally extending across said predetermined area of said sheet, thereby subdividing each of said respective columns to form at least two
June 3, 2007835 –התשס"ז בסיון י"ז
distinct areas of printed matter, and utilizing said subdivided sheets to form a booklet having pages of reduced height in the direction of its columns, while
substantially maintaining the original font size of the letters of said multi-column textual material.
__________
June 3, 2007 836 –התשס"ז בסיון י"ז
PATENTSפטנטים
שניתנו פטנטיםPATENTS GRANTED
13265113210113141813127513114712956112931911498214670214666414646014638414628714625413281313279314699214697714695614691714689714687214672114670514811614794414789514770314763414761414755714741314862914855114841414835514831614829014819414812814955614949914948914933814891014881614874314863715120415119215072615071515061615051215023015002315158115153615151115150415147115129315124415124112732512719312562812497712447110831610635799435142738142570142484142457142132142112127770127769143441143370143354143112142978142954142879142868143733143694143576143495143490143487143479143457144762144747144486144358144352144106144084143797145158145157145156145121145011144905144847144775145400145350145336145318145316145305145177145159145948145799145783145767145561145554145517145437134087133078123514122832121614121402146103145986135585135499135371135295135166134980134602134224152394152222152192137096136773136768136469135945154066153673153657153630153448153396153026152986156331156236155910155255155211155187154926154765158405158305158210157711157622156918156537156403138951138647138435138425116609116398158663158409140476140368140080139849139666139252139199139035141045141039140804140702140661140636140552140491159158141848141780141727141707141501141411141183162279161466160122159760159522159400159245159213164775164505164504164448164445163503163497163265
165038164931164930164834164782
שחודשו פטנטיםPATENTS RENEWED
8942889410893998935789311893038927789094896028957789545895418947789465894618944210482910482110480010478910477610477410450699435104891104881104880104868104853104844104835104830105017105009105003104995104970104965104930104896120249120213120157120121119944119417105048105036120325120295120280120279120260120257120255120251120380120361120354120352120351120348120345120332121790121614121218120455120442120430120425120407125214124977124850124760124572122647122315121981125598125590125504125492125483125392125361125356125748125735125711125688125649125645125622125615125856125848125841125838125822125819125805125796125975125968125954125945125926125911125909125861126153126096126086126054126050126028126022125986129319128592127325126358126331126303126180126179131716130941130447130368130229130169130168129760135499134536133610133609133469132793132651132425137548136811136773136768136469136125135893135523138690138647138577138435138277138094137970137757140476140458140423140379140080139910139387139035141591141557141522141411141320141045140933140702141848141814141763141758141752141740141672141632142570142132141989141970141964141942141939141889143354143086142978142879142784142738142687142645143645143637143602143601143590143556143495143479144199144100143998143997143739143733143698143694145158145157145156145121144847144775144465144229145767145745145606145437145393145305145219145159146664146562146219146204145993145948145799145783147089146958146956146910146897146872146759146705147668147663147634147422147413147374147339147226148743148637148414148316148128148116147895147703150512150230150023149651149556149489149485148816151416151281151107151103150989150715150647150519153026152488152286151581151549151511151504151464155934155499155498154944154926154153154013153657159222159158158305158210157622156851156476156331163497163485163484162279161466159999159522159396169917168934165038164931164930164834164775163501
June 3, 2007 –התשס"ז בסיון י"ז 838
חידוש אגרת תשלום אי בגלל פקעו שתוקפם פטנטיםPATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
123446
שנה לעשרים שחודשו פטנטיםPATENTS RENEWED FOR 20 YEARS
146287142068
June 3, 2007 –התשס"ז בסיון י"ז 840
NOTICEהודעה הפטנטים, לחוק66 סעיף לפי
1967תשכ"ז-Under section 66 of the Patents Law, 5727-1967
רשות ניתנה כי בזאת מודעמס' הפטנט בקשת לבעלת
133835This is to notify that permission has been granted to the owner of Patent Application No.
7/2003Acceptance published in journalביומן פורסם הקיבול דבר בקשת של הפירוט את לתקן
האמורה הפטנטTo amend the specification of the said Patent Application.
למתן להתנגד רשאי אדם כל חודשים שלושה תוך הרשות
זה, כפי פטנטים יומן מתאריך ובתקנה לחוק67 בסעיף שנקבע
הפטנטים, התשכ"ח- לתקנות991968.
Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968.
NOTICEהודעה הפטנטים, לחוק66 סעיף לפי
1967תשכ"ז-Under section 66 of the Patents Law, 5727-1967
רשות ניתנה כי בזאת מודעמס' הפטנט בקשת לבעלת
139592This is to notify that permission has been granted to the owner of Patent Application No.
5/2005Acceptance published in journalביומן פורסם הקיבול דבר בקשת של הפירוט את לתקן
האמורה הפטנטTo amend the specification of the said Patent Application.
למתן להתנגד רשאי אדם כל חודשים שלושה תוך הרשות
זה, כפי פטנטים יומן מתאריך ובתקנה לחוק67 בסעיף שנקבע
הפטנטים, התשכ"ח- לתקנות991968.
Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968.
June 3, 2007 –התשס"ז בסיון י"ז 842
NOTICEהודעה הפטנטים, לחוק66 סעיף לפי
1967תשכ"ז-Under section 66 of the Patents Law, 5727-1967
רשות ניתנה כי בזאת מודעמס' הפטנט בקשת לבעלת
153657This is to notify that permission has been granted to the owner of Patent Application No.
8/2006Acceptance published in journalביומן פורסם הקיבול דבר בקשת של הפירוט את לתקן
האמורה הפטנטTo amend the specification of the said Patent Application.
למתן להתנגד רשאי אדם כל חודשים שלושה תוך הרשות
זה, כפי פטנטים יומן מתאריך ובתקנה לחוק67 בסעיף שנקבע
הפטנטים, התשכ"ח- לתקנות991968.
Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968.
טעות תיקוןCorrigendum
Journal 10/2006יומן
P. 4206 Patent application 76608מס' פטנט בקשת4206ע' No 76608
Notice under section 64 of the Patents Law הפטנטים לחוק64 סעיף לפי הודעה. Delete the notice ההודעה את מחק
The notice had been published 9/2006ההודעה פורסמה קודם ביומן earlier in Journal 9/2006
ביומן המופיעים למדינת קודיםJune 3, 2007 –התשס"ז בסיון י"ז 844
COUNTRY CODES APPEARING IN THIS JOURNAL
Code Country or OrganizationAR ArgentinaAT AustriaAU AustraliaBA HerzegovinaBE BelgiumBR BrazilCA CanadaCH SwitzerlandCN ChinaCU CubaCZ Czech RepublicDE GermanyDK DenmarkEC EcuadorEP European Patent OfficeES SpainFI FinlandFR FranceGB United KingdomGE GeorgiaGR GreeceGT GuatemalaHR CroatiaHU HungaryIE IrelandIL IsraelIN IndiaIT ItalyJP JapanKR Republic of KoreaLK Sri LankaLU LuxembourgLV LatviaMX MexicoMY MalaysiaNL The NetherlandsNO Norway
NZ New ZealandPL PolandPT PortugalRU Russian FederationSE SwedenSG SingaporeSI SloveniaSK SlovakiaTH ThailandTR TurkeyTW TaiwanUA UkraineUS United States of AmericaUY UruguayUZ UzbekistanWO World Intellectual Property Organization (W.I.P.O.)ZA South Africa
DESIGNS מדגמים
June 3, 2007 –התשס"ז בסיון י"ז 846
שנרשמו מדגמיםDESIGNS REGISTERED
36120, 40378, 40379Class 23(01) סוג
31.1.2002MIGAN LTD. בע"מ מיגןFast connector מהיר מחבר
39787Class 6(01) סוג
15.8.2004JESSICA COHEN כהן ג'סיקהModular children's pouff לילדים מודלרי פוף
39943Class 9(01) סוג
18.11.2004TNUVA CENTRAL COOPERATIVE FOR THE MARKETING OF AGRICULTURAL PRODUCE IN ISRAEL LTD.
תוצרת לשווק שתופי מרכז תנובה בע"מ בישראל חקלאית
Bottle בקבוק
40022, 40024Class 6(01) סוג
6.12.2004RONEN YITZHAKI AND GLAMER DESIGN IN WOOD LTD.
בעץ עיצוב וגלמר יצחקי רונן בע"מ
Bed מיטה
40083Class 3(01) סוג
21.12.2004KETER PLASTIC LTD. בע"מ פלסטיק כתרBucket for tools עבודה לכלי דלי
40340Class 8(08) סוג
15.2.2005MOSHE LAVI לביא משה
Attachment assembly for road signs to a pole לעמוד תמרור להצמדת מערכת
40355Class 22(04) סוג
20.2.2005FAB MANUFACTURING & IMPORT OF INDUSTRIAL EQUIPMENT LTD.
תעשייתי ציוד ויבוא ייצור פאב בע"מ
Firearm grip נשק כלי של ידית40404
Class 22(04) סוג7.3.2005
FAB MANUFACTURING & IMPORT OF INDUSTRIAL EQUIPMENT LTD.
תעשייתי ציוד ויבוא ייצור פאב בע"מ
Accessory grip אביזרים עבור ידית
40448Class 6(06) סוג
14.3.2005L.B. ORLY LTD. בע"מ ל.ב. אורליProfile
הברית( )ארצות אמנה תאריך פרופיל
40480Class 11(01) סוג
20.3.2005ELIYAHU RAM (FADIDA) )פדידה( רם אליהוPendant תליון
40707Class 23(01) סוג
1.5.2005ODIS IRRIGATION EQUIPMENT (2002) LTD. AND ODIS FILTERING LTD.
(2002) השקיה אביזרי אודיס בע"מ סינון מפעלי ואודיס בע"מ
Cover for filtering unit למסנן מכסה
40868Class 3(01) סוג
20. 6.2005NIRIT DRORI AND ANAT NEVO נבו וענת דרורי ניריתBaby carrier לתינוק מנשא
June 3, 2007 –התשס"ז בסיון י"ז 848
41113Class 11(01) סוג
25. 7.2005H. STERN COMERCIO E INDUSTRIA S.A.
Jewelהברית( )ארצות אמנה תאריך
תכשיט
41507Class 21(02) סוג
12. 10.2005TAL COHEN כהן טלExercise bench להתעמלות ספסל
41522Class 9(03) סוג
17.10.2005N.V. NUTRICIA
Container מיכלConvention date (OHIM)
הברית( )ארצות אמנה תאריך 26.11.2005 )אוהיים( האמנה תאריך
41645Class 9(03) סוג
24. 11.2005ORION CORPORATION
Packageהברית( )ארצות אמנה תאריך
אריזה
41677, 43553Class 8(07) סוג
30. 11.2005SHULAMIT MEIRA BITTON ביטון מאירה שולמיתKey מפתח
41761Class 19(06) סוג
20.12.2005MERZ & KRELL GMBH & CO. KGAA
Writing instrument כתיבה כליConvention date (Germany) 15.7.2005 )גרמניה( האמנה תאריך
הברית( )ארצות אמנה תאריך
41862Class 28(03) סוג
11.1.2006UNILEVER PLC
Bottle בקבוקConvention date (U.S.A.)
הברית( )ארצות אמנה תאריך 26.7.2005 הברית( )ארצות האמנה תאריך
41866Class 9(01) סוג
17.1.2006UNILEVER PLC
Bottle בקבוקConvention date (U.S.A.)
הברית( )ארצות אמנה תאריך 26.7.2005 הברית( )ארצות האמנה תאריך
41924Class 2(03) סוג
29. 1.2006MOSHE HAREL AND GABRIEL BEN HAIM
חיים בן וגבריאל הראל משה
Headgear ראש כיסוי
41928Class 15(09) סוג
30. 1.2006B. VARTICOVSCHI LTD. בע"מ ב. ורטיקובסקיKey יהלומים לליטוש מכונה
42001Class 4(02) סוג
10.2.2006COLGATE-PALMOLIVE COMPANY
Electric toothbrush handle חשמלית שיניים מברשת של ידיתConvention date (U.S.A.)
הברית( )ארצות אמנה תאריך 17.8.2005 הברית( )ארצות האמנה תאריך
42271Class 11(01) סוג
4. 4.2006BEN ZIDEL זידל בןBracelet צמיד
June 3, 2007 –התשס"ז בסיון י"ז 850
42294Class 11(01) סוג
6. 4.2006H. STERN COMERCIO E INDUSTRIA S.A.
Jewelהברית( )ארצות אמנה תאריך
תכשיט
42303Class 11(01) סוג
6. 4.2006H. STERN COMERCIO E INDUSTRIA S.A.
Jewelryהברית( )ארצות אמנה תאריך
תכשיטים
42412, 42413Class 11(01) סוג
27. 4.2006GERALDO LTD. בע"מ ג'ראלדוJewel חן אבן
42452Class 19(04) סוג
14.5.2006KING JIM CO. LTD.
Pocket folder כיס אוגדןConvention date (Japan)
הברית( )ארצות אמנה תאריך 15.11.2005 )יפן( האמנה תאריך
42520, 42521Class 21(02) סוג
25. 5.2006GREENFIELD B.G LTD. ב.ג. בע"מ גרינפלדGymnastic apparatus להתעמלות מתקן
42594Class 11(01) סוג
12. 6.2006
DIAMINTANGIBLES INTERNATIONAL, LTD.Diamond
הברית( )ארצות אמנה תאריך יהלום
42597, 42598Class 11(01) סוג
13. 6.2006DIAMINTANGIBLES INTERNATIONAL, LTD.
Diamondהברית( )ארצות אמנה תאריך
יהלום
42606Class 8(08) סוג
14. 6.2006AMISHAY MARKETING COMPANY LTD.
(1980) לשיווק חברה עמישי בע"מ
Door stop דלת מעצור
42662Class 11(01) סוג
3. 7.2006JAFA SHAVIT שביט יפהOrnament קישוט
42679, 42680, 42681,42682, 42683
Class 6(06) סוג4. 7.2006
XI MODULAR DESIGN LTD. בע"מ מודולארי עיצוב קסאיProfile פרופיל
42698, 42699Class 6(01) סוג
5.7.2006NICOLETTI S.P.A.
Sofa ספהConvention date (Italy)
הברית( )ארצות אמנה תאריך 13.1.2006 )איטליה( האמנה תאריך
42797, 42800, 42801, 42802
Class 11(01) סוג
June 3, 2007 –התשס"ז בסיון י"ז 852
23. 7.2006H. STERN COMERCIO E INDUSTRIA S.A.
Jewelהברית( )ארצות אמנה תאריך
תכשיט
42806Class 9(03) סוג
25. 7.2006HISHTIL LTD. בע"מ חישתילForm for seedling שתילים לגידול תבנית
42808, 42809, 42812,42813
Class 25(01) סוג25. 7.2006
EXTAL LTD. בע"מ אקסטלProfile פרופיל
42832Class 6(03) סוג
1. 8.2006KETER PLASTIC LTD. בע"מ פלסטיק כתרCollapsible table מתקפל שולחן
42836Class 11(01) סוג
2. 8.2006JACOB SIMAN-TOV AND ITZHAK SIMAN-TOV
סימן-טוב ויצחק סימן-טוב יעקב
Gemstone חן אבן
42861Class 2(02) סוג
9. 8.2006DIGRIS IMPORT LTD. בע"מ יבוא דיגריסPants מכנסיים
42922, 42923, 42924Class 2(04) סוג
20. 8.2006PAPAYA FASHION LTD. בע"מ אופנה פאפאיהSole סוליה
42935
Class 19(06) סוג27. 8.2006
OMEGA CREATIVE INDUSTRIES KFAR GLICKSON, (1975) LIMITED PARTNERSHIP
) גליקסון כפר תעשיות אומגהמוגבלת (, שותפות1975
Painting assembly צביעה ערכת
42984, 42986Class 23(01) סוג
3. 9.2006ELGO IRRIGATION LTD. בע"מ השקייה אלגוIrrigator להשקיה מתקן
42989, 42990, 42991,42992, 42993
Class 8(06) סוג3. 9.2006
ARBRAHAM COHEN-HANDLES & PROFILES LTD.
ופרופילים כהן-ידיות אברהם בע"מ
Handle ידית42994
Class 8(07) סוג4. 9.2006
MUL-T-LOCK TECHNOLOGIES LTD.
בע"מ טכנולוגיות מולטילוק
Key head מפתח ראש
42998Class 25(01) סוג
4. 9.2006KOL CHEN LTD AND HAIM AZOULAY
אזולאי וחיים בע"מ חן כל
Profile פרופיל
43037, 43042Class 11(01) סוג
10. 9.2006H. STERN COMERCIO E INDUSTRIA S.A.
Jewelהברית( )ארצות אמנה תאריך
תכשיט
June 3, 2007 –התשס"ז בסיון י"ז 854
43073Class 24(04) סוג
17. 9.2006ILANIT SCHWAIZER PELEG פלג שוויצר אילניתPacifier מוצץ
43077Class 7(01) סוג
18. 9.2006FORMASTER S.A.
Jug water filterהברית( )ארצות אמנה תאריך
מים מסנן קנקן
43094Class 20(03) סוג
21. 9.2006AVIV ZAGURI ADVERTISEMENT בע"מ פרסומאים זגורי אביבAdvertisement device פרסום מתקן
43157, 43158Class 9(03) סוג
5. 10.2006SHAHAM Y. ARICHA AND SONS LTD.
בע"מ ובניו י. אריכא שחם
Trash container אשפתון
43159Class 25(03) סוג
5. 10.2006SHAHAM Y. ARICHA AND SONS LTD.
בע"מ ובניו י. אריכא שחם
Guard cabin לשומר מבנה
43160Class 23(01) סוג
5. 10.2006SHAHAM Y. ARICHA AND SONS LTD.
בע"מ ובניו י. אריכא שחם
Drinking fountain ברזיה
43161Class 20(03) סוג
5. 10.2006SHAHAM Y. ARICHA AND SONS LTD.
בע"מ ובניו י. אריכא שחם
Bulletin board מודעות לוח
43162, 43163, 43683Class 6(01) סוג
5. 10.2006SHAHAM Y. ARICHA AND SONS LTD.
בע"מ ובניו י. אריכא שחם
Sitting set ישיבה מערכת
43164, 43165Class 25(02) סוג
5. 10.2006SHAHAM Y. ARICHA AND SONS LTD.
בע"מ ובניו י. אריכא שחם
Barrier מחסום
43166, 43169Class 25(03) סוג
5. 10.2006SHAHAM Y. ARICHA AND SONS LTD.
בע"מ ובניו י. אריכא שחם
Pergola פרגולה
43168, 43171Class 6(01) סוג
5. 10.2006SHAHAM Y. ARICHA AND SONS LTD.
בע"מ ובניו י. אריכא שחם
Bench ספסל
43172Class 12(11) סוג
5. 10.2006SHAHAM Y. ARICHA AND SONS LTD.
בע"מ ובניו י. אריכא שחם
Bike device לאופניים מתקן
43174, 43175, 43176,43177
June 3, 2007 –התשס"ז בסיון י"ז 856
Class 23(01) סוג15. 10.2006
FORMASTER S.A.
Water filter cartridgeהברית( )ארצות אמנה תאריך
מים למסנן מחסנית
43198, 43200Class 11(01) סוג
15.10.2006H. STERN COMERCIO E INDUSTRIA S.A.
Jewelהברית( )ארצות אמנה תאריך
תכשיט
43222, 43223Class 11(01) סוג
22.10.2006H. STERN COMERCIO E INDUSTRIA S.A.
Jewelהברית( )ארצות אמנה תאריך
תכשיט
43244, 43245, 43246,43247, 43248
Class 11(01) סוג23.10.2006
H. STERN COMERCIO E INDUSTRIA S.A.
Jewelהברית( )ארצות אמנה תאריך
תכשיט
43271, 43272, 43273,43274, 43275, 43276,43277, 43278, 43279,
43280Class 27(03) סוג
2. 11.2006UNIQUE COMFORT ACCESSORIES LTD.
בע"מ נוחות אביזרי יוניק
Cigarette extinguisher סיגריות חונק
43290, 43291, 43292, 43293Class 2(04) סוג
7. 11.2006GAZIT SHOES T. VINER LTD. בע"מ ובניו ט. וינר גזית נעליShoe נעל
שחודשו מדגמיםDESIGNS RENEWED
27715 2771427713277122771127710275812744336366363053617236158361553608936088347943642936424364053640436403364023640136368
36495
June 3, 2007 –התשס"ז בסיון י"ז 858
שבוטלו מדגמיםDESIGNS VOID
26575265692655819128191261910319102190722664426639266382663326604266032659026589354643545435453354453544035438354362725235481354803547935474354733547235470354653550535502355013549335492354913548835482
368533685236851
Dr. Meir NoamCommissioner of Patents,Designs and Trade Marks
נועם מאיר ד"רהפטנטים, המדגמים רשם
מסחר וסימני
June 3, 2007 –התשס"ז בסיון י"ז 860
בפנקס רשומים בפרטים שינוייםCHANGES IN PARTICULARS ENTERED IN REGISTER
שקובלו לבקשות מפתחותINDICES OF APPLICATIONS ACCEPTED
NAME INDEXשמי מפתח
116223 בע"מ די.וי. מערכות3
בנגב, הרשות בן-גוריון אוניברסיטת147199 ופיתוח למחקר140429 בע"מ יישומים אוריקל
149324 בע"מ אי.סי.איי. טלקום147169 בע"מ איי.סי. קוד
167283 כץ אליעזר בע"מ פיונירס דיסק פלאש אם-סיסטמס
148619145572 ברמן אנה
140367 רון בינימין
150880 בע"מ אימג'ינג גיוון155138 בע"מ בביולוגיה יישומים גן
133693 בע"מ די-פארם
137455 בע"מ החזקות זולי
148375 בע"מ טויטופלסט151953 בע"מ נשק טי.די.אי. מערכות
143014 בע"מ מדיקל טראנספארמה
בע"מ ופיתוח למחקר חברה ידע
143202 ,150301151000 גוילי יצחק
144966 אליעזרוב ישראל167283 מרמורשטיין ישראל
150855 בע"מ רפואיות טכנולוגיות ניטי
161917 בע"מ סולריות מערכות סולל125855 בע"מ סלריס
149823, 149822 בע"מ ספידביט150251 בע"מ ספייסלוג'יק
149439 בע"מ ישראל פוליקום
135332 בע"מ טכנולוגיות קלוקוייז153136 בע"מ מתכת תעשיות קראוס קרמיקה( בע"מ )טכנולוגיות קראל
143780
145572 ברמן ראובן בע"מ לחימה אמצעי לפיתוח רפאל-רשות
141710
3DV SYSTEMS LIMITED 116223ABBOTT GMBH & CO. KG 146232ACCENT OPTICAL TECHNOLOGIES,
INC. 157691ADSIL, LC 151390AKZO NOBEL N.V. 145483ALEXANDER BECKMANN 145362ALLA PAVLOVNA TUZOVA 154360ALOIS PICHLER 157258ALZA CORPORATION 144756ANDEROL, INC. 159091ANGIOTECH INTERNATIONAL AG. 145069ANGIOTECH PHARMACEUTICALS, INC. 145069ANNA BERMAN 145572APPLIED VISION SYSTEMS, INC. 147672ARJO WIGGINS LIMITED 165463ASAT AG APPLIED SCIENCE & TECHNOLOGY 142876ASK 141761ASTRAZENECA AB 139297ASTRAZENECA AB 141410, 150403ATHEROS COMMUNICATIONS, INC. 147916AVENTIS PHARMA S.A. 136647
BANDSPEED, INC. 145090BASF AKTIENGESELLSCHAFT 147767BASF AKTIENGESELLSCHAFT 150173, 154303BAYER AKTIENGESELLSCHAFT 149748BAYER CROPSCIENCE S.A. 148162BELDEN WIRE & CABLE COMPANY 146993BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY 147199BENYAMIN RON 140367BIOFRONTERA BIOSCIENCE GMBH 142876Biogen Idec MA Inc. 126918BIOPHYSICA, INC. 143709BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 151011BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG 149984
BOREALIS TECHNOLOGY OY 158429
CABOT CORPORATION 151825CELGENE CORPORATION 135288CELLARIS LTD. 125855CENTAUR PHARMACEUTICALS, INC. 150403CEREL (CERAMIC TECHNOLOGIES) LTD. 143780CHUGAI SEIYAKU KABUSHIKI KAISHA 136310CLEAN EARTH TECHNOLOGIES, LLC 165884, 165885, 165886CLOCKWISE TECHNOLOGIES LTD. 135332COLEY PHARMACEUTICALS, INC. 139813COMPUTER ASSOCIATES THINK, INC. 142572, 143693, 143940COMPUTER ASSOCIATES THINK, INC. 144067, 145325COULTER PHARMACEUTICAL INC. 140028CV THERAPEUTICS, INC. 146471
DEERE & COMPANY 164542, 164842DERMATRENDS, INC. 150177DONALDSON COMPANY, INC. 154569, 154570D-PHARM LIMITED 133693DSM IP ASSETS B.V. 151586
ECI TELECOM LTD. 149324EGIS GYOGYSZERGYAR RT. 146420EISAI CO.,LTD. 151314ELI LILLY AND COMPANY 146810, 155700ELIEZER KATZ 167283ENZO THERAPEUTICS, INC. 137292ETHYPHARM 142787
F. HOFFMANN-LA ROCHE AG 150549F. LLI CITTERIO S.P.A. 152305FABBRICA D'ARMI PIETRO BERETTA S.P.A. 155711FIDELINE 137257FUMAKILLA LIMITED 150888
June 3, 2007 –התשס"ז בסיון י"ז ii
GALENIX DEVELOPPEMENT 148003GALMED INTERNATIONAL LIMITED 142650GE MEDICAL SYSTEMS GLOBAL TECHNOLOGY COMPANY, LLC 150811GENE BIO-APPLICATION LTD. 155138GENENTECH, INC. 135345GENZYME CORPORATION 146211GIVAUDAN SA 137893GIVEN IMAGING LTD. 150880GLAXOSMITHKLINE S.P.A. 147012GPI NIL HOLDINGS, INC. 128792GRUNENTHAL GMBH 148406
HARRIS CORPORATION 145125HARRY CONNICK, JR. 149816HONEYWELL INC. 149730
I.C. CODE LTD. 147169IBM CORPORATION 141458, 143013IBM CORPORATION 157506IHARA CHEMICAL INDUSTRY CO., LTD. 146758IMMUGEN PHARMACEUTICALS, INC. 145470INNOVAPARK, LLC 149880INSTITUT FIZIKI TVERDOGO TELA ROSSIISKOI AKADEMII NAUK 151182INTEL CORPORATION 149538INTER IKEA SYSTEMS B.V. 155357INTERNATIONAL BUSINESS MACHINES CORPORATION 142265, 147118INTROGENE B.V. 133032ISRAEL ELIEZEROV 144966ISRAEL MARMORSTEIN 167283ITALDATA INGEGNERIA DELL'IDEA S.P.A. 155372ITZHAK GVILI 151000
JANE, S.A. 156952JANSSEN PHARMACEUTICA N.V. 147327, 147328JONATHAN DALLAS TOYE 129912
KIRIN-AMGEN INC. 140669KRAUSZ METAL INDUSTRIES LTD. 153136KREIDO LABORATORIES 157789
LABORATOIRE L. LAFON 148042LABORATOIRE THERAMEX 148953LIFESCAN, INC. 150669LILLY ICOS LLC 146098LOEB HEALTH RESEARCH INSTITUTE AT THE OTTAWA HOSPITAL 139813LONZA AG 143229LOOK DYNAMICS, INC. 146688LTS LOHMANN THERAPIE-SYSTEME AG 148568LTS LOHMANN THERAPIE-SYSTEME AG 149812
M. KAINDL 161371MASSACHUSETTS INSTITUTE OF TECHNOLOGY 137299MASSACHUSETTS INSTITUTE OF TECHNOLOGY 148137MEDA PHARMA GMBH & CO. KG 148068MERCK & CO., INC. 159109MERCK PATENT GMBH 146707MIKKEL G. MANDT 158662MILKHAUS LABORATORY, INC. 131478, 138336MOELLER GEBAUDEAUTOMATION KG 146058M-SYSTEMS FLASH DISK PIONEERS LTD. 148619
N.V. ORGANON 145483NAGRACARD S.A. 148521NDS LIMITED 126552NEOTHERMIA CORPORATION 150159NEPHROS, INC. 155408, 156103NEWMAT, S.A. 148683NEXMED HOLDINGS, INC. 150306NIKEM RESEARCH S.R.L. 147012NITI MEDICAL TECHNOLOGIES LTD. 150855NORTH CAROLINA STATE
UNIVERSITY 150560NOVAMONT S.P.A. 151212NOVEXEL 136647NOVO NORDISK A/S 124939
OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIJU "KLINIKA INSTITUTA BIOREGUL YATSII I GERONTOLOGII" 146432OCCIDENTAL CHEMICAL CORPORATION 154653OLIVER BRUESTLE 136833ORTHOFIX INTERNATIONAL B.V. 145553ORTHO-MCNEIL PHARMACEUTICAL, INC. 137954, 147510ORYCLE APPLICATIONS LTD. 140429
PHARMACIA & UPJOHN COMPANY LLC 151789POLYCOM ISRAEL LTD. 149439POWDERJECT RESEARCH LIMITED 145668PRODEMEX, S.A. DE C.V. 151586
QLT USA, INC. 155006QUALCOMM INCORPORATED 138090, 147418, 147761, 147791, 147795QUALCOMM INCORPORATED 147628
RAFAEL-ARMAMENT DEVELOPMENT AUTHORITY LTD. 141710RECORDATI IRELAND LIMITED 147441RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY 147441REM TECHNOLOGIES, INC. 157290RESEARCH CORPORATION TECHNOLOGIES, INC. 140553REUBEN BERMAN 145572RHEINMETALL W & M GMBH 152972ROGER DE LATHOUWER 143886ROGUE VALLEY NATURAL
SPRINGS, INC. 153892RTP PHARMA INC. 138767
SAMSUNG ELECTRONICS CO., LTD. 141743SAMSUNG ELECTRONICS CO., LTD. 157663SANOFI AVENTIS 145150SANOFI AVENTIS 163286SANOFI-AVENTIS DEUTSCHLAND GMBH 146276, 149209SCANNEX TECHNOLOGIES, LLC 147319SCHERING AKTIENGESELLSCHAFT 136455SECURELOGIC LTD. 150251SILVERBROOK RESEARCH PTY. LTD. 146619, 164924, 166724SIMULA, INC. 154957SMITHKLINE BEECHAM CORPORATION 140028SMITHKLINE BEECHAM CORPORATION 148325SNECMA MOTEURS 149738SOCIETE DES PRODUITS NESTLE S.A. 143270SOLEL SOLAR SYSTEMS LTD. 161917SPEEDBIT LTD. 149822, 149823SPS VERPACKUNGS-SYSTEM GMBH 149898SUGEN, INC. 124728
T.D.I. ARMS SYSTEMS LTD. 151953TECHNISCHE UNIVERSITAT DRESDEN 143952THALES 149659THALES NEDERLAND B.V. 154133THE MOWER FAMILY CHF TREATMENT IRREVOCABLE TRUST 144290THE OTTAWA HEALTH RESEARCH INSTITUTE 139813THE PROCTER & GAMBLE COMPANY 147265THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 128058THE REGENTS OF THE UNIVERSITY
June 3, 2007 –התשס"ז בסיון י"ז iv
OF CALIFORNIA 143202THE REGENTS OF THE UNIVERSITY OF MICHIGAN 140028TOSHIO KITAMURA 136310TRANSPHARMA MEDICAL LTD. 143014TRIUMPH BRANDS, INC. 163624T-SYSTEMS INTERNATIONAL, INC. 143253TWITOPLAST LTD. 148375
UNITED TECHNOLOGIES CORPORATION 147091, 160163, 163398UNITED TECHNOLOGIES CORPORATION 163443UNIVERSITY OF BRITISH COLUMBIA 145069UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 144411
VACUUMSCHELZE GMBH 138199
WARCOP INVESTMENT LTD. 140367WAYPORT, INC. 149356WISCONSIN ALUMNI RESEARCH FOUNDATION 146923
WORLDWIDE COATINGS IP PTY LTD 152333WORLDWIDE FIRE RETARDANT IP PTY LTD. 152333WORLDWIDE THERMAL MANAGEMENT IP PTY LTD. 152333WYETH HOLDINGS CORPORATION 137617
YEDA RESEARCH AND DEVELOPMENT CO. LTD. 143202, 150301
ZULI HOLDINGS LTD. 137455
ענייני מפתחSUBJECT MATTER INDEX
A01G – 144701
A01J – 145605
A01H – 149773, 150925, 152186
A23N – 146356, 163176
A23J – 158263
A23K – 128541
A61B – 137514, 149645
A61F – 140059, 141980, 145629, 148121 ,150112
A61K – 123509, 130842, 131346, 134163 ,136804 ,140667 , 140670 ,140745 ,140899, 143012 ,143093 ,143234, 143294 ,143580 ,145112, 145580 ,146578 ,146974, 147212 ,147559 ,149085, 149580 ,150628 ,154975,
154976
A61J – 143119
A61M – 140475, 148609, 148636, 150960 ,151120 ,160450
A62B – 172238
A63B – 141219, 166971
A63H – 159934
B01D – 139539, 154033, 154244, 157906
B01F – 155267
B01J – 148287, 154390, 160321
B05B – 143319
B32B – 162235
B41J – 149952, 150382, 164954
B60N – 154444
B61L – 158815 B65D – 147222, 154878, 156431
C03B – 154708
C07C – 132518, 137964, 139922, 140744 ,146032 ,146372, 148111 ,148407 ,148761, 148870 ,149527 ,154974
C07D – 134787, 136717, 136827, 137828 ,139946 ,140032, 140062 ,141324 ,144026, 145375 ,145814 ,147898, 148218 ,148318 ,148782, 149063 ,149164 ,149289 ,
156943 ,157457
C07F – 145280, 145925, 150490, 158110
C07H – 144274 C07J – 149424, 150082, 153703
C07K– 110367, 123815, 127155, 128941 ,134968
C08F – 149332, 152174, 157798, 161973 ,164466
C08G – 158290
C08J – 150465, 157910
June 1, 2007 –התשס"ז בסיון ט"ו vi
C09D – 153090C12N– 107822, 127363, 128578,
129164 ,131171 ,132259, 134700 ,138353
C12P – 141645
C23C– 143076
D04H – 150139
D06B – 162231
E04C – 148699
F02K – 160696, 162142
F03B – 156993
F04B – 156196
F15D – 131589
F16J –146687
F16K – 166167
F24F – 159601
F25B – 152951
F25D – 159602
F41F – 156013
F42B – 145097, 148248, 154056
G01c – 145593, 149934
G01D – 157311
G01N – 145970, 154961
G01R – 143927
G01S – 156156
G02B – 128950, 156159, 156855
G03F – 154504 G06F – 135448, 146048, 147754,
147844
G06K –145905, 146673
G07B – 156675
G08B – 158270
G08G – 151258
H01L – 150784, 153153, 153156, 156319 ,156321 ,156523
H01R – 138621, 142552
H01T – 124696
H02G – 145847
H02H – 149861
H03F – 140564
H04B – 144258, 147792, 148207
H04H – 135184
H04J – 137058
H04L – 141464, 147513, 148037
H04N – 148356
H04Q– 135907, 147142, 147577
H05H – 152119
המשפטים, ירושלים הפטנטים, משרד רשות ע"י נערךהממשלתי, ירושלים במדפיס והודפס הופק
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEMPRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER
June 1, 2007 –התשס"ז בסיון ט"ו viii